0001610520 --12-31 30/06/2022 2022 Q2 FALSE 01/04/2022 0001610520 2022-06-30 0001610520 2022-03-31 0001610520 2021-12-31 0001610520 2022-01-01 2022-06-30 0001610520 ubs:SegmentGWMMember 2022-01-01 2022-06-30 0001610520 ubs:SegmentPCBMember 2022-01-01 2022-06-30 0001610520 ubs:SegmentAMMember 2022-01-01 2022-06-30 0001610520 ubs:SegmentIBMember 2022-01-01 2022-06-30 0001610520 ubs:SegmentGFMember 2022-01-01 2022-06-30 0001610520 2021-01-01 2021-06-30 0001610520 ubs:SegmentGWMMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentPCBMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentAMMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentIBMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentGFMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentGWMMember 2021-12-31 0001610520 ubs:SegmentPCBMember 2021-12-31 0001610520 ubs:SegmentAMMember 2021-12-31 0001610520 ubs:SegmentIBMember 2021-12-31 0001610520 ubs:SegmentGFMember 2021-12-31 0001610520 2021-06-30 0001610520 2020-12-31 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-04-01 2022-06-30 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-03-31 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-04-01 2021-06-30 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-06-30 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-01-01 2021-06-30 0001610520 ifrs-full:NoncontrollingInterestsMember 2022-04-01 2022-06-30 0001610520 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-03-31 0001610520 ifrs-full:NoncontrollingInterestsMember 2021-04-01 2021-06-30 0001610520 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:NoncontrollingInterestsMember 2021-01-01 2021-06-30 0001610520 2022-04-01 2022-06-30 0001610520 2022-01-01 2022-03-31 0001610520 2021-04-01 2021-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2022-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2022-03-31 0001610520 ubs:EURCurrencyExchangeRateMember 2022-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2022-03-31 0001610520 ubs:GBPCurrencyExchangeRateMember 2022-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2022-03-31 0001610520 ubs:JPYCurrencyExchangeRateMember 2022-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2022-03-31 0001610520 ubs:CHFCurrencyExchangeRateMember 2022-04-01 2022-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2022-01-01 2022-03-31 0001610520 ubs:CHFCurrencyExchangeRateMember 2021-04-01 2021-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2022-04-01 2022-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2022-01-01 2022-03-31 0001610520 ubs:EURCurrencyExchangeRateMember 2021-04-01 2021-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2022-04-01 2022-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2022-01-01 2022-03-31 0001610520 ubs:GBPCurrencyExchangeRateMember 2021-04-01 2021-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2022-04-01 2022-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2022-01-01 2022-03-31 0001610520 ubs:JPYCurrencyExchangeRateMember 2021-04-01 2021-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2021-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2021-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2021-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2021-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember 2022-03-31 0001610520 ifrs-full:RestructuringProvisionMember 2022-03-31 0001610520 ifrs-full:MiscellaneousOtherProvisionsMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember 2022-04-01 2022-06-30 0001610520 ifrs-full:RestructuringProvisionMember 2022-04-01 2022-06-30 0001610520 ifrs-full:MiscellaneousOtherProvisionsMember 2022-04-01 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember 2022-06-30 0001610520 ifrs-full:RestructuringProvisionMember 2022-06-30 0001610520 ifrs-full:MiscellaneousOtherProvisionsMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGWMMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentPCBMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentAMMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentIBMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGFMember 2022-03-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGWMMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentPCBMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentAMMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentIBMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGFMember 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGWMMember 2022-04-01 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentPCBMember 2022-04-01 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentAMMember 2022-04-01 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentIBMember 2022-04-01 2022-06-30 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGFMember 2022-04-01 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember 2022-06-30 0001610520 ubs:GovernmentBillsBondsMember 2022-06-30 0001610520 ifrs-full:InvestmentFundsMember 2022-06-30 0001610520 ubs:CorporateAndMunicipalBondsMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ubs:AssetBackedSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level2OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-06-30 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level2OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember 2022-03-31 0001610520 ubs:GovernmentBillsBondsMember 2022-03-31 0001610520 ifrs-full:InvestmentFundsMember 2022-03-31 0001610520 ubs:CorporateAndMunicipalBondsMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ubs:AssetBackedSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level2OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2022-03-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level2OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2022-03-31 0001610520 ubs:ForeignExchangeContractsMember 2022-06-30 0001610520 ubs:InterestRateContractsMember 2022-06-30 0001610520 ubs:EquityIndexContractsMember 2022-06-30 0001610520 ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ubs:CommodityContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-06-30 0001610520 ubs:ForeignExchangeContractsMember 2022-03-31 0001610520 ubs:InterestRateContractsMember 2022-03-31 0001610520 ubs:EquityIndexContractsMember 2022-03-31 0001610520 ubs:CreditDerivativeContractsMember 2022-03-31 0001610520 ubs:CommodityContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CommodityContractsMember 2022-03-31 0001610520 ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2022-06-30 0001610520 ubs:AuctionRateSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-06-30 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2022-03-31 0001610520 ubs:AuctionRateSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember 2021-12-31 0001610520 ubs:GovernmentBillsBondsMember 2021-12-31 0001610520 ifrs-full:InvestmentFundsMember 2021-12-31 0001610520 ubs:CorporateAndMunicipalBondsMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ubs:AssetBackedSecuritiesMember 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:GovernmentBillsBondsMember 2021-12-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AssetBackedSecuritiesMember 2021-12-31 0001610520 ubs:ForeignExchangeContractsMember 2021-12-31 0001610520 ubs:InterestRateContractsMember 2021-12-31 0001610520 ubs:EquityIndexContractsMember 2021-12-31 0001610520 ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ubs:CommodityContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:ForeignExchangeContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:CommodityContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:CommodityContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CommodityContractsMember 2021-12-31 0001610520 ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:FinancialAssetsForUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2021-12-31 0001610520 ubs:AuctionRateSecuritiesMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:StructuredSecuritiesFinancingTransactionsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-12-31 0001610520 ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ubs:OverTheCounterDebtInstrumentsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-06-30 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-06-30 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-06-30 0001610520 ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ubs:OverTheCounterDebtInstrumentsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2022-03-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-03-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-03-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2022-03-31 0001610520 ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ubs:OverTheCounterDebtInstrumentsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:AmountDueUnderUnitLinkedInvestmentContractsMember 2021-12-31 0001610520 ifrs-full:Level1OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2021-12-31 0001610520 ifrs-full:Level2OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OverTheCounterDebtInstrumentsMember 2021-12-31 0001610520 ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember 2022-06-30 0001610520 ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember 2022-03-31 0001610520 ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember 2021-12-31 0001610520 ifrs-full:InterestRateRiskMember 2022-06-30 0001610520 ifrs-full:CreditRiskMember 2022-06-30 0001610520 ifrs-full:CurrencyRiskMember 2022-06-30 0001610520 ifrs-full:EquityPriceRiskMember 2022-06-30 0001610520 ifrs-full:CommodityPriceRiskMember 2022-06-30 0001610520 ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember 2022-06-30 0001610520 ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:InterestRateRiskMember 2022-03-31 0001610520 ifrs-full:CreditRiskMember 2022-03-31 0001610520 ifrs-full:CurrencyRiskMember 2022-03-31 0001610520 ifrs-full:EquityPriceRiskMember 2022-03-31 0001610520 ifrs-full:CommodityPriceRiskMember 2022-03-31 0001610520 ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember 2022-03-31 0001610520 ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:InterestRateRiskMember 2021-12-31 0001610520 ifrs-full:CreditRiskMember 2021-12-31 0001610520 ifrs-full:CurrencyRiskMember 2021-12-31 0001610520 ifrs-full:EquityPriceRiskMember 2021-12-31 0001610520 ifrs-full:CommodityPriceRiskMember 2021-12-31 0001610520 ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ubs:UnsettledPurchaseOfNonDerivativeFinancialInstrumentsMember 2021-12-31 0001610520 ubs:UnsettledSalesOfNonDerivativeFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember 2022-06-30 0001610520 ifrs-full:DerivativesMember 2022-03-31 0001610520 ifrs-full:DerivativesMember 2021-12-31 0001610520 ifrs-full:DerivativesMember 2022-06-30 0001610520 ifrs-full:DerivativesMember 2022-03-31 0001610520 ifrs-full:DerivativesMember 2021-12-31 0001610520 ubs:CashCollateralPayablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ubs:CashCollateralPayablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ubs:CashCollateralPayablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-01-01 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-01-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-01-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2020-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2020-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-01-01 2021-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:InvestmentFundsMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTradingCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2021-06-30 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsMember 2020-12-31 0001610520 ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2020-12-31 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2020-12-31 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:LoansAndAdvancesToCustomersMember 2021-01-01 2021-06-30 0001610520 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-01-01 2021-06-30 0001610520 ifrs-full:EquityInvestmentsMember ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossMandatorilyMeasuredAtFairValueCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2021-01-01 2021-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2021-12-31 0001610520 ubs:EURCurrencyExchangeRateMember 2021-12-31 0001610520 ubs:GBPCurrencyExchangeRateMember 2021-12-31 0001610520 ubs:JPYCurrencyExchangeRateMember 2021-12-31 0001610520 ubs:CHFCurrencyExchangeRateMember 2022-01-01 2022-06-30 0001610520 ubs:CHFCurrencyExchangeRateMember 2021-01-01 2021-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2022-01-01 2022-06-30 0001610520 ubs:EURCurrencyExchangeRateMember 2021-01-01 2021-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2022-01-01 2022-06-30 0001610520 ubs:GBPCurrencyExchangeRateMember 2021-01-01 2021-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2022-01-01 2022-06-30 0001610520 ubs:JPYCurrencyExchangeRateMember 2021-01-01 2021-06-30 0001610520 ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2022-04-01 2022-06-30 0001610520 ubs:AuctionRateSecuritiesMember 2022-04-01 2022-06-30 0001610520 ubs:AssetBackedSecuritiesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:EquityInvestmentsMember 2022-04-01 2022-06-30 0001610520 ubs:InterestRateContractsNetMember 2022-04-01 2022-06-30 0001610520 ubs:CreditDerivativeContractsNetMember 2022-04-01 2022-06-30 0001610520 ubs:ForeignExchangeContractsNetMember 2022-04-01 2022-06-30 0001610520 ubs:EquityIndexContractsNetMember 2022-04-01 2022-06-30 0001610520 ubs:OtherFinancialInstrumentsNetMember 2022-04-01 2022-06-30 0001610520 ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-01-01 2022-03-31 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2022-01-01 2022-03-31 0001610520 ubs:AuctionRateSecuritiesMember 2022-01-01 2022-03-31 0001610520 ubs:AssetBackedSecuritiesMember 2022-01-01 2022-03-31 0001610520 ifrs-full:EquityInvestmentsMember 2022-01-01 2022-03-31 0001610520 ubs:InterestRateContractsNetMember 2022-01-01 2022-03-31 0001610520 ubs:CreditDerivativeContractsNetMember 2022-01-01 2022-03-31 0001610520 ubs:ForeignExchangeContractsNetMember 2022-01-01 2022-03-31 0001610520 ubs:EquityIndexContractsNetMember 2022-01-01 2022-03-31 0001610520 ubs:OtherFinancialInstrumentsNetMember 2022-01-01 2022-03-31 0001610520 ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ubs:StructuredSecuritiesFinancingTransactionsMember 2021-10-01 2021-12-31 0001610520 ubs:AuctionRateSecuritiesMember 2021-10-01 2021-12-31 0001610520 ubs:AssetBackedSecuritiesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:EquityInvestmentsMember 2021-10-01 2021-12-31 0001610520 ubs:InterestRateContractsNetMember 2021-10-01 2021-12-31 0001610520 ubs:CreditDerivativeContractsNetMember 2021-10-01 2021-12-31 0001610520 ubs:ForeignExchangeContractsNetMember 2021-10-01 2021-12-31 0001610520 ubs:EquityIndexContractsNetMember 2021-10-01 2021-12-31 0001610520 ubs:OtherFinancialInstrumentsNetMember 2021-10-01 2021-12-31 0001610520 2021-10-01 2021-12-31 0001610520 2021-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:RealEstateLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SmallMediumEnterpriseMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:LombardLoanMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CreditCardMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:CommodityTradeFinanceMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:FinancialIntermediariesAndHedgeFundsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OtherOffbalanceSheetCommitmentsMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:OffbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:RealEstateLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:RealEstateLendingMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:CorporateLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CreditCardMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherLoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember ubs:OtherLendingMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:NoncontrollingInterestsMember 2022-06-30 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2022-06-30 0001610520 ifrs-full:TreasurySharesMember 2022-06-30 0001610520 ifrs-full:RetainedEarningsMember 2022-06-30 0001610520 ifrs-full:OtherReservesMember 2022-06-30 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-06-30 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2022-06-30 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2022-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2021-12-31 0001610520 ifrs-full:TreasurySharesMember 2021-12-31 0001610520 ifrs-full:RetainedEarningsMember 2021-12-31 0001610520 ifrs-full:OtherReservesMember 2021-12-31 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-12-31 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-12-31 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2021-12-31 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-12-31 0001610520 ifrs-full:NoncontrollingInterestsMember 2021-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2021-06-30 0001610520 ifrs-full:TreasurySharesMember 2021-06-30 0001610520 ifrs-full:RetainedEarningsMember 2021-06-30 0001610520 ifrs-full:OtherReservesMember 2021-06-30 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-06-30 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-06-30 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2021-06-30 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2020-12-31 0001610520 ifrs-full:TreasurySharesMember 2020-12-31 0001610520 ifrs-full:RetainedEarningsMember 2020-12-31 0001610520 ifrs-full:OtherReservesMember 2020-12-31 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2020-12-31 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2020-12-31 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2020-12-31 0001610520 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-12-31 0001610520 ifrs-full:TreasurySharesMember 2022-01-01 2022-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2022-01-01 2022-06-30 0001610520 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001610520 ifrs-full:OtherReservesMember 2022-01-01 2022-06-30 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2022-01-01 2022-06-30 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-01-01 2022-06-30 0001610520 ifrs-full:TreasurySharesMember 2021-01-01 2021-06-30 0001610520 ubs:IssuedCapitalAndSharePremiumMember 2021-01-01 2021-06-30 0001610520 ifrs-full:RetainedEarningsMember 2021-01-01 2021-06-30 0001610520 ifrs-full:OtherReservesMember 2021-01-01 2021-06-30 0001610520 ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001610520 ifrs-full:ReserveOfCashFlowHedgesMember 2021-01-01 2021-06-30 0001610520 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-01-01 2021-06-30 0001610520 ubs:GoodsOrServicesTransferredOnRecurringBasisMember 2022-04-01 2022-06-30 0001610520 ubs:GoodsOrServicesTransferredOnRecurringBasisMember 2022-01-01 2022-03-31 0001610520 ubs:GoodsOrServicesTransferredOnRecurringBasisMember 2021-04-01 2021-06-30 0001610520 ubs:GoodsOrServicesTransferredOnRecurringBasisMember 2022-01-01 2022-06-30 0001610520 ubs:GoodsOrServicesTransferredOnRecurringBasisMember 2021-01-01 2021-06-30 0001610520 ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember 2022-04-01 2022-06-30 0001610520 ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember 2022-01-01 2022-03-31 0001610520 ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember 2021-04-01 2021-06-30 0001610520 ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember 2022-01-01 2022-06-30 0001610520 ifrs-full:GoodsOrServicesTransferredAtPointInTimeMember 2021-01-01 2021-06-30 0001610520 ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember 2022-04-01 2022-06-30 0001610520 ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember 2022-01-01 2022-03-31 0001610520 ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember 2021-04-01 2021-06-30 0001610520 ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember 2022-01-01 2022-06-30 0001610520 ubs:GoodsOrServicesTransferredOnPerformancebasedBasisMember 2021-01-01 2021-06-30 0001610520 ubs:SegmentGWMMember 2022-04-01 2022-06-30 0001610520 ubs:SegmentGWMMember 2022-01-01 2022-03-31 0001610520 ubs:SegmentGWMMember 2021-04-01 2021-06-30 0001610520 ubs:SegmentPCBMember 2022-04-01 2022-06-30 0001610520 ubs:SegmentPCBMember 2022-01-01 2022-03-31 0001610520 ubs:SegmentPCBMember 2021-04-01 2021-06-30 0001610520 ubs:SegmentAMMember 2022-04-01 2022-06-30 0001610520 ubs:SegmentAMMember 2022-01-01 2022-03-31 0001610520 ubs:SegmentAMMember 2021-04-01 2021-06-30 0001610520 ubs:SegmentIBMember 2022-04-01 2022-06-30 0001610520 ubs:SegmentIBMember 2022-01-01 2022-03-31 0001610520 ubs:SegmentIBMember 2021-04-01 2021-06-30 0001610520 ubs:SegmentGFMember 2022-04-01 2022-06-30 0001610520 ubs:SegmentGFMember 2022-01-01 2022-03-31 0001610520 ubs:SegmentGFMember 2021-04-01 2021-06-30 0001610520 ubs:SegmentGWMMember 2022-06-30 0001610520 ubs:SegmentPCBMember 2022-06-30 0001610520 ubs:SegmentAMMember 2022-06-30 0001610520 ubs:SegmentIBMember 2022-06-30 0001610520 ubs:SegmentGFMember 2022-06-30 0001610520 ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2022-06-30 0001610520 ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-06-30 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2022-03-31 0001610520 ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:MortgagesMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:MortgagesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:LoansAndAdvancesToCustomersMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToCustomersMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:AllowanceForCreditLossesMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember 2021-12-31 0001610520 ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OnBalanceSheetFinancialInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsAtAmortisedCostMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeCategoryMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashAndBankBalancesAtCentralBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansAndAdvancesToBanksMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ReverseRepurchaseAgreementsAndCashCollateralOnSecuritiesBorrowedMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:OtherFinancialAssetsAtAmortisedCostMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LoansToFinancialAdvisorsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ubs:IrrevocableCommittedProlongationOfLoansMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:LombardLoanMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2022-03-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-03-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-03-31 0001610520 ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-06-30 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:LombardLoanMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2022-06-30 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2022-06-30 0001610520 ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2022-06-30 0001610520 ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2022-06-30 0001610520 ubs:IrrevocableCommittedProlongationOfLoansMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:FinancialIntermediariesAndHedgeFundsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:LombardLoanMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LoanCommitmentsMember ifrs-full:TwelvemonthExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:FinancialIntermediariesAndHedgeFundsMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember 2021-12-31 0001610520 ifrs-full:FinancialGuaranteeContractsMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ifrs-full:LoanCommitmentsMember 2021-12-31 0001610520 ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:ForwardStartingTransactionsReverseRepurchaseAndSecuritiesBorrowingAgreementsMember 2021-12-31 0001610520 ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2021-12-31 0001610520 ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ubs:IrrevocableCommittedProlongationOfLoansMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:TwelvemonthExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:RealEstateLoanMember 2021-12-31 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:SmallMediumEnterpriseMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:LombardLoanMember ubs:CommittedRevocableCreditLinesMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CreditCardMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:CommittedRevocableCreditLinesMember ubs:CommodityTradeFinanceMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ifrs-full:LifetimeExpectedCreditLossesMember ubs:IrrevocableCommittedProlongationOfLoansMember 2021-12-31 0001610520 ubs:UpsideScenarioMember 2022-04-01 2022-06-30 0001610520 ubs:UpsideScenarioMember 2022-01-01 2022-03-31 0001610520 ubs:UpsideScenarioMember 2021-10-01 2021-12-31 0001610520 ubs:BaselineScenarioMember 2022-04-01 2022-06-30 0001610520 ubs:BaselineScenarioMember 2022-01-01 2022-03-31 0001610520 ubs:BaselineScenarioMember 2021-10-01 2021-12-31 0001610520 ubs:MildDownsideScenarioMember 2021-10-01 2021-12-31 0001610520 ubs:SevereGlobalInterestRateSteepeningScenarioMember 2022-01-01 2022-03-31 0001610520 ubs:SevereRussiaUkraineConflictScenarioMember 2022-04-01 2022-06-30 0001610520 ubs:SevereDownsideScenarioMember 2022-04-01 2022-06-30 0001610520 ubs:SevereDownsideScenarioMember 2022-01-01 2022-03-31 0001610520 ubs:SevereDownsideScenarioMember 2021-10-01 2021-12-31 0001610520 country:US ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:EurozoneMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:OneYearBeforeReportingYearMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:EurozoneMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:NotLaterThanOneYearMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:GrossDomesticProductMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember ubs:EurozoneMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:UnemploymentRateMember 2022-01-01 2022-06-30 0001610520 country:US ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:EurozoneMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 country:CH ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ubs:BaselineScenarioMember ubs:RealEstateMember 2022-01-01 2022-06-30 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:DebtSecuritiesIssuedAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsNetMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:InterestRateContractsNetMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsNetMember 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ubs:EquityIndexContractsNetMember 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:TopOfRangeMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:WeightedAverageMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:TopOfRangeMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:WeightedAverageMember ubs:CorporateAndMunicipalBondsMember ubs:BondPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountRateMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2022-04-01 2022-06-30 0001610520 ifrs-full:DiscountRateMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CorporateAndMunicipalBondsMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountRateMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CorporateAndMunicipalBondsMember 2021-10-01 2021-12-31 0001610520 ifrs-full:DiscountRateMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CorporateAndMunicipalBondsMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:TopOfRangeMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:WeightedAverageMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:TopOfRangeMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:MarketComparablePricesMember ifrs-full:WeightedAverageMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember ubs:LoanPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:MarketComparableAndSecuritizationModelMember ubs:TradedLoansLoansAtFairValueLoanCommitmentsAndGuaranteesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:AuctionRateSecuritiesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:AuctionRateSecuritiesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:AuctionRateSecuritiesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:AuctionRateSecuritiesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:WeightedAverageMember ubs:AuctionRateSecuritiesMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember ubs:FundingSpreadMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember ubs:FundingSpreadMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember ubs:FundingSpreadMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:OtherFinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedAsUponInitialRecognitionMember ubs:FundingSpreadMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:InterestRateContractsNetMember ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:InterestRateContractsNetMember ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:InterestRateContractsNetMember ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:InterestRateContractsNetMember ubs:HistoricalVolatilityForInterestRatesMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CreditDerivativeContractsNetMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember 2021-10-01 2021-12-31 0001610520 ifrs-full:CreditSpreadMeasurementInputMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CreditDerivativeContractsNetMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember ubs:BondPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CreditDerivativeContractsNetMember ubs:BondPriceEquivalentMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ubs:CreditDerivativeContractsNetMember ubs:BondPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:DiscountedCashFlowMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:TopOfRangeMember ubs:CreditDerivativeContractsNetMember ubs:BondPriceEquivalentMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityDividendYieldsMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityDividendYieldsMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember 2022-04-01 2022-06-30 0001610520 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityToFXCorrelationMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityToFXCorrelationMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityToEquityCorrelationMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityToEquityCorrelationMeasurementInputMember 2022-04-01 2022-06-30 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityDividendYieldsMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityDividendYieldsMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember 2021-10-01 2021-12-31 0001610520 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityToFXCorrelationMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityToFXCorrelationMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:BottomOfRangeMember ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ubs:EquityIndexContractsNetMember ubs:EquityToEquityCorrelationMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:OptionPricingModelMember ifrs-full:TopOfRangeMember ubs:EquityIndexContractsNetMember ubs:EquityToEquityCorrelationMeasurementInputMember 2021-10-01 2021-12-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2022-03-31 0001610520 ifrs-full:GrossCarryingAmountMember ubs:LoansAndAdvancesToCustomersMember ubs:OnbalanceSheetLoanPortfolioMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember 2021-12-31 0001610520 ifrs-full:RestructuringProvisionMember 2021-12-31 0001610520 ifrs-full:MiscellaneousOtherProvisionsMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGWMMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentPCBMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentAMMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentIBMember 2021-12-31 0001610520 ifrs-full:LegalProceedingsProvisionMember ubs:SegmentGFMember 2021-12-31 0001610520 2022-04-01 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ubs:SegmentIBMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ubs:SegmentPCBMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ubs:SegmentGWMMember 2022-04-01 2022-06-30 0001610520 ifrs-full:CorporateLoansMember ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SegmentPCBMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:ExpectedCreditLossesModelUpdatesMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:SegmentPCBMember ubs:IncreaseDecreaseOfExpectedCreditLossesWithProfitLossImpactDueToBookSizeAndQualityChangesMember 2022-04-01 2022-06-30 0001610520 ubs:CashCollateralReceivablesOnDerivativeInstrumentsMember 2021-12-31 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ubs:SegmentIBMember ubs:TravelIndustryRelatedMember 2022-04-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsCreditimpairedMember ubs:SegmentGFMember 2022-04-01 2022-06-30 0001610520 ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember 2022-06-30 0001610520 ubs:CrossBorderWealthManagementBusinessesMember 2022-06-30 0001610520 ubs:CrossBorderWealthManagementBusinessesMember 2022-01-01 2022-06-30 0001610520 ubs:UBSAGCrossBorderWealthManagementBusinessesLawsuitsMember 2022-01-01 2022-06-30 0001610520 ubs:UBSFranceSACrossBorderWealthManagementBusinessesLawsuitsMember 2022-01-01 2022-06-30 0001610520 ubs:MadoffLuxembourgMember 2022-01-01 2022-06-30 0001610520 ubs:MadoffUSMember 2022-01-01 2022-06-30 0001610520 ubs:PuertoRicoCustomerArbitrationClaimsMember 2022-01-01 2022-06-30 0001610520 ubs:EmployeeRetirementSystemPuertoRicoMember 2022-01-01 2022-06-30 0001610520 ubs:PuertoRicoMattersMember 2022-01-01 2022-06-30 0001610520 ubs:PuertoRicoInsuranceCompaniesClaimsMember 2022-01-01 2022-06-30 0001610520 ubs:ForexRelatedCivilLitigationMember 2022-01-01 2022-06-30 0001610520 ubs:TradingRelatedInquiriesMember 2022-01-01 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:PostmodelCreditLossExpenseAdjustmentMember 2022-06-30 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:PostmodelCreditLossExpenseAdjustmentMember 2022-03-31 0001610520 ifrs-full:FinancialInstrumentsNotCreditimpairedMember ubs:PostmodelCreditLossExpenseAdjustmentMember 2021-12-31 iso4217:EUR iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares
 
 
 
 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington,
 
D.C. 20549
_________________
 
FORM
6-K
 
 
REPORT OF FOREIGN PRIVATE
 
ISSUER
 
PURSUANT TO RULE 13a-16 OR
 
15d-16 UNDER
THE SECURITIES EXCHANGE
 
ACT OF 1934
 
Date: July 26, 2022
 
 
UBS Group AG
Commission File Number: 1-36764
 
UBS AG
 
Commission File Number: 1-15060
 
 
(Registrants' Name)
 
 
Bahnhofstrasse 45, Zurich, Switzerland
Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrants file or will file annual reports under cover of Form 20-F or Form
40-F.
 
Form 20-F
 
 
Form 40-F
 
 
 
 
 
 
This Form 6-K consists
 
of the Second
 
Quarter 2022
 
Report of UBS Group
 
AG, which appears
 
immediately following
this page.
 
UBS_Group_AG_2Q22p3i0.gif UBS_Group_AG_2Q22p3i1.jpg
 
 
 
 
UBS Group
 
Second
 
quarter 2022
 
report
 
 
 
 
 
 
 
 
Corporate calendar
 
UBS Group AG
P
ublication of the
third
 
quarter 202
2
 
report
:
 
Tuesday,
 
2
5
 
October
 
2022
 
Publication of the
fourth
 
quarter 2022 report:
 
Tuesday,
31
 
January
 
202
3
 
 
Corporate calendar
 
UBS AG
Publication of the
second quarter 20
2
2
 
report:
 
Friday
, 29 July
 
202
2
 
Publication dates of future quarterly
 
and annual reports and results
 
are made available as
part of the corporate calendar of
 
UBS AG at ubs.com/investors.
 
Contacts
Switchboards
For all general inquiries
 
ubs.com/contact
Zurich +41-44-234 1111
London +44-207-567
 
8000
New York
 
+1-212-821 3000
Hong Kong +852-2971 8888
Singapore +65-6495 8000
Investor Relations
UBS’s Investor Relations team manages
relationships with institutional
 
investors,
research analysts and credit
 
rating agencies.
 
ubs.com/investors
Zurich +41-44-234 4100
New York
 
+1-212-882 5734
Media Relations
UBS’s Media Relations team manages
relationships with global media and
journalists.
ubs.com/media
Zurich +41-44-234 8500
mediarelations@ubs.com
London +44-20-7567 4714
 
ubs-media-relations@ubs.com
New York
 
+1-212-882 5858
 
mediarelations@ubs.com
Hong Kong +852-2971 8200
sh-mediarelations-ap@ubs.com
Office of the Group Company
 
Secretary
The Group Company Secretary
 
handles
 
inquiries directed to
 
the Chairman or to
other members of the Board
 
of Directors.
UBS Group AG, Office
 
of the Group
Company Secretary
P.O.
 
Box, CH-8098 Zurich, Switzerland
sh-company-secretary@ubs.com
Zurich +41-44-235 6652
Shareholder Services
UBS’s Shareholder Services
 
team, a unit
of the Group Company Secretary’s
 
office,
manages relationships
 
with shareholders
and the registration of UBS Group
 
AG
registered shares.
 
UBS Group AG, Shareholder
 
Services
P.O.
 
Box, CH-8098 Zurich, Switzerland
sh-shareholder-services@ubs.com
Zurich +41-44-235 6652
US Transfer Agent
For global registered share
 
-related
inquiries in the US.
Computershare Trust
 
Company NA
P.O.
 
Box 505000
Louisville, KY 40233-5000,
 
USA
Shareholder online inquiries:
www-us.computershare.com/
investor/contact
Shareholder website:
computershare.com/investor
Calls from the US
 
+1-866-305-9566
Calls from outside the
 
US
+1-781-575-2623
TDD for hearing impaired
+1-800-231-5469
TDD for foreign shareholders
+1-201-680-6610
Imprint
Publisher: UBS Group
 
AG, Zurich, Switzerland | ubs.com
Language: English
 
© UBS 2022. The key symbol and UBS are
 
among the registered and unregistered
trademarks of UBS. All rights reserved.
 
 
 
 
 
 
 
1.
UBS
 
Group
3
6
2.
UBS business divisions
 
and
 
Group Functions
13
16
19
21
23
3.
Risk, capital, liquidity
 
and funding,
and balance sheet
25
30
39
40
43
4.
Consolidated
financial statements
45
77
5.
Significant regulated
 
subsidiary and
sub-group information
80
Appendix
82
85
87
88
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
2
 
Our key figures
As of or for the quarter ended
As of or year-to-date
USD m, except where indicated
30.6.22
31.3.22
31.12.21
30.6.21
30.6.22
30.6.21
Group results
Total revenues
 
8,917
 
9,382
 
8,705
 
8,897
 
18,299
 
17,574
Credit loss expense / (release)
 
7
 
18
 
(27)
 
(80)
 
25
 
(108)
Operating expenses
 
6,295
 
6,634
 
7,003
 
6,384
 
12,929
 
12,790
Operating profit / (loss) before tax
 
2,615
 
2,729
 
1,729
 
2,593
 
5,344
 
4,891
Net profit / (loss) attributable to shareholders
 
2,108
 
2,136
 
1,348
 
2,006
 
4,244
 
3,830
Diluted earnings per share (USD)
1
 
0.61
 
0.61
 
0.38
 
0.55
 
1.22
 
1.04
Profitability and growth
2
Return on equity (%)
 
14.6
 
14.3
 
8.9
 
13.7
 
14.4
 
13.1
Return on tangible equity
 
(%)
 
16.4
 
16.0
 
10.0
 
15.4
 
16.2
 
14.7
Return on common equity tier 1 capital (%)
 
18.9
 
19.0
 
11.9
 
19.3
 
18.9
 
18.8
Return on leverage ratio denominator,
 
gross (%)
 
3.4
 
3.5
 
3.3
 
3.4
 
3.5
 
3.4
Cost / income ratio (%)
 
70.6
 
70.7
 
80.5
 
71.8
 
70.7
 
72.8
Effective tax rate (%)
 
19.0
 
21.4
 
21.4
 
22.4
 
20.2
 
21.5
Net profit growth (%)
 
5.1
 
17.1
 
(17.6)
 
62.8
 
10.8
 
35.5
Resources
2
Total assets
 
1,113,193
 
1,139,922
 
1,117,182
 
1,086,519
 
1,113,193
 
1,086,519
Equity attributable to shareholders
 
56,845
 
58,855
 
60,662
 
58,765
 
56,845
 
58,765
Common equity tier 1 capital
3
 
44,798
 
44,593
 
45,281
 
42,583
 
44,798
 
42,583
Risk-weighted assets
3
 
315,685
 
312,037
 
302,209
 
293,277
 
315,685
 
293,277
Common equity tier 1 capital ratio (%)
3
 
14.2
 
14.3
 
15.0
 
14.5
 
14.2
 
14.5
Going concern capital ratio (%)
3
 
19.0
 
19.2
 
20.0
 
20.2
 
19.0
 
20.2
Total loss-absorbing capacity ratio (%)
3
 
33.7
 
34.2
 
34.7
 
35.6
 
33.7
 
35.6
Leverage ratio denominator
3
 
1,025,422
 
1,072,953
 
1,068,862
 
1,039,939
 
1,025,422
 
1,039,939
Common equity tier 1 leverage ratio
 
(%)
3
 
4.37
 
4.16
 
4.24
 
4.09
 
4.37
 
4.09
Liquidity coverage ratio (%)
4
 
161
 
160
 
155
 
156
 
161
 
156
Net stable funding ratio (%)
4
 
121
 
122
 
119
 
115
 
121
 
115
Other
Invested assets (USD bn)
5
 
3,912
 
4,380
 
4,596
 
4,485
 
3,912
 
4,485
Personnel (full-time equivalents)
 
71,294
 
71,697
 
71,385
 
71,304
 
71,294
 
71,304
Market capitalization
1
 
52,475
 
65,775
 
61,230
 
53,218
 
52,475
 
53,218
Total book value per share (USD)
1
 
17.45
 
17.57
 
17.84
 
16.90
 
17.45
 
16.90
Tangible book value per
 
share (USD)
1
 
15.51
 
15.67
 
15.97
 
15.05
 
15.51
 
15.05
1 Refer to
 
the “Share
 
information
 
and earnings
 
per share”
 
section of
 
this report
 
for more
 
information.
 
2 Refer to
 
the “Targets,
 
aspirations
 
and capital
 
guidance”
 
section of
 
our Annual
 
Report 2021
 
for more
information about our performance targets.
 
3 Based on the Swiss systemically
 
relevant bank framework as of 1
 
January 2020. Refer to the “Capital management”
 
section of this report for more information.
 
4 The
final Swiss net
 
stable funding
 
ratio (NSFR)
 
regulation became
 
effective
 
on 1 July 2021.
 
Prior to this
 
date, the NSFR
 
was based
 
on estimated pro
 
forma reporting.
 
Refer to the “Liquidity
 
and funding
 
management”
section of this report
 
for more information.
 
5 Consists of
 
invested assets
 
for Global Wealth
 
Management, Asset
 
Management and
 
Personal &
 
Corporate Banking.
 
Refer to
 
“Note 32
 
Invested assets
 
and net new
money” in the “Consolidated financial
 
statements” section
 
of our Annual Report 2021
 
for more information.
 
Alternative performance
 
measures
An alternative performance measure (an APM) is a financial measure
 
of historical or future financial performance,
financial position or
 
cash flows
 
other than
 
a financial measure
 
defined or
 
specified in the
 
applicable recognized
accounting standards
 
or
 
in other
 
applicable regulations.
 
We
 
report a
 
number of
 
APMs in
 
the
 
discussion of
 
the
financial and operating performance
 
of the Group, our business divisions
 
and our Group Functions.
 
We use APMs
to
 
provide
 
a
 
more
 
complete
 
picture
 
of
 
our
 
operating
 
performance
 
and
 
to
 
reflect
 
management’s
 
view
 
of
 
the
fundamental drivers of
 
our business
 
results. A
 
definition of
 
each APM,
 
the method
 
used to
 
calculate it
 
and the
information content are presented under “Alternative
 
performance measures” in the appendix
 
to this report. Our
APMs may
 
qualify as
 
non-GAAP measures
 
as defined
 
by US Securities
 
and Exchange
 
Commission
 
(SEC) regulations.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
3
 
UBS Group
Management report
 
Terms used in this report,
 
unless the context requires otherwise
“UBS,” “UBS
 
Group,” “UBS Group
 
AG consolidated,”
 
“Group,” “the
 
Group,” “we,”
 
“us” and “our”
UBS Group AG
 
and its consolidated
 
subsidiaries
“UBS AG consolidated”
 
UBS AG and its
 
consolidated subsidiaries
“UBS Group AG”
 
and “UBS
 
Group AG standalone”
 
UBS Group AG
 
on a standalone
 
basis
“UBS AG” and
 
“UBS AG standalone”
 
UBS AG on a standalone
 
basis
“UBS Switzerland
 
AG” and “UBS
 
Switzerland
 
AG standalone”
UBS Switzerland
 
AG on a standalone
 
basis
“UBS Europe SE consolidated”
 
UBS Europe SE and its
 
consolidated subsidiaries
“UBS Americas
 
Holding LLC” and
 
“UBS Americas
 
Holding LLC consolidated”
UBS Americas Holding
 
LLC and its consolidated
 
subsidiaries
“1m”
One million, i.e., 1,000,000
“1bn”
One billion, i.e., 1,000,000,000
“1trn”
One trillion, i.e., 1,000,000,000,000
 
 
 
Recent developments
Russia’s invasion
 
of Ukraine
The war
 
in Ukraine
 
has led
 
to one
 
of the
 
largest humanitarian
 
crises in
 
decades,
 
severe sanctions
 
imposed by
 
various
governments on Russia and
 
certain Russian entities and nationals, a
 
mass exodus of
 
businesses from Russia,
 
and
heightened volatility across global markets. The long-term consequences are still
 
difficult to assess, but there
 
will
likely be global ramifications
 
that are felt for some
 
time.
As a result of Russia’s invasion of Ukraine, several jurisdictions,
 
including the US, the EU, the UK, Switzerland and
others, continue to impose
 
extensive sanctions on Russia
 
and Belarus and certain Russian
 
and Belarusian entities
and nationals.
 
We are not conducting
 
any new business in
 
Russia or with Russia-domiciled
 
clients.
 
We have
 
reduced our exposure to Russia
 
following the invasion of
 
Ukraine in February 2022.
 
Our direct
 
country
risk exposure
 
to Russia
 
decreased
 
to USD
 
0.3bn as
 
of 30 June
 
2022 compared
 
with
 
USD 0.4bn
 
as of
 
31 March
 
2022
and
 
USD 0.6bn as of 31 December 2021. This includes trade finance exposures
 
in Personal & Corporate Banking,
a single loan in the Investment
 
Bank, nostro and cash
 
account balances and
 
issuer risk on trading
 
inventory within
the Investment
 
Bank. We
 
had no material
 
direct country
 
risk exposures
 
to Ukraine
 
or to Belarus
 
as of
 
30
 
June 2022.
 
Reliance on Russian,
 
Ukrainian or Belarusian
 
assets as collateral
 
for secured financing
 
is negligible.
 
Countries have
 
imposed, and
 
continue to impose,
 
novel forms
 
of sanctions.
 
For example,
 
in the
 
first quarter of
2022, the EU
 
and Switzerland prohibited acceptance of deposits in
 
excess of EUR 100,000 from Russian persons
not entitled to
 
residency in the European Economic Area
 
(the EEA) or Switzerland. Around 0.4% of
 
our invested
assets in Global Wealth Management as of 30 June 2022 related to such clients, compared with around 0.7% as
of 31 March 2022.
 
 
 
 
Second quarter 2022 report
 
4
 
We are
 
monitoring potential second-order impacts
 
on our
 
clients and
 
other counterparties, including those
 
that
may result
 
from a
 
prolongation or
 
escalation of
 
hostilities. These may
 
include, but
 
are not
 
limited
 
to, effects
 
of
supply chain disruptions and impacts on industry sectors that are affected by energy and other commodity prices
or dependent on specific
 
geographies.
We
 
continue
 
to
 
monitor
 
settlement
 
risk
 
on
 
certain
 
open
 
transactions
 
with
 
Russian
 
bank
 
and
 
non-bank
counterparties or Russian
 
underlyings, as market
 
closures and
 
the imposition of
 
exchange controls, sanctions
 
or
other measures
 
may further
 
limit our
 
ability to
 
settle transactions
 
or to
 
realize collateral
 
if required,
 
which
 
may result
in unexpected increases
 
in exposures.
 
Russia’s
 
invasion
 
of
 
Ukraine
 
and
 
the
 
imposition of
 
sanctions on
 
Russia
 
and
 
Belarus
 
have
 
increased
 
the
 
risk
 
of
cyberattacks from foreign
 
state actors, activists
 
or other parties.
 
As of 19 July 2022, more than 10,000 clients and 12,000 UBS
 
employees had donated
 
over USD 25m
 
to the UBS
Optimus Foundation
 
Ukraine Relief
 
Fund. Combined
 
with the
 
matched
 
funding from
 
UBS and our
 
strategic partner
XTX Markets, more than USD 50m
 
has been raised to support the immediate response to the humanitarian
 
crisis,
as
 
well
 
as
 
longer-term
 
recovery
 
efforts.
 
Through
 
partners,
 
including
 
Hope
 
and
 
Homes
 
for
 
Children
 
and
 
the
International Rescue
 
Committee,
 
we provide
 
a variety
 
of assistance
 
measures, such
 
as distributing
 
basic survival
 
and
medical supplies
 
and services,
 
making emergency
 
grants
 
to
 
local organizations serving
 
children, and
 
facilitating
refugee integration into
 
host countries.
 
Regulatory and legal
 
developments
Amendment of the Swiss
 
Capital Adequacy
 
Ordinance regarding
 
the final implementation
 
of Basel III
 
In July 2022,
 
the Swiss Federal Department of Finance (the
 
FDF) launched a consultation on amending the
 
Swiss
Capital Adequacy Ordinance
 
with the aim of implementing
 
the final elements of
 
the Basel Committee on Banking
Supervision (BCBS)
 
reforms
 
(Basel III) in
 
Swiss
 
law.
 
In
 
parallel, the
 
Swiss
 
Financial Market
 
Supervisory Authority
(FINMA) has opened a consultation
 
on the associated implementing
 
circulars.
 
We currently estimate
 
that the
 
implementation
 
of the revised
 
Basel III framework
 
may lead to a
 
net increase
 
in risk-
weighted assets
 
(RWA) of
 
around USD
 
20bn in
 
2024, excluding
 
mitigating
 
actions. The
 
estimate includes
 
credit risk
and operational
 
risk RWA
 
from the
 
finalization
 
of the
 
Basel III framework,
 
as well
 
as market
 
risk and
 
credit valuation
adjustment RWA from the
 
fundamental review
 
of the trading book (FRTB),
 
based on our current
 
understanding of
the relevant standards. The
 
precise impact might change
 
as a
 
result of new or
 
revised regulatory interpretations,
including
 
those
 
related
 
to
 
historical
 
operational
 
losses
 
and
 
model
 
calibration,
 
the
 
implementation
 
of
 
Basel III
standards into national
 
law, changes in
 
business growth, market
 
conditions and other
 
factors.
The consultations will
 
last until 25
 
October 2022.
 
The Swiss Federal
 
Council’s Capital
 
Adequacy
 
Ordinance and
 
the
associated
 
FINMA ordinances
 
are
 
scheduled to
 
enter
 
into force
 
on
 
1 July
 
2024, with
 
the
 
phasing in
 
of
 
certain
elements until 2028.
 
Revision of the Swiss
 
liquidity requirements
 
In June 2022, the Swiss Federal Council adopted the
 
revisions to the Swiss Liquidity Ordinance.
 
The revisions will
increase the
 
regulatory minimum
 
liquidity requirements
 
for systemically
 
important
 
banks, including
 
UBS Group AG.
The increase
 
in UBS’s
 
liquidity requirements
 
remains uncertain
 
pending supervisory
 
guidance from FINMA.
 
The final
rule became effective
 
on 1 July 2022, with
 
a transition period of
 
18 months.
 
In accordance with Article 31b of the Liquidity Ordinance, the FDF provided a report
 
to the Swiss Federal Council
in which it reviewed Swiss
 
and foreign provisions regarding the net stable
 
funding ratio. The report identified no
need for regulatory action.
FINMA revision of Circular
 
2008/21 “Operational
 
Risks – Banks”
 
In
 
July 2022,
 
FINMA completed
 
a
 
consultation regarding
 
the
 
revision of
 
Circular 2008/21
 
“Operational Risks
 
Banks,” which
 
will incorporate
 
the BCBS’s
 
new Principles
 
on Operational
 
Resilience
 
into the
 
FINMA framework.
 
The
circular will also cover
 
the updated Principles
 
for the Sound
 
Management
 
of Operational Risk,
 
which cover a
 
range
of issues, including
 
managing information
 
and communication
 
technology risks,
 
cyber risks, and
 
the risks involving
critical
 
data.
 
The
 
revised
 
circular
 
will
 
enter
 
into
 
force
 
on
 
1 January
 
2023,
 
and
 
firms
 
will
 
be
 
given
 
three
 
years
thereafter to comply with
 
the operational resilience
 
elements thereof.
 
 
 
 
 
Second quarter 2022 report
 
5
 
Developments regarding
 
sustainability and climate
 
risk
 
In
 
June
 
2022,
 
the
 
Swiss
 
Bankers
 
Association
 
issued
 
two
 
new
 
self-regulation
 
minimum
 
requirements.
 
One
requirement sets
 
standards for
 
the consideration
 
of sustainability
 
criteria
 
in the investment
 
advisory process
 
and the
other regulates the mortgage
 
advisory
 
process.
 
In parallel, in
 
June 2022 the FDF
 
jointly with industry associations, non-governmental organizations and selected
companies, including
 
UBS, developed
 
a voluntary
 
best-practice approach
 
for investing in
 
line with the
 
COP 21 Paris
Agreement. This
 
resulted in
 
the
 
Swiss Climate
 
Scores,
 
which
 
consist of
 
six
 
indicators that
 
provide transparency
regarding climate-related
 
information,
 
such as
 
carbon
 
emissions
 
and the
 
implied temperature
 
increase
 
of a
 
portfolio.
The scores were
 
developed to
 
underpin Switzerland’s
 
leading role
 
as a sustainable
 
financial center.
 
UBS will start its
implementation efforts
 
in the second half
 
of 2022.
 
In
 
April
 
2022,
 
the
 
US
 
Securities
 
and
 
Exchange
 
Commission
 
published
 
its
 
proposed
 
rules
 
on
 
climate-related
disclosures in
 
the US
 
Federal Register. The
 
proposal requires
 
qualitative disclosures on
 
climate risk
 
management
processes
 
inclusive
 
of
 
governance,
 
risk
 
identification
 
and
 
scenario
 
analyses,
 
and
 
quantitative
 
disclosures
 
on
greenhouse
 
gas
 
emissions
 
and
 
financial
 
statement
 
impacts.
 
As
 
proposed,
 
the
 
new
 
requirements
 
would
 
apply
beginning with our Annual
 
Report 2023.
 
Other developments
Sale of our shareholding
 
in Mitsubishi Corp.-UBS
 
Realty Inc.
In the second quarter of
 
2022, we completed the sale of
 
our 49% shareholding in our Japanese real
 
estate joint
venture, Mitsubishi Corp.-UBS Realty Inc., to KKR & Co. Inc
 
., as announced on 17 March 2022. The sale resulted
in
 
a pre
 
-tax gain
 
of
 
USD 848m in
 
Asset Management
 
and increased
 
our CET1
 
capital by
 
USD 979m. Our
 
asset
management, wealth management and investment banking
 
businesses operating in Japan
 
were not
 
affected by
the sale.
Organizational changes
 
As
 
announced on
 
12 July
 
2022,
 
Iqbal
 
Khan
 
will
 
become
 
sole
 
President Global
 
Wealth
 
Management, effective
3 October 2022,
 
following Tom
 
Naratil’s decision to step down as Co-President Global Wealth Management and
President UBS Americas.
 
Naureen Hassan
 
will join UBS
 
from the Federal
 
Reserve Bank
 
of New York to succeed
 
Tom
Naratil as
 
President UBS
 
Americas and
 
CEO of
 
UBS Americas
 
Holding LLC
 
and will
 
become a
 
member of
 
UBS’s
Group Executive Board on 3
 
October 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
6
 
Group performance
Income statement
For the quarter
 
ended
% change from
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Net interest income
1,665
1,771
1,628
(6)
2
3,436
3,241
Other net income from financial instruments measured
 
at fair value through profit or
 
loss
1,619
2,226
1,479
(27)
9
3,845
2,787
Net fee and commission income
4,774
5,353
5,557
(11)
(14)
10,127
11,248
Other income
859
32
233
268
891
297
Total revenues
8,917
9,382
8,897
(5)
0
18,299
17,574
Credit loss expense / (release)
7
18
(80)
(64)
25
(108)
Personnel expenses
4,422
4,920
4,772
(10)
(7)
9,343
9,573
General and administrative expenses
1,370
1,208
1,103
13
24
2,578
2,192
Depreciation, amortization and impairment of non
 
-financial assets
503
506
509
(1)
(1)
1,009
1,026
Operating expenses
6,295
6,634
6,384
(5)
(1)
12,929
12,790
Operating profit / (loss) before
 
tax
2,615
2,729
2,593
(4)
1
5,344
4,891
Tax expense / (benefit)
 
497
585
581
(15)
(15)
1,082
1,053
Net profit / (loss)
2,118
2,144
2,012
(1)
5
4,262
3,838
Net profit / (loss) attributable to non-controlling
 
interests
10
8
6
29
89
18
9
Net profit / (loss) attributable to shareholders
2,108
2,136
2,006
(1)
5
4,244
3,830
Comprehensive income
Total comprehensive income
 
1,079
 
(72)
 
2,602
 
(59)
 
1,008
 
2,263
Total comprehensive income attributable to
 
non-controlling interests
 
(17)
 
26
 
20
 
9
 
10
Total comprehensive
 
income attributable to shareholders
 
1,097
 
(98)
 
2,582
 
(58)
 
999
 
2,252
Results: 2Q22 vs 2Q21
Operating profit before
 
tax increased by
 
USD 22m,
 
or 1%,
 
to USD 2,615m, reflecting lower
 
operating expenses
and an
 
increase in total revenues, largely offset
 
by net
 
credit loss expenses of
 
USD 7m compared with net
 
credit
loss releases of
 
USD 80m in the second
 
quarter of 2021.
 
Operating expenses decreased by USD 89m,
 
or 1%, to
USD 6,295m,
 
which included
 
positive foreign
 
currency
 
effects. Personnel
 
expenses
 
decreased
 
by USD 350m,
 
mainly
reflecting lower expenses for salaries and variable compensation,
 
partly offset by a USD 267m increase in general
and
 
administrative expenses,
 
mainly
 
due
 
to
 
higher
 
expenses for
 
litigation, regulatory
 
and
 
similar matters.
 
Total
revenues increased by USD 20m to USD 8,917m, which included negative foreign currency effects.
 
Other income
increased
 
by
 
USD 626m,
 
largely
 
driven
 
by
 
USD 810m
 
higher
 
gains
 
on
 
sale
 
of
 
minority
 
shareholdings
 
in
 
Asset
Management,
 
partly offset
 
by real
 
estate-related losses of
 
USD 46m, compared with
 
gains of
 
USD 101m in
 
the
prior-year
 
quarter. In
 
addition, total
 
combined net
 
interest income
 
and other net
 
income from financial
 
instruments
measured
 
at
 
fair
 
value
 
through
 
profit
 
or
 
loss
 
increased
 
by
 
USD 178m.
 
These
 
effects
 
were
 
largely
 
offset
 
by
 
a
USD 783m decrease in net fee and commission income, reflecting negative market performance and lower levels
of IPO and follow-on
 
activity,
 
as well as a decrease
 
in the level of client
 
activity.
 
Total revenues: 2Q22 vs
 
2Q21
Net interest income and
 
other net income from
 
financial instruments
 
measured at
 
fair value through profit
 
or loss
Total combined net
 
interest income
 
and other
 
net income
 
from financial
 
instruments
 
measured at
 
fair value
 
through
profit
 
or
 
loss
 
increased
 
by
 
USD 178m
 
to
 
USD 3,284m,
 
mainly
 
driven
 
by
 
Global
 
Wealth
 
Management
 
and
 
the
Investment Bank, partly
 
offset by Group Functions.
Global Wealth
 
Management increased
 
by USD 227m
 
to USD 1,548m,
 
largely reflecting
 
higher net
 
interest income,
mainly due
 
to an
 
increase
 
in deposit
 
revenues,
 
which was
 
driven by
 
both higher
 
deposit margins,
 
as a
 
result of
 
rising
interest rates, and increased
 
deposit volumes.
The Investment
 
Bank increased
 
by USD
 
73m to
 
USD 1,370m.
 
Financing
 
increased
 
by USD 122m,
 
mainly as
 
the prior-
year quarter included an USD 87m loss incurred from the
 
exit of remaining exposures relating to the default of a
US-based client of our prime brokerage business in the first quarter of 2021. Derivatives & Solutions increased by
USD 107m, driven
 
by
 
Rates
 
and Foreign
 
Exchange, which
 
benefited from
 
elevated volatility
 
due
 
to
 
inflationary
concerns
 
and the
 
actions of
 
central
 
banks, partly
 
offset by
 
lower
 
revenues
 
in Credit
 
resulting from
 
widening spreads.
These increases were partly offset by a
 
USD 126m decrease in Global Banking, mainly reflecting lower Leveraged
Capital Markets revenues.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
7
 
Group Functions was negative
 
USD 265m
 
compared with negative USD
 
158m,
 
mainly reflecting the net effects
 
of
accounting asymmetries,
 
including hedge accounting
 
ineffectiveness,
 
within Group Treasury.
 
Refer to “Note 3 Net
 
interest income”
 
in the “Consolidated
 
financial statements”
 
section of this report
 
for more
information about
 
net interest income
 
Net interest income and
 
other net income from
 
financial instruments
 
measured at fair
 
value through profit
 
or loss
For the quarter
 
ended
% change from
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Net interest income from financial instruments measured
 
at amortized cost and fair value
through other comprehensive income
1,310
1,363
1,270
(4)
3
2,673
2,535
Net interest income from financial instruments measured
 
at fair value through profit or
loss
355
408
357
(13)
(1)
763
706
Other net income from financial instruments measured
 
at fair value through profit or
 
loss
1,619
2,226
1,479
(27)
9
3,845
2,787
Total
3,284
3,997
3,106
(18)
6
7,281
6,028
Global Wealth Management
1,548
1,442
1,321
7
17
2,991
2,622
of which: net interest income
1,268
1,141
1,026
11
24
2,409
2,023
of which: transaction-based income from foreign
 
exchange and other intermediary
activity
 
1
281
301
295
(7)
(5)
582
598
Personal & Corporate Banking
 
641
665
643
(4)
0
1,306
1,247
of which: net interest income
 
522
535
526
(2)
(1)
1,057
1,039
of which: transaction-based income from foreign
 
exchange and other intermediary
activity
 
1
119
130
117
(9)
2
249
208
Asset Management
(10)
(2)
4
515
(11)
(3)
Investment Bank
 
2
1,370
2,004
1,297
(32)
6
3,373
2,381
Global Banking
31
115
157
(73)
(80)
146
300
Global Markets
1,339
1,888
1,140
(29)
17
3,227
2,081
Group Functions
(265)
(112)
(158)
137
67
(377)
(218)
1 Mainly includes spread
 
-related income in connection
 
with client-driven transactions,
 
foreign currency translation
 
effects and income
 
and expenses from precious
 
metals, which are
 
included in the income
 
statement
line Other net income from
 
financial instruments
 
measured at fair
 
value through
 
profit or loss. The
 
amounts reported
 
on this line
 
are one component
 
of Transaction
 
-based income in
 
the management
 
discussion and
analysis in the
 
“Global Wealth
 
Management” and
 
“Personal
 
& Corporate Banking”
 
sections of this
 
report.
 
2 Investment Bank
 
information is
 
provided at the
 
business-line level
 
rather than
 
by financial statement
reporting line, in order to
 
reflect the underlying
 
business activities, which is
 
consistent with the structure
 
of the management discussion
 
and analysis in the
 
“Investment Bank”
 
section of this report.
 
Net fee and commission
 
income
Net fee and commission
 
income decreased by
 
USD 783m
 
to USD 4,774m.
Underwriting fees
 
decreased by
 
USD 276m
 
to USD 111m,
 
largely driven
 
by lower
 
equity underwriting
 
revenues
from public offerings in
 
the Investment Bank,
 
reflecting lower levels
 
of IPO and follow-on
 
activity.
Investment
 
fund
 
fees
 
and
 
fees
 
for
 
portfolio
 
management
 
and
 
related
 
services
 
decreased
 
by
 
USD 172m
 
and
USD 128m, respectively,
 
driven by Asset
 
Management and
 
Global Wealth Management,
 
mainly reflecting
 
negative
market performance,
 
partly offset
 
by the effects of
 
net new money
 
generation and
 
net new fee-generating
 
assets,
respectively.
 
In
 
addition,
 
Asset
 
Management
 
performance
 
fee
 
income
 
decreased,
 
mainly
 
in
 
our
 
Hedge
 
Fund
businesses and Equities.
 
Net brokerage
 
fees decreased
 
by USD 145m
 
to USD 818m,
 
reflecting lower
 
levels of
 
client activity
 
in Global Wealth
Management, particularly
 
in the Americas and
 
Asia Pacific,
 
and in the Investment
 
Bank in relation to
 
cash equities.
M&A
 
and corporate finance
 
fees decreased
 
by USD 110m
 
to USD 220m,
 
largely reflecting lower
 
revenues from
merger and acquisition transactions
 
in the Global Banking
 
business in the Investment
 
Bank.
 
Refer to “Note 4 Net
 
fee and commission
 
income” in the “Consolidated
 
financial statements”
 
section of this report
for more information
Other income
Other income was
 
USD 859m, compared
 
with USD
 
233m in the
 
prior-year quarter. The increase was largely
 
driven
by USD 810m
 
higher
 
gains on
 
sale of
 
minority
 
shareholdings in
 
Asset Management,
 
largely reflecting
 
an USD
 
848m
gain in the
 
second quarter
 
of 2022,
 
related to
 
the sale
 
of our
 
shareholding in
 
our Japanese
 
real estate
 
joint venture,
Mitsubishi Corp.-UBS
 
Realty Inc. This was
 
partly offset by USD 46m
 
of remeasurement losses
 
relating to properties
held for
 
sale,
 
compared with
 
gains
 
of USD 101m
 
in the
 
prior-year
 
quarter. The second
 
quarter of
 
2021 also
 
included
income of USD 45m related
 
to a legacy bankruptcy
 
claim.
 
Refer to the “Recent
 
developments” section
 
of this report for
 
more information
 
about the sale
 
of our shareholding
in Mitsubishi Corp.
 
-UBS Realty Inc.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
8
 
Credit loss expense
 
/ release: 2Q22 vs
 
2Q21
Total net credit
 
loss expenses were USD 7m, compared with net
 
credit loss releases of USD 80m in
 
the prior-year
quarter, reflecting USD
 
16m net credit loss expenses
 
related to stage 1 and
 
2 positions and USD 9m
 
net credit loss
releases
 
related to stage 3 positions.
 
Refer to “Note 7 Expected
 
credit loss measurement”
 
in the “Consolidated
 
financial statements”
 
section of this
report for more information
 
Credit loss expense
 
/ (release)
USD m
Global
 
Wealth
 
Management
Personal &
 
Corporate
 
Banking
Asset
Management
Investment
 
Bank
Group
 
Functions
Total
For the quarter
 
ended 30.6.22
Stages 1 and 2
(8)
26
0
(2)
0
16
Stage 3
6
8
0
(26)
2
(9)
Total credit loss expense /
 
(release)
(3)
35
0
(28)
2
7
For the quarter
 
ended 31.3.22
Stages 1 and 2
(5)
13
0
3
0
11
Stage 3
(2)
10
0
0
0
7
Total credit loss expense /
 
(release)
(7)
23
0
4
0
18
For the quarter
 
ended 30.6.21
Stages 1 and 2
(13)
(51)
0
(24)
1
(88)
Stage 3
0
5
0
3
0
8
Total credit loss expense /
 
(release)
(14)
(46)
0
(21)
1
(80)
Operating expenses:
 
2Q22 vs 2Q21
Operating expenses
For the quarter
 
ended
% change from
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Personnel expenses
 
4,422
4,920
4,772
(10)
(7)
 
9,343
 
9,573
of which: salaries and variable compensation
2,664
2,948
2,945
(10)
(10)
 
5,612
 
5,816
of which: financial advisor compensation
 
1
1,122
1,220
1,183
(8)
(5)
 
2,342
 
2,353
of which: other personnel expenses
 
2
637
752
644
(15)
(1)
 
1,388
 
1,403
General and administrative expenses
 
1,370
1,208
1,103
13
24
 
2,578
 
2,192
of which: net expenses for litigation, regulatory and similar
 
matters
221
57
63
287
247
 
278
 
72
of which: other general and administrative expenses
1,149
1,151
1,039
0
11
2,300
2,120
Depreciation, amortization and impairment of non
 
-financial assets
503
506
509
(1)
(1)
1,009
1,026
Total operating
 
expenses
6,295
6,634
6,384
(5)
(1)
 
12,929
 
12,790
1 Financial advisor
 
compensation
 
consists of
 
formulaic compensation
 
based
 
directly on
 
compensable
 
revenues generated
 
by financial
 
advisors and
 
supplemental
 
compensation calculated
 
on the
 
basis of financial
advisor productivity,
 
firm tenure,
 
new assets
 
and other
 
variables.
 
It also
 
includes expenses
 
related to
 
compensation
 
commitments with
 
financial advisors
 
entered into
 
at the time
 
of recruitment
 
that are
 
subject to
vesting requirements.
 
2 Consists of expenses
 
related to contractors,
 
social security, and
 
post-employment benefit
 
plans, as well as other
 
personnel expenses.
 
Personnel expenses
Personnel expenses
 
decreased by USD 350m
 
to USD 4,422m,
 
largely driven by
 
lower salary costs,
 
mainly reflecting
foreign currency effects,
 
lower variable compensation and a decrease in
 
financial advisor compensation resulting
from lower compensable
 
revenues.
 
Refer to “Note 5 Personnel
 
expenses” in the
 
“Consolidated
 
financial statements”
 
section of this report
 
for more
information
General and administrative
 
expenses
General and
 
administrative
 
expenses increased
 
by USD 267m
 
to USD 1,370m,
 
mainly driven
 
by higher
 
expenses for
litigation, regulatory and
 
similar matters,
 
travel and entertainment,
 
and IT.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
9
 
We believe that the industry continues to operate in an environment
 
in which expenses associated
 
with litigation,
regulatory and similar matters will
 
remain elevated for the foreseeable
 
future and we continue to be exposed
 
to a
number
 
of
 
significant claims
 
and
 
regulatory matters.
 
The
 
outcome of
 
many
 
of
 
these
 
matters, the
 
timing
 
of
 
a
resolution, and
 
the potential
 
effects of
 
resolutions on
 
our future
 
business, financial
 
results or financial
 
condition are
extremely difficult to
 
predict.
 
Refer to “Note 6 General
 
and administrative
 
expenses” in the “Consolidated
 
financial
 
statements” section
 
of this
report for more information
 
Refer to “Note 14 Provisions
 
and contingent liabilities”
 
in the “Consolidated
 
financial
 
statements” section
 
of this
report for more information
 
about litigation, regulatory
 
and similar matters
 
Refer to the “Regulatory
 
and legal developments”
 
and “Risk factors” sections
 
of our Annual
 
Report 2021 for more
information about litigation,
 
regulatory and
 
similar matters
Tax: 2Q22 vs 2Q21
We recognized income tax
 
expenses of USD 497m for
 
the second quarter of
 
2022, representing an effective tax
rate of
 
19.0%, compared
 
with
 
USD 581m and
 
an effective
 
tax rate
 
of 22.4%
 
for
 
the
 
second quarter
 
of
 
2021.
Current
 
tax
 
expenses
 
were
 
USD 367m,
 
compared
 
with
 
USD 362m,
 
and
 
related
 
to
 
taxable
 
profits
 
of
UBS Switzerland AG and
 
other entities. Deferred tax
 
expenses were USD 130m,
 
compared with USD 219m.
 
These
include
 
an
 
expense
 
of
 
USD 76m
 
that
 
primarily
 
relates
 
to
 
the
 
amortization
 
of
 
deferred
 
tax
 
assets
 
previously
recognized in relation to tax losses
 
carried forward and deductible temporary differences of UBS Americas Inc. In
addition,
 
they
 
include
 
an
 
expense
 
of
 
USD 54m
 
in
 
respect
 
of
 
a
 
decrease
 
in
 
the
 
expected
 
value
 
of
 
future
 
tax
deductions for deferred
 
compensation awards,
 
due to a decrease in
 
the Group’s share price
 
during the quarter.
The effective tax
 
rate for the second quarter of
 
2022 of 19.0%
 
is low primarily because no net
 
tax expense was
recognized in
 
respect of
 
the pre-tax
 
gain of
 
USD 848m that
 
resulted from
 
the sale
 
of our shareholding
 
in Mitsubishi
Corp.-UBS
 
Realty
 
Inc. However,
 
this impact
 
on the
 
effective
 
tax rate
 
was
 
partly
 
offset
 
by the
 
aforementioned
 
expense
of USD 54m in respect
 
of deferred compensation
 
awards.
 
Excluding
 
any
 
potential
 
effects
 
from
 
the
 
remeasurement of
 
deferred
 
tax
 
assets
 
in
 
connection
 
with
 
this
 
year’s
business planning
 
process and
 
any potential
 
US corporate
 
tax rate
 
changes or
 
other material
 
jurisdictional statutory
tax rate changes that could
 
be enacted, we
 
expect a tax rate
 
for
 
the second half
 
of 2022 of around 24%.
 
Refer to the “Recent
 
developments” section
 
of this report for
 
more information
 
about the sale
 
of our shareholding
in Mitsubishi Corp.
 
-UBS Realty Inc.
 
Total comprehensive
 
income attributable
 
to shareholders
In the second
 
quarter of 2022,
 
total comprehensive
 
income attributable
 
to shareholders
 
was positive
 
USD 1,097m,
reflecting net profit of USD
 
2,108m and other comprehensive
 
income (OCI),
 
net of tax, of negative
 
USD 1,011m.
OCI related
 
to cash
 
flow hedges
 
was negative USD 1,171m, mainly
 
reflecting net unrealized losses
 
on US
 
dollar
hedging derivatives resulting
 
from significant increases
 
in the relevant US
 
dollar long-term interest
 
rates.
Foreign currency translation OCI
 
was negative USD 577m, mainly resulting
 
from a weakening
 
of the
 
Swiss franc
(3%) and the euro (5%)
 
against the US dollar.
OCI associated with
 
financial assets measured
 
at fair value
 
through OCI (FVOCI) was
 
positive USD 330m, mainly
reflecting the reclassification
 
of a portfolio of high-quality
 
liquid assets from Financial
 
assets measured
 
at FVOCI to
Other financial assets
 
measured at amortized
 
cost, thereby reversing
 
post-tax unrealized
 
losses of USD 333m.
 
OCI related to own credit
 
on financial liabilities
 
designated at fair value was
 
positive USD 271m,
 
primarily due to a
widening of our own credit
 
spreads.
Defined
 
benefit plan
 
OCI
 
was
 
positive
 
USD 115m, reflecting
 
positive
 
net
 
pre-tax OCI
 
related
 
to
 
our
 
non-Swiss
pension plans of
 
USD 135m, mainly driven
 
by the
 
UK pension
 
plan, partly
 
offset by negative
 
pre-tax OCI
 
in our
Swiss pension plan of USD
 
13m.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
10
 
OCI related to cost
 
of hedging was positive USD 21m, mainly driven by a
 
widening of the US
 
dollar / euro cross-
currency basis that increased
 
the fair value
 
of the cross-currency swaps.
 
Refer to “Statement
 
of comprehensive income”
 
in the “Consolidated
 
financial statements”
 
section of this report
 
for
more information
 
Refer to “Note 1 Basis
 
of accounting” in the
 
“Consolidated fi
 
nancial statements”
 
section of this report
 
for more
information about the
 
reclassification
 
of financial assets
 
at FVOCI
 
Refer to “Note 21 Fair value
 
measurement” in
 
the “Consolidated
 
financial statements”
 
section of our
 
Annual Report
2021 for more informat
 
ion about
 
own credit on financial
 
liabilities designated
 
at fair value
 
Refer to “Note 27 Post
 
-employment benefit
 
plans” in the “Consolidated
 
financial statements”
 
section of our Annual
Report 2021 for more
 
information about
 
OCI related to defined
 
benefit plans
Sensitivity to interest
 
rate movements
As of 30 June 2022, we
 
estimate that a
 
parallel shift in yield curves
 
by +100 basis points
 
could lead to
 
a combined
increase in annual net interest
 
income of approximately
 
USD 1.8bn in Global
 
Wealth Management and
 
Personal
 
&
Corporate Banking in the first
 
year after such a shift.
 
Of this increase, approximately
 
USD 0.7bn would result from
changes in
 
US dollar
 
interest rates,
 
a similar
 
amount from
 
changes in
 
Swiss franc
 
interest rates
 
and USD 0.2bn
 
from
changes in
 
euro interest
 
rates.
 
A parallel
 
shift in
 
yield curves
 
by –100
 
basis points
 
could lead
 
to a combined
 
decrease
in annual
 
net interest
 
income
 
of approximately
 
USD 1.4bn
 
in Global
 
Wealth Management
 
and Personal
 
& Corporate
Banking in the first year
 
after such a shift,
 
mainly driven by positions
 
denominated in US
 
dollars.
These estimates
 
are based
 
on
 
a hypothetical scenario
 
of
 
an immediate
 
change in
 
interest rates,
 
equal across
 
all
currencies and relative to implied forward rates as of 30 June 2022 applied to
 
our banking book. These estimates
further assume
 
no
 
change to
 
balance sheet
 
size and
 
structure, constant
 
foreign exchange rates
 
and no
 
specific
management action.
 
 
Refer to the “Risk management
 
and control” section
 
of this report for
 
information about
 
interest rate
 
risk in the
banking book
Key figures and personnel
Below we
 
provide
 
an
 
overview of
 
selected key
 
figures of
 
the
 
Group. For
 
further information
 
about key
 
figures
related to capital management,
 
refer to the “Capital
 
management” section
 
of this report.
 
Cost / income ratio:
 
2Q22 vs 2Q21
The cost
 
/ income
 
ratio was
 
70.6%,
 
compared with
 
71.8%, mainly
 
reflecting a
 
decrease in
 
operating expenses,
 
and
includes the effect of the gain
 
on sale of our shareholding
 
in Mitsubishi Corp.-UBS
 
Realty Inc.
 
Personnel: 2Q22 vs 1Q22
The number of personnel employed
 
as of 30 June 2022 was broadly
 
stable at 71,294 (full-time equivalents),
 
a net
decrease of 403 compared
 
with 31 March 2022.
 
Equity,
 
CET1 capital and returns
As of or for the quarter ended
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Net profit
Net profit attributable to shareholders
 
2,108
 
2,136
 
2,006
 
4,244
 
3,830
Equity
 
Equity attributable to shareholders
 
56,845
 
58,855
 
58,765
 
56,845
 
58,765
Less: goodwill and intangible assets
6,312
6,383
6,452
6,312
6,452
Tangible equity attributable to
 
shareholders
50,533
52,472
52,313
50,533
52,313
Less: other CET1 deductions
5,734
7,878
9,730
5,734
9,730
CET1 capital
44,798
44,593
42,583
44,798
42,583
Returns
Return on equity (%)
14.6
14.3
13.7
14.4
13.1
Return on tangible equity
 
(%)
16.4
16.0
15.4
16.2
14.7
Return on CET1 capital (%)
18.9
19.0
19.3
18.9
18.8
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
11
 
Common equity tier
 
1 capital: 2Q22 vs
 
1Q22
During
 
the
 
second
 
quarter
 
of
 
2022,
 
our
 
common
 
equity
 
tier 1
 
(CET1)
 
capital
 
increased
 
by
 
USD 0.2bn
 
to
USD 44.8bn,
 
mainly driven by operating
 
profit before tax of USD 2.6bn
 
and a positive
 
pre-tax effect of USD 0.4bn
from the reclassification
 
of a
 
portfolio of
 
high-quality
 
liquid assets
 
from Financial
 
assets measured
 
at FVOCI
 
to Other
financial assets
 
measured at
 
amortized cost,
 
largely offset
 
by share
 
repurchases of
 
USD 1.6bn, negative
 
effects from
foreign currency translation
 
of USD 0.6bn,
 
dividend accruals
 
of USD 0.4bn
 
and current
 
tax expenses
 
of USD 0.4bn.
Return on CET1 capital:
 
2Q22 vs 2Q21
The annualized return
 
on CET1 capital was
 
18.9%, compared with
 
19.3%, driven by
 
higher net profit attributable
to shareholders, partly offset by
 
an increase in average
 
CET1 capital.
Risk-weighted assets:
 
2Q22 vs 1Q22
Risk-weighted assets (RWA) increased by USD 3.6bn to USD 315.7bn, primarily driven by increases
 
of USD 4.3bn
from model
 
updates
 
and USD 3.8bn
 
from asset
 
size and
 
other movements,
 
partly
 
offset by
 
a decrease
 
of USD 5.0bn
from currency effects.
Common equity tier
 
1 capital ratio: 2Q22 vs
 
1Q22
Our CET1 capital ratio decreased to 14.2% from 14.3%, reflecting
 
a USD 3.6bn increase in RWA, partly offset by
an increase in CET1 capital
 
of USD 0.2bn.
Leverage ratio denominator:
 
2Q22 vs 1Q22
The leverage ratio denominator (the LRD) decreased
 
by USD 47.5bn to USD 1,025.4bn,
 
driven by currency effects
of USD 27.3bn and a USD
 
20.3bn decrease due
 
to asset size and other
 
movements.
Common equity tier
 
1 leverage ratio:
 
2Q22 vs 1Q22
Our CET1 leverage ratio
 
increased to 4.37%
 
from 4.16%, primarily
 
due to a USD
 
47.5bn decrease in the LRD.
Going concern leverage
 
ratio: 2Q22 vs 1Q22
 
Our going concern
 
leverage ratio increased
 
to 5.8% from 5.6%,
 
mainly reflecting the aforementioned
 
decrease in
the LRD.
Results 6M22 vs 6M21
Operating profit before
 
tax increased by USD
 
453m, or 9%,
 
to USD 5,344m.
Total revenues
 
increased by
 
USD 725m,
 
or 4%, to
 
USD 18,299m,
 
which included
 
negative foreign
 
currency effects.
Total combined
 
net interest
 
income and
 
other net
 
income from
 
financial
 
instruments
 
measured at
 
fair value
 
through
profit or loss increased by USD 1,253m,
 
mainly reflecting the USD 861m
 
loss in the prior-year
 
period in relation to
a default
 
by a
 
US-based client
 
of
 
our prime
 
brokerage business.
 
Other income
 
increased by
 
USD 594m, largely
driven by
 
USD 810m
 
higher gains
 
on sale
 
of
 
minority shareholdings in
 
Asset Management, partly
 
offset by
 
real
estate-related losses
 
of USD 45m,
 
compared
 
with gains
 
of USD 100m
 
in the
 
prior-year
 
period. These
 
increases were
partly offset by USD 1,121m lower
 
net fee and
 
commission income, mainly reflecting a decrease in underwriting
fees, particularly
 
in Equity
 
Capital
 
Markets, and
 
a decrease
 
in net
 
brokerage
 
fees due
 
to lower
 
levels of
 
client activity
in
 
Global
 
Wealth
 
Management and
 
the
 
Investment Bank.
 
Investment fund
 
fees
 
decreased, reflecting
 
negative
market performance
 
and lower
 
performance fees,
 
and
 
revenues from
 
merger and
 
acquisition transactions
 
also
decreased.
Expected credit
 
loss
 
expenses
 
were
 
USD 25m,
 
compared
 
with
 
releases
 
of USD 108m
 
in the
 
prior-year
 
period. Stage
 
1
and 2 net
 
expenses were
 
USD 27m and
 
included scenario-related
 
net expenses
 
of USD 28m,
 
model change-related
net releases of
 
USD 23m, mainly in Global Wealth
 
Management Americas, and other net expenses
 
of USD 22m,
mainly including
 
book quality and
 
size effects from
 
corporate and
 
real estate
 
lending portfolios
 
in Switzerland.
 
This
was partly offset by a
 
USD 2m release of
 
stage 3 allowances.
Operating expenses increased by
 
USD 139m, or 1%,
 
to USD
 
12,929m, which included positive
 
foreign currency
effects.
 
General
 
and
 
administrative
 
expenses
 
increased
 
by
 
USD 386m,
 
mainly
 
reflecting
 
higher
 
expenses
 
for
litigation, regulatory and similar
 
matters, IT, outsourcing,
 
and travel and
 
entertainment.
 
This increase was
 
largely
offset by a
 
USD 230m
 
decrease in
 
personnel expenses,
 
largely driven
 
by lower
 
salary
 
costs,
 
mainly reflecting
 
foreign
currency effects.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
Group
 
AG
 
|
 
Group
 
performance
 
12
 
Outlook
High and
 
increasing
 
inflation and
 
tight labor
 
markets
 
in many
 
countries
 
have led
 
central banks
 
to raise
 
interest rates
at an
 
accelerated
 
pace. The
 
implications
 
of
 
Russia’s ongoing
 
war in
 
Ukraine,
 
including
 
higher
 
energy
 
and commodity
prices, as well
 
as the continuing effects of
 
the pandemic and related restrictions, particularly in Asia Pacific, have
increased uncertainty about
 
the global economic outlook.
 
As a result, equity and
 
fixed income valuations declined
steeply
 
in
 
the
 
second quarter
 
and
 
high
 
volatility persisted.
 
Against
 
this backdrop,
 
client
 
sentiment and
 
activity
among
 
our
 
private
 
clients
 
remained
 
muted
 
in
 
the
 
second
 
quarter
 
of
 
2022,
 
while
 
institutional
 
trading
 
activity
remained
 
strong.
 
We
 
expect
 
these
 
uncertainties to
 
continue
 
to
 
affect
 
client
 
sentiment,
 
which, combined
 
with
normal seasonality, may
 
also affect client activity
 
levels in the third quarter
 
of 2022.
While lower
 
asset valuations
 
will have
 
a negative
 
impact
 
on our recurring
 
net fee
 
income and
 
weak client
 
sentiment
may affect net
 
new assets in
 
our asset gathering businesses, we
 
expect higher interest rates
 
will positively affect
our net interest income.
Our clients
 
value our
 
capital strength
 
and expert
 
guidance, particularly in
 
these uncertain times,
 
and we
 
remain
focused on supporting
 
them with advice
 
and solutions.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Global
 
Wealth
 
Management
 
13
 
UBS business divisions
 
and
Group Functions
Management report
 
 
 
Global Wealth Management
Global Wealth Management
1
As of or for the quarter ended
% change from
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Net interest income
 
1,268
 
1,141
 
1,026
 
11
 
24
 
2,409
 
2,023
Recurring net fee income
2
 
2,614
 
2,806
 
2,774
 
(7)
 
(6)
 
5,419
 
5,403
Transaction-based income
2
 
793
 
954
 
953
 
(17)
 
(17)
 
1,747
 
2,136
Other income
 
2
 
3
 
8
 
(34)
 
(73)
 
5
 
44
Total revenues
 
4,677
 
4,904
 
4,760
 
(5)
 
(2)
 
9,581
 
9,606
Credit loss expense / (release)
 
(3)
 
(7)
 
(14)
 
(65)
 
(81)
 
(10)
 
(16)
Operating expenses
 
3,523
 
3,602
 
3,479
 
(2)
 
1
 
7,124
 
6,918
Business division operating
 
profit / (loss) before tax
 
1,157
 
1,310
 
1,294
 
(12)
 
(11)
 
2,467
 
2,704
Performance measures and
 
other information
Pre-tax profit growth (year-on-year,
 
%)
2
 
(10.6)
 
(7.0)
 
47.1
 
(8.8)
 
28.9
Cost / income ratio (%)
2
 
75.3
 
73.4
 
73.1
 
74.4
 
72.0
Average attributed equity (USD bn)
3
 
20.0
 
19.9
 
18.5
 
3
 
10
 
19.9
 
18.4
Return on attributed equity (%)
2,3
 
23.2
 
26.3
 
27.9
 
24.7
 
29.3
Financial advisor compensation
4
 
1,122
 
1,220
 
1,183
 
(8)
 
(5)
 
2,342
 
2,353
Net new fee-generating assets (USD bn)
2
 
0.4
 
19.4
 
25.0
 
19.8
 
61.2
Fee-generating assets (USD bn)
2
 
1,244
 
1,414
 
1,416
 
(12)
 
(12)
 
1,244
 
1,416
Fee-generating asset margin (bps)
2
 
79.6
 
81.6
 
82.3
 
80.6
 
84.1
Invested assets (USD bn)
2
 
2,811
 
3,145
 
3,230
 
(11)
 
(13)
 
2,811
 
3,230
Loans, gross (USD bn)
5
 
227.1
 
230.3
 
228.1
 
(1)
 
0
 
227.1
 
228.1
Customer deposits (USD bn)
5
 
349.3
 
372.3
 
344.2
 
(6)
 
1
 
349.3
 
344.2
Impaired loan portfolio as a percentage of total loan portfolio,
 
gross (%)
2,6
 
0.3
 
0.2
 
0.3
 
0.3
 
0.3
Advisors (full-time equivalents)
 
9,224
 
9,300
 
9,480
 
(1)
 
(3)
 
9,224
 
9,480
1 Comparatives may differ as a result of adjustments
 
following organizational changes,
 
restatements due to the retrospective
 
adoption of new accounting
 
standards or changes in accounting
 
policies, and events after
the reporting period.
 
2 Refer to “Alternative
 
performance measures” in the appendix
 
to this report for the
 
definition and calculation
 
method. From the
 
second quarter of 2022, assets
 
related to our Global Financial
Intermediaries business are excluded from f
 
ee-generating assets,
 
given that fee-generating investment
 
management products,
 
such as mandates, are not
 
central to this business. Furthermore,
 
client commitments
 
into
closed-ended private-market
 
investment funds are
 
included as fee-generating
 
assets once recurring fees
 
are charged, rather
 
than when commitments
 
are funded. These changes
 
were applied prospectively.
 
3 Refer
to the “Capital management” section of this report for more information.
 
4 Relates to licensed professionals with the ability to provide investment advice
 
to clients in the Americas. Consists of formulaic compensation
based directly
 
on compensable revenues
 
generated
 
by financial advisors
 
and supplemental
 
compensation calculated
 
on the basis
 
of financial advisor
 
productivity,
 
firm tenure,
 
new assets and
 
other variables.
 
It also
includes expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are
 
subject to vesting requirements. Recruitment loans to financial advisors were USD 1,673m
in the second quarter of 2022.
 
5 Loans and Customer
 
deposits in this table include customer
 
brokerage receivables
 
and payables, respectively,
 
which are presented in a separate
 
reporting line on the
 
balance sheet.
 
6 Refer to the “Risk management
 
and control” section of this report
 
for more information
 
about (credit-)impaired exposures.
 
Excludes loans to financial
 
advisors.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Global
 
Wealth
 
Management
 
14
 
Results: 2Q22 vs 2Q21
Profit
 
before tax
 
decreased by
 
USD 137m, or
 
11%, to
 
USD 1,157m, mainly driven
 
by
 
lower
 
total revenues
 
and
higher operating expenses.
Total revenues
Total
 
revenues
 
decreased
 
by
 
USD 83m
 
to
 
USD 4,677m, mainly
 
due
 
to
 
decreases
 
across
 
transaction-based and
recurring net fee income,
 
partly offset by an increase
 
in net interest income.
 
Net interest income increased by USD 242m, or 24%, to USD 1,268m, mainly reflecting higher deposit revenues,
which were
 
driven by
 
both higher
 
deposit margins,
 
as a
 
result of
 
rising interest
 
rates,
 
and increased
 
deposit
 
volumes.
Recurring net
 
fee income decreased
 
by USD 160m, or
 
6%, to
 
USD 2,614m, primarily driven by
 
negative market
performance and
 
foreign
 
currency effects,
 
partly
 
offset
 
by
 
net
 
new
 
fee-generating assets
 
over
 
the
 
past
 
twelve
months.
Transaction-based income
 
decreased by USD 160m,
 
or 17%, to USD 793m, mainly driven by lower levels
 
of client
activity, particularly in
 
the Americas and Asia
 
Pacific.
Credit loss expense
 
/ release
Net credit loss releases were USD 3m, primarily related to stage 1
 
and 2 positions, compared with net releases of
USD 14m in the second
 
quarter of 2021.
Operating expenses
Operating expenses
 
increased by
 
USD 44m to
 
USD 3,523m,
 
mainly driven
 
by an increase
 
in provisions
 
for litigation,
regulatory
 
and
 
similar
 
matters, as
 
well
 
as
 
higher
 
expenses
 
for
 
travel
 
and
 
entertainment, professional
 
fees
 
and
outsourcing. These effects were
 
partly offset by lower personnel
 
expenses.
Fee-generating assets:
 
2Q22 vs 1Q22
Fee-generating assets
 
decreased by USD 169.5bn,
 
or 12%, to
 
USD 1,244bn, almost
 
entirely driven
 
by net negative
market performance and foreign currency
 
effects. The change in fee-generating assets
 
included a net decrease of
USD 16bn from refinements
 
to our fee-generating asset classification.
 
Net new fee-generating asset inflows were
USD 0.4bn and included
 
an effect of USD
 
0.5bn due to the aforementioned
 
refinements.
Loans: 2Q22 vs 1Q22
Loans decreased
 
by USD 3.2bn
 
to USD 227.1bn,
 
mainly driven
 
by negative
 
foreign currency
 
effects, partly offset
 
by
net new loans of USD 0.9bn.
Results: 6M22 vs 6M21
Profit before tax decreased
 
by USD 237m, or
 
9%, to USD 2,467m,
 
mainly reflecting higher
 
operating expenses.
Total revenues decreased by USD
 
25m to USD 9,581m, as lower transaction-based
 
and other income were almost
entirely offset by increases
 
in net interest and
 
recurring net fee
 
income.
Net interest
 
income increased
 
by USD 386m,
 
or
 
19%,
 
to
 
USD 2,409m, mostly due
 
to
 
higher
 
deposit revenues,
driven by increases in deposit margins and volumes, as well as higher loan revenues, mainly driven
 
by higher loan
volumes and margins.
Recurring
 
net fee
 
income increased
 
by USD 16m
 
to USD
 
5,419m, primarily
 
driven by
 
net new
 
fee-generating
 
assets.
This was largely offset
 
by negative market
 
performance and foreign
 
currency effects.
Transaction-based
 
income decreased
 
by USD 389m,
 
or 18%,
 
to USD 1,747m,
 
mainly driven
 
by lower
 
levels of
 
client
activity, particularly in
 
Asia Pacific and the Americas.
Other
 
income
 
decreased
 
by
 
USD 39m to
 
USD 5m, mainly
 
driven
 
by
 
a
 
valuation loss
 
of
 
USD 6m
 
on
 
our
 
equity
ownership of SIX
 
Group, compared with
 
a USD 9m gain
 
in the
 
first half of
 
2021, and
 
lower gains from
 
sales of
securities positions.
Net credit loss releases were
 
USD 10m, compared
 
with net releases
 
of USD 16m.
Operating expenses
 
increased by USD
 
206m, or 3%,
 
to USD 7,124m,
 
mostly driven
 
by an increase
 
in provisions for
litigation,
 
regulatory
 
and
 
similar
 
matters,
 
as
 
well
 
as
 
higher
 
expenses
 
for
 
professional
 
fees
 
and
 
travel
 
and
entertainment.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Global
 
Wealth
 
Management
 
15
 
Regional breakdown
 
of performance
 
measures
As of or for the quarter ended 30.6.22
USD bn, except where indicated
Americas
1
Switzerland
EMEA
2
Asia Pacific
Global Wealth
Management
3
Total revenues (USD m)
 
2,639
 
474
 
925
 
641
 
4,677
Profit / (loss) before tax (USD m)
 
397
 
218
 
313
 
239
 
1,157
Cost / income ratio (%)
4
 
85.0
 
54.1
 
66.3
 
62.7
 
75.3
Loans, gross
 
99.4
5
 
42.6
 
43.4
 
41.1
 
227.1
Net new loans
 
3.8
 
0.4
 
(0.1)
 
(3.3)
 
0.9
Fee-generating assets
4
 
773
 
112
 
253
 
105
 
1,244
Net new fee-generating assets
4
 
(3.5)
 
1.1
 
(0.5)
 
3.3
 
0.4
Net new fee-generating asset growth
 
rate (%)
4
 
(1.6)
 
3.4
 
(0.6)
 
12.0
 
0.1
Invested assets
4
 
1,569
 
241
 
538
 
460
 
2,811
Advisors (full-time equivalents)
 
6,139
 
688
 
1,445
 
876
 
9,224
1 Including the following
 
business units:
 
United States and Canada;
 
and Latin America.
 
2 Including the following
 
business units:
 
Europe; Central
 
& Eastern Europe,
 
Greece and Israel;
 
and Middle East
 
and Africa.
 
3 Including minor functions, which are not included in the four regions individually presented in this table, with total revenues of negative USD 3m, USD 11m of operating loss before tax, USD 0.6bn of loans, USD
 
0.1bn
of net new loan inflows, USD 0.8bn
 
of fee-generating assets,
 
USD 0.0bn of net new fee-generating
 
asset outflows, USD 3bn
 
of invested assets and 76 advisors in the second quarter
 
of 2022.
 
4 Refer to “Alternative
performance measures”
 
in the appendix
 
to this report
 
for the
 
definition and calculation
 
method.
 
5 Loans include
 
customer brokerage
 
receivables,
 
which are
 
presented in a
 
separate reporting
 
line on the
 
balance
sheet.
 
Regional comments
 
2Q22 vs 2Q21,
 
except where indicated
 
Americas
Profit before
 
tax decreased by
 
USD 108m to USD 397m, mainly driven
 
by an increase
 
in provisions for
 
litigation,
regulatory and
 
similar matters. Total
 
revenues increased by
 
USD 30m, or
 
1%, to
 
USD 2,639m, mostly driven by
higher net
 
interest income.
 
The cost
 
/ income
 
ratio increased
 
to 85.0%
 
from 80.9%.
 
Loans increased
 
4% compared
with the first quarter of 2022,
 
to USD 99bn, reflecting USD
 
3.8bn of net new loans,
 
which were mostly securities-
based
 
loans
 
and
 
mortgages. Net
 
new
 
fee-generating assets
 
were
 
negative
 
USD 3.5bn,
 
resulting
 
in
 
a
 
negative
annualized net new
 
fee-generating asset
 
growth rate of 1.6%.
Switzerland
Profit before
 
tax increased
 
by USD 14m
 
to USD
 
218m. Total revenues
 
increased by
 
USD 10m, or
 
2%, to
 
USD 474m,
mainly
 
driven
 
by
 
higher
 
net
 
interest
 
income.
 
The
 
cost
 
/
 
income
 
ratio
 
decreased to
 
54.1%
 
from
 
57.5%.
 
Loans
decreased 2% compared with the first quarter
 
of 2022, to USD 43bn,
 
as USD 0.4bn of net new loans
 
were offset
by negative
 
foreign currency effects.
 
Net new
 
fee-generating assets were
 
USD 1.1bn, resulting in
 
an annualized
net new fee-generating
 
asset growth rate
 
of 3.4%.
EMEA
Profit before tax
 
increased by
 
USD 5m to
 
USD 313m.
 
Total revenues decreased by
 
USD 48m, or
 
5%, to USD
 
925m,
as higher
 
net interest income
 
was more
 
than offset
 
by decreases
 
in recurring
 
net fee
 
and transaction-based
 
income.
The cost / income ratio decreased
 
to 66.3% from 68.5%.
 
Loans decreased 4% compared with
 
the first quarter of
2022, to
 
USD 43bn,
 
reflecting net
 
new
 
loan outflows
 
and
 
negative foreign
 
currency
 
effects. Net
 
new fee-generating
assets
 
were
 
negative
 
USD 0.5bn, resulting
 
in
 
a
 
negative annualized
 
net
 
new
 
fee-generating asset
 
growth
 
rate
of 0.6%.
Asia Pacific
Profit
 
before
 
tax
 
decreased
 
by
 
USD 44m
 
to
 
USD 239m.
 
Total
 
revenues
 
decreased
 
by
 
USD 70m,
 
or
 
10%,
 
to
USD 641m, mainly driven
 
by lower
 
transaction-based income. The cost
 
/ income
 
ratio increased
 
to 62.7%
 
from
60.2%. Loans decreased 9% compared with the first quarter of 2022, to USD 41bn, reflecting USD 3.3bn of net
new loan
 
outflows as
 
the current
 
market uncertainty led
 
to clients deleveraging. Net
 
new fee-generating assets
were USD 3.3bn, resulting
 
in an annualized net
 
new fee-generating asset
 
growth rate of 12.0%.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Personal
 
&
 
Corporate
 
Banking
 
16
 
Personal & Corporate Banking
 
Personal & Corporate
 
Banking – in Swiss
 
francs
1
As of or for the quarter ended
% change from
Year-to-date
CHF m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Net interest income
 
502
 
493
 
480
 
2
 
5
 
996
 
950
Recurring net fee income
2
 
202
 
210
 
187
 
(3)
 
8
 
412
 
369
Transaction-based income
2
 
300
 
300
 
288
 
0
 
4
 
600
 
527
Other income
 
13
 
(1)
 
40
 
(67)
 
13
 
78
Total revenues
 
1,018
 
1,002
 
995
 
2
 
2
 
2,020
 
1,924
Credit loss expense / (release)
 
33
 
21
 
(42)
 
59
 
54
 
(64)
Operating expenses
 
587
 
586
 
581
 
0
 
1
 
1,173
 
1,174
Business division operating
 
profit / (loss) before tax
 
398
 
395
 
456
 
1
 
(13)
 
793
 
814
Performance measures and
 
other information
Pre-tax profit growth (year-on-year,
 
%)
2
 
(12.8)
 
10.4
 
99.5
 
(2.6)
 
47.7
Cost / income ratio (%)
2
 
57.7
 
58.5
 
58.4
 
58.1
 
61.0
Average attributed equity (CHF bn)
3
 
8.9
 
8.7
 
8.4
 
2
 
6
 
8.8
 
8.3
Return on attributed equity (%)
2,3
 
17.9
 
18.2
 
21.8
 
18.1
 
19.6
Net interest margin (bps)
2
 
142
 
141
 
139
 
141
 
138
Fee and trading income for Corporate
 
& Institutional Clients
2
 
213
 
221
 
210
 
(4)
 
1
 
434
 
402
Investment products for Personal Banking
 
(CHF bn)
2
 
21.4
 
23.1
 
22.5
 
(7)
 
(5)
 
21.4
 
22.5
Net new investment products for Personal Banking
 
(CHF bn)
2
 
0.46
 
0.97
 
0.85
 
1.43
 
1.70
Active Digital Banking clients in Personal Banking
 
(%)
2,4
 
73.6
 
73.2
 
69.8
 
73.4
 
69.6
Active Mobile Banking clients in Personal Banking
 
(%)
2
 
54.9
 
52.1
 
45.7
 
53.5
 
45.0
Active Digital Banking clients in Corporate & Institutional Clients
 
(%)
2
 
79.6
 
80.2
 
79.1
 
79.9
 
79.2
Loans, gross (CHF bn)
 
141.5
 
141.3
 
138.6
 
0
 
2
 
141.5
 
138.6
Customer deposits (CHF bn)
 
160.3
 
161.5
 
159.7
 
(1)
 
0
 
160.3
 
159.7
Impaired loan portfolio as a percentage of total loan portfolio,
 
gross (%)
2,5
 
0.9
 
0.8
 
1.0
 
0.9
 
1.0
1 Comparatives may differ as a result of adjustments
 
following organizational changes,
 
restatements due to the
 
retrospective adoption of new accounting
 
standards or changes in accounting
 
policies, and events after
the reporting period.
 
2 Refer to “Alternative
 
performance measures” in the
 
appendix to this report
 
for the definition and
 
calculation method.
 
3 Refer to the “Capital
 
management” section of
 
this report for more
information.
 
4 In the second
 
quarter of 2022, 85.7%
 
of clients of Personal
 
Banking were
 
“activated users”
 
of Digital Banking
 
(i.e., clients
 
who had logged
 
into Digital Banking
 
at least once in
 
the course of their
relationship with UBS).
 
5 Refer to the “Risk
 
management and control”
 
section of this report for more
 
information about (credit
 
-)impaired exposures.
 
Results
:
2Q22 vs 2Q21
Profit before tax decreased
 
by CHF 58m, or 13%, to
 
CHF 398m, reflecting
 
net credit loss expenses
 
compared with
net credit loss releases
 
in the second
 
quarter of 2021,
 
as well as
 
slightly higher operating
 
expenses,
 
partly offset by
higher
 
total revenues.
 
Profit before
 
tax in
 
the prior-year quarter
 
benefited from
 
a number
 
of
 
items that
 
totaled
around CHF 90m, including
 
CHF 42m of credit loss
 
releases.
Total revenues
Tota
 
l
 
revenues increased
 
by CHF 23m,
 
or 2%, to
 
CHF 1,018m, reflecting
 
a CHF 49m
 
increase from strong
 
business
momentum, with
 
higher net
 
interest, recurring
 
net
 
fee and
 
transaction-based income. This
 
was partly
 
offset by
lower other income.
Net interest income increased
 
by CHF 22m
 
to CHF 502m, mainly
 
driven by deposit revenues
 
due to higher deposit
margins
 
as a result
 
of rising interest rates, as well as
 
deposit management actions that led to higher deposit fees
and a decrease in liquidity and funding costs. Growth in loan volumes more than offset the effects from pressure
on loan margins.
Recurring
 
net fee
 
income increased
 
by CHF 15m
 
to CHF
 
202m, mostly
 
driven by
 
higher revenues
 
from account
 
fees,
as well as
 
higher revenues
 
from mandate
 
and custody
 
fees, mainly
 
due to net
 
new investment
 
product
 
inflows over
the past four quarters.
Transaction-based income
 
increased by CHF 12m
 
to CHF 300m, mainly driven by
 
higher revenues from credit card
and foreign exchange
 
transactions, including the effects of
 
a continued increase in
 
spending on travel
 
by clients
following the easing
 
of COVID-19-related
 
restrictions in certain countries.
 
Other income decreased by CHF 27m to CHF 13m, due to the second quarter of 2021 including a CHF 26m gain
from the sale of several
 
properties across
 
Switzerland.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Personal
 
&
 
Corporate
 
Banking
 
17
 
Credit loss expense
 
/ release
Net credit
 
loss
 
expenses were
 
CHF 33m, which
 
primarily related
 
to
 
stage 1 and
 
2
 
positions,
 
reflecting scenario-
related net
 
expenses related to corporate
 
lending, as well
 
as additional net
 
expenses from book quality
 
and size
changes, mainly across the corporate and real estate lending portfolios.
 
The second quarter of 2021 included net
credit loss releases of CHF 42m.
 
Operating expenses
Operating expenses
 
increased by
 
CHF 6m, or
 
1%, to CHF
 
587m, mainly
 
driven by
 
higher investments
 
in technology
in the second quarter
 
of 2022 and releases
 
of provisions for litigation,
 
regulatory and
 
similar matters in the
 
second
quarter of 2021.
 
These effects were
 
almost entirely offset by
 
lower personnel expenses in
 
the second quarter of
2022.
Results: 6M22 vs 6M21
Profit before
 
tax decreased by
 
CHF 21m, or
 
3%, to CHF
 
793m, mainly
 
reflecting net
 
credit loss expenses
 
compared
with net credit loss releases
 
in the first half of
 
2021,
 
partly offset by
 
higher total revenues.
Total revenues
 
increased by
 
CHF 96m,
 
or 5%,
 
to CHF 2,020m,
 
reflecting a
 
CHF 162m
 
increase
 
from strong
 
business
momentum, with higher transaction-based,
 
recurring net fee and net
 
interest income, partly offset by lower
 
other
income.
 
Net interest income increased
 
by CHF 46m
 
to CHF 996m, mainly
 
driven by deposit revenues
 
due to higher deposit
margins
 
as a result
 
of rising interest rates,
 
as well as deposit management actions that led
 
to higher deposit fees
and
 
a
 
decrease in
 
liquidity and
 
funding costs.
 
Growth
 
in
 
loans
 
more than
 
offset
 
the
 
impact
 
from pressure
 
on
margins.
Recurring net fee income increased
 
by CHF 43m
 
to CHF 412m, primarily reflecting
 
higher revenues from mandate
and custody
 
fees, mainly
 
due to net
 
new investment
 
product
 
inflows, as
 
well as
 
higher revenues
 
from account
 
fees.
Transaction-based income
 
increased by CHF 73m
 
to CHF 600m, mainly driven by
 
higher revenues from credit card
and foreign exchange transactions, reflecting
 
a continued increase in
 
spending on travel
 
by clients following
 
the
easing of COVID-19-related
 
restrictions in certain countries
 
in the first half
 
of 2022.
 
Other income
 
decreased by
 
CHF 65m
 
to CHF 13m,
 
mostly due to
 
the first half
 
of 2022
 
including a
 
valuation loss
 
of
CHF 16m
 
on our equity
 
ownership of SIX
 
Group, compared with
 
a CHF 26m gain
 
thereon in the first
 
half of 2021.
The prior-year
 
period also included
 
a CHF 26m gain
 
from the sale of several
 
properties across Switzerland.
Net credit loss expenses were CHF 54m, with net credit loss expenses
 
primarily related to stage 1 and 2 positions,
reflecting scenario-related
 
net expenses related
 
to corporate lending,
 
as well as additional
 
net expenses from
 
book
quality
 
and size
 
changes, mainly
 
across
 
the
 
corporate and
 
real estate
 
lending portfolios.
 
The
 
first half
 
of
 
2021
included net credit loss
 
releases of CHF 64m.
Total operating
 
expenses were
 
broadly stable
 
at CHF 1,173m.
 
Increased investments in
 
technology were
 
largely
offset by
 
lower personnel
 
expenses and
 
real estate
 
expenses, as
 
the prior-year period
 
included expenses
 
due to
accelerated depreciation
 
resulting from
 
the closure of
 
44 branches,
 
which led to lower
 
real estate expenses
 
for our
branch network in the
 
first half of 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Personal
 
&
 
Corporate
 
Banking
 
18
 
Personal & Corporate
 
Banking – in US
 
dollars
1
As of or for the quarter ended
% change from
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Net interest income
 
522
 
535
 
526
 
(2)
 
(1)
 
1,057
 
1,039
Recurring net fee income
2
 
210
 
227
 
205
 
(7)
 
3
 
438
 
403
Transaction-based income
2
 
312
 
325
 
315
 
(4)
 
(1)
 
637
 
576
Other income
 
14
 
(1)
 
44
 
(69)
 
13
 
85
Total revenues
 
1,058
 
1,086
 
1,089
 
(3)
 
(3)
 
2,144
 
2,102
Credit loss expense / (release)
 
35
 
23
 
(46)
 
54
 
57
 
(69)
Operating expenses
 
610
 
635
 
636
 
(4)
 
(4)
 
1,246
 
1,284
Business division operating
 
profit / (loss) before tax
 
413
 
428
 
498
 
(4)
 
(17)
 
841
 
888
Performance measures and
 
other information
Pre-tax profit growth (year-on-year,
 
%)
2
 
(17.1)
 
10.0
 
109.8
 
(5.2)
 
55.2
Cost / income ratio (%)
2
 
57.7
 
58.5
 
58.4
 
58.1
 
61.1
Average attributed equity (USD bn)
3
 
9.3
 
9.4
 
9.1
 
(2)
 
2
 
9.3
 
9.1
Return on attributed equity (%)
2,3
 
17.8
 
18.2
 
21.8
 
18.0
 
19.5
Net interest margin (bps)
2
 
139
 
140
 
142
 
139
 
140
Fee and trading income for Corporate
 
& Institutional Clients
2
 
221
 
240
 
230
 
(8)
 
(4)
 
461
 
439
Investment products for Personal Banking
 
(USD bn)
2
 
22.4
 
25.0
 
24.3
 
(10)
 
(8)
 
22.4
 
24.3
Net new investment products for Personal Banking
 
(USD bn)
2
 
0.48
 
1.05
 
0.93
 
1.53
 
1.86
Active Digital Banking clients in Personal Banking
 
(%)
2,4
 
73.6
 
73.2
 
69.8
 
73.4
 
69.6
Active Mobile Banking clients in Personal Banking
 
(%)
2
 
54.9
 
52.1
 
45.7
 
53.5
 
45.0
Active Digital Banking clients in Corporate & Institutional Clients
 
(%)
2
 
79.6
 
80.2
 
79.1
 
79.9
 
79.2
Loans, gross (USD bn)
 
148.2
 
152.9
 
149.8
 
(3)
 
(1)
 
148.2
 
149.8
Customer deposits (USD bn)
 
167.8
 
174.8
 
172.6
 
(4)
 
(3)
 
167.8
 
172.6
Impaired loan portfolio as a percentage of total loan portfolio,
 
gross (%)
2,5
 
0.9
 
0.8
 
1.0
 
0.9
 
1.0
1 Comparatives may differ as a result of adjustments
 
following organizational changes,
 
restatements due to the retrospective
 
adoption of new accounting
 
standards or changes in accounting
 
policies, and events after
the reporting period.
 
2 Refer to “Alternative
 
performance measures” in the
 
appendix to this report
 
for the definition and
 
calculation method.
 
3 Refer
 
to the “Capital management”
 
section of this report for
 
more
information.
 
4 In the second
 
quarter of 2022, 85.7%
 
of clients of Personal
 
Banking were
 
“activated users”
 
of Digital Banking
 
(i.e., clients
 
who had logged
 
into Digital Banking
 
at least once in
 
the course of their
relationship with UBS).
 
5 Refer to the “Risk
 
management and control”
 
section of this report for more
 
information about (credit
 
-)impaired exposures.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Asset
 
Management
 
19
 
Asset Management
Asset Management
1
As of or for the quarter ended
% change from
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Net management fees
2
 
515
 
561
 
588
 
(8)
 
(12)
 
1,076
 
1,133
Performance fees
 
9
 
17
 
40
 
(44)
 
(77)
 
26
 
133
Net gain from disposal of a joint venture / an associate
 
848
 
37
 
848
 
37
Total revenues
 
1,372
 
578
 
666
 
137
 
106
 
1,950
 
1,303
Credit loss expense / (release)
 
0
 
0
 
0
 
0
 
0
Operating expenses
 
413
 
404
 
410
 
2
 
1
 
817
 
820
Business division operating
 
profit / (loss) before tax
 
959
 
174
 
255
 
450
 
276
 
1,133
 
482
Performance measures and
 
other information
Pre-tax profit growth (year-on-year,
 
%)
3
 
275.7
 
(23.1)
 
62.0
 
135.0
 
53.4
Cost / income ratio (%)
3
 
30.1
 
69.8
 
61.7
 
41.9
 
63.0
Average attributed equity (USD bn)
4
 
1.7
 
1.8
 
2.1
 
(2)
 
(17)
 
1.8
 
2.2
Return on attributed equity (%)
3,4
 
221.3
 
39.5
 
49.0
 
129.5
 
44.7
Gross margin on invested assets (bps)
3
 
50
 
20
 
23
 
34
 
23
Information by business line
 
/ asset class
Net new money (USD bn)
3
Equities
 
(10.4)
 
(2.4)
 
(2.4)
 
(12.8)
 
4.0
Fixed Income
 
(0.3)
 
4.1
 
(1.3)
 
3.8
 
12.2
of which: money market
 
0.5
 
(6.5)
 
(6.7)
 
(6.0)
 
(2.4)
Multi-asset & Solutions
 
1.4
 
4.0
 
3.7
 
5.4
 
7.5
Hedge Fund Businesses
 
(1.6)
 
1.6
 
1.5
 
0.0
 
3.5
Real Estate & Private Markets
 
(0.7)
 
0.4
 
0.6
 
(0.4)
 
1.2
Total net new
 
money
 
(11.7)
 
7.7
 
2.1
 
(3.9)
 
28.3
of which: net new money excluding
 
money market
 
(12.1)
 
14.2
 
8.8
 
2.0
 
30.7
Invested assets (USD bn)
3
Equities
 
449
 
537
 
559
 
(16)
 
(20)
 
449
 
559
Fixed Income
 
262
 
277
 
280
 
(5)
 
(6)
 
262
 
280
of which: money market
 
85
 
86
 
94
 
(1)
 
(10)
 
85
 
94
Multi-asset & Solutions
 
163
 
185
 
187
 
(12)
 
(13)
 
163
 
187
Hedge Fund Businesses
 
53
 
56
 
53
 
(5)
 
1
 
53
 
53
Real Estate & Private Markets
 
99
 
99
 
95
 
0
 
4
 
99
 
95
Total invested assets
 
1,026
 
1,154
 
1,174
 
(11)
 
(13)
 
1,026
 
1,174
of which: passive strategies
 
440
 
516
 
501
 
(15)
 
(12)
 
440
 
501
Information by region
Invested assets (USD bn)
3
Americas
 
261
 
278
 
277
 
(6)
 
(6)
 
261
 
277
Asia Pacific
 
153
 
175
 
189
 
(12)
 
(19)
 
153
 
189
Europe, Middle East and Africa (excluding
 
Switzerland)
 
263
 
315
 
320
 
(17)
 
(18)
 
263
 
320
Switzerland
 
349
 
386
 
388
 
(9)
 
(10)
 
349
 
388
Total invested assets
 
1,026
 
1,154
 
1,174
 
(11)
 
(13)
 
1,026
 
1,174
Information by channel
Invested assets (USD bn)
3
Third-party institutional
 
593
 
672
 
686
 
(12)
 
(14)
 
593
 
686
Third-party wholesale
 
119
 
137
 
141
 
(13)
 
(16)
 
119
 
141
UBS’s wealth management businesses
 
314
 
345
 
346
 
(9)
 
(9)
 
314
 
346
Total invested assets
 
1,026
 
1,154
 
1,174
 
(11)
 
(13)
 
1,026
 
1,174
1 Comparatives may differ as a result of adjustments
 
following organizational changes,
 
restatements due to the retrospective
 
adoption of new accounting
 
standards or changes in accounting
 
policies, and events after
the reporting period.
 
2 Net management
 
fees include transaction
 
fees, fund admin
 
istration revenues
 
(including net
 
interest and trading
 
income from
 
lending activities and
 
foreign exchange
 
hedging as part
 
of the
fund services offering), distribution fees,
 
incremental fund-related
 
expenses, gains or losses from
 
seed money and co-investme
 
nts, funding costs, the
 
negative pass-through impact
 
of third-party performance fees,
 
and
other items that are
 
not Asset Management’s
 
performance fees.
 
3 Refer to
 
“Alternative
 
performance measures”
 
in the appendi
 
x
 
to this report
 
for the
 
definition and calculation
 
method.
 
4 Refer to
 
the “Capital
management” section of this report
 
for more information.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Asset
 
Management
 
20
 
Results: 2Q22 vs 2Q21
Profit before tax increased by
 
USD 704m, or 276%,
 
to USD 959m, driven by
 
a gain of USD 848m
 
from the sale of
our shareholding in
 
the Mitsubishi Corp.-UBS Realty Inc.
 
joint venture.
 
Profit before tax
 
in the
 
second quarter of
2021 included a post-tax gain
 
of USD 37m related to the
 
sale of our minority interest
 
in Clearstream Fund Centre.
Excluding
 
these
 
gains,
 
profit
 
before
 
tax
 
decreased
 
by
 
USD 107m,
 
or
 
49%,
 
to
 
USD 111m,
 
reflecting
 
lower
 
net
management and performance
 
fees.
 
Refer to the “Recent
 
developments” section
 
of this report for
 
more information
 
about the sale
 
of our shareholding
in Mitsubishi Corp.
 
-UBS Realty Inc.
Total revenues
Total
 
revenues increased
 
by
 
USD 706m, or
 
106%,
 
to
 
USD 1,372m. This
 
included the
 
aforementioned gains
 
of
USD 848m
 
in the second quarter
 
of 2022 and USD 37m in
 
the prior-year quarter.
 
Net management
 
fees decreased
 
by USD 73m,
 
or 12%,
 
to USD 515m,
 
reflecting negative
 
market performance
 
and
foreign currency effects,
 
partly offset by net
 
new money generation
 
over the past twelve months.
 
Performance fees
 
decreased by USD 31m
 
to USD 9m, mainly
 
in our Hedge Fund
 
Businesses and Equities.
Operating expenses
Operating expenses
 
were broadly
 
stable at
 
USD 413m.
 
Lower salary
 
costs,
 
partly reflecting
 
foreign currency
 
effects,
were mainly offset
 
by increases across
 
a number of other
 
expense lines,
 
including variable compensation-related
expenses.
Invested assets: 2Q22
 
vs 1Q22
 
Invested assets decreased by
 
USD 128bn to USD 1,026bn,
 
reflecting negative market performance of USD 84bn,
foreign currency effects of USD 31bn and net new money
 
outflows of USD 12bn.
 
Excluding money market flows,
net new money outflows
 
were USD 12bn,
 
primarily driven
 
by Equities.
Results: 6M22 vs 6M21
Profit
 
before
 
tax
 
increased
 
by
 
USD 651m,
 
or
 
135%,
 
to
 
USD 1,133m,
 
driven
 
by
 
the
 
aforementioned
 
gain
 
of
USD 848m. Profit
 
before
 
tax in
 
the
 
prior-year period included
 
the aforementioned
 
gain of
 
USD 37m.
 
Excluding
these gains,
 
profit before tax decreased by USD 159m, or 36%, to
 
USD 286m, reflecting lower performance and
net management fees.
Total
 
revenues
 
increased
 
by
 
USD 647m,
 
or
 
50%,
 
to
 
USD 1,950m.
 
This
 
included
 
the
 
aforementioned
 
gains
 
of
USD 848m
 
in the first half of
 
2022 and USD 37m in
 
the prior-year
 
period.
Net management
 
fees decreased by
 
USD 57m, or
 
5%, to
 
USD 1,076m, reflecting negative market
 
performance
and foreign currency
 
effects, partly offset
 
by net new money generation
 
over the past twelve months.
 
Performance
 
fees
 
decreased
 
by
 
USD 107m
 
to
 
USD 26m,
 
mainly
 
in
 
our
 
Hedge
 
Fund
 
Businesses
 
and
 
Equities,
compared with the
 
particularly high levels of
 
performance fees in
 
the first half of
 
2021.
Operating expenses
 
were broadly
 
stable at
 
USD 817m. Lower
 
salary costs,
 
partly reflecting
 
foreign currency
 
effects,
were mainly offset
 
by increases
 
across a number of
 
other expense lines,
 
including variable compensation-related
expenses.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Investment
 
Bank
 
21
 
Investment Bank
Investment Bank
1
As of or for the quarter ended
% change from
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Advisory
 
209
 
216
 
300
 
(3)
 
(30)
 
425
 
523
Capital Markets
 
168
 
334
 
581
 
(50)
 
(71)
 
502
 
1,147
Global Banking
 
377
 
550
 
881
 
(32)
 
(57)
 
927
 
1,670
Execution Services
 
399
 
496
 
443
 
(19)
 
(10)
 
895
 
998
Derivatives & Solutions
 
839
 
1,418
 
773
 
(41)
 
9
 
2,257
 
2,020
Financing
 
479
 
444
 
352
 
8
 
36
 
924
 
33
Global Markets
 
1,718
 
2,358
 
1,567
 
(27)
 
10
 
4,076
 
3,051
of which: Equities
 
1,274
 
1,705
 
1,194
 
(25)
 
7
 
2,979
 
2,114
of which: Foreign Exchange,
 
Rates and Credit
 
444
 
653
 
373
 
(32)
 
19
 
1,097
 
937
Total revenues
 
2,094
 
2,908
 
2,449
 
(28)
 
(14)
 
5,003
 
4,720
Credit loss expense / (release)
 
(28)
 
4
 
(21)
 
33
 
(24)
 
(23)
Operating expenses
 
1,712
 
1,976
 
1,802
 
(13)
 
(5)
 
3,688
 
3,663
Business division operating
 
profit / (loss) before tax
 
410
 
929
 
668
 
(56)
 
(39)
 
1,339
 
1,080
Performance measures and
 
other information
Pre-tax profit growth (year-on-year,
 
%)
2
 
(38.7)
 
125.6
 
9.1
 
23.9
 
(18.2)
Cost / income ratio (%)
2
 
81.8
 
67.9
 
73.6
 
73.7
 
77.6
Average attributed equity (USD bn)
3
 
13.3
 
13.2
 
13.0
 
1
 
3
 
13.2
 
13.0
Return on attributed equity (%)
2,3
 
12.3
 
28.2
 
20.6
 
20.2
 
16.7
Average VaR (1-day, 95%
 
confidence, 5 years of historical data)
 
11
 
10
 
11
 
4
 
(2)
 
11
 
11
1 Comparative figures in this table may differ as a result of adjustments following organizational changes,
 
restatements due to the retrospective adoption of new accounting
 
standards or changes in accounting policies,
and events after the reporting period.
 
2 Refer to “Alternative
 
performance measures”
 
in the appendix to this
 
report for the definition and calculation
 
method.
 
3 Refer to the “Capital
 
management” section of
 
this
report for more information.
Results: 2Q22 vs 2Q21
Profit before
 
tax decreased
 
by USD 258m,
 
or
 
39%, to
 
USD 410m, mainly driven
 
by lower
 
total revenues, partly
offset by lower operating
 
expenses.
Total revenues
Total
 
revenues decreased
 
by USD 355m,
 
or 14%,
 
to
 
USD 2,094m, reflecting lower
 
revenues in
 
Global Banking,
partly offset by higher revenues
 
in Global Markets.
Global
 
Banking
Global Banking revenues
 
decreased by USD 504m,
 
or 57%, to USD
 
377m, mostly
 
driven by lower Capital
 
Markets
revenues, compared with a
 
51% decrease in the
 
overall global fee pool.
Advisory
 
revenues
 
decreased
 
by
 
USD 91m,
 
or
 
30%,
 
to
 
USD 209m,
 
due
 
to
 
lower
 
revenues
 
from
 
merger
 
and
acquisition transactions,
 
compared with
 
a 28% reduction in
 
the global merger and
 
acquisition fee pool.
Capital Markets revenues
 
decreased by USD 413m,
 
or 71%, to
 
USD 168m. Equity
 
Capital Markets (ECM)
 
revenues
decreased
 
by
 
USD 235m, or
 
83%,
 
reflecting lower
 
levels of
 
IPO
 
and
 
follow-on activity,
 
compared
 
with
 
a 73%
decrease in
 
the
 
global ECM
 
fee pool,
 
reflecting a
 
challenging
 
market
 
environment.
 
Leveraged Capital
 
Markets (LCM)
fee revenues decreased
 
by USD 79m, or 64%,
 
compared with a 60%
 
decrease in
 
the global LCM fee pool.
Global
 
Markets
Global Markets revenues increased
 
by USD 151m, or
 
10%, to
 
USD 1,718m, partly due to
 
the second quarter of
2021 including
 
an USD 87m
 
loss incurred from
 
the exit
 
of remaining
 
exposure relating
 
to the
 
default of
 
a US-based
client
 
of
 
our prime
 
brokerage business
 
in
 
the
 
first quarter
 
of
 
2021. Excluding
 
that
 
loss, revenues
 
increased
 
by
USD 64m, or 4%, primarily
 
driven by higher revenues
 
in Rates and Foreign
 
Exchange, partly offset
 
by lower Credit
and Cash Equities revenues.
Execution Services revenues decreased by USD 44m, or 10%,
 
to USD 399m, partly driven by lower
 
Cash Equities
revenues due to lower exchange-traded
 
volumes. Derivatives & Solutions
 
revenues increased by USD 66m,
 
or 9%,
to USD 839m,
 
driven by
 
Rates and
 
Foreign Exchange,
 
benefiting
 
from elevated
 
volatility
 
due to
 
inflationary
 
concerns
and the actions of central
 
banks, partly offset
 
by lower revenues
 
in Credit resulting from
 
widening spreads.
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Investment
 
Bank
 
22
 
Financing revenues increased by USD 127m,
 
or 36%, to USD 479m. Excluding the aforementioned
 
USD 87m loss
in the second quarter of
 
2021,
 
revenues increased by USD 40m, or 9%, due to higher
 
Equity Financing revenues
and increases in Clearing,
 
which benefited
 
from a higher interest
 
rate environment.
Equities
Global Markets Equities revenues increased by USD 80m, or 7%, to
 
USD 1,274m, as the second quarter of 2021
included the
 
aforementioned
 
loss in
 
our prime
 
brokerage
 
business. Excluding
 
that
 
loss, Equities
 
revenues decreased
by USD 7m, or 1%.
Foreign Exchange,
 
Rates and Credit
Global Markets
 
Foreign Exchange,
 
Rates and
 
Credit revenues
 
increased by
 
USD 71m,
 
or 19%,
 
to USD
 
444m, mainly
driven by
 
Foreign Exchange and Rates, due
 
to elevated volatility,
 
inflationary concerns and the actions
 
of central
banks, partly offset by
 
decreases in Credit revenues resulting
 
from widening spreads.
Credit loss expense /
 
release
Net credit
 
loss releases
 
were USD 28m, primarily
 
related to
 
a stage 3
 
net release, compared
 
with net
 
credit loss
releases of USD 21m.
 
Operating expenses
Operating expenses decreased by USD 90m, or 5%, to
 
USD 1,712m, mainly driven by favorable foreign currency
effects and
 
lower variable compensation,
 
partly offset
 
by higher
 
expenses on
 
technology and increases
 
across a
number of other expense
 
lines.
Results: 6M22 vs 6M21
Profit before tax
 
increased by USD 259m, or
 
24%, to
 
USD 1,339m, due to the
 
prior-year period including a
 
loss
related
 
to
 
the
 
default of
 
a
 
client
 
reported within
 
Financing in
 
Global
 
Markets. This
 
was partly
 
offset
 
by
 
lower
revenues in Global Banking.
Total revenues
 
increased
 
by USD 283m,
 
or 6%,
 
to USD
 
5,003m, reflecting
 
higher revenues
 
in Global
 
Markets,
 
offset
by lower revenues in
 
Global Banking.
Global Banking
 
revenues decreased
 
by USD 743m,
 
or
 
44%, to
 
USD 927m, reflecting
 
lower
 
revenues in
 
Capital
Markets and Advisory.
Advisory
 
revenues
 
decreased
 
by
 
USD 98m,
 
or
 
19%,
 
to
 
USD 425m,
 
due
 
to
 
lower
 
revenues
 
from
 
merger
 
and
acquisition transactions,
 
compared with a
 
6% decrease in the
 
global merger and
 
acquisition fee pool.
Capital Markets
 
revenues decreased
 
by USD 645m,
 
or 56%,
 
to USD 502m,
 
mainly reflecting
 
a USD 426m,
 
or 75%,
decrease in Equity Capital
 
Markets revenues,
 
compared with a decrease
 
in the global ECM
 
fee pool of 71%.
Global Markets revenues increased by USD 1,025m, or 34%, to USD 4,076m, partly due to the first half of 2021
including an USD 861m loss on
 
the default of a
 
US-based client of our prime brokerage business. Excluding that
loss, revenues increased by USD 164m,
 
or 4%, primarily driven by higher revenues
 
in our Rates, Foreign Exchange
and Equity Derivatives
 
businesses, partly
 
offset by lower revenues
 
in Credit and Cash Equities.
Execution Services revenues decreased by USD 103m, or 10%, to USD 895m, mainly driven by Cash Equities due
to lower exchange-traded
 
volumes, particularly
 
in Asia Pacific.
Derivatives
 
&
 
Solutions
 
revenues
 
increased
 
by
 
USD 237m,
 
or
 
12%,
 
to
 
USD 2,257m,
 
driven
 
by
 
Rates,
 
Foreign
Exchange and
 
Equity Derivatives,
 
on elevated
 
volatility,
 
inflationary concerns
 
and the
 
actions of
 
central
 
banks, partly
offset by Credit, due to
 
widening credit spreads.
Financing revenues increased by USD 891m
 
to USD 924m, predominantly due to
 
the first half
 
of 2021
 
including
the
 
aforementioned loss in
 
our prime
 
brokerage business. Excluding
 
that loss,
 
revenues increased
 
by USD
 
30m,
or 3%.
Global Markets Equities revenues increased by USD 865m, or 41%, to USD 2,979m, due to the first half of 2021
including the aforementioned loss in our prime brokerage business. Global Markets Foreign Exchange, Rates and
Credit
 
revenues increased
 
by USD 160m,
 
or
 
17%, to
 
USD 1,097m, driven
 
by higher
 
revenues in
 
our
 
Rates and
Foreign Exchange businesses,
 
partly offset by decreases
 
in Credit revenues.
Net credit loss releases were
 
largely unchanged.
Operating expenses increased by
 
USD 25m, or 1%,
 
to USD 3,688m, as
 
favorable foreign exchange
 
effects were
more than offset by increases
 
across
 
a number of expense
 
lines.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
UBS
 
business
 
divisions
 
and
 
Group
 
Functions
 
|
 
Group
 
Functions
 
23
 
Group Functions
Group Functions
1
As of or for the quarter ended
% change from
Year-to-date
USD m, except where indicated
30.6.22
31.3.22
30.6.21
1Q22
2Q21
30.6.22
30.6.21
Results
Total revenues
 
(284)
 
(95)
 
(67)
 
199
 
323
 
(379)
 
(158)
Credit loss expense / (release)
 
2
 
0
 
1
 
194
 
2
 
1
Operating expenses
 
37
 
18
 
56
 
110
 
(34)
 
54
 
105
Operating profit / (loss) before
 
tax
 
(324)
 
(112)
 
(124)
 
188
 
161
 
(436)
 
(263)
of which: Group Treasury
 
(239)
 
(162)
 
(125)
 
48
 
91
 
(400)
 
(229)
of which: Non-core and Legacy Portfolio
 
1
 
45
 
(24)
 
(97)
 
46
 
(19)
of which: Group Services
 
(86)
 
5
 
25
 
(82)
 
(14)
1 Comparatives may differ as a result of adjustments
 
following organizational changes,
 
restatements due to the retrospective
 
adoption of new accounting
 
standards or changes in accounting
 
policies, and events after
the reporting period.
 
Results: 2Q22 vs 2Q21
Group Functions recorded
 
a loss before tax of
 
USD 324m, compared
 
with a loss of USD 124m.
Group Treasury
The Group Treasury result was negative USD 239m, compared
 
with negative USD
 
125m. Income from accounting
asymmetries,
 
including
 
hedge
 
accounting
 
ineffectiveness,
 
was
 
net negative
 
USD 214m,
 
compared
 
with
 
net
 
negative
income of
 
USD 84m. Accounting asymmetries are
 
generally expected
 
to mean
 
revert
 
to
 
zero over
 
time. Income
related to
 
centralized
 
Group Treasury risk
 
management
 
was negative
 
USD 19m, compared
 
with negative
 
USD 33m.
Operating expenses
 
decreased by USD 1m
 
to USD 6m.
Non-core and Legacy Portfolio
The Non-core and Legacy Portfolio
 
result was positive USD
 
1m, compared with negative
 
USD 24m. This result was
mainly due to
 
valuation gains of
 
USD 9m
 
on our
 
USD 1.6bn portfolio of auction rate
 
securities (ARS),
 
compared
with valuation losses of USD 25m
 
in the second quarter of 2021. Our remaining exposures to
 
ARS were all rated
investment grade as
 
of 30
 
June 2022.
Group Services
The
 
Group
Services
 
result
 
was
negative
 
USD
 
86
m,
 
compared
 
with
positive
 
USD
 
25
m,
 
mainly
 
related
 
to
remeasurement losses of
 
USD 46m
 
on properties
 
held for sale
 
in the second
 
quarter of
 
2022,
 
compared with
 
gains
of USD 72m
 
in the second
 
quarter of 2021.
 
The second
 
quarter of 2022 also
 
included higher funding
 
costs related
to deferred tax assets, partly
 
offset by lower expenses
 
relating to our legal entity
 
transformation program.
Results: 6M22 vs 6M21
Group Functions recorded
 
a loss before tax
 
of USD 436m, compared
 
with a loss of USD 263m.
The Group
 
Treasury result
 
was negative
 
USD 400m, compared
 
with negative
 
USD 229m. This
 
included income
 
from
accounting asymmetries, including hedge accounting ineffectiveness, of net negative USD 352m, compared with
net negative income of USD 174m.
 
Income related to centralized Group Treasury risk management
 
was negative
USD 36m, compared with negative USD 35m
 
in the first half
 
of 2021.
 
Operating expenses decreased by USD 7m
to USD 13m.
The Non-core
 
and Legacy
 
Portfolio result
 
was positive
 
USD 46m, compared
 
with negative
 
USD 19m. This
 
result was
mainly due to valuation gains of USD 58m
 
on our USD 1.6bn portfolio of ARS, compared with valuation gains of
USD 36m in the same period
 
last year.
The Group
 
Services
 
result was
 
negative
 
USD 82m,
 
compared
 
with
 
negative
 
USD 14m,
 
mainly due
 
to remeasurement
losses of
 
USD 46m
 
on properties held for
 
sale in
 
the first half
 
of 2022,
 
compared with gains
 
of USD 72m
 
in the
same period last year.
 
The first half
 
of 2022 also included
 
higher funding costs
 
related to
 
deferred tax assets,
 
partly
offset by lower expenses
 
relating to our legal entity
 
transformation program.
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Risk
 
management
 
and
 
control
 
25
 
Risk management and control
 
This
 
section provides
 
information about
 
key
 
developments during
 
the
 
reporting
 
period
 
and
 
should
 
be
 
read
 
in
conjunction with the
 
“Risk management and
 
control” section of
 
our Annual Report
 
2021.
 
Credit risk
 
Overall banking products
 
exposure
Overall
 
banking
 
products
 
exposure
 
decreased
 
by
 
USD 17bn
 
to
 
USD 689bn
 
as
 
of
 
30 June
 
2022,
 
driven
 
by
 
a
USD 16bn decrease in
 
balances at central
 
banks and
 
an USD 8bn decrease
 
in loans
 
and advances to
 
customers,
primarily in Global Wealth Management
 
and Personal & Corporate Banking
 
due to the US dollar appreciating and
clients in
 
Asia Pacific
 
deleveraging.
 
This was
 
partially offset
 
by a
 
USD 9bn increase
 
in other
 
financial
 
assets
 
measured
at amortized
 
cost,
 
primarily due
 
to a reclassification
 
of a portfolio
 
of Financial
 
assets measured
 
at fair
 
value through
other comprehensive income.
Credit-impaired
 
gross
 
exposure
 
increased
 
by
 
USD 111m
 
to
 
USD 2,605m.
 
Total
 
net
 
credit
 
loss
 
expenses
 
were
USD 7m, reflecting
 
USD 16m
 
net credit
 
loss expenses
 
related to
 
stage 1 and
 
2 positions
 
and USD 9m
 
net credit loss
releases related to
 
stage 3 positions.
In aggregate,
 
exposure
 
related to
 
traded
 
products
 
increased
 
by USD 2.4bn
 
to
 
USD 55.4bn
 
during the
 
second
 
quarter
of 2022,
 
driven primarily by increased
 
market volatility.
 
Refer to the “Group
 
performance” section
 
and “Note 7 Expected
 
credit loss measurement”
 
in the “Consolidated
financial statements”
 
section of this report
 
for more
 
information about
 
credit loss expense
 
/ release
 
Refer to “Note 1 Basis
 
of accounting” in the
 
“Consolidated financial
 
statements” section
 
of this report for
 
more
information about the
 
reclassification
 
of a portfolio
 
of Financial assets
 
measured at fair
 
value through other
comprehensive income
Loan underwriting
In the Investment Bank,
 
mandated loan underwriting
 
commitments on a
 
notional basis increased by USD
 
1.8bn to
USD 4.8bn as
 
of 30 June 2022
 
,
 
driven by
 
a higher
 
level of
 
origination activity in
 
the loan
 
underwriting business
compared with the prior quarter, yet below 2021 levels.
 
USD 0.7bn of commitments
 
had not yet been distributed
as originally planned
 
as of 30 June 2022.
Loan underwriting exposures are classified as held for trading, with fair values reflecting the market conditions at
the end of the quarter.
 
Credit hedges are
 
in place to help
 
protect against fair value
 
movements in the
 
portfolio.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Risk
 
management
 
and
 
control
 
26
 
Banking and traded
 
products exposure
 
in our business
 
divisions and Group Functions
30.6.22
USD m
Global Wealth
Management
Personal &
Corporate
Banking
Asset
 
Management
Investment
 
Bank
Group
 
Functions
Total
Banking products
1
Gross exposure
 
337,929
 
225,420
 
1,533
 
73,478
 
50,560
 
688,920
of which: loans and advances to customers
 
(on-balance sheet)
 
221,405
 
148,159
 
0
 
13,369
 
1,758
 
384,691
of which: guarantees and loan commitments (off-balance
 
sheet)
 
10,628
 
27,915
 
0
 
13,736
 
7,980
 
60,259
Traded products
2,3
Gross exposure
 
9,866
 
531
 
0
 
44,998
 
55,396
of which: over-the-counter derivatives
 
7,325
 
510
 
0
 
17,923
 
25,758
of which: securities financing transactions
 
0
 
0
 
0
 
19,020
 
19,020
of which: exchange-traded derivatives
 
2,541
 
21
 
0
 
8,056
 
10,618
Other credit lines, gross
4
 
11,955
 
21,921
 
0
 
5,776
 
103
 
39,756
Total credit-impaired exposure,
 
gross (stage 3)
 
869
 
1,473
 
0
 
257
 
6
 
2,605
Total allowances and provisions for expected
 
credit losses (stages 1 to 3)
 
236
 
708
 
0
 
157
 
6
 
1,107
of which: stage 1
 
73
 
132
 
0
 
59
 
4
 
267
of which: stage 2
 
43
 
166
 
0
 
41
 
0
 
250
of which: stage 3 (allowances and provisions for credit
 
-impaired exposures)
 
120
 
410
 
0
 
57
 
3
 
590
31.3.22
USD m
Global Wealth
Management
Personal &
Corporate
Banking
Asset
 
Management
Investment
 
Bank
Group
Functions
Total
Banking products
1
Gross exposure
 
343,285
 
233,355
 
1,680
 
76,267
 
51,780
 
706,367
of which: loans and advances to customers (on
 
-balance sheet)
 
224,675
 
152,898
 
0
 
13,555
 
1,862
 
392,990
of which: guarantees and loan commitments (off-balance
 
sheet)
 
10,303
 
28,794
 
5
 
14,380
 
7,053
 
60,535
Traded products
2,3
Gross exposure
 
10,109
 
505
 
0
 
42,382
 
52,997
of which: over-the-counter derivatives
 
7,687
 
485
 
0
 
14,622
 
22,793
of which: securities financing transactions
 
0
 
0
 
0
 
20,331
 
20,331
of which: exchange-traded derivatives
 
2,423
 
20
 
0
 
7,429
 
9,872
Other credit lines, gross
4
 
12,220
 
22,686
 
0
 
6,380
 
110
 
41,396
Total credit-impaired exposure, gross
 
(stage 3)
 
685
 
1,550
 
0
 
259
 
0
 
2,494
Total allowances and provisions for expected
 
credit losses (stages 1 to 3)
 
253
 
703
 
0
 
189
 
3
 
1,148
of which: stage 1
 
82
 
127
 
0
 
62
 
3
 
275
of which: stage 2
 
42
 
153
 
0
 
39
 
0
 
234
of which: stage 3 (allowances and provisions for credit
 
-impaired exposures)
 
130
 
422
 
0
 
88
 
0
 
639
1 IFRS 9 gross exposure
 
including other financial
 
assets at amortized
 
cost, but excluding
 
cash, receivables
 
from securities financing
 
transactions, cash
 
collateral receivables
 
on derivative instruments,
 
financial assets
at FVOCI,
 
irrevocable committed
 
prolongation
 
of existing
 
loans
 
and unconditionally
 
revocable committed
 
credit
 
lines, and
 
forward
 
starting reverse
 
repurchase
 
and securities
 
borrowing agreements.
 
2 Internal
management view of
 
credit risk, which
 
differs in certain
 
respects from IFRS.
 
3 As counterparty
 
risk for traded
 
products is managed
 
at counterparty level,
 
no further split
 
between exposures
 
in the Investment
 
Bank
and Group Functions is provided.
 
4 Unconditionally revocable committed
 
credit lines.
 
 
Global Wealth Management
 
and Personal &
 
Corporate Banking
 
loans and advances to
 
customers, gross
1
Global Wealth Management
Personal & Corporate Banking
Total
USD m
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
Secured by residential real estate
 
59,830
 
59,894
 
106,579
 
109,484
 
166,409
 
169,378
Secured by commercial / industrial real estate
 
3,902
 
3,877
 
17,991
 
18,701
 
21,892
 
22,578
Secured by cash
 
34,948
 
36,286
 
2,993
 
3,007
 
37,941
 
39,294
Secured by securities
 
107,131
 
108,809
 
1,975
 
2,048
 
109,106
 
110,858
Secured by guarantees and other
 
collateral
 
13,264
 
13,725
 
6,380
 
7,136
 
19,645
 
20,861
Unsecured loans and advances to customers
 
2,330
 
2,084
 
12,241
 
12,521
 
14,571
 
14,605
Total loans and advances
 
to customers, gross
 
221,405
 
224,675
 
148,159
 
152,898
 
369,564
 
377,573
Allowances
 
(142)
 
(153)
 
(573)
 
(542)
 
(715)
 
(695)
Total loans and advances
 
to customers, net of allowances
 
221,263
 
224,522
 
147,586
 
152,356
 
368,849
 
376,878
1 Collateral arrangements
 
generally incorporate
 
a range of
 
collateral, including
 
cash, securities, real
 
estate and other
 
collateral. UBS
 
applies a risk
 
-based approach that
 
generally prioritizes collateral
 
according to its
liquidity profile.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Risk
 
management
 
and
 
control
 
27
 
Market risk
We
 
continued
 
to
 
maintain
 
generally low
 
levels
 
of
 
management value-at-risk
 
(VaR).
 
Average
 
management VaR
(1-day, 95% confidence level) increased marginally to
 
USD 12m from USD 11m
 
at the end
 
of the first quarter of
2022.
There were
 
no new
 
Group
 
VaR negative
 
backtesting
 
exceptions
 
in the
 
second
 
quarter
 
of 2022,
 
and the
 
total
 
number
of negative backtesting exceptions within the most recent 250-business-day window decreased to 1 from
 
2. The
Swiss Financial
 
Market
 
Supervisory
 
Authority
 
(FINMA)
 
VaR multiplier
 
derived from
 
backtesting
 
exceptions
 
for market
risk risk-weighted assets
 
was unchanged compared
 
with the prior quarter,
 
at 3.0.
 
Management value
 
-at-risk (1-day,
 
95% confidence, 5 years
 
of historical data)
 
of our business
 
divisions and
Group Functions
 
by general market risk
 
type
1
Average by risk type
USD m
Min.
Max.
Period end
Average
Equity
Interest
rates
Credit
spreads
Foreign
exchange
Commodities
Global Wealth Management
 
1
 
2
 
1
 
1
 
0
 
1
 
1
 
0
 
0
Personal & Corporate Banking
 
0
 
0
 
0
 
0
 
0
 
0
 
0
 
0
 
0
Asset Management
 
0
 
0
 
0
 
0
 
0
 
0
 
0
 
0
 
0
Investment Bank
 
9
 
15
 
13
 
11
 
8
 
8
 
5
 
4
 
3
Group Functions
 
4
 
5
 
5
 
4
 
1
 
4
 
3
 
1
 
0
Diversification effect
2,3
 
(4)
 
(4)
 
(1)
 
(3)
 
(4)
 
(1)
 
0
Total as of 30.6.22
 
10
 
16
 
15
 
12
 
8
 
10
 
5
 
4
 
3
Total as of 31.3.22
 
8
 
18
 
11
 
11
 
6
 
9
 
6
 
4
 
3
1 Statistics at individual levels may
 
not be summed to deduce the corresponding
 
aggregate figures. The
 
minima and maxima for each
 
level may occur on
 
different days, and, likewise,
 
the VaR for each business
 
line or
risk type,
 
being driven
 
by the extreme
 
loss tail
 
of the corresponding
 
distribution of
 
simulated profits
 
and losses
 
for that
 
business
 
line or risk
 
type, may
 
well be
 
driven by
 
different days
 
in the
 
historical time
 
series,
rendering invalid the simple summation
 
of figures to arrive at the aggregate total.
 
2 The difference
 
between the sum of the
 
standalone VaR for the
 
business divisions and Group Functions
 
and the VaR for the Group
as a whole.
 
3 As the minima and
 
maxima for different business
 
divisions and Group
 
Functions occur on different
 
days, it is not
 
meaningful to calculate a portfolio
 
diversification effect.
 
Economic value of equity
 
and net interest income
 
sensitivity
The economic value of equity (EVE) sensitivity in the banking book to a +1-basis-point
 
parallel shift in yield curves
was
 
negative
 
USD 27.1m as
 
of
 
30 June 2022,
 
compared
 
with
 
negative USD 28.3m
 
as
 
of
 
31 March
 
2022,
 
the
change predominantly
 
driven by rising market rates.
 
EVE represents the present value of future cash flows related
to the banking book irrespective
 
of accounting treatment and,
 
as per specific FINMA requirements,
 
disregards the
sensitivity of
 
USD 4.2m from
 
additional
 
tier 1 (AT1)
 
capital instruments that
 
otherwise would be
 
included under
general BCBS guidance.
The majority of
 
our interest rate risk
 
in the banking book
 
is a
 
reflection of the net
 
asset duration that we
 
run to
offset our modeled
 
sensitivity
 
of net USD
 
19.9m (31
 
March 2022:
 
USD 20.9m)
 
assigned to
 
our equity,
 
goodwill and
real estate,
 
with the
 
aim
 
of generating
 
a stable
 
net interest
 
income contribution.
 
Of
 
this, USD
 
14.3m
 
and USD
 
4.7m
are
 
attributable
 
to
 
the
 
US
 
dollar
 
and
 
the
 
Swiss
 
franc
 
portfolios, respectively
 
(31 March 2022:
 
USD 14.9m and
USD 5.2m, respectively).
In
 
addition to
 
the
 
sensitivity
 
mentioned above,
 
we
 
calculate the
 
six
 
interest
 
rate shock
 
scenarios prescribed
 
by
FINMA. The “Parallel up” scenario, assuming all positions were fair valued, was
 
the most severe and
 
would have
resulted
 
in
 
a
 
change
 
in
 
EVE
 
of
 
negative
 
USD
 
5.
1
bn,
or
 
8
.
5
%
,
 
of
our
tier
 
1
 
capital
 
(31
 
March
 
2022:
negative USD 5.5bn, or 9.1%),
 
which is well below the 15% threshold
 
as per the BCBS supervisory
 
outlier test for
high levels of interest rate
 
risk in the banking
 
book.
 
The immediate effect on
 
our tier 1 capital in the “Parallel up” scenario as of 30 June 2022 would have been only
a decrease of USD 0.1bn, or
 
0.2% (31 March 2022:
 
USD 1.0bn or 1.7%),
 
reflecting the fact that
 
the vast majority
of
 
our
 
banking
 
book
 
is
 
accrual
 
accounted
 
or
 
subject
 
to
 
hedge
 
accounting.
 
The
 
“Parallel
 
up”
 
scenario
 
would
subsequently have a positive
 
effect on net interest
 
income,
 
assuming a constant
 
balance sheet.
UBS also applies granular
 
internal interest
 
rate shock scenarios
 
to its banking book positions
 
to monitor its specific
risk profile.
 
Refer to “Interest rate
 
risk in the banking
 
book” in the “Market
 
risk” section
 
of our Annual Report
 
2021 for
 
more
information about the
 
management of interest
 
rate risk in the
 
banking book
 
Refer to “Sensitivity to
 
interest rate
 
movements” in the
 
“Group performance”
 
section of this report
 
for more
information about the
 
effects of increases
 
in interest
 
rates on the net interest
 
income of Global
 
Wealth
Management and Personal
 
& Corporate Banking
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Risk
 
management
 
and
 
control
 
28
 
Interest rate risk –
 
banking book
USD m
+1 bp
Parallel up
2
Parallel down
2
Steepener
3
Flattener
4
Short-term up
5
Short-term down
6
CHF
 
(2.7)
 
(379.3)
 
438.7
 
(311.2)
 
231.3
 
55.4
 
(52.5)
EUR
 
(1.1)
 
(203.8)
 
241.1
 
(86.1)
 
53.3
 
(11.5)
 
13.8
GBP
 
0.1
 
14.3
 
(16.7)
 
(29.2)
 
30.4
 
33.4
 
(33.6)
USD
 
(23.1)
 
(4,477.3)
 
4,466.7
 
(1,046.1)
 
(5.1)
 
(1,824.0)
 
2,001.0
Other
 
(0.2)
 
(63.0)
 
66.7
 
9.2
 
(22.3)
 
(45.0)
 
47.5
Effect on EVE
1
 
- FINMA as of 30.6.22
 
(27.1)
 
(5,109.2)
 
5,196.4
 
(1,463.3)
 
287.7
 
(1,791.7)
 
1,976.2
Additional tier 1 (AT1) capital instruments
 
4.2
 
793.4
 
(857.5)
 
(36.7)
 
211.7
 
517.8
 
(538.5)
Effect on EVE
1
 
- in line with BCBS as of 30.6.22
 
(22.9)
 
(4,315.8)
 
4,339.0
 
(1,500.0)
 
499.4
 
(1,273.8)
 
1,437.7
Effect on EVE
1
 
- FINMA as of 31.3.22
 
(28.3)
 
(5,475.5)
 
5,142.5
 
(1,384.7)
 
96.0
 
(1,993.6)
 
2,270.0
Effect on EVE
1
 
- in line with BCBS as of 31.3.22
 
(23.5)
 
(4,572.0)
 
4,162.6
 
(1,399.1)
 
309.8
 
(1,428.0)
 
1,681.2
1 Economic value
 
of equity.
 
2 Rates across
 
all tenors
 
move by ±150
 
bps for Swiss
 
franc, ±200
 
bps for euro
 
and US
 
dollar,
 
and ±250
 
bps for
 
pound sterling.
 
3 Short-term
 
rates
 
decrease and long
 
-term rates
increase.
 
4 Short-term rates
 
increase and long
 
-term rates decrease.
 
5 Short-term rates
 
increase more than long
 
-term rates.
 
6 Short-term rates
 
decrease more than long-
 
term rates.
 
Country
 
risk
 
We remain watchful
 
of a
 
range of
 
geopolitical developments and political changes
 
in a
 
number of
 
countries, as
well as international
 
tensions arising
 
from Russia’s
 
invasion of
 
Ukraine. As
 
described
 
in the “Recent
 
developments”
section of
 
this report, our
 
direct exposure to Russia,
 
Belarus and Ukraine
 
is limited, and
 
we continue to
 
monitor
potential
 
second-order
 
impacts.
 
We
 
do
 
have
 
significant
 
country
 
risk
 
exposure
 
to
 
major
 
European
 
economies,
including Germany, the
 
UK and France.
There continue to be concerns regarding a resurgence in global inflation,
 
and the timing and economic impact of
central
 
bank
 
policy
 
responses
 
(e.g.,
 
interest
 
rate
 
hikes
 
and
 
tapering
 
of
 
quantitative
 
easing).
 
There
 
are
 
related
concerns about increasing
 
energy prices in a number of countries,
 
and global supply chain
 
stresses and tight labor
markets are creating negative pressure on growth. China
 
has experienced a slowing economy following
 
the post-
pandemic boom, as well
 
as recent COVID-19-related
 
lockdowns.
We continue to
 
monitor potential
 
trade policy
 
disputes, as well
 
as economic and
 
political developments
 
in addition
to those
 
mentioned above. A number of
 
emerging markets are facing
 
economic, political and market pressures,
particularly
 
in light
 
of challenges
 
related
 
to the
 
COVID-19 pandemic,
 
but our
 
exposure
 
to emerging
 
market
 
countries
is diversified.
 
Refer to the “Risk management
 
and control” section
 
of our Annual Report
 
2021 for more
 
information
 
Refer to the “Recent
 
developments” section
 
of this report for
 
more information
 
about
 
our exposure and response
to Russia’s
 
invasion of Ukraine
 
Non-financial risk
Operational resilience
 
continues to
 
be
 
a
 
focus
 
area for
 
us,
 
as
 
well as
 
for
 
regulators globally.
 
We
 
have a
 
global
program
 
to
 
enhance
 
our
 
operational-resilience
 
capabilities,
 
including
 
addressing
 
developing
 
regulatory
requirements.
 
Increases in
 
the
 
sophistication
 
of cyberattacks
 
and fraud
 
are noted
 
worldwide,
 
especially
 
with regard
 
to ransomware
attacks. We believe that to date, our security controls, regular communications to help employees to stay alert to
cyber threats while working
 
remotely, and enhanced
 
monitoring
 
of cyber threats have
 
been generally effective.
 
No
cybersecurity incidents had a material effect
 
on our operations during the second quarter of 2022.
 
UBS continues
to be vigilant, particularly in view
 
of the potential for cyber threats
 
to intensify, both in volume
 
and sophistication,
as a result of Russia’s invasion
 
of Ukraine.
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Risk
 
management
 
and
 
control
 
29
 
Our response
 
to the
 
COVID-19 pandemic
 
has relied
 
upon our
 
business continuity
 
management and
 
operational
 
risk
processes. They have enabled us
 
to: maintain stable operations while
 
complying with governmental measures to
contain COVID-19;
 
continue to
 
serve our clients
 
without material
 
impact; and
 
support the safety
 
and well-being
 
of
our staff.
Hybrid working
 
arrangements can lead
 
to increased
 
conduct risk,
 
inherent risk of
 
fraudulent activities, potential
increases in the number
 
of suspicious transactions
 
and increased information
 
security risks. We have
 
implemented
additional monitoring and supervision
 
intended to mitigate these risks
 
and continue to review
 
the effectiveness of
these measures. In addition,
 
changes to the work environment, including permanent hybrid and the introduction
of agile ways of working,
 
may introduce new
 
challenges for supervision
 
and monitoring.
Achieving
 
fair
 
outcomes
 
for
 
our
 
clients,
 
upholding
 
market
 
integrity
 
and
 
cultivating
 
the
 
highest
 
standards
 
of
employee conduct
 
are of
 
critical
 
importance
 
to the
 
firm.
 
We maintain
 
a conduct
 
risk framework
 
across
 
our activities,
which is designed to align our
 
standards and conduct with
 
these objectives and to retain
 
momentum on fostering
a strong culture.
We are continuing our efforts
 
regarding innovation
 
and digitalization to
 
create value for our clients.
 
As part of the
resulting transformation, we
 
focus on
 
timely changes
 
to frameworks, including consideration
 
of new
 
or
 
revised
controls, working practices
 
and oversight,
 
with the
 
aim of
 
mitigating any
 
new risks
 
introduced, including those
around data ethics.
Competition
 
to
 
find
 
new
 
business
 
opportunities
 
across
 
the
 
financial
 
services
 
industry,
 
both
 
for
 
firms
 
and
 
for
customers, is increasing. Thus,
 
suitability risk, product selection, cross-divisional
 
service offerings, quality of advice
and price
 
transparency also remain
 
areas of
 
heightened focus
 
for UBS
 
and for
 
the
 
industry as
 
a whole
 
.
 
Market
volatility and major legislative change programs (such
 
as the Swiss
 
Financial Services Act (FIDLEG) in
 
Switzerland,
Regulation Best
 
Interest (Reg
 
BI) in the
 
US and
 
the revised
 
Markets in
 
Financial Instruments
 
Directive (MiFID
 
II) in the
EU),
 
along
 
with new
 
requirements for
 
sustainable investments,
 
all significantly
 
impact
 
the industry
 
and
 
require
adjustments to
 
control processes.
 
We
 
regularly
 
monitor our
 
suitability, product
 
and
 
conflicts-of-interest control
frameworks
 
to
 
assess
 
whether
 
they
 
are
 
reasonably
 
designed
 
to
 
facilitate
 
adherence
 
to
 
applicable
 
laws
 
and
regulatory expectations.
 
Cross-border risk remains an
 
area of
 
regulatory attention for global
 
financial institutions, with a
 
strong focus on
fiscal transparency, as well as market access, particularly third-country market access into the European Economic
Area (the EEA). There is also an ongoing high level of attention regarding the risk
 
that tax authorities may, on the
basis
 
of
 
new
 
interpretations of
 
existing
 
law,
 
seek
 
to
 
impose
 
taxation
 
based
 
on
 
the
 
existence
 
of
 
a
 
permanent
establishment. We maintain
 
a series of controls
 
designed to address
 
these risks.
Financial crime,
 
including money
 
laundering, terrorist
 
financing, sanctions
 
violations, fraud,
 
bribery and corruption,
continues
 
to
 
present
 
a
 
major
 
risk,
 
as
 
technological
 
innovation
 
and
 
geopolitical
 
developments
 
increase
 
the
complexity
 
of doing
 
business
 
and heightened
 
regulatory
 
attention
 
continues.
 
An effective
 
financial
 
crime prevention
program
 
therefore
 
remains
 
essential
 
for
 
UBS.
 
Money
 
laundering
 
and
 
financial fraud
 
techniques are
 
becoming
increasingly sophisticated,
 
and geopolitical
 
volatility makes
 
the sanctions
 
landscape
 
more complex,
 
as new or
 
novel
sanctions may be imposed that require complex implementation
 
in a short time frame. This was evidenced by the
extensive
 
sanctions
 
arising
 
from
 
Russia’s
 
invasion
 
of
 
Ukraine.
 
New
 
risks
 
continue
 
to
 
emerge,
 
such
 
as
 
virtual
currencies and related
 
activities or investments.
The Office
 
of the
 
Comptroller
 
of the
 
Currency
 
issued a
 
Cease and
 
Desist Order
 
against
 
the firm
 
in May
 
2018 relating
to our US branch
 
know-your-client
 
(KYC) and
 
anti-money-laundering
 
(AML) programs.
 
In response,
 
we initiated an
extensive program
 
for
 
the purpose
 
of
 
ensuring sustainable
 
remediation of
 
US-relevant Bank
 
Secrecy Act
 
/
 
AML
issues across
 
all our
 
US legal
 
entities. We introduced
 
significant improvements to the
 
framework between 2019
and 2021 and are continuing
 
to implement these.
 
We continued to
 
focus on strategic
 
enhancements to our
 
global AML /
 
KYC and
 
sanctions programs to address
evolving
 
risk
 
profiles
 
and
 
regulatory
 
expectations,
 
including
 
the
 
exploration
 
of
 
new
 
technologies
 
and
 
more
sophisticated monitoring.
 
Refer to ”Russia’s
 
invasion of Ukraine”
 
in the ”Recent
 
developments” section
 
of this report for
 
more information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
30
 
Capital management
The
 
disclosures
 
in
 
this
 
section
 
are
 
provided
 
for
 
UBS Group AG
 
on
 
a
 
consolidated
 
basis
 
and
 
focus
 
on
 
key
developments
 
during the
 
reporting
 
period
 
and information
 
in accordance
 
with
 
the
 
Basel III framework,
 
as applicable
to Swiss systemically
 
relevant banks (SRBs).
UBS Group AG
 
is
 
a
 
holding
 
company
 
and
 
conducts
 
substantially
 
all
 
of
 
its
 
operations
 
through
 
UBS AG
 
and
subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of
 
their respective capital
to,
 
and
 
provide
 
substantial liquidity
 
to,
 
such
 
subsidiaries. Many
 
of
 
these subsidiaries
 
are
 
subject to
 
regulations
requiring compliance
 
with minimum capital,
 
liquidity and similar
 
requirements.
 
Refer to “Capital management”
 
in the “Capital, liquidity
 
and funding, and
 
balance sheet” section
 
of our Annual
Report 2021 for more
 
information about
 
our capital management
 
objectives, planning
 
and activities, as
 
well as the
Swiss SRB total loss
 
-absorbing capacity
 
framework and
 
the Swiss SRB going
 
and gone
 
concern requirements
 
Refer to our 30 June 20
 
22 Pillar 3 Report
 
,
 
which will be available
 
as of 19 August 2022
 
under “Pillar 3 disclosures”
 
at
ubs.com/investors
, for more information
 
relating to additional
 
regulatory disclosures
 
for UBS Group AG
 
on a
consolidated basis, as
 
well as our significant regu
 
lated subsidiaries
 
and sub-groups
 
(UBS AG standalone,
UBS Switzerland AG
 
standalone, UBS Europe
 
SE consolidated and
 
UBS Americas Holding
 
LLC consolidated)
 
Refer to our UBS AG
 
second quarter 2022
 
report,
 
which will be available
 
as of 29 July
 
2022 under “Quarterly
reporting” at
ubs.com/investors
, for more information
 
about capital and
 
other regulatory
 
information for
 
UBS AG
consolidated in accordance
 
with the Basel III framework,
 
as applicable to
 
Swiss SRBs
Swiss SRB going and gone
 
concern requirements
 
and information
As of 30.6.22
RWA
LRD
USD m, except where indicated
in %
in %
Required going concern capital
Total going concern
 
capital
 
14.32
1
 
45,207
 
5.00
1
 
51,271
Common equity tier 1 capital
 
10.02
 
31,633
 
3.50
2
 
35,890
of which: minimum capital
 
4.50
 
14,206
 
1.50
 
15,381
of which: buffer capital
 
5.50
 
17,363
 
2.00
 
20,508
of which: countercyclical buffer
 
0.02
 
64
Maximum additional tier 1 capital
 
4.30
 
13,574
 
1.50
 
15,381
of which: additional tier 1 capital
 
3.50
 
11,049
 
1.50
 
15,381
of which: additional tier 1 buffer capital
 
0.80
 
2,525
Eligible going concern capital
Total going concern
 
capital
 
18.98
 
59,907
 
5.84
 
59,907
Common equity tier 1 capital
 
14.19
 
44,798
 
4.37
 
44,798
Total loss-absorbing
 
additional tier 1 capital
3
 
4.79
 
15,108
 
1.47
 
15,108
of which: high-trigger loss-absorbing additional tier 1 capital
 
4.40
 
13,889
 
1.35
 
13,889
of which: low-trigger loss-absorbing additional tier 1 capital
0.39
 
1,219
 
0.12
1,219
Required gone concern capital
Total gone concern
 
loss-absorbing capacity
4
 
10.77
 
34,011
 
3.78
 
38,756
of which: base requirement
5
 
12.86
 
40,597
 
4.50
 
46,144
of which: additional requirement for market share
 
and LRD
 
1.44
 
4,546
 
0.50
 
5,127
of which: applicable reduction on requirements
 
(3.53)
 
(11,132)
 
(1.22)
 
(12,515)
of which: rebate granted
6
 
(3.14)
 
(9,897)
 
(1.10)
 
(11,280)
of which: reduction for usage of low-trigger
 
tier 2 capital instruments
 
(0.39)
 
(1,236)
 
(0.12)
 
(1,236)
Eligible gone concern capital
Total gone concern
 
loss-absorbing capacity
 
14.68
 
46,342
 
4.52
 
46,342
Total tier 2 capital
 
0.95
 
3,009
 
0.29
 
3,009
of which: low-trigger loss-absorbing tier 2 capital
 
0.78
 
2,471
 
0.24
 
2,471
of which: non-Basel III-compliant tier 2 capital
 
0.17
 
538
 
0.05
 
538
TLAC-eligible senior unsecured
 
debt
 
13.73
 
43,333
 
4.23
 
43,333
Total loss-absorbing
 
capacity
Required total loss-absorbing
 
capacity
 
25.09
 
79,218
 
8.78
 
90,027
Eligible total loss-absorbing capacity
 
33.66
 
106,248
 
10.36
 
106,248
Risk-weighted assets / leverage ratio
 
denominator
Risk-weighted assets
 
315,685
Leverage ratio denominator
 
1,025,422
1 Includes applicable add-ons of 1.44% for RWA and 0.50% for LRD.
 
2 Our minimum CET1 leverage ratio requirement
 
of 3.5% consists of a 1.5% base requirement,
 
a 1.5% base buffer capital requirement, a 0.25%
LRD add-on requirement and
 
a 0.25% market
 
share add-on requirement
 
based on our Swiss
 
credit business.
 
3 Includes outstanding
 
low-trigger loss
 
-absorbing additional
 
tier 1 (AT1) capital
 
instruments, which
 
are
available under the Swiss SRB framework to meet the going concern requirements until their first call date. As of their first call date, these instruments are eligible to meet the gone concern requirements.
 
4 A maximum
of 25% of the gone concern requirements can
 
be met with instruments that have a remaining
 
maturity of between one and two yea
 
rs. Once at least 75%
 
of the minimum gone concern requirement
 
has been met with
instruments that have
 
a remaining
 
maturity of greater
 
than two years,
 
all instruments that
 
have a remaining
 
maturity of betwe
 
en one and
 
two years remain
 
eligible to
 
be included in
 
the total gone
 
concern capital.
 
5 The gone concern
 
requirement after
 
the application
 
of the rebate for
 
resolvability
 
measures and the reduction
 
for the use
 
of higher quality capital
 
instruments is
 
floored at 10%
 
and 3.75% for the
 
RWA-
 
and LRD-
based requirements, respectively.
 
This means that
 
the combined reduction
 
may not exceed 4.3 percentage
 
points for the RWA-
 
based requirement of 14.3%
 
and 1.25 percentage points for the
 
LRD-based requirement
of 5.0%.
 
6 Based on
 
the actions we
 
completed up
 
to December 2021
 
to improve resolvability,
 
FINMA granted
 
an increase in
 
the rebate on
 
the gone
 
concern requirement from
 
55.0% to
 
65.0% of the
 
maximum
rebate, effective from 1 July
 
2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
31
 
We are
 
subject to the
 
going and gone
 
concern requirements
 
of the Swiss
 
Capital Adequacy
 
Ordinance that
 
include
the too-big-to-fail provisions applicable to Swiss SRBs. The table on
 
the previous page provides the risk-weighted
asset (RWA)-
 
and leverage ratio
 
denominator (LRD)-based
 
requirements and
 
information as
 
of 30 June 2022.
The applicable
 
gone concern
 
requirement
 
floor
 
as of
 
30 June
 
2022 was
 
10% for
 
RWA and
 
3.75%
 
for LRD
 
purposes.
This floor
 
was increased by 1.4% for
 
RWA and 0.75%
 
for LRD in
 
the first quarter of
 
2022. The
 
aforementioned
requirements are also
 
applicable to UBS AG
 
consolidated. UBS Switzerland
 
AG and
 
UBS AG are subject
 
to going
and gone concern requirements
 
on a standalone basis.
 
Total loss-absorbing capacity
The table below provides Swiss SRB going and gone concern
 
information based on the Swiss SRB framework and
requirements that are discussed under “Capital
 
management” in the “Capital, liquidity and funding,
 
and balance
sheet” section of our Annual
 
Report 2021.
 
Swiss SRB going and gone
 
concern information
USD m, except where indicated
30.6.22
31.3.22
31.12.21
Eligible going concern capital
Total going concern
 
capital
 
59,907
 
60,053
 
60,488
Total tier 1 capital
 
59,907
 
60,053
 
60,488
Common equity tier 1 capital
 
44,798
 
44,593
 
45,281
Total loss-absorbing
 
additional tier 1 capital
 
15,108
 
15,460
 
15,207
of which: high-trigger loss-absorbing additional tier 1 capital
 
13,889
 
14,223
 
12,783
of which: low-trigger loss-absorbing additional tier 1 capital
 
1,219
 
1,236
 
2,425
Eligible gone concern capital
Total gone concern
 
loss-absorbing capacity
 
46,342
 
46,520
 
44,264
Total tier 2 capital
 
3,009
 
3,050
 
3,144
of which: low-trigger loss-absorbing tier 2 capital
 
2,471
 
2,507
 
2,596
of which: non-Basel III-compliant tier 2 capital
 
538
 
543
 
547
TLAC-eligible senior unsecured
 
debt
 
43,333
 
43,470
 
41,120
Total loss-absorbing
 
capacity
Total loss-absorbing
 
capacity
 
106,248
 
106,573
 
104,752
Risk-weighted assets / leverage ratio
 
denominator
Risk-weighted assets
 
315,685
 
312,037
 
302,209
Leverage ratio denominator
 
1,025,422
 
1,072,953
 
1,068,862
Capital and loss-absorbing capacity
 
ratios (%)
Going concern capital ratio
 
19.0
 
19.2
 
20.0
of which: common equity tier 1 capital ratio
 
14.2
 
14.3
 
15.0
Gone concern loss-absorbing capacity ratio
 
14.7
 
14.9
 
14.6
Total loss-absorbing
 
capacity ratio
 
33.7
 
34.2
 
34.7
Leverage ratios (%)
Going concern leverage ratio
 
5.8
 
5.6
 
5.7
of which: common equity tier 1 leverage ratio
 
4.37
 
4.16
 
4.24
Gone concern leverage ratio
 
4.5
 
4.3
 
4.1
Total loss-absorbing
 
capacity leverage ratio
 
10.4
 
9.9
 
9.8
Total loss-absorbing
 
capacity and movement
 
Our total loss-absorbing
 
capacity (TLAC)
 
decreased by USD 0.3bn
 
to USD 106.2bn
 
in the second quarter
 
of 2022.
Going concern capital
 
and movement
Our
 
going
 
concern capital
 
decreased
 
by
 
USD 0.1bn
 
to
 
USD 59.9bn.
 
Our
 
common
 
equity
 
tier 1
 
(CET1)
 
capital
increased by USD 0.2bn to USD 44.8bn, mainly driven by operating profit before tax of USD 2.6bn and a positive
pre-tax effect of
 
USD 0.4bn from
 
the reclassification
 
of a portfolio
 
of high-quality
 
liquid assets from
 
Financial assets
measured
 
at
 
fair
 
value
 
through
 
other
 
comprehensive
 
income
 
(FVOCI)
 
to
 
Other
 
financial
 
assets
 
measured
 
at
amortized cost,
 
largely offset
 
by share
 
repurchases of
 
USD 1.6bn,
 
negative effects
 
from foreign
 
currency translation
of USD 0.6bn, dividend accruals
 
of USD 0.4bn and current
 
tax expenses of USD
 
0.4bn.
 
Refer to “Note 1 Basis
 
of accounting” in the
 
“Consolidated financial
 
statements” section
 
of this report for
 
more
information about the
 
reclassification
 
of financial assets
 
at FVOCI
Our additional
 
tier 1 (AT1)
 
capital decreased
 
by USD 0.4bn
 
to USD 15.1bn,
 
mainly reflecting
 
interest rate
 
risk hedge,
foreign currency translation
 
and other effects.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
32
 
Gone concern loss-absorbing
 
capacity and movement
Our total gone
 
concern loss-absorbing
 
capacity decreased
 
by USD 0.2bn
 
to USD 46.3bn,
 
mainly due
 
to two calls
 
of
TLAC-eligible unsecured
 
debt denominated
 
in US
 
dollars amounting
 
to
 
USD 3.0bn and interest
 
rate risk
 
hedge,
foreign
 
currency
 
translation
 
and
 
other
 
effects,
 
largely
 
offset
 
by
 
eight
 
new
 
issuances
 
of
 
TLAC-eligible
 
senior
unsecured debt, denominated
 
in US dollars, euro and
 
Australian dollars,
 
amounting to USD 5.2bn
 
equivalent.
 
 
Refer to “Bondholder
 
information” at
 
ubs.com/investors
for more information
 
about the eligibility
 
of capital and
senior unsecured
 
debt instruments and
 
about key features
 
and terms and conditions
 
of capital instruments
Loss-absorbing capacity
 
and leverage ratios
Our CET1 capital ratio decreased to 14.2% from 14.3%, reflecting
 
a USD
 
3.6bn increase in RWA, partly offset by
an increase in CET1 capital
 
of USD 0.2bn.
 
Our CET1 leverage ratio
 
increased to 4.37%
 
from 4.16%, primarily
 
due to a USD 47.5bn
 
decrease in the LRD.
Our
 
gone concern
 
loss-absorbing capacity
 
ratio
 
decreased
 
to
 
14.7%
 
from 14.9%,
 
due
 
to
 
the
 
aforementioned
increase in RWA and the
 
decrease in gone concern
 
loss-absorbing capacity
 
of USD 0.2bn.
 
Our gone concern leverage ratio increased to
 
4.5% from 4.3%, mainly reflecting the aforementioned
 
decrease in
the LRD.
 
Swiss SRB total loss
 
-absorbing capacity
 
movement
USD m
Going concern capital
Swiss SRB
Common equity tier 1 capital
 
as of 31.3.22
 
44,593
Operating profit before tax
 
2,615
Current tax (expense) / benefit
 
(367)
Reclassification of financial assets from fair value
 
through OCI to amortized
 
cost, before tax
1
 
449
Share repurchase program
 
(1,632)
Foreign currency translation effects, before
 
tax
 
(582)
Other
2
 
(278)
Common equity tier 1 capital
 
as of 30.6.22
 
44,798
Loss-absorbing additional tier 1 capital
 
as of 31.3.22
 
15,460
Interest rate risk hedge, foreign
 
currency translation and other
 
effects
 
(351)
Loss-absorbing additional tier 1 capital
 
as of 30.6.22
 
15,108
Total going concern
 
capital as of 31.3.22
 
60,053
Total going concern
 
capital as of 30.6.22
 
59,907
Gone concern loss-absorbing capacity
Tier 2 capital as of 31.3.22
 
3,050
Interest rate risk hedge, foreign
 
currency translation and other
 
effects
 
(41)
Tier 2 capital as of 30.6.22
 
3,009
TLAC-eligible senior unsecured
 
debt as of 31.3.22
 
43,470
Issuance of TLAC-eligible senior unsecured
 
debt
 
5,191
Call of TLAC-eligible senior unsecured debt
 
(3,000)
Interest rate risk hedge, foreign
 
currency translation and other
 
effects
 
(2,328)
TLAC-eligible senior unsecured
 
debt as of 30.6.22
 
43,333
Total gone concern
 
loss-absorbing capacity as of 31.3.22
 
46,520
Total gone concern
 
loss-absorbing capacity as of 30.6.22
 
46,342
Total
 
loss-absorbing capacity
Total loss-absorbing
 
capacity as of 31.3.22
 
106,573
Total loss-absorbing
 
capacity as of 30.6.22
 
106,248
1 Effective 1 April 2022, a portfolio of
 
assets previously classified as Financial
 
assets measured at fair value
 
through other
 
comprehensive income was
 
reclassified to Other financial
 
assets measured at amortized cost.
Refer to “Note 1 Basis of accounting”
 
in the “Consolidated financial
 
statements” section
 
of this report for more information.
 
2 Includes dividend accruals
 
for the current year (negative
 
USD 0.4bn) and movements
related to other items.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
33
 
Reconciliation of IFRS equity
 
to Swiss SRB common
 
equity tier 1 capital
USD m
30.6.22
31.3.22
31.12.21
Total IFRS equity
 
57,184
 
59,212
 
61,002
Equity attributable to non-controlling interests
 
(339)
 
(356)
 
(340)
Defined benefit plans, net of tax
 
(471)
 
(446)
 
(270)
Deferred tax assets recognized for tax loss carry-
 
forwards
 
(4,401)
 
(4,520)
 
(4,565)
Deferred tax assets on temporary differences,
 
excess over threshold
 
(81)
 
(49)
Goodwill, net of tax
1
 
(5,776)
 
(5,822)
 
(5,838)
Intangible assets, net of tax
 
(174)
 
(191)
 
(180)
Compensation-related components (not recognized
 
in net profit)
 
(1,912)
 
(1,744)
 
(1,700)
Expected losses on advanced internal ratings
 
-based portfolio less provisions
 
(501)
 
(518)
 
(482)
Unrealized (gains) / losses from cash flow hedges,
 
net of tax
 
2,713
 
1,556
 
(628)
Own credit related to gains / losses on financial liabilities measured
 
at fair value that existed at the balance
 
sheet date, net of tax
 
(392)
 
(114)
 
315
Own credit related to gains / losses on derivative financial
 
instruments that existed at the balance sheet date
 
(111)
 
(84)
 
(50)
Unrealized gains related to financial assets at fair
 
value through OCI, net of tax
 
0
 
(1)
 
(68)
Prudential valuation adjustments
 
(211)
 
(183)
 
(167)
Accruals for dividends to shareholders for 2021
 
(1,668)
 
(1,700)
Other
2
 
(809)
 
(448)
 
1
Total common equity tier 1 capital
 
44,798
 
44,593
 
45,281
1 Includes goodwill related to significant investments in financial institutions of USD 21m as of 30 June 2022 (31 March 2022: USD 22m; 31 December 2021: USD 22m) presented on the balance sheet line Investments
in associates.
 
2 Includes dividend accrual
 
s
 
for the current year and
 
other items.
 
Additional information
Sensitivity to currency
 
movements
 
Risk
 
-weighted
 
assets
We estimate that a 10% depreciation
 
of the US dollar against other
 
currencies would have increased our
 
RWA by
USD 13bn and
 
our CET1
 
capital by
 
USD 1.3bn as of
 
30 June 2022
 
(31 March 2022:
 
USD 13bn and
 
USD 1.3bn,
respectively) and
 
decreased our
 
CET1 capital
 
ratio 14 basis
 
points (31 March
 
2022:
 
17 basis points).
 
Conversely, we
estimate that
 
a 10%
 
appreciation of
 
the US
 
dollar against
 
other currencies
 
would have decreased
 
our RWA
 
by
USD 12bn
 
and
 
our
 
CET1
 
capital
 
by
 
USD 1.2bn
 
(31 March
 
2022:
 
USD 12bn
 
and
 
USD 1.2bn,
 
respectively)
 
and
increased our CET1 capital
 
ratio 15 basis points
 
(31 March 2022: 16
 
basis points).
Leverage ratio
 
denominator
We estimate that a 10% depreciation of
 
the US dollar against other currencies would have increased our LRD by
USD 61bn as of 30 June 2022 (31 March
 
2022: USD 64bn) and decreased our Swiss SRB going concern leverage
ratio 18 basis
 
points (31 March 2022: 18 basis points). Conversely, we
 
estimate that
 
a 10%
 
appreciation of
 
the US
dollar
 
against other
 
currencies
 
would have
 
decreased
 
our
 
LRD
 
by
 
USD 55bn (31 March
 
2022:
 
USD 58bn)
 
and
increased our Swiss SRB
 
going concern
 
leverage ratio 18 basis
 
points (31 March 2022: 18 basis points)
 
.
The aforementioned
 
sensitivities
 
do not
 
consider
 
foreign currency
 
translation
 
effects related
 
to defined
 
benefit plans
other than those related
 
to the currency
 
translation of the
 
net equity of foreign
 
operations.
 
Refer to “Active
 
management of sensitivity
 
to currency movements”
 
under “Capital
 
management” in the
 
“Capital,
liquidity and funding,
 
and balance sheet”
 
section of our Annual
 
Report 2021 for more
 
information
Estimated effect on capital
 
from litigation, regulatory
 
and similar matters subject
 
to provisions and contingent
liabilities
We
 
have
 
estimated the
 
loss
 
in
 
capital
 
that
 
we
 
could incur
 
as
 
a
 
result
 
of
 
the
 
risks associated
 
with
 
the
 
matters
described in “Note 14 Provisions and contingent liabilities” in the “Consolidated financial statements” section of
this report. We
 
have employed
 
for this
 
purpose the
 
advanced
 
measurement approach
 
(AMA) methodology
 
that we
use when
 
determining the capital requirements
 
associated with operational risks, based
 
on a
 
99.9% confidence
level over
 
a 12-month
 
horizon.
 
The methodology
 
takes
 
into consideration
 
UBS
 
and industry
 
experience
 
for the
 
AMA
operational risk categories to which those matters correspond, as well as the external environment affecting risks
of these types, in isolation from
 
other areas. On this basis,
 
we estimate the maximum
 
loss in capital that we
 
could
incur over
 
a 12-month
 
period as
 
a result of our
 
risks associated
 
with these
 
operational risk
 
categories at
 
USD 4.7bn
as of
 
30 June 2022. This estimate is not
 
related to and
 
does not take into
 
account any provisions recognized for
any of
 
these matters
 
and does
 
not constitute
 
a subjective
 
assessment
 
of our
 
actual
 
exposure in
 
any of
 
these matters.
 
Refer to “Non-financial
 
risk” in the “Risk
 
management and
 
control” section
 
of our Annual Report
 
2021 for more
information
 
Refer to “Note 14 Provisions
 
and contingent liabilities”
 
in the “Consolidated
 
financial
 
statements” section
 
of this
report for more information
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
34
 
Risk-weighted assets
 
During the second
 
quarter of 2022,
 
RWA increased
 
by USD 3.6bn
 
to USD 315.7bn,
 
primarily driven
 
by increases of
USD 4.3bn from model updates and USD 3.8bn from
 
asset size and other movements, partly offset
 
by a decrease
of USD 5.0bn from currency
 
effects.
 
Movement in risk-
 
weighted assets by key
 
driver
USD bn
RWA as of
31.3.22
Currency
effects
Methodology
and policy
changes
Model
updates /
changes
Regulatory
add-ons
Asset size
and other
1
RWA as of
30.6.22
Credit and counterparty credit
 
risk
2
 
195.4
 
(4.7)
 
0.1
 
2.9
 
0.3
 
2.0
 
196.0
Non-counterparty-related risk
3
 
23.9
 
(0.3)
 
(0.3)
 
23.3
Market risk
 
13.9
 
(0.7)
 
0.2
 
2.1
 
15.5
Operational risk
 
78.8
 
2.0
 
0.0
 
80.9
Total
 
312.0
 
(5.0)
 
0.1
 
4.3
 
0.5
 
3.8
 
315.7
1 Includes the Pillar 3 categories “Asset
 
size,” “Credit quality
 
of counterparties,”
 
“Acquisitions
 
and disposals” and “Other.”
 
For more information,
 
refer to our 30 June 2022
 
Pillar 3 report, which will be available
 
as
of 19 August 2022 under “Pillar 3 disclosures” at ub
 
s.com/investors.
 
2 Includes settlement risk, credit valuation
 
adjustments, equity exposures
 
in the banking book, investments in funds and securitization
 
exposures
in the banking book.
 
3 Non-counterparty
 
-related risk includes deferred
 
tax assets recognized
 
for temporary differences,
 
property, equipment,
 
software and other items.
Credit and counterparty
 
credit risk
Credit and counterparty
 
credit risk
 
RWA was
 
USD 196.0bn as
 
of 30 June
 
2022. The
 
increase of
 
USD 0.6bn included
negative currency effects
 
of USD 4.7bn.
 
Asset size and other
 
movements resulted
 
in a USD 2.0bn increase
 
in RWA.
 
 
Global Wealth Management RWA increased by USD 2.9bn, mainly due to higher RWA related to Lombard and
other loans.
 
Investment Bank RWA
 
decreased by USD 0.6bn,
 
mainly reflecting lower
 
RWA related to
 
loans.
 
Asset
 
Management RWA
 
decreased
 
by
 
USD 0.5bn, primarily
 
reflecting lower
 
RWA
 
related
 
to
 
investments in
funds.
 
Group Functions RWA increased
 
by USD 0.3bn.
 
Personal & Corporate Banking
 
RWA decreased by USD
 
0.1bn.
Model updates resulted
 
in an
 
RWA increase of
 
USD 2.9bn, mainly driven by
 
USD 1.1bn from updates
 
to margin
period of
 
risk for prime
 
brokerage
 
clients,
 
as well as
 
USD 1.0bn from
 
updates to
 
the loss-given-default
 
(LGD) model
for mortgages
 
in Switzerland.
 
Furthermore,
 
the second
 
quarter of
 
2022 also
 
included a
 
USD 0.7bn
 
quarterly phase-
in impact
 
for structured
 
margin loans
 
and similar
 
products in
 
Global Wealth
 
Management
 
and a
 
USD 0.1bn
 
increase
due to an LGD model
 
update for leveraged
 
finance clients
 
in the Investment
 
Bank.
 
Regulatory
 
add-ons
 
resulted
 
in an
 
RWA
 
increase
 
of USD
 
0.3bn, due
 
to the
 
implementation
 
of an
 
exposure-at-default
floor for prime brokerage
 
clients.
We
 
expect
 
that
 
further
 
methodology changes,
 
model updates
 
and
 
regulatory add-ons
 
will
 
increase
 
credit
 
and
counterparty credit
 
risk RWA
 
by
 
around USD 2bn
 
in
 
the
 
third quarter
 
of
 
2022. The
 
extent and
 
timing of
 
RWA
changes may vary as methodology changes and model
 
updates are completed and receive regulatory approval.
 
In
addition, changes in the
 
composition of the
 
relevant portfolios and
 
other market
 
factors will affect RWA.
 
Refer to the “Risk management
 
and control” section
 
of this report
 
for more information
 
Refer to our 30 June 2022
 
Pillar 3 report,
 
which will be available
 
as of 19 August
 
2022 under “Pillar 3
 
disclosures” at
ubs.com/investors
, for more information
 
 
Refer to “Credit risk
 
models” in the “Risk
 
management and
 
control” section
 
of our Annual
 
Report 2021 for more
information
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
35
 
Market risk
Market risk
 
RWA increased
 
by USD 1.7bn
 
to USD 15.5bn
 
in the
 
second quarter
 
of 2022,
 
mainly due
 
to a
 
USD 2.1bn
increase in asset
 
size and other
 
movements primarily
 
related to
 
higher average
 
regulatory and
 
stressed value-at-risk
levels in
 
the Investment
 
Bank’s
 
Global Markets
 
business
 
on the
 
back of
 
continued
 
market volatility
 
from the
 
previous
quarter, as well as an
 
increase of USD 0.2bn in regulatory add-ons that reflected updates from the monthly risks-
not-in-VaR assessment.
 
This was partially
 
offset by a decrease
 
of USD 0.7bn primarily driven
 
by the introduction
 
of
a VaR model change. The integration
 
of time decay into the regulatory
 
VaR model is subject to further discussions
between the Swiss Financial
 
Market Supervisory
 
Authority (FINMA)
 
and UBS.
 
Refer to the “Risk management
 
and control” section
 
of this report for
 
more information
 
Refer to our 30 June 2022
 
Pillar 3 report,
 
which will be available
 
as of 19 August
 
2022 under “Pillar 3
 
disclosures” at
 
ubs.com/investors,
 
for more information
 
 
Refer to ”Market risk”
 
in the “Risk management
 
and control”
 
section of our Annual
 
Report 2021 for more
information
Operational risk
Operational risk RWA increased
 
by USD 2.0bn to USD 80.9bn
 
as of 30 June 2022.
 
Following a review with FINMA
on the
 
French cross-border matter,
 
we reflected additional operational risk RWA of
 
USD 4.1bn in the first half
 
of
2022, USD 2.1bn in the first
 
quarter and USD 2.0bn
 
in the second
 
quarter.
 
Refer to “Note 14 Provisions
 
and contingent liabilities”
 
in the “Consolidated
 
financial
 
statements” section
 
of this
report for more information
 
about the French
 
cross-border
 
matter
 
Refer to “Non-financial
 
risk” in the “Risk
 
management and
 
control” section
 
of our Annual Report
 
2021 for
information about the
 
AMA model
 
Risk-weighted assets
 
by business division
 
and Group Functions
USD bn
Global Wealth
Management
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
 
Functions
Total
RWA
30.6.22
Credit and counterparty credit
 
risk
1
 
61.8
 
62.5
 
2.8
 
62.0
 
6.9
 
196.0
Non-counterparty-related risk
2
 
5.8
 
1.9
 
0.6
 
3.6
 
11.5
 
23.3
Market risk
 
1.0
 
0.0
 
13.1
 
1.4
 
15.5
Operational risk
 
37.4
 
9.1
 
3.1
 
21.2
 
10.1
 
80.9
Total
 
106.0
 
73.5
 
6.5
 
99.9
 
29.8
 
315.7
31.3.22
Credit and counterparty credit
 
risk
1
 
58.6
 
63.6
 
3.4
 
62.7
 
7.1
 
195.4
Non-counterparty-related risk
2
 
6.0
 
1.9
 
0.6
 
3.7
 
11.7
 
23.9
Market risk
 
2.3
 
0.0
 
10.5
 
1.0
 
13.9
Operational risk
 
36.5
 
8.8
 
3.1
 
20.7
 
9.8
 
78.8
Total
 
103.4
 
74.4
 
7.0
 
97.6
 
29.6
 
312.0
30.6.22 vs 31.3.22
Credit and counterparty credit
 
risk
1
 
3.2
 
(1.1)
 
(0.6)
 
(0.7)
 
(0.1)
 
0.6
Non-counterparty-related risk
2
 
(0.2)
 
(0.1)
 
0.0
 
(0.1)
 
(0.2)
 
(0.6)
Market risk
 
(1.3)
 
0.0
 
2.6
 
0.3
 
1.7
Operational risk
 
0.9
 
0.2
 
0.1
 
0.5
 
0.3
 
2.0
Total
 
2.6
 
(1.0)
 
(0.5)
 
2.3
 
0.2
 
3.6
1 Includes settlement risk, credit valuation adjustments, equity exposures in the banking book and securitization exposures
 
in the banking book.
 
2 Non-counterparty-related risk includes
 
deferred tax assets recognized
for temporary differences (30
 
June 2022: USD 10.9bn;
 
31 March 2022: USD 11.2bn),
 
as well as property, equipment,
 
software and other items (30
 
June 2022: USD 12.4bn;
 
31 March 2022: USD 12.7bn).
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
36
 
Leverage ratio denominator
During the
 
second quarter
 
of 2022,
 
the LRD
 
decreased
 
by USD 47.5bn
 
to USD
 
1,025.4bn,
 
driven by
 
currency
 
effects
of USD 27.3bn and a USD
 
20.3bn decrease due
 
to asset size and
 
other movements.
 
Movement in leverage ratio
 
denominator
 
by key driver
USD bn
LRD as of
 
31.3.22
Currency
 
effects
Asset size and
 
other
LRD as of
 
30.6.22
On-balance sheet exposures (excluding derivative
 
exposures and SFTs)
1
 
845.1
 
(20.7)
 
(20.1)
 
804.3
Derivative exposures
 
101.8
 
(3.3)
 
5.7
 
104.1
Securities financing transactions
 
106.0
 
(2.6)
 
(5.2)
 
98.2
Off-balance sheet items
 
31.7
 
(0.7)
 
(0.9)
 
30.1
Deduction items
 
(11.6)
 
0.1
 
0.2
 
(11.3)
Total
 
1,073.0
 
(27.3)
 
(20.3)
 
1,025.4
1 The exposures exclude
 
derivative financial instruments,
 
cash collateral receivables
 
on derivative instruments,
 
receivables from
 
SFTs, and
 
margin loans,
 
as well as prime brokerage
 
receivables and financial
 
assets at
fair value not held for trading,
 
both related to SFTs. These
 
exposures are presented
 
separately under Derivative
 
exposures and Securities financing
 
transactions in this
 
table.
 
 
The LRD movements
 
described below exclude
 
currency effects.
 
On-balance
 
sheet
 
exposures de
 
creased
 
by
 
USD 20.1bn,
 
mainly
 
driven
 
by
 
lower
 
trading
 
portfolio
 
assets
 
in
 
the
Investment Bank, as
 
well as a
 
decrease in central bank
 
balances,
 
partly offset by purchases
 
of high-quality liquid
asset securities in Group Treasury.
Derivative
 
exposures
 
increased
 
by
 
USD 5.7bn,
 
mainly
 
driven
 
by
 
the
 
Investment
 
Bank,
 
reflecting
 
market-driven
movements and higher
 
margin requirements,
 
partly offset by
 
decreases due to lower
 
client activity
 
levels.
 
Securities financing
 
transactions decreased
 
by USD 5.2bn,
 
mainly due to
 
excess cash reinvestment
 
trade roll-offs in
Group Treasury,
 
as well as a decrease
 
resulting from improved
 
collateralization in
 
the Investment Bank.
 
Refer to the “Balance
 
sheet and off-balance
 
sheet” section of this
 
report for
 
more information
 
about balance
 
sheet
movements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
37
 
Leverage ratio denominator
 
by business division
 
and Group Functions
USD bn
Global Wealth
Management
 
Personal &
Corporate
Banking
Asset
Management
Investment
Bank
Group
Functions
Total
 
30.6.22
Total IFRS assets
 
397.1
 
222.4
 
18.6
 
388.3
 
86.8
 
1,113.2
Difference in scope of consolidation
1
 
0.0
 
0.0
 
(14.5)
 
(0.1)
 
0.1
 
(14.6)
Less: derivative exposures and SFTs
2
 
(28.3)
 
(12.1)
 
(0.1)
 
(216.1)
 
(37.6)
 
(294.3)
On-balance sheet exposures
 
368.8
 
210.3
 
4.0
 
172.0
 
49.2
 
804.3
Derivative exposures
 
6.8
 
1.1
 
0.0
 
88.8
 
7.5
 
104.1
Securities financing transactions
 
24.1
 
11.4
 
0.1
 
41.1
 
21.6
 
98.2
Off-balance sheet items
 
6.3
 
16.0
 
7.2
 
0.6
 
30.1
Items deducted from Swiss SRB tier 1 capital
 
(5.2)
 
(0.2)
 
(1.3)
 
(0.5)
 
(4.2)
 
(11.3)
Total
 
400.7
 
238.6
 
2.8
 
308.6
 
74.8
 
1,025.4
31.3.22
Total IFRS assets
 
407.9
 
231.9
 
23.0
 
381.3
 
95.9
 
1,139.9
Difference in scope of consolidation
1
 
0.0
 
0.0
 
(18.7)
 
(0.1)
 
0.0
 
(18.8)
Less: derivative exposures and SFTs
2
 
(27.9)
 
(12.1)
 
(0.1)
 
(189.3)
 
(46.7)
 
(276.0)
On-balance sheet exposures
 
380.0
 
219.8
 
4.2
 
191.9
 
49.2
 
845.1
Derivative exposures
 
7.0
 
1.3
 
0.0
 
87.2
 
6.2
 
101.8
Securities financing transactions
 
23.7
 
11.2
 
0.1
 
42.8
 
28.2
 
106.0
Off-balance sheet items
 
6.6
 
16.6
 
0.0
 
7.5
 
0.9
 
31.7
Items deducted from Swiss SRB tier 1 capital
 
(5.3)
 
(0.2)
 
(1.3)
 
(0.4)
 
(4.4)
 
(11.6)
Total
 
412.0
 
248.8
 
3.0
 
329.1
 
80.0
 
1,073.0
30.6.22 vs 31.3.22
Total IFRS assets
 
(10.7)
 
(9.5)
 
(4.4)
 
7.0
 
(9.1)
 
(26.7)
Difference in scope of consolidation
1
 
0.0
 
0.0
 
4.2
 
0.0
 
0.1
 
4.2
Less: derivative exposures and SFTs
2
 
(0.5)
 
0.0
 
0.0
 
(26.9)
 
9.1
 
(18.2)
On-balance sheet exposures
 
(11.2)
 
(9.5)
 
(0.2)
 
(19.9)
 
0.1
 
(40.7)
Derivative exposures
 
(0.2)
 
(0.3)
 
0.0
 
1.5
 
1.3
 
2.4
Securities financing transactions
 
0.3
 
0.1
 
0.0
 
(1.8)
 
(6.5)
 
(7.8)
Off-balance sheet items
 
(0.3)
 
(0.6)
 
0.0
 
(0.4)
 
(0.3)
 
(1.6)
Items deducted from Swiss SRB tier 1 capital
 
0.1
 
0.0
 
0.0
 
(0.1)
 
0.2
 
0.3
Total
 
(11.3)
 
(10.2)
 
(0.2)
 
(20.5)
 
(5.2)
 
(47.5)
1 Represents the
 
difference between
 
the IFRS
 
and the
 
regulatory scope
 
of consolidation,
 
which is
 
the applicable
 
scope for
 
the LRD
 
calculation.
 
2 The exposures
 
consist
 
of derivative
 
financial instruments,
 
cash
collateral receivables on derivative
 
instruments,
 
receivables from SFTs, and
 
margin loans, as well as
 
prime brokerage receivables
 
and financial assets at fair value
 
not held for trading, both
 
related to SFTs, all
 
of which
are in accordance with the regulatory
 
scope of consolidation. These
 
exposures are presented
 
separately under Derivative
 
exposures and Securities financing
 
transactions in this
 
table.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Capital
 
management
 
38
 
Equity attribution and return
 
on attributed equity
Under our
 
equity attribution
 
framework,
 
tangible equity
 
is attributed
 
based on
 
a weighting
 
of
 
50% each
 
for
 
average
risk-weighted assets
 
(RWA) and average
 
leverage ratio denominator
 
(LRD), which
 
both include resource
 
allocations
from Group Functions
 
to the business divisions (the
 
BDs). Average RWA and
 
LRD are converted to common
 
equity
tier 1 (CET1) capital
 
equivalents using capital
 
ratios of 12.5%
 
and 3.75%, respectively. If
 
the attributed
 
tangible
equity calculated under the weighted-driver
 
approach is less than the CET1 capital
 
equivalent of risk-based capital
(RBC) for any BD, the
 
CET1 capital equivalent
 
of RBC is used as a
 
floor for that BD.
In addition to tangible equity,
 
we allocate equity
 
to the BDs to support
 
goodwill and intangible
 
assets.
We also
 
allocate to
 
the
 
BDs attributed
 
equity related
 
to certain
 
CET1
 
deduction
 
items, such
 
as compensation-related
components and expected
 
losses on the advanced
 
internal ratings-based
 
portfolio, less general
 
provisions.
We attribute all
 
remaining Basel III capital deduction items
 
to Group
 
Functions. These items include
 
deferred tax
assets
 
(DTAs) recognized
 
for
 
tax
 
loss
 
carry-forwards, DTAs
 
on
 
temporary differences in
 
excess of
 
the
 
threshold,
accruals for shareholder
 
returns and
 
unrealized gains from
 
cash flow hedges.
 
Refer to the “Capital, liquidity
 
and funding, and
 
balance sheet”
 
section of our Annual
 
Report 2021 for more
information about the
 
equity attribution
 
framework
 
Refer to the “Balance
 
sheet and off-
 
balance sheet” section
 
of this report for
 
more information
 
about movements
 
in
equity attributable to shareholders
 
Average attributed
 
equity
For the quarter
 
ended
Year-to-date
USD bn
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Global Wealth Management
 
20.0
 
19.9
 
18.5
 
19.9
 
18.4
Personal & Corporate Banking
 
9.3
 
9.4
 
9.1
 
9.3
 
9.1
Asset Management
 
1.7
 
1.8
 
2.1
 
1.8
 
2.2
Investment Bank
 
13.3
 
13.2
 
13.0
 
13.2
 
13.0
Group Functions
 
13.5
 
15.5
 
15.7
 
14.5
 
15.9
of which: deferred tax assets
1
 
5.3
 
5.4
 
6.1
 
5.3
 
6.2
of which: related to retained RWA and LRD
2
 
2.9
 
3.1
 
3.1
 
3.0
 
3.2
of which: accruals for shareholder returns and others
3
 
5.4
 
7.1
 
6.4
 
6.2
 
6.5
Average equity attributed to
 
business divisions and Group Functions
 
57.8
 
59.8
 
58.4
 
58.8
 
58.6
1 Includes average attributed
 
equity related to the
 
Basel III capital deduction
 
items for deferred
 
tax assets (deferred tax
 
assets recognized
 
for tax loss carry
 
-forwards and deferred tax
 
assets on temporary
 
differences,
excess over threshold), as well
 
as retained RWA and
 
LRD related to deferred tax
 
assets.
 
2 Excludes average
 
attributed equity
 
related to retained RWA
 
and LRD related to
 
deferred tax assets.
 
3 Includes attributed
equity related to dividend accruals,
 
unrealized gains from cash flow hedges,
 
and a balancing item for capital held in excess
 
of the 12.5% / 3.75% capital and leverage ratio
 
calibration thresholds for equity
 
attribution.
 
Return on attributed equity
1
For the quarter
 
ended
Year-to-date
in %
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Global Wealth Management
 
23.2
 
26.3
 
27.9
 
24.7
 
29.3
Personal & Corporate Banking
 
17.8
 
18.2
 
21.8
 
18.0
 
19.5
Asset Management
 
221.3
 
39.5
 
49.0
 
129.5
 
44.7
Investment Bank
 
12.3
 
28.2
 
20.6
 
20.2
 
16.7
1 Return on attributed equity for
 
Group Functions is not
 
shown, as it is not meaningful.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Liquidity
 
and
 
funding
 
management
 
39
 
Liquidity and funding management
Strategy, objectives
 
and governance
 
This
 
section
 
provides
 
liquidity
 
and
 
funding
 
management information
 
and
 
should
 
be
 
read
 
in
 
conjunction with
“Liquidity and
 
funding management” in
 
the “Capital, liquidity
 
and
 
funding, and
 
balance sheet”
 
section of
 
our
Annual Report 2021, which provides more information about the Group’s strategy, objectives and governance in
connection with liquidity
 
and funding management.
Liquidity coverage
 
ratio
The
 
quarterly average
 
liquidity coverage
 
ratio
 
(the
 
LCR)
 
of
 
UBS
 
Group
 
increased 1 percentage
 
point
 
to
 
161%,
remaining above the
 
prudential requirement communicated by
 
the Swiss
 
Financial Market Supervisory Authority
(FINMA).
The movement in the average LCR was driven by a
 
decrease in net cash outflows of USD 3bn to USD 155bn due
to
 
lower
 
outflows
 
from
 
customer deposit
 
balances, partly
 
offset
 
by
 
a
 
decrease in
 
high-quality
 
liquid
 
assets
 
of
USD 3bn to USD 249bn,
 
mainly reflecting
 
lower average cash
 
balances,
 
driven by debt maturities
 
and decreases in
customer deposits, partly
 
offset by lower funding
 
consumption
 
in the business divisions.
 
Refer to our
 
30 June 2022 Pillar
 
3 report,
 
which will be available
 
as of 19 August 2022
 
under “Pillar 3 disclosures”
 
at
ubs.com/investors
, and to “Liquidity
 
and funding management”
 
in the “Capital,
 
liquidity and funding,
 
and balance
sheet” section of our Annual
 
Report 2021 for more
 
information about
 
the LCR
 
Liquidity coverage ratio
USD bn, except where indicated
Average 2Q22
1
Average 1Q22
1
High-quality liquid assets
 
249
 
253
Net cash outflows
 
155
 
158
Liquidity coverage ratio (%)
2
 
161
 
160
1 Calculated based on an average
 
of 64 data points in the second quarter of 2022
 
and 64 data points in the first quarter
 
of 2022.
 
2 Calculated after the application
 
of haircuts and inflow and outflow
 
rates, as well
as, where applicable, caps
 
on Level 2 assets and cash
 
inflows.
 
Net stable funding
 
ratio
 
As of 30 June 2022,
 
the net stable funding
 
ratio (the NSFR)
 
of UBS Group decreased
 
1 percentage point
 
to 121%,
remaining above the
 
prudential requirement
 
communicated
 
by FINMA.
The movement in
 
the NSFR was driven
 
by USD 18bn lower available stable
 
funding, mainly due to
 
a decrease in
customer deposit
 
balances,
 
and USD
 
11bn
 
lower
 
required
 
stable funding,
 
mainly due
 
to a
 
decrease in
 
trading
 
assets.
 
 
Refer to our 30 June 2022
 
Pillar 3 report,
 
which will be available
 
as of 19 August 2022
 
under “Pillar 3 disclosures”
 
at
ubs.com/investors
, and to “Liquidity
 
and funding management”
 
in the “Capital,
 
liquidity and funding,
 
and balance
sheet” section of our Annual
 
Report 2021 for more
 
information about
 
the NSFR
 
Net stable funding ratio
USD bn, except where indicated
30.6.22
31.3.22
Available stable funding
 
552
 
569
Required stable funding
 
456
 
468
Net stable funding ratio (%)
 
121
 
122
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Balance
 
sheet
 
and
 
off
-
balance
 
sheet
 
40
 
Balance sheet and off-balance sheet
Strategy, objectives
 
and governance
This
 
section provides
 
balance
 
sheet and
 
off-balance sheet
 
information and
 
should be
 
read in
 
conjunction with
“Balance sheet and
 
off-balance sheet” in
 
the “Capital, liquidity and
 
funding, and balance sheet”
 
section of our
Annual Report
 
2021, which
 
provides more
 
information about
 
the Group’s
 
balance sheet
 
and off-balance
 
sheet
positions.
Balances disclosed
 
in this report represent
 
quarter-end
 
positions, unless indicated
 
otherwise. Intra-quarter
 
balances
fluctuate in the ordinary
 
course of business and
 
may differ from quarter-end
 
positions.
Balance sheet assets
 
(30 June 2022
 
vs 31 March 2022)
Total
 
assets
 
were
 
USD 1,113bn
 
as
 
of
 
30
 
June
 
2022.
 
The
 
decrease
 
of
 
USD 27bn
 
included
 
currency
 
effects
 
of
approximately USD
 
26bn.
Cash and balances at
 
central banks decreased by USD 16bn, mainly driven by
 
lower customer deposits in Global
Wealth Management,
 
higher margin
 
requirements, currency
 
effects, as
 
well as net
 
redemptions of
 
short- and long-
term
 
debt,
 
partly
 
offset
 
by
 
lower
 
funding
 
consumption
 
in
 
the
 
Investment
 
Bank
 
and
 
net
 
roll-offs
 
of
 
securities
financing transactions.
 
Trading
 
portfolio assets decreased by USD 15bn, primarily reflecting lower inventory levels
held to
 
hedge client
 
positions in
 
our Financing
 
and Derivative
 
& Solution
 
businesses
 
in the
 
Investment
 
Bank.
 
Lending
assets
 
decreased
 
by
 
USD 10bn,
 
predominantly
 
reflecting
 
currency
 
effects.
 
Securities
 
financing
 
transactions
 
at
amortized cost decreased by USD 6bn, predominantly reflecting excess cash reinvestment trade roll-offs in Group
Treasury.
 
Non-financial
 
assets
 
and
 
financial
 
assets
 
for
 
unit-linked
 
investment
 
contracts
 
decreased
 
by
 
USD 5bn,
mostly
 
reflecting
 
market
-
driven
 
decreases
 
and
 
outflows
 
from
 
unit
-
linked
 
investment
 
contracts
 
in
 
Asset
Management.
These decreases
 
were
 
partly offset
 
by a
 
USD 25bn
 
increase
 
in Derivatives
 
and cash
 
collateral
 
receivables
 
on derivative
instruments,
 
mainly
 
in
 
our
 
Derivatives &
 
Solutions
 
and
 
Financing businesses,
 
primarily
 
reflecting
 
market-driven
movements on
 
foreign currency
 
and interest
 
rate contracts
 
amid volatility
 
in exchange
 
rates
 
and increases
 
in interest
rates,
 
respectively.
 
Other financial assets measured at amortized cost and fair value increased by USD 3bn, mainly
driven by purchases of
 
securities in our high-quality
 
liquid asset portfolio.
 
Refer to the “Consolidated
 
financial statements”
 
section of this report
 
for more information
Included within Other
 
financial assets measured at
 
amortized cost and fair
 
value is
 
a portfolio of
 
financial assets
reclassified effective from 1 April 2022 from Financial assets measured at fair value through other comprehensive
income
 
to
 
Other
 
financial
 
assets
 
measured
 
at
 
amortized
 
cost,
 
in
 
line
 
with
 
the
 
principles
 
in
 
IFRS 9,
Financial
Instruments
.
 
Refer to “Note 1 Basis
 
of accounting” in the
 
“Consolidated financial
 
statements” section
 
of this report for
 
more
information
 
Assets
As of
% change from
USD bn
30.6.22
31.3.22
31.3.22
Cash and balances at central banks
 
190.4
 
206.8
 
(8)
Lending
1
 
400.5
 
410.1
 
(2)
Securities financing transactions at amortized cost
 
63.3
 
69.5
 
(9)
Trading portfolio
2
 
99.5
 
114.7
 
(13)
Derivatives and cash collateral receivables
 
on derivative instruments
 
204.3
 
179.6
 
14
Brokerage receivables
 
19.3
 
20.8
 
(7)
Other financial assets measured at amortized cost and
 
fair value
3
 
83.1
 
80.3
 
3
Non-financial assets and financial assets for unit
 
-linked investment contracts
 
52.9
 
58.2
 
(9)
Total assets
 
1,113.2
 
1,139.9
 
(2)
1 Consists of loans and
 
advances to customers
 
and banks.
 
2 Consists of financial
 
assets at fair value
 
held for trading.
 
3 Consists of financial
 
assets at fair value
 
not held for trading,
 
financial assets measured
 
at
fair value through other comprehensive
 
income and other financial
 
assets measured at amortized
 
cost, but excludes financial
 
assets for unit-linked
 
investment contracts.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Balance
 
sheet
 
and
 
off
-
balance
 
sheet
 
41
 
Balance sheet liabilities
 
(30 June 2022 vs
 
31 March 2022)
Total
 
liabilities were
 
USD 1,056bn as
 
of
 
30
 
June
 
2022. The
 
decrease of
 
USD 25bn included
 
currency effects
 
of
approximately USD
 
22bn.
Customer deposits decreased by USD 29bn,
 
mainly reflecting decreases in Global Wealth Management in EMEA,
the
 
Americas
 
and
 
Asia
 
Pacific,
 
as
 
well
 
as
 
currency
 
effects
 
of
 
USD 12bn.
 
Customer
 
time
 
deposits
 
increased
 
by
USD 17bn to
 
USD 67bn, mainly
 
reflecting
 
shifts from
 
on-demand customer
 
deposits in
 
Global Wealth
 
Management
as interest rates increased during the quarter. Short-term borrowings
 
decreased by USD 8bn, mainly
 
driven by net
maturities
 
of commercial
 
paper and
 
certificates
 
of deposit
 
in Group
 
Treasury,
 
as well
 
as lower
 
amounts
 
due to
 
banks,
mainly in Personal
 
& Corporate Banking.
 
Trading portfolio
 
liabilities decreased
 
by USD 4bn,
 
driven by
 
our Financing
business in
 
the
 
Investment Bank,
 
mainly reflecting
 
a reduction
 
in
 
short positions
 
after the
 
end of
 
the
 
Japanese
dividend season.
 
Non-financial
 
liabilities and
 
financial
 
liabilities related
 
to
 
unit-linked
 
investment
 
contracts
 
decreased
by USD 4bn,
 
driven by
 
decreases in
 
unit-linked investment
 
contracts in
 
line with
 
the
 
asset side,
 
partly offset
 
by
higher compensation-related
 
liabilities. Debt
 
issued designated
 
at fair value
 
and long-term
 
debt issued measured
 
at
amortized
 
cost decreased
 
by
 
USD 3bn, mainly
 
driven
 
by
 
currency effects
 
partly offset
 
by
 
net
 
issuances of
 
debt
measured at fair value
 
in our Derivatives & Solutions
 
business.
These decreases were
 
partly offset by a USD
 
19bn increase in Derivatives
 
and cash collateral
 
payables on
 
derivative
instruments,
 
mainly
 
in
 
our
 
Derivatives &
 
Solutions
 
and
 
Financing businesses,
 
primarily
 
reflecting
 
market-driven
movements,
 
broadly in line with the
 
asset side. Other financial
 
liabilities measured
 
at amortized cost and fair
 
value
increased by
 
USD 3bn, mainly reflecting
 
higher securities financing transactions measured
 
at fair
 
value in
 
Group
Treasury.
 
The “Liabilities
 
by product
 
and currency”
 
table
 
in this
 
section provides
 
more information
 
about
 
our funding
 
sources.
 
Refer to “Bondholder
 
information” at
 
ubs.com/investors
for more information
 
about capital and senior
 
debt
instruments
 
 
Refer to the “Consolidated
 
financial statements”
 
section of this report
 
for more information
 
Liabilities and equity
As of
 
% change from
USD bn
30.6.22
31.3.22
31.3.22
Short-term borrowings
1
 
46.7
 
54.2
 
(14)
Securities financing transactions at amortized cost
 
6.0
 
7.1
 
(16)
Customer deposits
 
512.2
 
541.5
 
(5)
Debt issued designated at fair value and long-term debt
 
issued measured at amortized cost
2
 
162.6
 
165.4
 
(2)
Trading portfolio
3
 
30.4
 
34.7
 
(12)
Derivatives and cash collateral payables on derivative
 
instruments
 
197.4
 
178.1
 
11
Brokerage payables
 
49.8
 
48.0
 
4
Other financial liabilities measured at amortized
 
cost and fair value
4
 
24.0
 
21.3
 
13
Non-financial liabilities and financial liabilities related to unit
 
-linked investment contracts
 
26.9
 
30.5
 
(12)
Total liabilities
 
1,056.0
 
1,080.7
 
(2)
Share capital
 
0.3
 
0.3
 
(6)
Share premium
 
13.2
 
15.4
 
(14)
Treasury shares
 
(4.4)
 
(5.8)
 
(24)
Retained earnings
 
46.6
 
46.5
 
0
Other comprehensive income
5
 
1.2
 
2.5
 
(55)
Total equity attributable to
 
shareholders
 
56.8
 
58.9
 
(3)
Equity attributable to non-controlling interests
 
0.3
 
0.4
 
(5)
Total equity
 
57.2
 
59.2
 
(3)
Total liabilities and
 
equity
 
1,113.2
 
1,139.9
 
(2)
1 Consists
 
of short-term
 
debt issued
 
measured at
 
amortized cost
 
and amounts
 
due to
 
banks.
 
2 The
 
classification
 
of debt
 
issued measured
 
at amortized
 
cost into
 
short-term and
 
long-term is
 
based on
 
original
contractual maturity and therefore long-term
 
debt also includes debt with a remaining time to maturity of less than one year.
 
This classification does not consider any
 
early redemption features.
 
3 Consists of financial
liabilities at fair value held
 
for trading.
 
4 Consists of
 
other financial liabilities
 
measured at amortized cost
 
and other financial liabilities
 
designated at fair value,
 
but excludes financial
 
liabilities related to
 
unit-linked
investment contracts.
 
5 Excludes other comprehensive
 
income related to
 
defined benefit plans and own credit,
 
which is recorded directly
 
in Retained earnings.
 
Equity (30 June 2022
 
vs 31 March 2022)
Equity attributable to
 
shareholders decreased
 
by USD 2,010m to USD
 
56,845m as of 30 June
 
2022.
The
 
decrease
 
of
 
USD 2,010m
 
was
 
mainly
 
driven
 
by
 
distributions
 
to
 
shareholders of
 
USD 1,668m,
 
reflecting
 
a
dividend payment of USD 0.50 per
 
share. In addition, net
 
treasury share activity reduced equity by
 
USD 1,633m.
This was predominantly
 
due to repurchases
 
of USD 1,632m
 
of shares under
 
our 2022 share repurchase
 
program.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Balance
 
sheet
 
and
 
off
-
balance
 
sheet
 
42
 
These
 
decreases
 
were
 
partly
 
offset
 
by
positive
 
t
otal
 
comprehensive
 
income
 
attributable
 
to
 
s
hareholders
 
of
 
USD 1,097m,
 
reflecting net
 
profit of
 
USD 2,108m and
 
negative other
 
comprehensive
 
income (OCI)
 
of USD 1,011m.
OCI
 
mainly
 
included
 
negative
 
cash
 
flow
 
hedge
 
OCI
 
of
 
USD 1,171m, negative
 
OCI
 
related
 
to
 
foreign
 
currency
translation
 
of
 
USD 577m, positive
 
OCI
 
associated
 
with
 
financial
 
assets
 
measured
 
at
 
fair
 
value
 
through OCI
 
of
USD 330m, positive
 
OCI related
 
to own
 
credit on
 
financial liabilities
 
designated at
 
fair
 
value
 
of
 
USD 271m and
positive defined benefit
 
plan OCI of USD
 
115m.
In
 
the
 
second
 
quarter of
 
2022, we
 
canceled
 
177,787,273 shares
 
purchased under
 
our
 
2021
 
share
 
repurchase
program, as approved
 
by shareholders
 
at the 2022 Annual
 
General Meeting. The
 
cancellation of shares resulted
 
in
reclassifications within equity
 
but had no net effect
 
on our total equity
 
attributable to shareholders.
 
Refer to the “Share
 
information and earnings
 
per share” section
 
of this report for
 
more information
 
about our
share repurchase
 
programs
 
Refer to the “Group
 
performance” and “Consolidated
 
financial statements”
 
sections of this report
 
for more
information
 
Liabilities by product
 
and currency
USD bn
As a percentage of total liabilities
All currencies
All currencies
USD
CHF
EUR
Other
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
Short-term borrowings
46.7
54.2
4.4
5.0
2.3
2.8
0.4
0.5
0.6
0.7
1.0
1.1
of which: amounts due to banks
15.2
16.6
1.4
1.5
0.5
0.5
0.4
0.4
0.1
0.2
0.4
0.4
of which: short-term debt issued
1
31.5
37.5
3.0
3.5
1.8
2.3
0.0
0.0
0.5
0.5
0.6
0.7
Securities financing transactions at
amortized cost
6.0
7.1
0.6
0.7
0.5
0.5
0.0
0.0
0.0
0.0
0.0
0.1
Customer deposits
512.2
541.5
48.5
50.1
22.5
23.5
17.0
17.4
4.8
5.0
4.2
4.3
of which: demand deposits
211.2
244.8
20.0
22.6
6.8
8.6
6.1
6.4
4.1
4.3
3.0
3.4
of which: retail savings / deposits
234.3
246.8
22.2
22.8
11.0
11.6
10.7
10.7
0.5
0.5
0.0
0.0
of which: time deposits
66.7
49.9
6.3
4.6
4.7
3.4
0.2
0.2
0.2
0.2
1.2
0.9
Debt issued designated at fair value
and long-term debt issued measured
at amortized cost
2
162.6
165.4
15.4
15.3
9.4
9.2
1.6
1.6
3.0
3.1
1.4
1.4
Trading portfolio
3
30.4
34.7
2.9
3.2
1.1
1.0
0.1
0.1
0.7
0.8
0.9
1.3
Derivatives and cash collateral
payables on derivative instruments
197.4
178.1
18.7
16.5
15.7
13.4
0.4
0.3
1.4
1.4
1.2
1.4
Brokerage payables
49.8
48.0
4.7
4.4
3.5
3.3
0.0
0.0
0.3
0.3
0.9
0.8
Other financial liabilities measured at
amortized cost and fair value
4
24.0
21.3
2.3
2.0
1.3
0.9
0.2
0.2
0.5
0.5
0.3
0.3
Non-financial liabilities and financial
liabilities related to unit-linked
investment contracts
26.9
30.5
2.5
2.8
0.5
0.4
0.1
0.1
0.3
0.4
1.6
2.0
Total liabilities
1,056.0
1,080.7
100.0
100.0
56.8
55.0
19.9
20.2
11.7
12.2
11.5
12.6
1 Short-term debt issued consists
 
of certificates of deposit, commercial
 
paper, acceptances
 
and promissory notes,
 
and other money market
 
paper.
 
2 The classification
 
of debt issued measured at amortized
 
cost into
short-term and long-term
 
is based on
 
original contractual
 
maturity and therefore
 
long-term debt
 
also includes
 
debt with a
 
remaining time
 
to maturity of
 
less than one
 
year. This
 
classification does
 
not consider any
early redemption features.
 
3 Consists of financial liabilities
 
at fair value held for trading.
 
4 Consists of other financial
 
liabilities measured at amortized
 
cost and other financial liabilities designated
 
at fair value, but
excludes financial liabilities
 
related to unit-linked
 
investment contracts.
 
Off-balance sheet (30
 
June 2022 vs 31 March
 
2022)
Guarantees and Loan commitments
 
were broadly unchanged as of 30
 
June 2022 compared
 
with 31 March 2022.
Committed unconditionally revocable credit lines decreased by USD 2bn, driven by
 
currency effects in Personal &
Corporate Banking and a
 
decrease in credit lines
 
provided to corporate clients in
 
our Global Banking business in
the Investment
 
Bank. Forward
 
starting
 
reverse repurchase
 
agreements and
 
Forward starting
 
repurchase
 
agreements
decreased by
 
USD 2bn and USD 1bn,
 
respectively, in Group
 
Treasury, reflecting fluctuations
 
in levels
 
of
 
business
division activity in short-dated
 
securities financing transactions.
 
Off-balance sheet
As of
% change from
USD bn
30.6.22
31.3.22
31.3.22
Guarantees
1,2
 
20.9
 
20.8
 
0
Loan commitments
1,3
 
37.7
 
38.0
 
(1)
Committed unconditionally revocable credit lines
 
39.8
 
41.4
 
(4)
Forward starting reverse repurchase
 
agreements
3
 
4.0
 
6.4
 
(38)
Forward starting repurchase
 
agreements
3
 
2.9
 
3.4
 
(16)
1 Guarantees and loan commitments are shown net of sub-participations.
 
2 Includes guarantees measured at fair value through
 
profit or loss.
 
3 Derivative loan commitments,
 
as well as forward starting repurchase
and reverse repurchase agreements,
 
measured at fair value
 
through profit or loss
 
are not included. Refer
 
to “Note 9 Derivative
 
instruments” in the “Consolidated
 
financial statements”
 
section of this report for more
information.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Risk,
 
capital,
 
liquidity
 
and
 
funding,
 
and
 
balance
 
sheet
 
|
 
Share
 
information
 
and
 
earnings
 
per
 
share
 
43
 
Share information and earnings per share
UBS Group AG shares
 
are
 
listed
 
on
 
the
 
SIX
 
Swiss
 
Exchange
 
(SIX). They
 
are
 
also
 
listed
 
on
 
the
 
New
 
York
 
Stock
Exchange
 
(the
 
NYSE)
 
as
 
global
 
registered
 
shares.
 
Each
 
share
 
has
 
a
 
nominal
 
value
 
of
 
CHF 0.10.
 
Shares
 
issued
decreased
 
in
 
the
 
second
 
quarter
 
of
 
2022,
 
as
 
177,787,273
 
shares
 
acquired
 
under
 
our
 
2021
 
share
 
repurchase
program were canceled
 
by means of a capital
 
reduction, as approved
 
by shareholders
 
at the 2022 Annual General
Meeting. We
 
also intend
 
to cancel
 
the remaining
 
shares purchased
 
under the
 
2021 program,
 
subject to
 
shareholder
approval.
We held
 
267m shares as of
 
30 June 2022, of
 
which 155m shares had
 
been acquired under our
 
2021 and 2022
share repurchase program for cancellation purposes. The remaining 112m shares are primarily held to
 
hedge our
share delivery obligations
 
related to employee
 
share-based compensation
 
and participation
 
plans.
Treasury
 
shares
 
held
 
decreased
 
by
 
86m
 
shares
 
in
 
the
 
second
 
quarter
 
of
 
2022.
 
This
 
mainly
 
reflected
 
the
aforementioned cancellation
 
of
 
178m
 
shares, partly
 
offset
 
by
 
repurchases of
 
92.7m
 
shares
 
(acquisition cost
 
of
CHF 1,575m, or USD 1,633m)
 
under our 2022
 
share repurchase program.
From 1 January 2022
 
to 30 June 2022,
 
we repurchased 180m
 
shares for
 
a total acquisition
 
cost of
 
CHF 3,091m
(USD 3,270m) under the
 
2021 and
 
2022 share repurchase programs.
 
We expect to
 
execute around
 
USD 5bn of
repurchases in aggregate
 
in 2022 under the
 
2021 and 2022 share
 
repurchase programs.
 
Refer to the “Equity,
 
CET1 capital and returns”
 
table in the
 
“Group performance”
 
section of this report
 
for more
information about equity
 
attributable to
 
shareholders and tangible
 
equity attributable
 
to shareholders
 
 
As of or for the quarter ended
As of or year-to-date
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Basic and diluted earnings (USD m)
Net profit / (loss) attributable to shareholders for basic
 
EPS
 
2,108
 
2,136
 
2,006
 
4,244
 
3,830
Less: (profit) / loss on own equity derivative contracts
 
(5)
 
0
 
(1)
 
(3)
 
(2)
Net profit / (loss) attributable to shareholders for diluted
 
EPS
 
2,103
 
2,136
 
2,005
 
4,241
 
3,828
Weighted average
 
shares outstanding
Weighted average shares outstanding for basic
 
EPS
1
 
3,304,598,259
 
3,380,254,237
 
3,502,478,236
 
3,342,426,249
 
3,520,450,363
Effect of dilutive potential shares resulting from notional employee
 
shares, in-the-money
options and warrants outstanding
2
 
128,725,327
 
148,405,048
 
138,873,741
 
138,710,134
 
144,776,805
Weighted average shares outstanding for diluted
 
EPS
 
3,433,323,586
 
3,528,659,285
 
3,641,351,977
 
3,481,136,383
 
3,665,227,168
Earnings per share (USD)
Basic
 
0.64
 
0.63
 
0.57
 
1.27
 
1.09
Diluted
 
0.61
 
0.61
 
0.55
 
1.22
 
1.04
Shares outstanding and potentially dilutive
 
instruments
Shares issued
 
3,524,635,722
 
3,702,422,995
 
3,702,422,995
 
3,524,635,722
 
3,702,422,995
Treasury shares
3
 
267,270,042
 
353,284,628
 
225,877,281
 
267,270,042
 
225,877,281
of which: related to the 2021 share repurchase program
 
62,548,000
 
240,335,273
 
83,090,525
 
62,548,000
 
83,090,525
of which: related to the 2022 share repurchase program
 
92,749,500
 
92,749,500
Shares outstanding
 
3,257,365,680
 
3,349,138,367
 
3,476,545,714
 
3,257,365,680
 
3,476,545,714
Potentially dilutive instruments
4
 
5,366,916
 
12,337,848
 
10,459,279
 
5,404,012
 
12,229,370
Other key figures
Total book value per share (USD)
 
17.45
 
17.57
 
16.90
 
17.45
 
16.90
Tangible book value per
 
share (USD)
 
15.51
 
15.67
 
15.05
 
15.51
 
15.05
Share price (USD)
5
 
16.11
 
19.64
 
15.31
 
16.11
 
15.31
Market capitalization (USD m)
 
52,475
 
65,775
 
53,218
 
52,475
 
53,218
1 The weighted average shares outstanding for basic EPS
 
are calculated by taking the number of shares at the beginning of the period, adjusted by the number
 
of shares acquired or issued during the period, multiplied
by a time-weighted factor for the period outstanding. As a result,
 
balances are affected by the timing of acquisitions and issuances
 
during the period.
 
2 The weighted average number of shares
 
for notional employee
awards with performance conditions
 
reflects all potentially dilutive
 
shares that are expected to vest
 
under the terms of the
 
awards.
 
3 Based on a settlement
 
date view.
 
4 Reflects potential shares that
 
could dilute
basic earnings per share in
 
the future, but
 
were not dilutive for the
 
periods presented. It
 
mainly includes equity derivative
 
contracts and equit
 
y-based awards subject
 
to absolute and
 
relative performance conditions.
 
5 Represents the share price as
 
listed on the SIX Swiss Exchange,
 
translated to US dollars
 
using the closing exchange
 
rate as of the respective
 
date.
 
Ticker symbols UBS Group
 
AG
Security identification
 
codes
Trading exchange
SIX / NYSE
Bloomberg
Reuters
ISIN
CH0244767585
SIX Swiss Exchange
UBSG
UBSG SW
UBSG.S
Valoren
24 476 758
New York Stock
 
Exchange
UBS
UBS UN
UBS.N
CUSIP
CINS H42097 10 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
45
 
UBS Group AG interim consolidated financial
statements (unaudited)
Income statement
For the quarter
 
ended
Year-to-date
USD m
Note
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Interest income from financial instruments measured
 
at amortized cost and fair value through
other comprehensive income
3
2,380
2,144
2,106
4,525
4,203
Interest expense from financial instruments measured
 
at amortized cost
3
(1,070)
(781)
(836)
(1,852)
(1,669)
Net interest income from financial instruments measured
 
at fair value through profit or
 
loss
3
355
408
357
763
706
Net interest income
3
1,665
1,771
1,628
3,436
3,241
Other net income from financial instruments measured
 
at fair value through profit or
 
loss
1,619
2,226
1,479
3,845
2,787
Fee and commission income
4
5,224
5,837
6,041
11,061
12,210
Fee and commission expense
4
(450)
(484)
(484)
(934)
(962)
Net fee and commission income
4
4,774
5,353
5,557
10,127
11,248
Other income
859
32
233
891
297
Total revenues
8,917
9,382
8,897
18,299
17,574
Credit loss expense / (release)
7
7
18
(80)
25
(108)
Personnel expenses
5
4,422
4,920
4,772
9,343
9,573
General and administrative expenses
6
1,370
1,208
1,103
2,578
2,192
Depreciation, amortization and impairment of non
 
-financial assets
503
506
509
1,009
1,026
Operating expenses
6,295
6,634
6,384
12,929
12,790
Operating profit / (loss) before
 
tax
2,615
2,729
2,593
5,344
4,891
Tax expense / (benefit)
497
585
581
1,082
1,053
Net profit / (loss)
2,118
2,144
2,012
4,262
3,838
Net profit / (loss) attributable to non-controlling
 
interests
10
8
6
18
9
Net profit / (loss) attributable to shareholders
2,108
2,136
2,006
4,244
3,830
Earnings per share (USD)
Basic
0.64
0.63
0.57
1.27
1.09
Diluted
0.61
0.61
0.55
1.22
1.04
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
46
 
 
Statement of comprehensive
 
income
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Comprehensive income attributable
 
to shareholders
1
Net profit / (loss)
2,108
2,136
2,006
4,244
3,830
Other comprehensive income that
 
may be reclassified to the income statement
Foreign currency translation
Foreign currency translation movements related
 
to net assets of foreign operations,
 
before tax
(1,030)
(482)
463
(1,512)
(999)
Effective portion of changes in fair value of hedging
 
instruments designated as net investment hedges,
 
before tax
443
217
(202)
660
506
Foreign currency translation differences on foreign
 
operations reclassified to the
 
income statement
8
0
(10)
8
(9)
Effective portion of changes in fair value of hedging
 
instruments designated as net investment hedges reclassified
 
to
the income statement
(4)
0
8
(4)
8
Income tax relating to foreign currency
 
translations, including the impact of net investment
 
hedges
5
2
(4)
8
6
Subtotal foreign currency translation, net
 
of tax
(577)
(263)
255
(840)
(489)
Financial assets measured at
 
fair value through other comprehensive
 
income
Net unrealized gains / (losses), before tax
(3)
(439)
21
(442)
(110)
Net realized gains / (losses) reclassified to the income
 
statement from equity
0
0
(3)
0
(9)
Reclassification of financial assets to Other financial assets
 
measured at amortized cost
2
449
449
Income tax relating to net unrealized gains / (losses)
(116)
112
(4)
(3)
31
Subtotal financial assets measured at fair value through
 
other comprehensive income, net of tax
330
(327)
14
3
(88)
Cash flow hedges of interest rate
 
risk
Effective portion of changes in fair value of derivative
 
instruments designated as cash flow hedges,
 
before tax
(1,298)
(2,465)
542
(3,763)
(630)
Net (gains) / losses reclassified to the income statement
 
from equity
(149)
(237)
(268)
(386)
(522)
Income tax relating to cash flow hedges
276
518
(51)
794
215
Subtotal cash flow hedges, net of tax
(1,171)
(2,184)
222
(3,355)
(937)
Cost of hedging
Cost of hedging, before tax
21
77
(16)
98
(23)
Income tax relating to cost of hedging
0
0
0
0
0
Subtotal cost of hedging, net of tax
21
77
(16)
98
(23)
Total other comprehensive
 
income that may be reclassified to
 
the income statement, net of tax
(1,396)
(2,697)
475
(4,093)
(1,537)
Other comprehensive income that will not
 
be reclassified to the income
 
statement
Defined benefit plans
Gains / (losses) on defined benefit plans, before
 
tax
122
41
(21)
163
(157)
Income tax relating to defined benefit plans
(7)
(1)
4
(8)
27
Subtotal defined benefit plans, net of tax
115
40
(17)
155
(130)
Own credit on financial liabilities designated
 
at fair value
Gains / (losses) from own credit on financial liabilities designated
 
at fair value, before tax
296
423
118
719
89
Income tax relating to own credit on
 
financial liabilities designated at fair value
(26)
0
0
(26)
0
Subtotal own credit on financial liabilities designated
 
at fair value, net of tax
271
423
118
693
89
Total other comprehensive
 
income that will not be reclassified to
 
the income statement, net of tax
385
463
102
848
(40)
Total other comprehensive
 
income
(1,011)
(2,234)
576
(3,245)
(1,577)
Total comprehensive
 
income attributable to shareholders
1,097
(98)
2,582
999
2,252
Comprehensive income attributable
 
to non-controlling interests
Net profit / (loss)
10
8
6
18
9
Total other comprehensive
 
income that will not be reclassified to the
 
income statement, net of tax
(28)
18
14
(10)
2
Total comprehensive
 
income attributable to non-controlling interests
(17)
26
20
9
10
Total
 
comprehensive income
Net profit / (loss)
2,118
2,144
2,012
4,262
3,838
Other comprehensive income
(1,039)
(2,216)
591
(3,255)
(1,576)
of which: other comprehensive income that may be reclassified to
 
the income statement
(1,396)
(2,697)
475
(4,093)
(1,537)
of which: other comprehensive income that will not be
 
reclassified to the income statement
357
481
116
839
(39)
Total comprehensive
 
income
1,079
(72)
2,602
1,008
2,263
1 Refer to
 
the “Group performance” section of this report for more information.
 
2 Effective 1 April 2022, a portfolio of assets previously classified as Financial assets measured at fair value through other
 
comprehensive
income was reclassified to
 
Other financial assets measured
 
at amortized cost. Refer
 
to Note 1 for more information.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
47
 
 
Balance sheet
USD m
Note
30.6.22
31.3.22
31.12.21
Assets
Cash and balances at central banks
190,353
206,773
192,817
Loans and advances to banks
16,596
17,914
15,480
Receivables from securities financing transactions
63,291
69,452
75,012
Cash collateral receivables on derivative
 
instruments
 
9
43,763
39,253
30,514
Loans and advances to customers
 
7
383,898
392,189
397,761
Other financial assets measured at amortized cost
 
10
37,528
28,697
26,209
Total financial assets
 
measured at amortized cost
735,428
754,279
737,794
Financial assets at fair value held for trading
 
8
99,507
114,744
130,821
of which: assets pledged as collateral that may be
 
sold or repledged by counterparties
33,830
40,217
43,397
Derivative financial instruments
8, 9
160,524
140,309
118,142
Brokerage receivables
 
8
19,289
20,762
21,839
Financial assets at fair value not held for trading
 
8
57,637
60,999
60,080
Total financial assets
 
measured at fair value through profit or
 
loss
336,957
336,814
330,882
Financial assets measured at
 
fair value through other comprehensive
 
income
 
8
2,251
9,093
8,844
Investments in associates
1,094
1,150
1,243
Property, equipment
 
and software
12,049
12,491
12,888
Goodwill and intangible assets
6,312
6,383
6,378
Deferred tax assets
9,119
9,131
8,876
Other non-financial assets
 
10
9,984
10,581
10,277
Total assets
1,113,193
1,139,922
1,117,182
Liabilities
Amounts due to banks
15,202
16,649
13,101
Payables from securities financing
 
transactions
5,956
7,110
5,533
Cash collateral payables on derivative instruments
 
9
40,468
39,609
31,798
Customer deposits
512,216
541,470
542,007
Debt issued measured at amortized cost
 
12
121,896
131,492
139,155
Other financial liabilities measured at amortized cost
 
10
9,930
9,641
9,001
Total financial liabilities measured
 
at amortized cost
705,669
745,971
740,595
Financial liabilities at fair value held for trading
 
8
30,450
34,687
31,688
Derivative financial instruments
8, 9
156,888
138,443
121,309
Brokerage payables designated at
 
fair value
 
8
49,798
48,015
44,045
Debt issued designated at fair value
8, 11
72,264
71,470
73,799
Other financial liabilities designated at fair value
8, 10
28,566
30,325
30,074
Total financial liabilities measured
 
at fair value through profit or
 
loss
337,966
322,940
300,916
Provisions
 
14
3,465
3,478
3,518
Other non-financial liabilities
 
10
8,910
8,322
11,151
Total liabilities
1,056,010
1,080,711
1,056,180
Equity
Share capital
304
322
322
Share premium
13,202
15,355
15,928
Treasury shares
(4,412)
(5,811)
(4,675)
Retained earnings
46,598
46,451
43,851
Other comprehensive income recognized
 
directly in equity, net of tax
1,152
2,538
5,236
Equity attributable to shareholders
56,845
58,855
60,662
Equity attributable to non-controlling
 
interests
339
356
340
Total equity
57,184
59,212
61,002
Total liabilities and
 
equity
1,113,193
1,139,922
1,117,182
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
48
 
 
Statement of changes
 
in equity
USD m
Share
capital and
share
premium
Treasury
shares
Retained
earnings
OCI
recognized
directly in
equity,
net of tax
1
of which:
foreign
currency
translation
of which:
financial
assets
measured
at fair value
through OCI
of which:
cash flow
hedges
Total equity
attributable
to
shareholders
Balance as of 1 January 2022
2
16,250
(4,675)
43,851
5,236
4,653
(7)
628
60,662
Acquisition of treasury shares
(3,684)
3
(3,684)
Delivery of treasury shares under share-based compensation plans
(742)
815
74
Other disposal of treasury shares
(3)
111
3
107
Cancellation of treasury shares related to the 2021 share repurchase
program
4
(1,520)
3,022
(1,502)
0
Share-based compensation expensed in the income statement
384
384
Tax (expense) / benefit
7
7
Dividends
(834)
5
(834)
5
(1,668)
Equity classified as obligation to purchase own
 
shares
(40)
(40)
Translation effects recognized
 
directly in retained earnings
(13)
13
0
13
0
Share of changes in retained earnings of associates and joint ventures
0
0
New consolidations / (deconsolidations) and other
 
increases / (decreases)
4
3
(3)
(3)
4
Total comprehensive income for the period
5,092
(4,093)
(840)
3
(3,355)
999
of which: net profit / (loss)
4,244
4,244
of which: OCI, net of tax
848
(4,093)
(840)
3
(3,355)
(3,245)
Balance as of 30 June 2022
2
13,506
(4,412)
46,598
1,152
3,813
(7)
(2,713)
56,845
Non-controlling interests as of 30 June 2022
339
Total equity as of 30 June 2022
57,184
Balance as of 1 January 2021
2
17,091
(4,068)
38,776
7,647
5,188
151
2,321
59,445
Acquisition of treasury shares
(2,057)
3
(2,057)
Delivery of treasury shares under share-based compensation plans
(654)
727
73
Other disposal of treasury shares
4
32
3
36
Cancellation of treasury shares related to the 2018–2021
 
share repurchase
program
(252)
2,044
(1,792)
0
Share-based compensation expensed in the income statement
346
346
Tax (expense) / benefit
8
8
Dividends
(651)
5
(651)
5
(1,301)
Translation effects recognized
 
directly in retained earnings
19
(19)
0
(19)
0
Share of changes in retained earnings of associates and joint ventures
2
2
New consolidations / (deconsolidations) and other
 
increases / (decreases)
(39)
(39)
Total comprehensive income for the period
3,789
(1,537)
(489)
(88)
(937)
2,252
of which: net profit / (loss)
3,830
3,830
of which: OCI, net of tax
(40)
(1,537)
(489)
(88)
(937)
(1,577)
Balance as of 30 June 2021
2
15,853
(3,322)
40,143
6,091
4,699
63
1,365
58,765
Non-controlling interests as of 30 June 2021
284
Total equity as of 30 June 2021
59,050
1 Excludes other comprehensive
 
income related to
 
defined benefit plans and
 
own credit that is recorded
 
directly in Retained ear
 
nings.
 
2 Excludes non-controlling interests.
 
3 Includes treasury
 
shares acquired and
disposed of by the Investment
 
Bank in its
 
capacity as a market
 
maker with regard
 
to UBS shares
 
and related derivatives,
 
and to hedge certain
 
issued structured
 
debt instruments.
 
These acquisitions
 
and disposals are
reported based on the sum of the net monthly movements.
 
4 Reflects the cancellation of
177,787,273
 
shares purchased under UBS’s 2021
 
share repurchase program as approved by shareholders at the
 
2022 Annual
General Meeting. Swiss
 
tax law requires
 
Switzerland-domiciled
 
companies with
 
shares listed
 
on a Swiss
 
stock exchange to
 
reduce capital
 
contribution reserves
 
by at least
50
% of the
 
total capital
 
reduction amount
exceeding the nominal value
 
upon cancellation
 
of the shares.
 
5 Reflects the
 
payment of an ordinary cash
 
dividend of USD
0.50
 
per dividend-bearing share in April
 
2022 (2021: USD
0.37
 
per dividend-bearing share
paid in April 2021). Swiss tax
 
law requires Switzerland-domiciled
 
companies with shares listed
 
on a Swiss stock exchange to
 
pay no more than
50
% of dividends from capital
 
contribution reserves,
 
with the remainder
required to be paid from retained
 
earnings.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
49
 
 
 
Statement of cash flows
Year-to-date
USD m
30.6.22
30.6.21
Cash flow from / (used in)
 
operating activities
Net profit / (loss)
4,262
3,838
Non-cash items included in net
 
profit and other adjustments:
Depreciation, amortization and impairment of non
 
-financial assets
1,009
1,026
Credit loss expense / (release)
25
(108)
Share of net (profit) / loss of associates and joint ventures and
 
impairment related to associates
(12)
(74)
Deferred tax expense / (benefit)
350
285
Net loss / (gain) from investing activities
(732)
(239)
Net loss / (gain) from financing activities
(14,379)
2,070
Other net adjustments
9,399
4,747
Net change in operating
 
assets and liabilities:
Loans and advances to banks and amounts due
 
to banks
3,000
3,872
Securities financing transactions
10,833
(10,249)
Cash collateral on derivative instruments
(4,699)
(2,179)
Loans and advances to customers and customer
 
deposits
(13,203)
(20,180)
Financial assets and liabilities at fair value held
 
for trading and derivative financial instruments
13,104
(1,225)
Brokerage receivables and payables
8,239
2,047
Financial assets at fair value not held for trading
 
and other financial assets and liabilities
1,706
14,533
Provisions and other non-financial assets and liabilities
125
87
Income taxes paid, net of refunds
(878)
(386)
Net cash flow from / (used in) operating
 
activities
18,150
(2,136)
Cash flow from / (used in)
 
investing activities
Purchase of subsidiaries, associates and intangible assets
0
(1)
Disposal of subsidiaries, associates and intangible
 
assets
1
911
437
Purchase of property,
 
equipment and software
(761)
(896)
Disposal of property, equipment
 
and software
3
264
Purchase of financial assets measured at fair value through
 
other comprehensive income
(2,821)
(1,950)
Disposal and redemption of financial assets measured at
 
fair value through other comprehensive
 
income
2,291
2,324
Net (purchase) / redemption of debt securities measured at amortized
 
cost
(4,254)
116
Net cash flow from / (used in)
 
investing activities
(4,630)
295
Cash flow from / (used in)
 
financing activities
Net short-term debt issued / (repaid)
(10,440)
(3,877)
Net movements in treasury shares and own
 
equity derivative activity
(3,521)
(1,967)
Distributions paid on UBS shares
(1,668)
(1,301)
Issuance of debt designated at fair value and long
 
-term debt measured at amortized cost
48,460
63,501
Repayment of debt designated at fair value and
 
long-term debt measured at amortized cost
(36,309)
(45,274)
Net cash flows from other financing activities
(352)
(288)
Net cash flow from / (used in)
 
financing activities
(3,830)
10,795
Total
 
cash flow
Cash and cash equivalents at the beginning
 
of the period
207,875
173,531
Net cash flow from / (used in) operating, investing
 
and financing activities
9,690
8,954
Effects of exchange rate differences on cash and
 
cash equivalents
(9,656)
(5,390)
Cash and cash equivalents at the end
 
of the period
2
207,909
177,095
Additional information
Net cash flow from / (used in) operating
 
activities includes:
Interest received in cash
6,088
5,469
Interest paid in cash
2,675
2,659
Dividends on equity investments, investment
 
funds and associates received in cash
1,059
1,263
1 Includes cash proceeds from the
 
sale of UBS’s shareholding
 
in its Japanese real estate
 
joint venture, Mitsubishi
 
Corp.-UBS
 
Realty Inc. Refer to the “Recent developments”
 
section of this report for more information.
 
2 Consists
 
of balances
 
with an
 
original maturity
 
of three
 
months or
 
less.
 
USD
4,434
m and
 
USD
3,432
m (mainly reflected
 
in Loans
 
and advances
 
to banks)
 
were restricted
 
as of
 
30 June 2022
 
and 30 June
 
2021,
respectively. Refer to “Note
 
23 Restricted and transferred
 
financial assets” in the
 
“Consolidated financial
 
statements” section of
 
the Annual Report 2021
 
for more information.
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
50
 
Notes to the UBS Group AG interim consolidated
financial statements (unaudited)
 
Note 1
 
Basis of accounting
Basis of preparation
The
 
consolidated financial statements (the
 
financial statements) of
 
UBS Group
 
AG
 
and its
 
subsidiaries (together,
“UBS” or
 
the
 
“Group”)
 
are prepared
 
in accordance
 
with International
 
Financial
 
Reporting
 
Standards (IFRS),
 
as issued
by the International Accounting Standards Board (the
 
IASB) and are presented
 
in US dollars
 
(USD). These interim
financial statements are
 
prepared in accordance
 
with IAS 34,
Interim Financial Reporting
.
In preparing
 
these interim financial statements, the same
 
accounting policies and methods of
 
computation have
been applied as
 
in the UBS Group
 
AG consolidated
 
annual financial
 
statements for
 
the period
 
ended 31 December
2021, except for the changes described in this Note.
 
These interim financial statements are
 
unaudited and should
be read in conjunction
 
with UBS Group AG’s
 
audited consolidated
 
financial statements
 
in the Annual Report
 
2021
and the
 
“Management report” sections of
 
this report, including
 
the disclosure regarding
 
the sale of
 
UBS’s
49
%
shareholding
 
in
its
 
Japanese
 
real
 
estate
 
joint
 
venture,
 
Mitsubishi
 
Corp.
-
UBS
 
Realty
 
Inc.
,
 
in
the
“Recent
developments” section of
 
this report. In the opinion of
 
management, all necessary adjustments have been made
for a fair presentation
 
of the Group’s financial
 
position, results of
 
operations and
 
cash flows.
 
Preparation of these
 
interim financial statements requires management to
 
make estimates and assumptions
 
that
affect
 
the
 
reported
 
amounts
 
of
 
assets,
 
liabilities,
 
income,
 
expenses
 
and
 
disclosures
 
of
 
contingent
 
assets
 
and
liabilities. These
 
estimates and
 
assumptions are
 
based on the
 
best available
 
information. Actual
 
results in the future
could differ
 
from such
 
estimates and
 
differences
 
may be
 
material to
 
the financial
 
statements.
 
Revisions to
 
estimates,
based on regular reviews, are recognized in
 
the period in which they
 
occur. For more information about areas of
estimation
 
uncertainty that
 
are
 
considered
 
to
 
require critical
 
judgment, refer
 
to
 
“Note
 
1a
 
Material accounting
policies” in the “Consolidated
 
financial statements”
 
section of the Annual
 
Report 2021.
Changes to the presentation
 
of the financial statements
 
Effective
 
from the
 
second
 
quarter
 
of 2022,
 
UBS
 
has made
 
several changes
 
to simplify
 
the presentation
 
of the
 
income
statement alongside other primary
 
financial statements and
 
disclosure notes and to align them with management
information.
 
In
 
particular,
Total
 
operating
 
income
 
has
 
been
 
renamed
Total
 
revenues
 
and
 
excludes
Credit
 
loss
(expense)
 
/ release
, which is now separately
 
presented below
Total revenues
.
 
Reclassification of a portfolio
 
from
Financial assets
 
measured at fair value
 
through other
comprehensive
 
income to
Other financial assets
 
measured at
 
amortized cost
 
Effective from
 
1 April 2022,
 
UBS has reclassified
 
a portfolio
 
of financial
 
assets from
Financial assets
 
measured
 
at fair
value through
 
other comprehensive
 
income
 
(FVOCI) with
 
a fair value
 
of USD
6.9
bn (the
 
Portfolio)
 
to
Other financial
assets
 
measured at
 
amortized cost
 
in
 
line
 
with
 
the
 
principles in
 
IFRS 9,
Financial
 
Instruments
,
 
which
 
require a
reclassification when an
 
entity changes
 
its business model
 
for managing financial
 
assets.
The Portfolio’s cumulative
 
fair value losses of USD
449
m pre-tax and USD
333
m post-tax, previously recognized
 
in
Other comprehensive
 
income
, have been removed from equity
 
and adjusted against the value of the assets
 
at the
reclassification date,
 
so that the Portfolio is
 
measured as if the assets
 
had always been classified
 
at amortized cost,
with a value as of 1 April
 
2022 of USD
7.4
bn.
 
The reclassification had
 
no effect on the income
 
statement.
 
The
 
reclassified
 
Portfolio
 
is
 
made
 
up
 
of
 
high-quality
 
liquid
 
assets,
 
primarily
 
US
 
government
 
treasuries
 
and
 
US
government agency
 
mortgage-backed securities,
 
held and separately managed
 
by UBS Bank USA (BUSA).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
51
 
 
Note 1
 
Basis of accounting
 
(continued)
The
 
accounting
 
reclassification
 
has
 
arisen
 
as
 
a
 
direct
 
result
 
of
 
the
 
transformation
 
of
 
UBS’s
 
Global
 
Wealth
Management Americas
 
business that
 
has
 
significantly impacted
 
BUSA. Th
 
is includes
 
initiatives approved
 
by
 
the
Group Executive
 
Board to
 
significantly
 
grow and
 
extend the
 
business, as
 
disclosed
 
on 1 February
 
2022 during
 
UBS’s
fourth quarter 2021 earnings presentation, along with UBS’s
 
decision to acquire Wealthfront, an industry-leading
digital wealth management provider. BUSA’s
 
deposit base has
 
grown by more
 
than 100% in
 
the last
 
two years,
generating substantial
 
cash balances,
 
with a
 
number of new
 
products being
 
launched, including
 
new deposit
 
types
that are longer in duration,
 
additional lending
 
and a broader range
 
of customer segments targeted.
Following the
 
commencement of these
 
activities and
 
the announcement made
 
in
 
the first
 
quarter of
 
2022, the
Portfolio is
 
no longer
 
held in
 
a business
 
model to
 
collect the
 
contractual cash
 
flows and
 
sell the
 
assets, but
 
is instead
solely held to collect the contractual cash flows until the assets
 
mature,
 
requiring a reclassification
 
of the Portfolio
in line with IFRS 9
 
with effect
 
from 1 April 2022.
The fair
 
value of the
 
Portfolio as of
 
30 June 2022
 
was USD
6.4
bn. A
 
pre-tax fair value
 
loss of
 
USD
264
m would
have been recognized in
Other comprehensive
 
income
 
during the second quarter of 2022 if the Portfolio had not
been reclassified.
Currency translation
 
rates
The
 
following table
 
shows the
 
rates of
 
the main
 
currencies used
 
to translate
 
the financial
 
information of
 
UBS’s
operations with a functional
 
currency other than the
 
US dollar into US
 
dollars.
 
Closing exchange rate
Average rate
1
As of
For the quarter
 
ended
Year-to-date
30.6.22
31.3.22
31.12.21
30.6.21
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
1 CHF
1.05
1.08
1.10
1.08
1.04
1.08
1.10
1.06
1.09
1 EUR
1.05
1.11
1.14
1.19
1.06
1.12
1.20
1.09
1.20
1 GBP
1.22
1.31
1.35
1.38
1.25
1.33
1.39
1.29
1.39
100 JPY
0.74
0.82
0.87
0.90
0.76
0.85
0.91
0.80
0.92
1 Monthly income statement
 
items of operations
 
with a functional
 
currency other than the
 
US dollar are translated
 
into US dollars
 
using month-end rates.
 
Disclosed average
 
rates for a quarter
 
represent an average
 
of
three month-end rates, weighted
 
according to
 
the income and expense volumes
 
of all operations of the Group with the same functional
 
currency for each month. Weighted
 
average rates for individual
 
business divisions
may deviate from the weighted
 
average rates for
 
the Group.
 
 
Note 2
 
Segment reporting
USD m
Global Wealth
Management
Personal &
Corporate
Banking
Asset
 
Management
Investment
Bank
Group
Functions
UBS
For the six months ended
 
30 June 2022
1
Net interest income
2,409
1,057
(7)
104
(126)
3,436
Non-interest income
7,172
1,088
1,958
4,899
(253)
14,862
Total revenues
9,581
2,144
1,950
5,003
(379)
18,299
Credit loss expense / (release)
(10)
57
0
(24)
2
25
Operating expenses
7,124
1,246
817
3,688
54
12,929
Operating profit / (loss) before
 
tax
2,467
841
1,133
1,339
(436)
5,344
Tax expense / (benefit)
1,082
Net profit / (loss)
4,262
As of 30 June 2022
1
Total assets
2
397,111
222,424
18,621
388,281
86,755
1,113,193
For the six months ended
 
30 June 2021
1
Net interest income
2,023
1,039
(7)
244
(58)
3,241
Non-interest income
7,583
1,063
1,310
4,476
(99)
14,333
Total revenues
9,606
2,102
1,303
4,720
(158)
17,574
Credit loss expense / (release)
(16)
(69)
0
(23)
1
(108)
Operating expenses
6,918
1,284
820
3,663
105
12,790
Operating profit / (loss) before
 
tax
2,704
888
482
1,080
(263)
4,891
Tax expense / (benefit)
1,053
Net profit / (loss)
3,838
As of 31 December 2021
1
Total assets
395,235
225,370
25,639
346,431
124,507
1,117,182
1 Refer to “Note 2 Segment reporting”
 
in the “Consolidated financial
 
statements” section
 
of the Annual Report 2021 for
 
more information
 
about the Group’s reporting
 
segments.
 
2 In the first quarter
 
of 2022,
UBS refined t
 
he methodology
 
applied to
 
allocate balance
 
sheet resources
 
from Group
 
Functions to
 
the business
 
divisions, with
 
prospective e
 
ffect. If the
 
new methodology
 
had been applied
 
as of 31
 
December
2021, balance sheet assets allocated
 
to business divisions would
 
have been USD
17
bn higher, of
 
which USD
14
bn would have related to the
 
Investment Bank.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
52
 
 
 
Note 3
 
Net interest income
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Interest income from loans and deposits
1
1,886
1,660
1,612
3,546
3,197
Interest income from securities financing transactions
2
209
118
126
327
261
Interest income from other financial instruments measured
 
at amortized cost
118
72
68
191
141
Interest income from debt instruments measured at fair
 
value through other comprehensive
 
income
6
41
16
47
51
Interest income from derivative instruments designated as
 
cash flow hedges
 
160
253
284
413
553
Total interest income
 
from financial instruments measured at
 
amortized cost and fair value through
 
other comprehensive
income
2,380
2,144
2,106
4,525
4,203
Interest expense on loans and deposits
3
262
139
136
401
273
Interest expense on securities financing transactions
4
288
224
293
512
551
Interest expense on debt issued
498
396
381
893
792
Interest expense on lease liabilities
22
23
26
45
53
Total interest expense
 
from financial instruments measured at
 
amortized cost
1,070
781
836
1,852
1,669
Total net interest income
 
from financial instruments measured at amortized
 
cost and fair value through
 
other comprehensive
income
1,310
1,363
1,270
2,673
2,535
Net interest income from financial instruments
 
measured at fair value through
 
profit or loss
355
408
357
763
706
Total net interest income
1,665
1,771
1,628
3,436
3,241
1 Consists of interest income
 
from cash and balances
 
at central banks,
 
loans and advances
 
to banks and customers,
 
and cash collateral
 
receivables on derivative
 
instruments, as well
 
as negative interest
 
on amounts
due to banks,
 
customer
 
deposits, and
 
cash col
 
lateral payables
 
on derivative
 
instruments.
 
2 Includes
 
interest income
 
on receivables
 
from securities
 
financing transactions
 
and negative
 
interest, including
 
fees, on
payables from securities
 
financing transactions.
 
3 Consists
 
of interest expense
 
on amounts due
 
to banks, cash
 
collateral
 
payables on derivative
 
instruments, and
 
customer deposits,
 
as well as negative
 
interest on
cash and balances at central banks, loans and advances to banks,
 
and cash collateral receivables on derivative
 
instruments.
 
4 Includes interest expense on payables from securities financing
 
transactions and negative
interest, including fees, on receivables
 
from securities financing transactions.
 
 
 
Note 4
 
Net fee and commission
 
income
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Underwriting fees
111
172
387
283
780
M&A and corporate finance fees
220
237
330
456
568
Brokerage fees
869
1,077
1,037
1,946
2,395
Investment fund fees
1,233
1,388
1,405
2,620
2,842
Portfolio management and related services
2,298
2,463
2,426
4,761
4,710
Other
492
501
455
993
916
Total fee and commission
 
income
1
5,224
5,837
6,041
11,061
12,210
of which: recurring
3,593
3,860
3,823
7,453
7,443
of which: transaction-based
1,621
1,958
2,176
3,579
4,631
of which: performance-based
10
19
42
29
136
Fee and commission expense
450
484
484
934
962
Net fee and commission income
4,774
5,353
5,557
10,127
11,248
1 Reflects third-party fee and commission income for the second quarter of 2022 of USD
3,281
m for Global Wealth Management (first quarter of 2022: USD
3,637
m; second quarter of 2021: USD
3,585
m), USD
421
m
for Personal & Corporate
 
Banking (first
 
quarter of 2022: USD
446
m; second quarter
 
of 2021: USD
399
m), USD
720
m for Asset Management
 
(first quarter of
 
2022: USD
762
m; second quarter
 
of 2021: USD
805
m),
USD
801
m for the Investment Bank (first
 
quarter of 2022: USD
988
m; second quarter of 2021: USD
1,243
m) and USD
1
m for Group Functions (first quarter
 
of 2022: USD
4
m; second quarter of 2021:
 
USD
9
m).
 
 
 
Note 5
 
Personnel expenses
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Salaries and variable compensation
2,664
2,948
2,945
5,612
5,816
Financial advisor compensation
1
1,122
1,220
1,183
2,342
2,353
Contractors
80
83
98
163
196
Social security
218
285
241
503
508
Post-employment benefit plans
199
249
173
448
439
Other personnel expenses
139
135
132
274
260
Total personnel expenses
4,422
4,920
4,772
9,343
9,573
1 Financial
 
advisor compensation
 
consists of
 
formulaic
 
compensation
 
based directly
 
on compensable
 
revenues generated
 
by financial
 
advisors and
 
supplemental compensation
 
calculated on
 
the basis
 
of financial
advisor productivity,
 
firm tenure,
 
new assets
 
and other
 
variables. It
 
also includes
 
expenses related
 
to compensation
 
commitments
 
with financial
 
advisors entered
 
into at
 
the time
 
of recruitment that
 
are subject to
vesting requirements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
53
 
 
Note 6
 
General and administrative
 
expenses
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Outsourcing costs
227
227
206
454
407
IT expenses
286
289
256
576
522
Consulting, legal and audit fees
144
129
130
272
229
Real estate and logistics costs
152
147
151
298
302
Market data services
101
106
105
207
206
Marketing and communication
61
40
52
101
94
Travel and entertainment
46
20
13
67
21
Litigation, regulatory and similar matters
1
221
57
63
278
72
Other
133
192
126
325
337
Total general and administrative
 
expenses
1,370
1,208
1,103
2,578
2,192
1 Reflects the net increase in
 
provisions for litigation, regulatory
 
and similar matters recognized
 
in the income statement.
 
Refer to Note 14b for more
 
information.
 
 
 
Note 7
 
Expected credit loss
 
measurement
 
a) Credit loss expense
 
/ release
 
Total
 
net
 
credit loss
 
expenses in
 
the
 
second quarter
 
of
 
2022
 
were
 
USD
7
m,
 
reflecting USD
16
m net
 
credit loss
expenses related to stage
 
1 and 2 positions and
 
USD
9
m net credit loss releases
 
related to stage
 
3 positions.
 
Stage 1 and 2 net expenses included: scenario-related net expenses of USD
10
m related to Personal & Corporate
Banking corporate lending; net
 
releases of USD
9
m from model
 
changes, mainly in Global
 
Wealth Management
Americas; and additional net expenses of
 
USD
14
m from book quality and
 
size changes, mainly across corporate
and real estate lending
 
portfolios of Personal &
 
Corporate Banking.
Stage 3 net credit loss releases were
 
USD
9
m, driven by a release of USD
26
m in the Investment Bank,
 
including a
reduction of
 
the allowance
 
for a
 
single defaulted
 
travel-industry-related counterparty (USD
28
m), mainly
 
due to
improved cash
 
flow assumptions.
 
Personal &
 
Corporate Banking,
 
Global Wealth
 
Management and
 
Non-core
 
legacy
contributed net expenses
 
of USD
8
m, USD
6
m and USD
2
m, respectively.
 
b) Changes to ECL models,
 
scenarios, scenario weights
 
and post-model adjustments
Scenarios
 
The expected credit loss (ECL) scenarios, along with the related macroeconomic factors, were reviewed in light of
the
 
economic and
 
political conditions
 
prevailing
 
in the
 
second quarter
 
of 2022
 
through
 
a series
 
of
 
governance
meetings, with input and
 
feedback from UBS
 
Risk and Finance experts
 
across the business
 
divisions and regions.
 
The baseline scenario assumptions on a calendar-year basis are included in the table below
 
and outline a weaker
economic forecast for
 
2022 compared with
 
2021.
As
 
a
 
response to
 
inflationary developments
 
and Russia’s
 
invasion of
 
Ukraine, in
 
the
 
first
 
quarter of
 
2022,
 
UBS
replaced the mild global interest rate
 
steepening scenario applied
 
at year-end
 
2021 with the severe global interest
rate steepening scenario. The aim was to reflect the
 
rising trend in inflation and ongoing tightening of monetary
policy measures, which would lead
 
to substantially lower GDP
 
growth in key
 
markets. For the second
 
quarter of
2022,
 
a new
 
severe Russia–Ukraine conflict scenario was
 
developed. It has
 
similar dynamics to
 
the severe global
interest rate steepening scenario,
 
but includes an escalating
 
energy crisis and
 
disruptions
 
in the delivery of Russian
energy.
 
These factors result in
 
surging commodity prices and accelerated inflation in
 
major economies compared
with the severe
 
global interest
 
rate steepening
 
scenario. Eurozone
 
economic activity
 
in particular
 
is impacted in
 
this
scenario, due to the region’s
 
reliance on its supply
 
of energy from
 
Russia.
The global crisis scenario and
 
the asset price inflation
 
scenario were updated with
 
current macroeconomic
 
factors,
but remain materially
 
unchanged.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
54
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
Scenario weights
 
UBS kept scenario weights in line with those applied
 
in the first quarter of 2022, with the
25
% weight previously
assigned to the severe global
 
interest rate steepening scenario instead applied to the
 
replacement severe Russia–
Ukraine conflict
 
scenario.
 
Scenario weights
 
applied
 
in the
 
second
 
and first
 
quarters
 
of 2022
 
differ from
 
those applied
for annual reporting 2021,
 
in order to account for the
 
more adverse outlook.
 
Post-model adjustments
Total stage 1 and 2 allowances
 
and provisions
 
amounted to
 
USD
517
m as
 
of 30 June
 
2022 and
 
include post-model
adjustments (PMA)
 
of USD
155
m (31 March 2022:
 
USD
204
m; 31 December 2021:
 
USD
224
m).
The PMA represent
 
uncertainty and
 
risk related to
 
substantially
 
heightened geopolitical
 
tensions and
 
the continued
COVID-19 pandemic,
 
which cannot be fully
 
and reliably modeled
 
due to a lack of
 
sufficiently supportable
 
data.
 
The
 
PMA
 
were reduced
 
during
 
the
 
first and
 
second quarters
 
of
 
2022
 
as
 
the application
 
of
 
different and
 
more
adverse scenarios and scenario
 
assumptions in UBS’s
 
models addressed some of
 
the uncertainties that had
 
been
reflected in the PMA
 
in prior periods.
 
 
Comparison of shock
 
factors
Baseline
Key parameters
2021
2022
2023
Real GDP growth (annual percentage
 
change)
US
 
5.5
2.9
2.4
Eurozone
5.1
2.9
2.2
Switzerland
3.1
2.5
1.5
Unemployment rate (%, annual
 
average)
US
 
5.4
3.5
3.2
Eurozone
7.7
6.8
6.8
Switzerland
3.0
2.1
1.9
Real estate (annual percentage change,
 
Q4)
US
 
16.1
2.0
1.7
Eurozone
7.9
5.0
1.7
Switzerland
6.0
4.0
0.0
Economic scenarios and
 
weights applied
Assigned weights in %
ECL scenario
30.6.22
31.3.22
31.12.21
Upside
0.0
0.0
5.0
Baseline
55.0
55.0
55.0
Mild global interest rate steepening
 
-
-
10.0
Severe global interest rate steepening
 
-
25.0
-
Severe Russia–Ukraine conflict scenario
25.0
-
-
Global crisis
 
20.0
20.0
30.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
55
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
 
c) ECL-relevant balance
 
sheet and off-balance
 
sheet positions
 
including
 
ECL allowances and provisions
The following
 
tables provide
 
information
 
about financial
 
instruments and
 
certain
 
non-financial instruments
 
that are
subject
 
to
 
ECL
 
requirements.
 
For
 
amortized-cost
 
instruments,
 
the
 
carrying
 
amount
 
represents
 
the
 
maximum
exposure to credit risk, taking into account the allowance for credit losses. Financial assets measured at fair value
through other
 
comprehensive
 
income (FVOCI) are
 
also subject to
 
ECL; however,
 
unlike amortized-cost
 
instruments,
the allowance
 
for credit
 
losses for
 
FVOCI instruments
 
does not
 
reduce the
 
carrying
 
amount of
 
these financial
 
assets.
Instead, the
 
carrying
 
amount
 
of financial
 
assets measured
 
at FVOCI
 
represents
 
the
 
maximum exposure
 
to credit
 
risk.
In addition to recognized financial assets, certain
 
off-balance sheet financial
 
instruments and other credit lines are
also subject to ECL. The maximum exposure to credit risk
 
for off-balance sheet financial instruments is calculated
based on the maximum
 
contractual amounts.
 
USD m
30.6.22
Carrying amount
1
ECL allowances
Financial instruments measured at
 
amortized cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
190,353
190,296
57
0
(13)
0
(13)
0
Loans and advances to banks
16,596
16,479
117
0
(8)
(7)
(1)
0
Receivables from securities financing transactions
63,291
63,291
0
0
(2)
(2)
0
0
Cash collateral receivables on derivative
 
instruments
43,763
43,763
0
0
0
0
0
0
Loans and advances to customers
383,898
366,452
15,759
1,686
(793)
(128)
(163)
(501)
of which: Private clients with mortgages
150,884
142,050
8,064
770
(126)
(27)
(72)
(27)
of which: Real estate financing
43,291
39,358
3,925
7
(59)
(17)
(42)
0
of which: Large corporate clients
12,208
10,791
1,088
329
(141)
(27)
(17)
(98)
of which: SME clients
13,309
11,744
1,167
397
(249)
(22)
(22)
(205)
of which: Lombard
140,333
140,251
0
82
(37)
(7)
0
(29)
of which: Credit cards
1,760
1,384
349
27
(36)
(10)
(9)
(17)
of which: Commodity trade finance
3,699
3,686
0
12
(94)
(5)
0
(89)
Other financial assets measured at amortized cost
2
37,528
36,977
391
160
(99)
(18)
(7)
(74)
of which: Loans to financial advisors
2,447
2,171
144
132
(78)
(11)
(2)
(64)
Total financial assets
 
measured at amortized cost
735,428
717,257
16,325
1,846
(915)
(155)
(184)
(575)
Financial assets measured at
 
fair value through other comprehensive
 
income
2
2,251
2,251
0
0
0
0
0
0
Total on-balance
 
sheet financial assets in scope of ECL requirements
737,679
719,508
16,325
1,846
(915)
(155)
(184)
(575)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
22,556
21,381
1,028
146
(40)
(16)
(9)
(15)
of which: Large corporate clients
3,539
2,710
734
95
(10)
(3)
(3)
(4)
of which: SME clients
1,213
1,034
128
51
(9)
(1)
(1)
(7)
of which: Financial intermediaries and hedge funds
 
12,113
12,021
92
0
(16)
(11)
(5)
0
of which: Lombard
2,332
2,332
0
0
(1)
0
0
(1)
of which: Commodity trade finance
2,388
2,387
0
0
(1)
(1)
0
0
Irrevocable loan commitments
37,703
35,308
2,359
37
(113)
(67)
(46)
0
of which: Large corporate clients
22,649
21,001
1,642
6
(94)
(60)
(34)
0
Forward starting reverse repurchase
 
and securities borrowing agreements
3,985
3,985
0
0
0
0
0
0
Committed unconditionally revocable credit lines
39,756
37,407
2,306
42
(37)
(27)
(10)
0
of which: Real estate financing
9,123
8,931
193
0
(5)
(5)
0
0
of which: Large corporate clients
4,354
3,662
687
5
(6)
(1)
(5)
0
of which: SME clients
4,660
4,240
392
29
(16)
(13)
(3)
0
of which: Lombard
7,697
7,693
0
4
0
0
0
0
of which: Credit cards
9,162
8,725
433
3
(6)
(4)
(2)
0
of which: Commodity trade finance
172
172
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
5,156
5,136
18
2
(2)
(2)
0
0
Total off-balance sheet
 
financial instruments and other
 
credit lines
109,156
103,217
5,712
228
(192)
(112)
(66)
(15)
Total allowances and
 
provisions
(1,107)
(267)
(250)
(590)
1 The carrying amount
 
of financial assets measured
 
at amortized cost represents
 
the total gross exposure
 
net of the respective ECL
 
allowances.
 
2 Effective
 
1 April 2022, a portfolio
 
of assets previously classified
 
as
Financial assets measured at fair
 
value through other comprehensive
 
income was reclassified to
 
Other financial assets
 
measured at amortized cost.
 
Refer to Note 1 for more information.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
56
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
 
USD m
31.3.22
Carrying amount
1
ECL allowances
Financial instruments measured at
 
amortized cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
206,773
206,728
46
0
(6)
0
(6)
0
Loans and advances to banks
17,914
17,850
65
0
(9)
(8)
(1)
0
Receivables from securities financing transactions
69,452
69,452
0
0
(2)
(2)
0
0
Cash collateral receivables on derivative
 
instruments
39,253
39,253
0
0
0
0
0
0
Loans and advances to customers
392,189
375,198
15,513
1,478
(801)
(121)
(155)
(525)
of which: Private clients with mortgages
153,645
145,272
7,702
671
(126)
(27)
(71)
(28)
of which: Real estate financing
43,920
40,006
3,907
7
(57)
(17)
(40)
0
of which: Large corporate clients
13,432
11,966
1,169
296
(143)
(21)
(14)
(108)
of which: SME clients
13,911
11,995
1,508
407
(260)
(22)
(20)
(218)
of which: Lombard
144,398
144,374
0
24
(34)
(7)
0
(27)
of which: Credit cards
1,709
1,341
341
28
(36)
(10)
(9)
(17)
of which: Commodity trade finance
4,441
4,425
7
9
(103)
(6)
0
(96)
Other financial assets measured at amortized cost
28,697
28,228
302
168
(109)
(27)
(7)
(75)
of which: Loans to financial advisors
2,388
2,164
86
138
(86)
(20)
(3)
(63)
Total financial assets
 
measured at amortized cost
754,279
736,708
15,925
1,646
(927)
(158)
(170)
(600)
Financial assets measured at
 
fair value through other comprehensive
 
income
9,093
9,093
0
0
0
0
0
0
Total on-balance
 
sheet financial assets in scope of ECL requirements
763,371
745,800
15,925
1,646
(927)
(158)
(170)
(600)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
22,496
21,264
1,072
159
(66)
(17)
(10)
(39)
of which: Large corporate clients
3,459
2,621
736
102
(32)
(3)
(4)
(26)
of which: SME clients
1,318
1,154
107
57
(11)
(1)
(1)
(9)
of which: Financial intermediaries and hedge funds
 
11,428
11,307
121
0
(16)
(12)
(5)
0
of which: Lombard
2,545
2,545
0
0
(1)
0
0
(1)
of which: Commodity trade finance
2,680
2,680
0
0
(1)
(1)
0
0
Irrevocable loan commitments
38,039
35,827
2,123
89
(112)
(68)
(44)
0
of which: Large corporate clients
23,698
21,723
1,916
58
(98)
(63)
(35)
0
Forward starting reverse repurchase
 
and securities borrowing agreements
6,432
6,432
0
0
0
0
0
0
Committed unconditionally revocable credit lines
41,396
38,616
2,715
65
(40)
(30)
(10)
0
of which: Real estate financing
9,621
9,343
278
0
(7)
(5)
(2)
0
of which: Large corporate clients
4,618
3,862
733
23
(5)
(2)
(3)
0
of which: SME clients
4,793
4,254
503
37
(15)
(12)
(3)
0
of which: Lombard
8,216
8,216
0
0
0
0
0
0
of which: Credit cards
9,398
8,941
453
4
(6)
(5)
(2)
0
of which: Commodity trade finance
280
280
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
5,355
5,342
12
2
(2)
(2)
0
0
Total off-balance sheet
 
financial instruments and other
 
credit lines
113,718
107,482
5,922
314
(221)
(117)
(64)
(39)
Total allowances and
 
provisions
(1,148)
(275)
(234)
(639)
1 The carrying amount
 
of financial assets measured
 
at amortized cost represents
 
the total gross exposure
 
net of the respective ECL
 
allowances.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
57
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
 
USD m
31.12.21
Carrying amount
1
ECL allowances
Financial instruments measured at
 
amortized cost
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Cash and balances at central banks
192,817
192,817
0
0
0
0
0
0
Loans and advances to banks
15,480
15,453
26
1
(8)
(7)
(1)
0
Receivables from securities financing transactions
75,012
75,012
0
0
(2)
(2)
0
0
Cash collateral receivables on derivative
 
instruments
30,514
30,514
0
0
0
0
0
0
Loans and advances to customers
397,761
380,564
15,620
1,577
(850)
(126)
(152)
(572)
of which: Private clients with mortgages
152,479
143,505
8,262
711
(132)
(28)
(71)
(33)
of which: Real estate financing
43,945
40,463
3,472
9
(60)
(19)
(40)
0
of which: Large corporate clients
13,990
12,643
1,037
310
(170)
(22)
(16)
(133)
of which: SME clients
14,004
12,076
1,492
436
(259)
(19)
(15)
(225)
of which: Lombard
149,283
149,255
0
27
(33)
(6)
0
(28)
of which: Credit cards
1,716
1,345
342
29
(36)
(10)
(9)
(17)
of which: Commodity trade finance
3,813
3,799
7
7
(114)
(6)
0
(108)
Other financial assets measured at amortized cost
26,209
25,718
302
189
(109)
(27)
(7)
(76)
of which: Loans to financial advisors
2,453
2,184
106
163
(86)
(19)
(3)
(63)
Total financial assets
 
measured at amortized cost
737,794
720,079
15,948
1,767
(969)
(161)
(160)
(647)
Financial assets measured at
 
fair value through other comprehensive
 
income
8,844
8,844
0
0
0
0
0
0
Total on-balance
 
sheet financial assets in scope of ECL requirements
746,638
728,923
15,948
1,767
(969)
(161)
(160)
(647)
Total exposure
ECL provisions
Off-balance sheet (in scope of ECL)
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 3
Guarantees
20,972
19,695
1,127
150
(41)
(18)
(8)
(15)
of which: Large corporate clients
3,464
2,567
793
104
(6)
(3)
(3)
0
of which: SME clients
1,353
1,143
164
46
(8)
(1)
(1)
(7)
of which: Financial intermediaries and hedge funds
 
9,575
9,491
84
0
(17)
(13)
(4)
0
of which: Lombard
2,454
2,454
0
0
(1)
0
0
(1)
of which: Commodity trade finance
3,137
3,137
0
0
(1)
(1)
0
0
Irrevocable loan commitments
39,478
37,097
2,335
46
(114)
(72)
(42)
0
of which: Large corporate clients
23,922
21,811
2,102
9
(100)
(66)
(34)
0
Forward starting reverse repurchase
 
and securities borrowing agreements
1,444
1,444
0
0
0
0
0
0
Committed unconditionally revocable credit lines
40,778
38,207
2,508
63
(38)
(28)
(10)
0
of which: Real estate financing
7,328
7,046
281
0
(5)
(4)
(1)
0
of which: Large corporate clients
5,358
4,599
736
23
(7)
(4)
(3)
0
of which: SME clients
5,160
4,736
389
35
(15)
(11)
(3)
0
of which: Lombard
8,670
8,670
0
0
0
0
0
0
of which: Credit cards
9,466
9,000
462
4
(6)
(5)
(2)
0
of which: Commodity trade finance
117
117
0
0
0
0
0
0
Irrevocable committed prolongation of existing loans
5,611
5,527
36
48
(3)
(3)
0
0
Total off-balance sheet
 
financial instruments and other
 
credit lines
108,284
101,971
6,006
307
(196)
(121)
(60)
(15)
Total allowances and
 
provisions
(1,165)
(282)
(220)
(662)
1 The carrying amount
 
of financial assets measured
 
at amortized cost represents
 
the total gross exposure
 
net of the respective ECL allowances.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
58
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
The table below
 
provides information
 
about the
 
ECL gross exposure
 
and the ECL
 
coverage ratio
 
for UBS’s
 
core loan
portfolios (i.e.,
Loans and
 
advances to customers
and
 
Loans to
 
financial advisors
) and
 
relevant off-balance sheet
exposures.
Cash and
 
balances
 
at central
 
banks
,
Loans and
 
advances
 
to banks
,
Receivables
 
from securities
 
financing
transactions
,
Cash
 
collateral
 
receivables
 
on
 
derivative instruments
 
and
Financial
 
assets
 
measured
 
at
 
fair
 
value
through other comprehensive
 
income
 
are not included
 
in the table below,
 
due to their lower sensitivity
 
to ECL.
ECL coverage ratios are calculated by dividing ECL allowances and provisions
 
by the gross carrying amount of the
related exposures.
 
Coverage ratios for core loan
 
portfolio
30.6.22
Gross carrying amount (USD
 
m)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
151,010
142,077
8,136
798
8
2
88
7
342
Real estate financing
43,350
39,375
3,967
8
14
4
106
14
505
Total real estate lending
194,360
181,452
12,103
805
10
2
94
8
344
Large corporate clients
12,349
10,818
1,105
427
114
25
153
37
2,286
SME clients
13,558
11,766
1,190
602
184
19
187
34
3,400
Total corporate lending
25,907
22,584
2,294
1,029
151
22
170
35
2,938
Lombard
140,370
140,259
0
111
3
1
0
1
2,641
Credit cards
1,796
1,394
359
43
201
72
263
111
3,805
Commodity trade finance
3,793
3,692
0
101
248
15
0
15
8,768
Other loans and advances to customers
18,466
17,201
1,167
98
28
8
7
8
3,796
Loans to financial advisors
2,525
2,182
147
196
307
50
163
57
3,278
Total other lending
166,949
164,728
1,672
549
18
3
76
4
4,293
Total
1
387,216
368,763
16,069
2,383
22
4
103
8
2,373
Gross exposure (USD m)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
6,860
6,658
199
3
4
3
9
3
786
Real estate financing
10,336
10,126
210
0
11
6
232
11
0
Total real estate lending
17,196
16,784
409
3
8
5
123
8
786
Large corporate clients
30,750
27,581
3,062
107
36
23
136
35
368
SME clients
7,301
6,603
589
109
45
23
178
36
649
Total corporate lending
38,051
34,184
3,651
216
37
23
143
35
510
Lombard
12,931
12,927
0
4
1
0
0
0
0
Credit cards
9,162
8,725
433
3
7
5
36
7
0
Commodity trade finance
2,615
2,615
0
0
4
4
0
4
0
Financial intermediaries and hedge funds
16,668
16,151
517
0
11
7
129
11
0
Other off-balance sheet commitments
8,548
7,845
701
2
11
8
5
8
0
Total other lending
49,924
48,264
1,651
9
7
5
52
7
0
Total
2
105,171
99,232
5,712
228
18
11
115
17
644
1 Includes Loans and
 
advances to customers
 
of USD
384,691
m and Loans to financial
 
advisors of USD
2,525
m, which are presented
 
on the balance sheet
 
line Other assets
 
measured at amortized
 
cost.
 
2 Excludes
Forward starting reverse
 
repurchase and securities
 
borrowing agreements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
59
 
 
Note 7
 
Expected credit loss
 
measurement (continued)
Coverage ratios for core loan
 
portfolio
31.3.22
Gross carrying amount (USD m)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
153,771
145,299
7,773
699
8
2
91
6
403
Real estate financing
43,977
40,023
3,947
7
13
4
102
13
455
Total real estate lending
197,748
185,321
11,720
707
9
2
95
8
404
Large corporate clients
13,574
11,987
1,184
404
105
17
122
27
2,666
SME clients
14,170
12,017
1,528
626
183
18
130
31
3,489
Total corporate lending
27,745
24,004
2,712
1,029
145
18
127
29
3,166
Lombard
144,432
144,381
0
51
2
0
0
0
5,326
Credit cards
1,745
1,351
350
44
204
72
256
110
3,803
Commodity trade finance
4,544
4,432
7
105
226
14
2
14
9,157
Other loans and advances to customers
16,776
15,831
879
66
25
8
9
8
4,517
Loans to financial advisors
2,473
2,184
88
201
347
92
322
101
3,132
Total other lending
169,970
168,178
1,325
468
18
3
95
4
4,986
Total
1
395,463
377,503
15,757
2,204
22
4
100
8
2,667
Gross exposure (USD m)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
7,972
7,733
236
3
3
3
7
3
241
Real estate financing
10,787
10,499
287
0
9
6
118
9
0
Total real estate lending
18,759
18,232
523
3
7
5
68
7
241
Large corporate clients
31,774
28,206
3,384
183
43
24
124
35
1,410
SME clients
7,512
6,693
700
119
48
23
159
36
791
Total corporate lending
39,286
34,899
4,084
303
44
24
130
35
1,166
Lombard
13,761
13,761
0
0
1
0
0
0
0
Credit cards
9,398
8,941
453
4
7
5
34
7
0
Commodity trade finance
2,960
2,960
0
0
4
4
0
4
0
Financial intermediaries and hedge funds
10,739
10,141
598
0
16
12
83
16
0
Other off-balance sheet commitments
12,384
12,115
265
4
9
5
40
6
0
Total other lending
49,241
47,918
1,315
8
8
5
58
7
0
Total
2
107,286
101,049
5,922
314
21
12
108
17
1,255
1 Includes Loans and
 
advances to customers
 
of USD
392,990
m and Loans to financial
 
advisors of USD
2,473
m, which are presented
 
on the balance sheet
 
line Other assets
 
measured at amortized
 
cost.
 
2 Excludes
Forward starting reverse
 
repurchase and securities
 
borrowing agreements.
 
Coverage ratios for core loan
 
portfolio
31.12.21
Gross carrying amount (USD m)
ECL coverage (bps)
On-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
152,610
143,533
8,333
744
9
2
85
6
446
Real estate financing
44,004
40,483
3,512
10
14
5
114
14
231
Total real estate lending
196,615
184,016
11,845
754
10
3
94
8
443
Large corporate clients
14,161
12,665
1,053
443
120
18
148
28
2,997
SME clients
14,263
12,095
1,507
661
182
16
103
25
3,402
Total corporate lending
28,424
24,760
2,560
1,104
151
17
121
26
3,240
Lombard
149,316
149,261
0
55
2
0
0
0
5,026
Credit cards
1,752
1,355
351
46
204
72
255
109
3,735
Commodity trade finance
3,927
3,805
7
115
290
15
3
15
9,388
Other loans and advances to customers
18,578
17,493
1,010
75
25
9
15
10
3,730
Loans to financial advisors
2,539
2,203
109
226
338
88
303
99
2,791
Total other lending
176,111
174,117
1,477
517
18
3
93
4
4,718
Total
1
401,150
382,893
15,882
2,374
23
4
98
8
2,673
Gross exposure (USD m)
ECL coverage (bps)
Off-balance sheet
Total
Stage 1
Stage 2
Stage 3
Total
Stage 1
Stage 2
Stage 1&2
Stage 3
Private clients with mortgages
9,123
8,798
276
49
3
3
9
3
15
Real estate financing
8,766
8,481
285
0
9
7
88
9
0
Total real estate lending
17,889
17,278
562
49
6
5
49
6
15
Large corporate clients
32,748
28,981
3,630
136
34
25
110
35
1
SME clients
8,077
7,276
688
114
38
19
151
30
585
Total corporate lending
40,826
36,258
4,318
250
35
24
117
34
266
Lombard
14,438
14,438
0
0
1
0
0
0
0
Credit cards
9,466
9,000
462
4
7
5
34
7
0
Commodity trade finance
3,262
3,262
0
0
4
4
0
4
0
Financial intermediaries and hedge funds
12,153
11,784
369
0
15
12
120
15
0
Other off-balance sheet commitments
8,806
8,507
296
4
15
6
30
7
0
Total other lending
48,126
46,991
1,127
8
9
5
61
7
0
Total
2
106,840
100,527
6,006
307
18
12
100
17
486
1 Includes Loans and
 
advances to customers
 
of USD
398,611
m and Loans to financial
 
advisors of USD
2,539
m, which are presented
 
on the balance sheet
 
line Other assets
 
measured at amortized
 
cost.
 
2 Excludes
Forward starting reverse
 
repurchase and securities
 
borrowing agreements.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
60
 
 
Note 8
 
Fair value measurement
 
a) Fair value hierarchy
The fair
 
value hierarchy classification of
 
financial and non-financial
 
assets and liabilities
 
measured at fair
 
value is
summarized in the table
 
below.
During
 
the first
 
six months
 
of 2022,
 
assets and
 
liabilities transferred from
 
Level 2 to
 
Level 1, or
 
from Level
 
1
 
to
Level 2, that were held
 
for the entire reporting
 
period, were not material.
 
Determination of fair values
 
from quoted market prices or valuation techniques
1
30.6.22
31.3.22
31.12.21
USD m
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial assets measured at
 
fair value on a recurring basis
Financial assets at fair value held for trading
85,270
12,314
1,923
99,507
97,078
15,044
2,623
114,744
113,697
14,825
2,299
130,821
of which: Equity instruments
70,284
982
85
71,351
82,256
512
278
83,047
97,958
1,090
149
99,197
of which: Government bills / bonds
8,633
1,409
9
10,052
7,579
1,491
10
9,080
7,135
1,351
10
8,496
of which: Investment fund units
5,728
1,040
18
6,786
6,495
2,030
16
8,541
7,843
1,364
21
9,229
of which: Corporate and municipal bonds
619
7,056
673
8,349
741
8,949
611
10,301
708
7,604
556
8,868
of which: Loans
0
1,553
1,010
2,563
0
1,726
1,577
3,303
0
3,099
1,443
4,542
of which: Asset-backed securities
5
274
128
407
6
336
131
473
53
317
120
489
Derivative financial instruments
1,185
157,586
1,753
160,524
1,511
137,115
1,683
140,309
522
116,479
1,140
118,142
of which: Foreign exchange
527
82,845
3
83,375
749
66,803
6
67,558
255
53,043
7
53,305
of which: Interest rate
0
37,930
351
38,281
0
36,372
772
37,144
0
32,747
494
33,241
of which: Equity / index
0
33,266
680
33,946
0
29,477
450
29,927
0
27,861
384
28,245
of which: Credit derivatives
0
1,446
640
2,087
0
1,392
338
1,730
0
1,179
236
1,414
of which: Commodities
0
1,936
76
2,013
0
2,886
58
2,944
0
1,590
16
1,606
Brokerage receivables
0
19,289
0
19,289
0
20,762
0
20,762
0
21,839
0
21,839
Financial assets at fair value not held for trading
20,844
32,623
4,171
57,637
25,704
31,262
4,033
60,999
27,278
28,622
4,180
60,080
of which: Financial assets for unit-linked
investment contracts
14,341
0
8
14,348
18,475
0
1
18,476
21,110
187
6
21,303
of which: Corporate and municipal bonds
131
14,361
249
14,741
137
12,665
288
13,090
123
13,937
306
14,366
of which: Government bills / bonds
5,954
4,607
0
10,561
6,713
4,561
0
11,274
5,624
3,236
0
8,860
of which: Loans
0
3,301
976
4,277
0
3,815
869
4,684
0
4,982
892
5,874
of which: Securities financing transactions
0
9,881
108
9,989
0
9,677
100
9,776
0
5,704
100
5,804
of which: Auction rate securities
0
0
1,644
1,644
0
0
1,635
1,635
0
0
1,585
1,585
of which: Investment fund units
317
471
112
901
291
544
112
947
338
574
117
1,028
of which: Equity instruments
101
0
721
822
89
0
699
788
83
2
681
765
Financial assets measured at
 
fair value through other comprehensive
 
income on a recurring basis
Financial assets measured at fair value through
other comprehensive income
55
2,196
0
2,251
2,341
6,751
0
9,093
2,704
6,140
0
8,844
of which: Asset-backed securities
2
0
0
0
0
0
4,639
0
4,639
0
4,849
0
4,849
of which: Government bills / bonds
2
0
18
0
18
2,293
19
0
2,312
2,658
27
0
2,686
of which: Corporate and municipal bonds
55
2,178
0
2,233
48
2,093
0
2,141
45
1,265
0
1,310
Non-financial assets measured at
 
fair value on a recurring basis
Precious metals and other physical commodities
4,377
0
0
4,377
4,626
0
0
4,626
5,258
0
0
5,258
Non-financial assets measured at
 
fair value on a non-recurring
 
basis
Other non-financial assets
3
0
0
105
105
0
0
24
24
0
0
26
26
Total assets measured
 
at fair value
111,730
224,008
7,951
343,689
131,261
210,934
8,363
350,557
149,459
187,905
7,645
345,010
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
61
 
 
Note 8
 
Fair value measurement
 
(continued)
Determination of fair values
 
from quoted market prices or valuation techniques
 
(continued)
1
30.6.22
31.3.22
31.12.21
USD m
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Total
Financial liabilities measured at fair value
 
on a recurring basis
Financial liabilities at fair value held for trading
24,393
5,932
125
30,450
26,770
7,841
76
34,687
25,413
6,170
105
31,688
of which: Equity instruments
16,323
440
89
16,852
19,390
328
61
19,778
18,328
513
83
18,924
of which: Corporate and municipal bonds
39
4,159
33
4,231
32
5,728
15
5,775
30
4,219
17
4,266
of which: Government bills / bonds
6,979
1,049
0
8,028
6,857
1,047
0
7,905
5,883
826
0
6,709
of which: Investment fund units
1,051
261
2
1,314
491
695
1
1,187
1,172
555
6
1,733
Derivative financial instruments
1,293
153,884
1,711
156,888
1,505
135,069
1,869
138,443
509
118,558
2,242
121,309
of which: Foreign exchange
486
81,982
26
82,494
737
65,303
33
66,073
258
53,800
21
54,078
of which: Interest rate
0
34,585
96
34,681
0
33,518
221
33,739
0
28,398
278
28,675
of which: Equity / index
0
33,561
1,076
34,638
0
32,182
1,142
33,324
0
33,438
1,511
34,949
of which: Credit derivatives
0
1,448
373
1,820
0
1,421
370
1,791
0
1,412
341
1,753
of which: Commodities
0
2,107
76
2,183
0
2,530
74
2,604
0
1,503
63
1,566
Financial liabilities designated at
 
fair value on a recurring basis
Brokerage payables designated at
 
fair value
0
49,798
0
49,798
0
48,015
0
48,015
0
44,045
0
44,045
Debt issued designated at fair value
0
60,270
11,994
72,264
0
58,798
12,672
71,470
0
59,606
14,194
73,799
Other financial liabilities designated at fair value
0
27,684
881
28,566
0
29,346
979
30,325
0
29,258
816
30,074
of which: Financial liabilities related to unit-
linked investment contracts
0
14,503
0
14,503
0
18,661
0
18,661
0
21,466
0
21,466
of which: Securities financing transactions
0
12,024
2
12,026
0
9,386
2
9,388
0
6,375
2
6,377
of which: Over-the-counter
 
debt instruments
0
1,157
879
2,036
0
1,299
970
2,269
0
1,334
794
2,128
Total liabilities measured
 
at fair value
25,686
297,569
14,711
337,966
28,275
279,069
15,596
322,940
25,922
257,637
17,357
300,916
1 Bifurcated embedded derivatives are
 
presented on the same balance sheet lines
 
as their host contracts and are not included
 
in this table. The
 
fair value of these derivatives was not
 
material for the periods presented.
 
2 Effective 1 April 2022, a portfolio
 
of assets previously classified
 
as Financial assets measured
 
at fair value through
 
other comprehensive income was
 
reclassified to Other financial
 
assets measured at amortized
 
cost.
Refer to Note 1 for more information.
 
3 Other non-financial assets
 
primarily consist of properties and
 
other non-current assets
 
held for sale, which are measured
 
at the lower of their net carrying amount
 
or fair value
less costs to sell.
 
 
b) Valuation adjustments
The table below summarizes
 
the changes in
 
deferred day-1 profit
 
or loss reserves during the
 
relevant period.
 
Deferred day-1 profit
 
or loss is generally released
 
into
Other net
 
income from
 
financial
 
instruments
 
measured
 
at fair
value
 
through
 
profit
 
or
 
loss
when
 
the
 
pricing
 
of
 
equivalent
 
products
 
or
 
the
 
underlying
 
parameters
 
become
observable or when the
 
transaction is closed
 
out.
 
Deferred day-1 profit
 
or loss reserves
For the quarter
 
ended
Year-to-date
USD m
30.6.22
31.3.22
30.6.21
30.6.22
30.6.21
Reserve balance at the beginning of the
 
period
425
418
387
418
269
Profit / (loss) deferred on new transactions
86
75
97
161
278
(Profit) / loss recognized in the income statement
(58)
(69)
(79)
(127)
(142)
Foreign currency translation
(1)
0
0
(1)
(1)
Reserve balance at the end of the period
451
425
405
451
405
 
The table below summarizes
 
other valuation adjustment
 
reserves recognized
 
on the balance sheet.
 
Other valuation adjustment
 
reserves on the balance sheet
As of
Life-to-date gain / (loss), USD m
30.6.22
31.3.22
31.12.21
Own credit adjustments on financial liabilities
 
designated at fair value
406
114
(315)
of which: debt issued designated at fair value
308
29
(347)
of which: other financial liabilities designated at fair value
98
85
32
Credit valuation adjustments
1
(36)
(45)
(44)
Funding valuation adjustments
(8)
(41)
(49)
Debit valuation adjustments
5
4
2
Other valuation adjustments
(869)
(887)
(913)
of which: liquidity
(326)
(343)
(341)
of which: model uncertainty
(543)
(544)
(571)
1 Amount does not include reserves
 
against defaulted counterparties.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
62
 
 
Note 8
 
Fair value measurement
 
(continued)
 
c) Level 3 instruments:
 
valuation techniques
 
and inputs
The
 
table below
 
presents material
 
Level 3 assets
 
and
 
liabilities, together
 
with
 
the
 
valuation techniques
 
used
 
to
measure fair value, as well as
 
the inputs used in
 
a given valuation technique that are considered significant as
 
of
30 June 2022 and unobservable,
 
and a range of values
 
for those unobservable
 
inputs.
The range of values represents
 
the highest-
 
and lowest-level
 
inputs used in the valuation
 
techniques.
 
Therefore the
range does
 
not reflect
 
the level
 
of uncertainty
 
regarding
 
a particular
 
input or
 
an assessment
 
of the reasonableness
 
of
the Group’s
 
estimates
 
and assumptions,
 
but rather the
 
different
 
underlying
 
characteristics
 
of the relevant
 
assets and
liabilities
 
held by
 
the Group.
 
The significant
 
unobservable
 
inputs disclosed
 
in the table
 
below are
 
consistent with
 
those included
 
in “Note
 
21 Fair
value measurement” in
 
the “Consolidated
 
financial statements”
 
section of the Annual
 
Report 2021.
 
Valuation techniques and inputs used
 
in the fair value measurement of
 
Level 3 assets and liabilities
Fair value
Significant unobservable
input(s)
1
Range of inputs
Assets
Liabilities
Valuation technique(s)
30.6.22
31.12.21
USD bn
30.6.22
31.12.21
30.6.22
31.12.21
low
high
weighted
average
2
low
high
weighted
average
2
unit
1
Financial assets and liabilities at fair value held for
 
trading and Financial assets at fair
 
value not held for trading
Corporate and municipal
bonds
0.9
0.9
0.0
0.0
Relative value to
market comparable
Bond price equivalent
14
103
88
16
143
98
points
Discounted expected
cash flows
Discount margin
447
447
434
434
basis
points
Traded loans, loans
measured at fair value,
loan commitments and
guarantees
2.3
2.8
0.0
0.0
Relative value to
market comparable
Loan price equivalent
20
100
98
0
101
99
points
Discounted expected
cash flows
Credit spread
200
800
374
175
800
436
basis
points
Market comparable
and securitization
model
Credit spread
125
1,423
329
28
1,544
241
basis
points
Auction rate securities
1.6
1.6
Discounted expected
cash flows
Credit spread
115
197
154
115
197
153
basis
points
Investment fund units
3
0.1
0.1
0.0
0.0
Relative value to
market comparable
Net asset value
Equity instruments
3
0.8
0.8
0.1
0.1
Relative value to
market comparable
Price
Debt issued designated at
fair value
4
12.0
14.2
Other financial liabilities
designated at fair value
0.9
0.8
Discounted expected
cash flows
Funding spread
25
175
24
175
basis
points
Derivative financial instruments
Interest rate
0.4
0.5
0.1
0.3
Option model
Volatility of interest rates
67
155
65
81
basis
points
Credit derivatives
0.6
0.2
0.4
0.3
Discounted expected
cash flows
Credit spreads
 
6
416
1
583
basis
points
Bond price equivalent
3
185
2
136
points
Equity / index
0.7
0.4
1.1
1.5
Option model
Equity dividend yields
0
12
0
11
%
Volatility of equity stocks,
equity and other indices
3
145
4
98
%
Equity-to-FX correlation
(29)
84
(29)
76
%
Equity-to-equity correlation
(25)
100
(25)
100
%
1 The ranges of significant unobservable
 
inputs are represented in
 
points, percentages and
 
basis points. Points are
 
a percentage of par (e.g.,
 
100 points would be 100%
 
of par).
 
2 Weighted averages
 
are provided for
most non-derivative financial instruments and were calculated by weighting
 
inputs based on the fair values of the respective instruments. Weighted
 
averages are not provided for inputs related to Other financial liabilities
designated at fair
 
value
 
and Derivative
 
financial instruments,
 
as this would
 
not be meaningful.
 
3 The range
 
of inputs is
 
not disclosed,
 
as there
 
is a dispersion
 
of values given
 
the diverse
 
nature of the investments.
 
4 Debt issued designated at fair value
 
primarily consists of UBS structured
 
notes, which include variable
 
maturity notes with various
 
equity and foreign exchange
 
underlying risks, rat
 
es-linked and credit
 
-linked notes, all
of which have embedded derivative parameters
 
that are considered to be unobservable.
 
The equivalent derivative
 
instrument parameters are
 
presented in the respective derivative financial
 
instruments lines in this table.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
63
 
 
Note 8
 
Fair value measurement
 
(continued)
 
d) Level 3 instruments:
 
sensitivity to
 
changes in unobservable
 
input assumptions
 
The table below summarizes those financial assets and
 
liabilities classified as Level 3 for which a change in one or
more of
 
the unobservable inputs
 
to
 
reflect reasonably possible
 
alternative assumptions would
 
change fair
 
value
significantly, and the estimated
 
effect thereof.
 
The
 
sensitivity data
 
shown below
 
presents an
 
estimation of
 
valuation uncertainty based
 
on
 
reasonably possible
alternative values
 
for Level 3 inputs
 
at the balance
 
sheet date and
 
does not represent
 
the estimated
 
effect of stress
scenarios. Typically, these
 
financial assets and
 
liabilities are
 
sensitive to
 
a combination of
 
inputs from
 
Levels 1–3.
Although well-defined interdependencies may exist between Level 1 / 2 parameters and Level 3 parameters (e.g.,
between interest
 
rates, which
 
are generally
 
Level 1 or
 
Level 2, and
 
prepayments,
 
which are generally
 
Level 3), these
have not been incorporated
 
in the table. Furthermore,
 
direct interrelationships
 
between the Level
 
3 parameters are
not a significant element
 
of the valuation uncertainty.
 
Sensitivity of fair value measurements
 
to changes in unobservable input
 
assumptions
1
30.6.22
31.3.22
31.12.21
USD m
Favorable
 
changes
Unfavorable
 
changes
Favorable
 
changes
Unfavorable
 
changes
Favorable
 
changes
Unfavorable
 
changes
Traded loans, loans
 
designated at fair value,
 
loan commitments and guarantees
25
(32)
15
(20)
19
(13)
Securities financing transactions
53
(55)
47
(52)
41
(53)
Auction rate securities
79
(79)
79
(79)
66
(66)
Asset-backed securities
25
(19)
25
(18)
20
(20)
Equity instruments
177
(152)
170
(144)
173
(146)
Interest rate derivatives, net
41
(54)
69
(62)
29
(19)
Credit derivatives, net
7
(6)
8
(7)
5
(8)
Foreign exchange derivatives,
 
net
11
(7)
16
(9)
19
(11)
Equity / index derivatives, net
382
(374)
410
(367)
368
(335)
Other
71
(98)
53
(81)
50
(73)
Total
869
(877)
892
(839)
790
(744)
1 Sensitivity of issued and over-the-counter
 
debt instruments is reported
 
with the equivalent
 
derivative or securities financing
 
instrument.
 
e) Level 3 instruments:
 
movements during
 
the period
The
 
table
 
on
 
the
 
following
 
page
 
presents
 
additional
 
information
 
about
 
material
 
Level 3
 
assets
 
and
 
liabilities
measured at fair value on
 
a recurring basis. Level 3 assets
 
and liabilities may be hedged
 
with instruments classified
as Level 1 or Level
 
2 in the fair value hierarchy
 
and, as a result,
 
realized and unrealized
 
gains and losses
 
included in
the table may not
 
include the effect
 
of related hedging
 
activity. Furthermore,
 
the realized
 
and unrealized
 
gains and
losses presented in
 
the table are not limited solely to those arising from Level 3 inputs, as valuations are generally
derived from both observable
 
and unobservable
 
parameters.
Assets
 
and
 
liabilities
 
transferred
 
into
 
or
 
out
 
of
 
Level 3
 
are
 
presented
 
as
 
if
 
those
 
assets
 
or
 
liabilities
 
had
 
been
transferred at the beginning
 
of the year.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
64
 
 
Note 8
 
Fair value measurement
 
(continued)
Movements of Level 3
 
instruments
USD bn
Balance at
the beginning
of the period
Net gains /
losses
included in
compre-
hensive
income
1
of which:
related to
instruments
held at the
end of the
period
Purchases
Sales
Issuances
Settlements
Transfers
 
into
 
Level 3
Transfers
 
out of
 
Level 3
Foreign
 
currency
 
translation
Balance at
the end
of the period
For the six months ended
 
30 June 2022
2
Financial assets at fair value held
 
for
trading
2.3
(0.1)
(0.2)
0.3
(1.3)
1.0
0.0
0.1
(0.3)
(0.0)
1.9
of which: Investment fund units
0.0
(0.0)
(0.0)
0.0
(0.0)
0.0
0.0
0.0
(0.0)
(0.0)
0.0
of which: Corporate and municipal
bonds
0.6
(0.0)
(0.0)
0.2
(0.1)
0.0
0.0
0.0
(0.0)
(0.0)
0.7
of which: Loans
1.4
(0.1)
(0.1)
0.0
(1.2)
1.0
0.0
0.0
(0.2)
(0.0)
1.0
Derivative financial instruments –
assets
1.1
0.5
0.6
0.0
0.0
0.5
(0.4)
0.2
(0.2)
(0.0)
1.8
of which: Interest rate
0.5
0.1
0.1
0.0
0.0
0.0
(0.1)
0.1
(0.1)
(0.0)
0.4
of which: Equity / index
0.4
0.3
0.3
0.0
0.0
0.2
(0.2)
0.0
(0.0)
(0.0)
0.7
of which: Credit derivatives
0.2
0.1
0.1
0.0
0.0
0.2
(0.0)
0.1
0.0
0.0
0.6
Financial assets at fair value not
 
held
for trading
4.2
0.1
0.1
0.6
(0.6)
0.0
(0.0)
0.0
(0.1)
(0.1)
4.2
of which: Loans
0.9
(0.0)
(0.0)
0.5
(0.2)
0.0
0.0
0.0
(0.1)
(0.0)
1.0
of which: Auction rate securities
1.6
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
of which: Equity instruments
0.7
0.0
0.0
0.0
(0.1)
0.0
0.0
0.0
0.0
(0.0)
0.7
Derivative financial instruments –
liabilities
2.2
(0.6)
(0.6)
0.0
0.0
0.9
(0.8)
0.1
(0.1)
(0.1)
1.7
of which: Interest rate
0.3
(0.2)
(0.2)
0.0
0.0
0.1
(0.0)
0.0
0.0
(0.0)
0.1
of which: Equity / index
1.5
(0.3)
(0.3)
0.0
0.0
0.6
(0.7)
0.0
(0.1)
(0.0)
1.1
of which: Credit derivatives
0.3
(0.1)
(0.1)
0.0
0.0
0.1
0.0
0.1
(0.0)
(0.0)
0.4
Debt issued designated at fair value
14.2
(2.5)
(2.3)
0.0
0.0
4.2
(2.7)
0.7
(1.5)
(0.4)
12.0
Other financial liabilities designated at
fair value
0.8
(0.0)
(0.0)
0.0
0.0
0.2
(0.1)
0.0
(0.0)
(0.0)
0.9
 
For the six months ended
 
30 June 2021
Financial assets at fair value held
 
for
trading
2.3
(0.0)
(0.0)
0.3
(0.8)
0.4
0.0
0.2
(0.2)
(0.0)
2.1
of which: Investment fund units
0.0
(0.0)
(0.0)
0.0
(0.0)
0.0
0.0
0.0
(0.0)
(0.0)
0.0
of which: Corporate and municipal
bonds
0.8
0.0
0.0
0.1
(0.1)
0.0
0.0
0.0
(0.1)
(0.0)
0.8
of which: Loans
1.1
0.0
0.0
0.1
(0.5)
0.4
0.0
0.0
(0.2)
0.0
1.0
Derivative financial instruments –
assets
1.8
(0.2)
(0.1)
0.0
0.0
0.5
(0.4)
(0.0)
(0.1)
(0.0)
1.5
of which: Interest rate
0.5
(0.1)
(0.1)
0.0
0.0
0.0
(0.1)
0.0
0.0
(0.0)
0.3
of which: Equity / index
0.9
0.1
0.1
0.0
0.0
0.3
(0.4)
(0.0)
(0.1)
(0.0)
0.8
of which: Credit derivatives
0.3
(0.1)
(0.1)
0.0
0.0
0.1
(0.0)
0.0
(0.0)
0.0
0.3
Financial assets at fair value not
 
held
for trading
3.9
0.1
0.1
0.7
(0.3)
0.0
0.0
0.1
(0.0)
(0.0)
4.5
of which: Loans
0.9
(0.0)
0.0
0.4
(0.1)
0.0
0.0
0.0
(0.0)
(0.0)
1.1
of which: Auction rate securities
1.5
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6
of which: Equity instruments
0.5
0.1
0.1
0.1
(0.1)
0.0
0.0
0.0
(0.0)
(0.0)
0.6
Derivative financial instruments –
liabilities
3.5
0.2
(0.0)
0.0
0.0
0.7
(1.2)
0.0
(0.2)
(0.0)
2.9
of which: Interest rate
0.5
(0.1)
(0.1)
0.0
0.0
0.1
(0.0)
0.0
(0.0)
(0.0)
0.5
of which: Equity / index
2.3
0.4
0.2
0.0
0.0
0.5
(1.1)
0.0
(0.2)
(0.0)
1.9
of which: Credit derivatives
0.5
(0.2)
(0.2)
0.0
0.0
0.1
(0.0)
0.0
(0.0)
(0.0)
0.4
Debt issued designated at fair value
11.0
0.3
0.2
0.0
0.0
7.2
(2.9)
0.2
(0.8)
(0.2)
14.7
Other financial liabilities designated at
fair value
0.7
(0.0)
(0.0)
0.0
0.0
0.1
(0.2)
0.0
(0.0)
(0.0)
0.6
1 Net gains / losses included in comprehensive
 
income are recognized in Net interest
 
income and Other net income
 
from financial instruments
 
measured at fair value through profit
 
or loss in the Income statement,
 
and
also in Gains / (losses) from own
 
credit on financial liabilities
 
designated at fair value,
 
before tax in the Statement
 
of comprehensive income.
 
2 Total Level
 
3 assets as of 30 June 2022 were
 
USD
8.0
bn (31 December
2021: USD
7.6
bn). Total Level 3 liabilities
 
as of 30 June 2022 were
 
USD
14.7
bn (31 December 2021:
 
USD
17.4
bn).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
65
 
 
Note 8
 
Fair value measurement
 
(continued)
 
f) Financial instruments
 
not measured
 
at fair value
The
 
table below
 
reflects the
 
estimated fair
 
values of
 
financial instruments not
 
measured at
 
fair
 
value. Valuation
principles applied when
 
determining fair value estimates for
 
financial instruments not measured at fair
 
value are
consistent with those described in “Note 21 Fair Value measurement”
 
in the “Consolidated financial statements”
section of the Annual
 
Report 2021.
 
Financial instruments not measured
 
at fair value
30.6.22
31.3.22
31.12.21
USD bn
Carrying
amount
Fair value
Carrying
amount
Fair value
Carrying
amount
Fair value
Assets
Cash and balances at central banks
190.4
190.4
206.8
206.8
192.8
192.8
Loans and advances to banks
16.6
16.6
17.9
17.9
15.5
15.5
Receivables from securities financing transactions
63.3
63.3
69.5
69.5
75.0
75.0
Cash collateral receivables on derivative
 
instruments
43.8
43.8
39.3
39.3
30.5
30.5
Loans and advances to customers
383.9
373.6
392.2
386.2
397.8
396.9
Other financial assets measured at amortized cost
1
37.5
36.0
28.7
28.2
26.2
26.5
Liabilities
Amounts due to banks
15.2
15.2
16.6
16.6
13.1
13.1
Payables from securities financing
 
transactions
6.0
6.0
7.1
7.1
5.5
5.5
Cash collateral payables on derivative instruments
40.5
40.5
39.6
39.6
31.8
31.8
Customer deposits
512.2
512.1
541.5
541.4
542.0
542.0
Debt issued measured at amortized cost
121.9
120.0
131.5
132.2
139.2
141.1
Other financial liabilities measured at amortized cost
2
6.7
6.7
6.2
6.2
5.4
5.4
1 Effective 1 April 2022, a portfolio of
 
assets previously classified as Financial
 
assets measured at fair value
 
through other comprehensive
 
income was reclassified to
 
Other financial assets measured at
 
amortized cost.
Refer to Note 1 for more information.
 
2 Excludes lease liabilities.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
66
 
 
Note 9
 
Derivative instruments
 
a) Derivative instruments
As of 30.6.22, USD bn
Derivative
financial
assets
Notional values
related to derivative
financial assets
1
Derivative
financial
liabilities
Notional values
related to derivative
financial liabilities
1
Other
notional
values
2
Derivative financial instruments
Interest rate
38.3
1,083
34.7
1,049
9,799
Credit derivatives
2.1
48
1.8
47
0
Foreign exchange
83.4
3,252
82.5
3,092
33
Equity / index
33.9
388
34.6
457
69
Commodities
2.0
78
2.2
70
16
Loan commitments measured at FVTPL
0.0
1
0.0
7
Unsettled purchases of non-derivative financial instruments
3
0.3
29
0.5
22
Unsettled sales of non-derivative financial instruments
3
0.5
30
0.5
24
Total derivative financial
 
instruments, based on IFRS
 
netting
4
160.5
4,910
156.9
4,769
9,916
Further netting potential not recognized
 
on the balance sheet
5
(146.5)
(141.0)
of which: netting of recognized
 
financial liabilities / assets
(116.0)
(116.0)
of which: netting with collateral received / pledged
(30.5)
(24.9)
Total derivative financial
 
instruments, after consideration
 
of further
netting potential
14.0
15.9
As of 31.3.22, USD bn
Derivative financial instruments
Interest rate
37.1
1,080
33.7
1,055
9,569
Credit derivatives
1.7
50
1.8
48
0
Foreign exchange
67.6
3,315
66.1
3,183
20
Equity / index
29.9
477
33.3
566
80
Commodities
2.9
82
2.6
65
17
Loan commitments measured at FVTPL
0.0
1
0.0
5
Unsettled purchases of non-derivative financial instruments
3
0.3
26
0.5
30
Unsettled sales of non-derivative financial instruments
3
0.7
45
0.4
18
Total derivative financial
 
instruments, based on IFRS
 
netting
4
140.3
5,075
138.4
4,971
9,686
Further netting potential not recognized
 
on the balance sheet
5
(126.6)
(121.4)
of which: netting of recognized
 
financial liabilities / assets
(101.7)
(101.7)
of which: netting with collateral received / pledged
(25.0)
(19.7)
Total derivative financial
 
instruments, after consideration
 
of further
netting potential
13.7
17.0
As of 31.12.21, USD bn
Derivative financial instruments
Interest rate
33.2
991
28.7
943
8,675
Credit derivatives
1.4
45
1.8
46
0
Foreign exchange
53.3
3,031
54.1
2,939
1
Equity / index
28.2
457
34.9
604
80
Commodities
1.6
58
1.6
56
15
Loan commitments measured at FVTPL
0.0
1
0.0
8
Unsettled purchases of non-derivative financial instruments
3
0.1
13
0.2
11
Unsettled sales of non-derivative financial instruments
3
0.2
18
0.1
9
Total derivative financial
 
instruments, based on IFRS
 
netting
4
118.1
4,614
121.3
4,617
8,771
Further netting potential not recognized
 
on the balance sheet
5
(107.4)
(107.0)
of which: netting of recognized
 
financial liabilities / assets
(88.9)
(88.9)
of which: netting with collateral received / pledged
(18.5)
(18.1)
Total derivative financial
 
instruments, after consideration
 
of further
netting potential
10.7
14.3
1 In cases where
 
derivative financial
 
instruments are
 
presented on
 
a net basis
 
on the balance
 
sheet, the
 
respective notional
 
values of the
 
netted derivative
 
financial instruments
 
are still presented
 
on a gross
 
basis.
Notional amounts of client
 
-cleared ETD and OTC
 
transactions through
 
central clearing counterparties
 
are not disclosed,
 
as they have a significantly
 
different risk profile.
 
2 Other notional
 
values relate to
 
derivatives
that are cleared through
 
either a central
 
counterparty or an
 
exchange. The
 
fair value of these
 
derivatives is presented
 
on the balance
 
sheet net of the corresponding
 
cash margin under
 
Cash collateral receivables
 
on
derivative instruments and
 
Cash collateral
 
payables on derivative
 
instruments and was
 
not material for all
 
periods presented.
 
3 Changes in the
 
fair value of
 
purchased and sold
 
non-derivative financial
 
instruments
between trade date and settlement date are recognized as derivative financial instruments.
 
4 Financial assets and liabilities are presented
 
net on the balance sheet if UBS has the unconditional and legally enforceable
right to offset the recognized
 
amounts, both in the
 
normal course of business
 
and in the event of
 
default, bankruptcy or insolvency
 
of UBS or its counterparties,
 
and intends either
 
to settle on a net
 
basis or to realize
the asset and settle the
 
liability simultan
 
eously.
 
5 Reflects the netting
 
potential in accordance
 
with enforceable master
 
netting and similar
 
arrangements where
 
not all criteria
 
for a net
 
presentation on the balance
sheet have been met. Refer to “Note
 
22 Offsetting financial assets
 
and financial liabilities”
 
in the “Consolidated financial
 
statements” section
 
of the Annual Report 2021 for
 
more information.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
67
 
 
Note 9
 
Derivative instruments
 
(continued)
 
b) Cash collateral
 
on derivative instruments
USD bn
Receivables
30.6.22
Payables
30.6.22
Receivables
31.3.22
Payables
31.3.22
Receivables
31.12.21
Payables
31.12.21
Cash collateral on derivative instruments,
 
based on IFRS netting
1
43.8
40.5
39.3
39.6
30.5
31.8
Further netting potential not recognized
 
on the balance sheet
2
(23.2)
(22.6)
(19.0)
(21.4)
(18.4)
(16.4)
of which: netting of recognized
 
financial liabilities / assets
(20.4)
(19.9)
(15.8)
(18.2)
(15.2)
(13.1)
of which: netting with collateral received / pledged
(2.8)
(2.8)
(3.2)
(3.2)
(3.3)
(3.3)
Cash collateral on derivative
 
instruments, after consideration
 
of further netting potential
20.6
17.9
20.3
18.2
12.1
15.4
1 Financial assets and
 
liabilities are
 
presented net on the
 
balance sheet if
 
UBS has the unconditional
 
and legally enforceable
 
right to offset the
 
recognized amounts,
 
both in the normal
 
course of business
 
and in the
event of default,
 
bankruptcy or insolvency
 
of UBS
 
or its counterparties,
 
and intends
 
either to
 
settle on a
 
net basis or
 
to realize
 
the asset
 
and settle
 
the liability
 
simultaneously.
 
2 Reflects
 
the netting
 
potential in
accordance with
 
enforceable master
 
netting and
 
similar arrangements
 
where not
 
all criteria
 
for a net
 
presentation
 
on the bala
 
nce sheet
 
have been
 
met. Refer
 
to “Note
 
22 Offsetting
 
financial assets
 
and financial
liabilities” in the “Consolidated
 
financial statements”
 
section of the Annual Report 2021
 
for more information.
 
 
 
Note
 
10
 
Other assets and
 
liabilities
 
 
a) Other financial assets
 
measured at amortized
 
cost
USD m
30.6.22
31.3.22
31.12.21
Debt securities
1
29,812
21,192
18,858
Loans to financial advisors
2,447
2,388
2,453
Fee-
 
and commission-related receivables
1,970
1,953
1,972
Finance lease receivables
1,283
1,325
1,356
Settlement and clearing accounts
 
501
492
455
Accrued interest income
681
547
520
Other
833
801
594
Total other financial assets
 
measured at amortized cost
37,528
28,697
26,209
1 Effective 1 April 2022, a portfolio of
 
assets previously classified as
 
Financial assets measured
 
at fair value through other comprehensive
 
income was reclassified to
 
Other financial assets
 
measured at amortized cost.
Refer to Note 1 for more information.
 
 
b) Other non-financial
 
assets
USD m
30.6.22
31.3.22
31.12.21
Precious metals and other physical commodities
 
4,377
4,626
5,258
Deposits and collateral provided in connection
 
with litigation, regulatory and similar matters
1
2,150
2,280
1,526
Prepaid expenses
1,037
1,143
1,108
VAT and other
 
tax receivables
440
469
638
Properties and other non
 
-current assets held for sale
340
313
32
Assets of disposal groups held for sale
823
1,018
1,093
Other
817
731
621
Total other non-financial
 
assets
9,984
10,581
10,277
1 Refer to Note 14 for more information.
 
 
c) Other financial
 
liabilities measured
 
at amortized cost
USD m
30.6.22
31.3.22
31.12.21
Other accrued expenses
1,711
1,780
1,876
Accrued interest expenses
1,195
822
1,094
Settlement and clearing accounts
1,882
1,691
1,304
Lease liabilities
3,252
3,422
3,558
Other
 
1,891
1,925
1,167
Total other financial liabilities
 
measured at amortized cost
9,930
9,641
9,001
 
d) Other financial
 
liabilities designated
 
at fair value
 
USD m
30.6.22
31.3.22
31.12.21
Financial liabilities related to unit-linked investment
 
contracts
14,503
18,661
21,466
Securities financing transactions
12,026
9,388
6,377
Over-the-counter debt instruments
2,036
2,269
2,128
Other
0
8
103
Total other financial liabilities designated
 
at fair value
28,566
30,325
30,074
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
68
 
 
Note 10
 
Other assets and
 
liabilities (continued)
 
e) Other non-financial
 
liabilities
USD m
30.6.22
31.3.22
31.12.21
Compensation-related liabilities
5,421
4,818
7,257
of which: net defined benefit liability
480
576
633
Deferred tax liabilities
207
174
300
Current tax liabilities
973
947
1,398
VAT and other
 
tax payables
643
772
590
Deferred income
245
260
240
Liabilities of disposal groups held for sale
1,351
1,289
1,298
Other
70
61
68
Total other non-financial
 
liabilities
8,910
8,322
11,151
 
 
 
Note
 
11
 
Debt issued designated
 
at fair value
USD m
30.6.22
31.3.22
31.12.21
Issued debt instruments
Equity-linked
1
39,629
44,252
47,059
Rates-linked
16,916
14,933
16,369
Credit-linked
2,147
1,951
1,723
Fixed-rate
5,411
3,727
2,868
Commodity-linked
4,640
3,995
2,911
Other
3,523
2,612
2,868
of which: debt that contributes to total loss-absorbing
 
capacity
1,864
1,990
2,136
Total debt issued designated
 
at fair value
72,264
71,470
73,799
of which: issued by UBS AG with original maturity greater
 
than one year
2
56,308
55,739
57,967
1 Includes investment fund unit-linked
 
instruments issued.
 
2 Based on original contractual
 
maturity without considering
 
any early redemption features.
 
As of 30 June 2022,
 
100
% of the balance was unsecured
(31 March 2022:
100
%; 31 December 2021:
100
%).
 
 
 
Note
 
12
 
Debt issued measured
 
at amortized cost
USD m
30.6.22
31.3.22
31.12.21
Short-term debt
1
31,525
37,539
43,098
Senior unsecured debt that
 
contributes to total loss-absorbing capacity (TLAC)
41,469
41,479
38,984
Senior unsecured debt other than
 
TLAC
21,421
23,024
27,590
of which: issued by UBS AG with original maturity greater
 
than one year
2
20,099
21,619
23,307
Covered bonds
1,351
1,389
Subordinated debt
18,304
18,664
18,640
of which: high-trigger loss-absorbing additional tier 1 capital instruments
12,076
12,372
11,052
of which: low-trigger loss-absorbing additional tier 1 capital
 
instruments
1,219
1,236
2,425
of which: low-trigger loss-absorbing tier 2 capital instruments
2,471
2,507
2,596
of which: non-Basel III-compliant tier 2 capital instruments
538
543
547
Debt issued through the Swiss central mortgage
 
institutions
9,177
9,435
9,454
Long-term debt
3
90,371
93,953
96,057
Total debt issued
 
measured at amortized cost
4
121,896
131,492
139,155
1 Debt with an original contractual
 
maturity of less than
 
one year,
 
mainly consisting of certificates
 
of deposit and commercial
 
paper.
 
2 Based on original
 
contractual maturity without
 
considering any early
redemption features. As of
 
30 June 2022,
100
% of the balance was
 
unsecured (31 March 2022:
100
%; 31 December 2021:
100
%).
 
3 Debt with an original contractual
 
maturity greater than or equal
 
to one year.
The classification of
 
debt issued into short-term
 
and long-term does not consider
 
any early redemption features.
 
4 Net of bifurcated
 
embedded derivatives,
 
the fair value of which
 
was not material for
 
the periods
presented.
 
 
 
Note 13
 
Interest rate benchmark
 
reform
During 2022,
 
UBS has continued
 
to manage the
 
transition to
 
alternative reference
 
rates (ARRs)
 
under the oversight
of the
 
dedicated
 
Group-wide
 
forum, with
 
an increased
 
focus on
 
the US
 
region. The
 
transition of
 
non-USD
 
interbank
offered rates (IBORs) is largely
 
complete, with efforts now focused on managing the transition of remaining
 
USD
LIBOR exposures.
On
 
15 March
 
2022,
 
the
 
US
 
enacted
 
federal
 
legislation,
 
the
 
“Adjustable
 
Interest
 
Rate
 
(LIBOR)
 
Act,”
 
which
 
is
substantially based
 
on, and supersedes,
 
the New York
 
State London
 
Interbank Offered
 
Rate (LIBOR) legislation.
 
The
Adjustable Interest Rate
 
(LIBOR) Act provides a legislative
 
solution for USD LIBOR
 
legacy products governed by
 
any
US state law should
 
such products fail
 
to transition prior to the
 
USD LIBOR cessation
 
date of 30 June 2023.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
69
 
 
Note 13
 
Interest rate benchmark
 
reform (continued)
Non-derivative instruments
Most
 
of
 
the
 
USD
21
bn
 
mortgages linked
 
to
 
CHF
 
LIBOR
 
that
 
were
 
outstanding as
 
of
 
31 December 2021
 
were
automatically transitioned
 
to
 
Swiss
 
Average
 
Rate
 
Overnight (SARON)
 
during
 
the
 
first
 
quarter
 
of
 
2022. A
 
small
number of transitions
 
took place in
 
the second
 
quarter of 2022,
 
with the remaining
 
due to transition
 
later in 2022,
on their
 
next roll
 
date. Substantially
 
all of
 
the US
 
securities-based
 
lending outstanding
 
as of
 
31 December 2021
 
was
transitioned to
 
Secured Overnight Financing
 
Rate (SOFR) during
 
the first
 
quarter of
 
2022.
 
In January
 
2022, UBS
completed the transition of USD LIBOR-linked non-derivative balances
 
related to brokerage accounts to SOFR. No
other material transitions
 
of USD LIBOR-linked
 
contracts occurred
 
in the first half
 
of 2022.
 
Derivative instruments
 
UBS successfully transitioned the
 
remaining non-USD IBOR derivatives not
 
transacted through clearing houses or
exchanges during the first quarter of 2022,
 
which ensured an orderly transition when converting
 
high volumes of
transactions at the time
 
of rate cessation. No material
 
USD LIBOR-linked
 
derivatives have transitioned
 
in 2022.
 
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
a) Provisions
The table below presents
 
an overview of total
 
provisions.
USD m
30.6.22
31.3.22
31.12.21
Provisions other than provisions for expected credit
 
losses
3,272
3,257
3,322
Provisions for expected credit losses
1
192
221
196
Total provisions
3,465
3,478
3,518
1 Refer to Note 7c for more information.
 
 
The following table
 
presents additional information
 
for provisions other
 
than provisions
 
for expected credit losses.
USD m
Litigation,
regulatory and
similar matters
1
Restructuring
2
Other
3
Total
Balance as of 31 December 2021
2,798
172
352
3,322
Balance as of 31 March 2022
2,758
159
340
3,257
Increase in provisions recognized in the income statement
235
67
15
318
Release of provisions recognized in the income statement
(14)
(7)
(5)
(27)
Provisions used in conformity with designated purpose
(101)
(72)
(6)
(178)
Foreign currency translation / unwind
 
of discount
(80)
(5)
(13)
(98)
Balance as of 30 June 2022
2,799
142
331
3,272
1 Consists of provisions for losses
 
resulting from legal, liability
 
and compliance risks.
 
2 Primarily consists of
 
personnel-related restructuring
 
provisions of USD
102
m as of 30 June 2022
 
(31 March 2022: USD
114
m;
31 December 2021: USD
125
m) and provisions for
 
onerous contracts of USD
40
m as of 30 June 2022 (31 March
 
2022: USD
45
m; 31 December 2021: USD
47
m).
 
3 Mainly includes
 
provisions related to real estate,
employee benefits and operational
 
risks.
Restructuring provisions primarily relate
 
to personnel-related provisions and
 
onerous contracts. Personnel-related
restructuring provisions are generally used within a short period of time.
 
The level of personnel-related provisions
can
 
change
 
when
 
natural
 
staff
 
attrition
 
reduces
 
the
 
number of
 
people
 
affected
 
by
 
a
 
restructuring
 
event,
 
and
therefore results in lower estimated costs. Onerous contracts for property are recognized when UBS is committed
to
 
pay for
 
non-lease components, such
 
as utilities,
 
service charges,
 
taxes and
 
maintenance, when
 
a property
 
is
vacated or not fully
 
recovered from sub-tenants.
 
Information about provisions and contingent liabilities in respect of litigation, regulatory and similar matters, as a
class,
 
is
 
included in
 
Note
 
14b.
 
There
 
are
 
no
 
material
 
contingent liabilities
 
associated with
 
the
 
other
 
classes
 
of
provisions.
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
70
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
 
b) Litigation, regulatory
 
and similar matters
The Group operates in a legal and
 
regulatory environment that exposes it to significant litigation and similar risks
arising from disputes and
 
regulatory proceedings. As a result, UBS
 
(which for purposes of
 
this Note may
 
refer to
UBS
 
Group
 
AG
 
and/or
 
one
 
or
 
more
 
of
 
its
 
subsidiaries, as
 
applicable) is
 
involved
 
in
 
various
 
disputes
 
and
 
legal
proceedings, including
 
litigation, arbitration,
 
and regulatory and
 
criminal investigations.
Such matters are
 
subject to many
 
uncertainties, and
 
the outcome and
 
the timing
 
of resolution are
 
often difficult
 
to
predict, particularly
 
in the
 
earlier stages
 
of
 
a case.
 
There are
 
also
 
situations where
 
the
 
Group may
 
enter
 
into a
settlement agreement.
 
This
 
may
 
occur
 
in
 
order
 
to
 
avoid
 
the
 
expense,
 
management distraction
 
or
 
reputational
implications of
 
continuing to
 
contest liability,
 
even for
 
those matters
 
for
 
which the
 
Group believes
 
it
 
should be
exonerated. The uncertainties inherent
 
in all such matters affect the amount and timing of any potential
 
outflows
for both matters
 
with respect
 
to which
 
provisions have
 
been established
 
and other
 
contingent liabilities.
 
The Group
makes
 
provisions for
 
such
 
matters brought
 
against it
 
when, in
 
the
 
opinion of
 
management after
 
seeking
 
legal
advice, it
 
is more likely
 
than not that
 
the Group has
 
a present legal or
 
constructive obligation as a
 
result of past
events, it
 
is probable
 
that
 
an outflow
 
of resources
 
will be
 
required,
 
and the
 
amount
 
can be
 
reliably estimated.
 
Where
these factors
 
are otherwise
 
satisfied, a
 
provision may
 
be
 
established for
 
claims that
 
have not
 
yet been
 
asserted
against
 
the Group,
 
but
 
are nevertheless
 
expected to
 
be, based
 
on the
 
Group’s experience
 
with similar
 
asserted
claims.
 
If
 
any
 
of
 
those
 
conditions
 
is
 
not
 
met, such
 
matters
 
result
 
in
 
contingent liabilities.
 
If
 
the
 
amount of
 
an
obligation cannot be
 
reliably estimated, a
 
liability exists that
 
is not
 
recognized even if
 
an outflow of
 
resources is
probable. Accordingly, no provision is
 
established even if the
 
potential outflow of resources with
 
respect to such
matters could be significant.
 
Developments relating to a
 
matter that occur after the relevant reporting
 
period, but
prior
 
to
 
the
 
issuance of
 
financial statements,
 
which affect
 
management’s assessment of
 
the provision
 
for such
matter
 
(because, for
 
example, the
 
developments provide
 
evidence of
 
conditions that
 
existed at
 
the
 
end
 
of
 
the
reporting
 
period), are
 
adjusting events
 
after
 
the
 
reporting period
 
under IAS
 
10
 
and
 
must be
 
recognized in
 
the
financial statements for
 
the reporting period.
Specific litigation, regulatory and other matters are described below, including all such matters that management
considers to
 
be
 
material and
 
others
 
that management
 
believes to
 
be
 
of
 
significance due
 
to potential
 
financial,
reputational and other effects. The amount of damages claimed, the size of
 
a transaction or other information is
provided
 
where
 
available
 
and
 
appropriate
 
in
 
order
 
to
 
assist
 
users
 
in
 
considering
 
the
 
magnitude
 
of
 
potential
exposures.
In the case of certain matters below,
 
we state that we have established a
 
provision, and for the other matters,
 
we
make no such statement.
 
When we make
 
this statement and we
 
expect disclosure
 
of the amount of
 
a provision to
prejudice seriously our position with other parties
 
in the matter
 
because it would reveal
 
what UBS believes to be
the
 
probable and
 
reliably estimable
 
outflow, we
 
do
 
not disclose
 
that amount.
 
In
 
some cases
 
we are
 
subject
 
to
confidentiality obligations that
 
preclude such
 
disclosure. With
 
respect to
 
the matters for
 
which we
 
do not
 
state
whether we have established
 
a provision, either: (a)
 
we have not established a provision,
 
in which case the matter
is treated as a contingent
 
liability under the applicable
 
accounting standard;
 
or (b) we have established a
 
provision
but
 
expect disclosure of
 
that fact
 
to prejudice
 
seriously our
 
position with
 
other parties
 
in the
 
matter because
 
it
would reveal the fact that
 
UBS believes an outflow
 
of resources to
 
be probable and reliably
 
estimable.
With respect to certain litigation, regulatory and similar matters for which we have established provisions, we are
able to
 
estimate the expected timing of
 
outflows. However, the aggregate amount of
 
the expected outflows for
those matters for which
 
we are able to
 
estimate expected
 
timing is immaterial
 
relative to
 
our current and
 
expected
levels of liquidity over
 
the relevant time periods.
The
 
aggregate
 
amount
 
provisioned
 
for
 
litigation,
 
regulatory
 
and
 
similar
 
matters
 
as
 
a
 
class
 
is
 
disclosed
 
in
 
the
“Provisions” table
 
in
 
Note 14a
 
above. It
 
is
 
not practicable
 
to
 
provide an
 
aggregate estimate
 
of
 
liability for
 
our
litigation, regulatory and similar matters
 
as a class of contingent liabilities. Doing so would require UBS to provide
speculative legal
 
assessments
 
as to claims
 
and proceedings
 
that involve
 
unique fact
 
patterns or
 
novel legal
 
theories,
that have not
 
yet been initiated or
 
are at
 
early stages of
 
adjudication, or as to
 
which alleged damages have
 
not
been quantified
 
by the claimants.
 
Although UBS
 
therefore cannot
 
provide a
 
numerical estimate
 
of the future
 
losses
that could arise
 
from litigation, regulatory
 
and similar matters,
 
UBS believes
 
that the aggregate
 
amount of possible
future losses from this class
 
that are more than
 
remote substantially
 
exceeds the level
 
of current provisions.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
71
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
Litigation, regulatory
 
and similar
 
matters
 
may also
 
result in
 
non-monetary
 
penalties and
 
consequences.
 
A guilty
 
plea
to, or conviction of, a crime could have material
 
consequences for UBS.
 
Resolution of regulatory proceedings
 
may
require UBS to obtain waivers of regulatory
 
disqualifications to maintain
 
certain operations, may entitle
 
regulatory
authorities to limit, suspend or terminate licenses and regulatory authorizations,
 
and may permit financial market
utilities to
 
limit, suspend
 
or
 
terminate UBS’s participation in
 
such utilities.
 
Failure to
 
obtain such
 
waivers, or
 
any
limitation, suspension
 
or termination
 
of licenses,
 
authorizations
 
or participations,
 
could have
 
material consequences
for UBS.
The
 
risk of
 
loss
 
associated with
 
litigation, regulatory
 
and similar
 
matters is
 
a component
 
of operational
 
risk for
purposes of
 
determining capital
 
requirements.
 
Information
 
concerning our
 
capital requirements
 
and the calculation
of operational risk for
 
this purpose is included
 
in the “Capital management”
 
section of this report.
 
Provisions for litigation, regulatory
 
and similar matters by business division
 
and in Group Functions
1
USD m
Global Wealth
Manage-
ment
Personal &
Corporate
Banking
Asset
Manage-
ment
Investment
Bank
Group
Functions
Total
Balance as of 31 December 2021
1,338
181
8
310
962
2,798
Balance as of 31 March 2022
1,309
176
8
307
958
2,758
Increase in provisions recognized in the income statement
129
0
0
101
6
235
Release of provisions recognized in the income statement
(7)
0
0
(6)
(1)
(14)
Provisions used in conformity with designated purpose
(80)
0
0
(5)
(15)
(101)
Foreign currency translation / unwind
 
of discount
(60)
(9)
0
(10)
(1)
(80)
Balance as of 30 June 2022
1,289
168
8
387
946
2,799
1 Provisions, if
 
any, for
 
the matters
 
described in items
 
3 and 4
 
of this Note
 
are recorded in
 
Global Wealth
 
Management, and
 
provisions, if
 
any, for
 
the matters
 
described in item 2
 
are recorded in
 
Group Functions.
Provisions, if any,
 
for the matters described
 
in items 1 and 6
 
of this Note are allocated
 
between Global Wealth
 
Management and Personal
 
& Corporate Banking,
 
provisions, if any,
 
for the matters described
 
in item 5
are allocated between the Investment
 
Bank and Group Functions,
 
and provisions, if
 
any, for the matters
 
described in item 7 are
 
allocated between Global
 
Wealth Management and
 
Investment Bank.
 
 
1. Inquiries regarding
 
cross-border wealth
 
management businesses
 
Tax
 
and regulatory
 
authorities in a
 
number of
 
countries have made
 
inquiries, served requests
 
for information or
examined
 
employees
 
located
 
in
 
their
 
respective
 
jurisdictions
 
relating
 
to
 
the
 
cross-border
 
wealth
 
management
services provided by
 
UBS and
 
other financial institutions. It
 
is possible
 
that the implementation of
 
automatic tax
information exchange and
 
other measures relating to cross-border provision
 
of financial services could give
 
rise to
further inquiries in the future. UBS has received disclosure orders from the Swiss Federal Tax
 
Administration (FTA)
to transfer information based
 
on requests for
 
international administrative assistance in tax matters. The
 
requests
concern a number of UBS account numbers pertaining to current and former clients and are based
 
on data from
2006 and
 
2008. UBS
 
has taken
 
steps to
 
inform affected
 
clients
 
about the
 
administrative
 
assistance
 
proceedings and
their procedural
 
rights, including the right
 
to appeal. The
 
requests are based on
 
data received from
 
the German
authorities, who seized
 
certain data related
 
to UBS
 
clients booked in
 
Switzerland during their investigations and
have apparently
 
shared this
 
data
 
with other
 
European countries.
 
UBS expects additional
 
countries to
 
file similar
requests.
Since 2013, UBS (France) S.A., UBS AG
 
and certain former employees have been under investigation in France in
relation to UBS’s cross-border business with French clients. In connection with this investigation,
 
the investigating
judges ordered UBS
 
AG to provide bail (“
caution
”) of EUR
1.1
bn.
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
72
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
On 20 February
 
2019, the court
 
of first instance
 
returned a
 
verdict finding
 
UBS AG
 
guilty of unlawful
 
solicitation of
clients on French territory and aggravated
 
laundering of the proceeds
 
of tax fraud, and UBS (France) S.A.
 
guilty of
aiding and
 
abetting unlawful
 
solicitation and
 
of
 
laundering the
 
proceeds of
 
tax fraud.
 
The
 
court imposed
 
fines
aggregating EUR
3.7
bn on UBS AG and UBS (France) S.A. and awarded EUR
800
m of civil damages to the French
state. A trial in
 
the French Court
 
of Appeal took
 
place in March
 
2021. On 13 December
 
2021, the Court
 
of Appeal
found UBS
 
AG guilty of
 
unlawful solicitation and aggravated laundering of
 
the proceeds of
 
tax fraud. The
 
court
ordered
 
a
 
fine
 
of
 
EUR
3.75
m,
 
the
 
confiscation of
 
EUR
1
bn,
 
and
 
awarded civil
 
damages
 
to
 
the
 
French
 
state
 
of
EUR
800
m. The
 
court also
 
found UBS
 
(France) SA
 
guilty of
 
the aiding
 
and abetting
 
of unlawful
 
solicitation and
ordered it to pay a
 
fine of EUR
1.875
m. UBS AG has
 
filed an appeal with the
 
French Supreme
 
Court to preserve
 
its
rights.
 
The
 
notice
 
of
 
appeal
 
enables
 
UBS
 
AG
 
to
 
thoroughly assess
 
the
 
verdict of
 
the
 
Court
 
of
 
Appeal
 
and
 
to
determine next steps
 
in the
 
best interest of
 
its stakeholders. The
 
fine and
 
confiscation imposed by
 
the Court
 
of
Appeal are suspended during
 
the appeal. The civil damages
 
award has been paid to the French
 
state (EUR
99
m of
which was deducted from
 
the bail), subject
 
to the result of
 
UBS’s appeal.
Our balance
 
sheet at
 
30 June 2022
 
reflected provisions
 
with respect
 
to
 
this matter
 
in an
 
amount of
 
EUR
1.1
bn
(USD
1.15
bn).
 
The
 
wide
 
range
 
of
 
possible
 
outcomes
 
in
 
this
 
case
 
contributes to
 
a
 
high
 
degree
 
of
 
estimation
uncertainty and the
 
provision reflects
 
our best estimate
 
of possible financial
 
implications, although
 
actual penalties
and civil damages could
 
exceed (or may be
 
less than) the provision
 
amount.
Our balance
 
sheet at
 
30 June
 
2022 reflected
 
provisions
 
with
 
respect to
 
matters
 
described
 
in this
 
item 1
 
in an
 
amount
that UBS believes to be appropriate under the applicable accounting
 
standard. As in the case of other matters for
which
 
we
 
have
 
established
 
provisions,
 
the
 
future
 
outflow
 
of
 
resources
 
in
 
respect
 
of
 
such
 
matters
 
cannot
 
be
determined with
 
certainty based
 
on
 
currently available
 
information and
 
accordingly may
 
ultimately prove
 
to
 
be
substantially greater (or
 
may be less) than
 
the provision
 
that we have recognized.
2. Claims related to sales
 
of residential mortgage-backed
 
securities and mortgages
From 2002
 
through 2007, prior
 
to the
 
crisis in
 
the US
 
residential loan
 
market, UBS was
 
a substantial issuer
 
and
underwriter of US residential mortgage-backed securities
 
(RMBS) and was a purchaser and seller of US residential
mortgages.
 
In November 2018, the
 
DOJ filed a
 
civil complaint in
 
the District Court
 
for the Eastern
 
District of New York.
 
The
complaint
 
seeks
 
unspecified
 
civil
 
monetary
 
penalties
 
under
 
the
 
Financial
 
Institutions
 
Reform,
 
Recovery
 
and
Enforcement Act of 1989
 
related to UBS’s issuance, underwriting and sale of 40
 
RMBS transactions in 2006 and
2007.
 
UBS moved
 
to
 
dismiss the
 
civil complaint
 
on 6 February
 
2019. On
 
10 December 2019,
 
the
 
district court
denied UBS’s motion
 
to dismiss.
 
Our
 
balance sheet
 
at 30
 
June 2022
 
reflected a
 
provision with
 
respect to
 
matters described
 
in
 
this item
 
2
 
in an
amount that
 
UBS believes
 
to
 
be
 
appropriate under the
 
applicable accounting standard.
 
As
 
in the
 
case of
 
other
matters for which we have established
 
provisions, the future outflow
 
of resources in respect of this matter
 
cannot
be determined with certainty based on
 
currently available information
 
and accordingly may ultimately
 
prove to be
substantially greater (or
 
may be less) than
 
the provision that we
 
have recognized.
3. Madoff
In relation to
 
the Bernard
 
L. Madoff
 
Investment Securities
 
LLC (BMIS)
 
investment fraud,
 
UBS AG,
 
UBS (Luxembourg)
S.A. (now UBS Europe SE,
 
Luxembourg branch) and certain other UBS subsidiaries have been
 
subject to inquiries
by a
 
number of
 
regulators, including
 
the Swiss
 
Financial
 
Market Supervisory
 
Authority (FINMA)
 
and the
 
Luxembourg
Commission
 
de
 
Surveillance du
 
Secteur Financier.
 
Those
 
inquiries
 
concerned two
 
third-party
 
funds
 
established
under Luxembourg law,
 
substantially all assets
 
of which
 
were with
 
BMIS, as
 
well as
 
certain funds
 
established in
offshore
 
jurisdictions with
 
either
 
direct or
 
indirect
 
exposure
 
to
 
BMIS. These
 
funds faced
 
severe
 
losses,
 
and
 
the
Luxembourg funds are in liquidation. The documentation
 
establishing both funds identifies UBS entities
 
in various
roles,
 
including custodian,
 
administrator,
 
manager, distributor
 
and promoter,
 
and indicates
 
that UBS
 
employees
serve as board members.
In 2009 and 2010,
 
the liquidators
 
of the two Luxembourg
 
funds filed claims
 
against UBS entities,
 
non-UBS entities
and
 
certain
 
individuals, including
 
current
 
and
 
former
 
UBS
 
employees, seeking
 
amounts
 
totaling
 
approximately
EUR
2.1
bn, which
 
includes amounts
 
that the
 
funds may
 
be held liable
 
to pay the
 
trustee for
 
the liquidation
 
of BMIS
(BMIS Trustee).
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
73
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
A large number of alleged
 
beneficiaries have filed
 
claims against UBS entities
 
(and non-UBS entities) for purported
losses relating to
 
the Madoff fraud. The
 
majority of these cases have
 
been filed in
 
Luxembourg, where decisions
that the claims in eight test cases were
 
inadmissible have been affirmed
 
by the Luxembourg Court of Appeal,
 
and
the Luxembourg
 
Supreme Court
 
has dismissed a further
 
appeal in one of the test
 
cases.
In
 
the US,
 
the BMIS
 
Trustee filed claims
 
against UBS
 
entities, among others,
 
in relation
 
to the
 
two Luxembourg
funds and one
 
of the offshore
 
funds. The total
 
amount claimed
 
against all
 
defendants in these
 
actions was not
 
less
than USD
2
bn. In
 
2014, the US
 
Supreme Court rejected the
 
BMIS Trustee’s motion for
 
leave to appeal
 
decisions
dismissing
 
all claims
 
except
 
those for
 
the
 
recovery
 
of approximately
 
USD
125
m of
 
payments alleged
 
to be
 
fraudulent
conveyances and
 
preference
 
payments. In
 
2016, the
 
bankruptcy court
 
dismissed these
 
claims
 
against
 
the
 
UBS
entities. In February
 
2019, the Court
 
of Appeals reversed
 
the dismissal
 
of the BMIS Trustee’s
 
remaining claims,
 
and
the US Supreme Court subsequently denied a petition seeking review of the Court of Appeals’ decision. The case
has been remanded to
 
the Bankruptcy Court
 
for further proceedings.
4. Puerto Rico
Declines since 2013 in the market prices of Puerto Rico municipal bonds and of closed-end funds (funds)
 
that are
sole-managed and co-managed by
 
UBS Trust
 
Company of Puerto
 
Rico and distributed
 
by UBS Financial
 
Services
Incorporated
 
of Puerto
 
Rico (UBS
 
PR) led
 
to multiple
 
regulatory inquiries,
 
which
 
in 2014
 
and 2015,
 
led to
 
settlements
with
 
the
 
Office
 
of
 
the
 
Commissioner
 
of
 
Financial
 
Institutions
 
for
 
the
 
Commonwealth
 
of
 
Puerto
 
Rico,
 
the
 
US
Securities and Exchange
 
Commission (SEC)
 
and the Financial
 
Industry Regulatory
 
Authority.
Since then, UBS clients in
 
Puerto Rico who own the funds or Puerto
 
Rico municipal bonds and/or who used their
UBS
 
account assets
 
as collateral
 
for UBS
 
non-purpose loans
 
filed customer
 
complaints and
 
arbitration demands
seeking
 
aggregate
 
damages
 
of USD
3.4
bn, of
 
which
 
USD
3.2
bn have
 
been resolved
 
through
 
settlements,
 
arbitration
or
 
withdrawal of
 
claims. Allegations
 
include fraud,
 
misrepresentation and unsuitability
 
of
 
the funds
 
and of
 
the
loans.
A
 
shareholder derivative
 
action
 
was
 
filed
 
in
 
2014
 
against
 
various UBS
 
entities
 
and
 
current
 
and
 
certain
 
former
directors of
 
the funds,
 
alleging
 
hundreds
 
of millions
 
of US
 
dollars in
 
losses in
 
the funds.
 
In 2021,
 
the parties
 
reached
an agreement to settle
 
this matter for USD
15
m, subject to court
 
approval.
 
In
 
2011,
 
a
 
purported
 
derivative
 
action
 
was
 
filed
 
on
 
behalf
 
of
 
the
 
Employee
 
Retirement
 
System
 
of
 
the
Commonwealth
 
of
 
Puerto
 
Rico
 
(System)
 
against
 
over
 
40
 
defendants,
 
including
 
UBS
 
PR,
 
which
 
was
 
named
 
in
connection with
 
its underwriting
 
and consulting
 
services. Plaintiffs
 
alleged that
 
defendants violated
 
their purported
fiduciary duties
 
and contractual
 
obligations in
 
connection
 
with the
 
issuance and
 
underwriting
 
of USD
3
bn of bonds
by the System in 2008 and
 
sought damages of over USD
800
m. In 2016, the court granted the
 
System’s request
to join
 
the action as a
 
plaintiff. In 2017, the
 
court denied defendants’ motion to dismiss the complaint. In 2020,
the court denied plaintiffs’
 
motion for summary
 
judgment.
 
Beginning
 
in
 
2015,
 
certain
 
agencies
 
and
 
public
 
corporations
 
of
 
the
 
Commonwealth
 
of
 
Puerto
 
Rico
(Commonwealth) defaulted
 
on
 
certain interest
 
payments on
 
Puerto Rico
 
bonds. In
 
2016, US
 
federal legislation
created an oversight board with
 
power to oversee Puerto Rico’s
 
finances and to
 
restructure its debt. The oversight
board has imposed
 
a stay on the
 
exercise of certain
 
creditors’ rights.
 
In 2017, the
 
oversight board
 
placed certain of
the bonds into a bankruptcy-like
 
proceeding under the
 
supervision of a Federal
 
District Judge.
 
In
 
May
 
2019, the
 
oversight board
 
filed
 
complaints in
 
Puerto Rico
 
federal
 
district court
 
bringing
 
claims against
financial, legal and accounting
 
firms that had participated
 
in Puerto Rico municipal
 
bond offerings, including UBS,
seeking a
 
return
 
of
 
underwriting and
 
swap
 
fees paid
 
in
 
connection with
 
those offerings.
 
UBS
 
estimates that
 
it
received approximately
 
USD
125
m in fees in the relevant
 
offerings.
In August 2019,
 
and February
 
and November
 
2020, four
 
US insurance
 
companies
 
that insured
 
issues of Puerto
 
Rico
municipal bonds sued UBS and several
 
other underwriters of Puerto Rico
 
municipal bonds in three separate
 
cases.
The actions
 
collectively
 
seek recovery
 
of an
 
aggregate
 
of USD
955
m in damages
 
from the
 
defendants.
 
The plaintiffs
in these cases claim that defendants failed to reasonably investigate financial statements in the offering materials
for
 
the
 
insured
 
Puerto
 
Rico
 
bonds
 
issued
 
between
 
2002
 
and
 
2007,
 
which
 
plaintiffs argue
 
they
 
relied
 
upon
 
in
agreeing to
 
insure the
 
bonds notwithstanding
 
that they
 
had
 
no contractual
 
relationship with
 
the
 
underwriters.
Defendants’ motions to
 
dismiss have been
 
granted in
 
all three
 
cases; those decisions
 
are being
 
appealed by the
plaintiffs.
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
74
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
Our balance sheet
 
at 30 June 2022
 
reflected provisions
 
with respect to
 
matters described
 
in this item
 
4 in amounts
that UBS believes to be appropriate under the applicable accounting
 
standard. As in the case of other matters for
which
 
we
 
have
 
established
 
provisions,
 
the
 
future
 
outflow
 
of
 
resources
 
in
 
respect
 
of
 
such
 
matters
 
cannot
 
be
determined with
 
certainty based
 
on
 
currently available
 
information and
 
accordingly may
 
ultimately prove
 
to
 
be
substantially greater (or
 
may be less) than
 
the provisions that
 
we have recognized.
5. Foreign exchange, LIBOR
 
and benchmark rates,
 
and other trading
 
practices
Foreign exchange-related regulatory
 
matters:
 
Beginning in 2013,
 
numerous authorities commenced
 
investigations
concerning possible
 
manipulation of
 
foreign exchange
 
markets and
 
precious metals
 
prices. As
 
a result
 
of
 
these
investigations, UBS
 
entered
 
into
 
resolutions with
 
Swiss,
 
US
 
and
 
United
 
Kingdom
 
regulators
 
and
 
the
 
European
Commission. UBS
 
was granted
 
conditional
 
immunity by
 
the Antitrust
 
Division of
 
the DOJ
 
and by
 
authorities
 
in other
jurisdictions in
 
connection
 
with
 
potential competition
 
law
 
violations relating
 
to
 
foreign
 
exchange
 
and
 
precious
metals businesses.
Foreign exchange-related civil
 
litigation:
 
Putative class actions have been filed since
 
2013 in US federal courts and
in other jurisdictions
 
against UBS and
 
other banks
 
on behalf of
 
putative classes
 
of persons who engaged
 
in foreign
currency transactions with any of the defendant
 
banks. UBS has resolved US federal court class actions
 
relating to
foreign currency transactions with the defendant banks and persons
 
who transacted in foreign exchange futures
contracts and options
 
on such futures
 
under a settlement
 
agreement that
 
provides for UBS to
 
pay an aggregate
 
of
USD
141
m and
 
provide cooperation to
 
the settlement classes.
 
Certain class members
 
have excluded
 
themselves
from that
 
settlement
 
and have
 
filed individual
 
actions
 
in US
 
and English
 
courts against
 
UBS
 
and other
 
banks, alleging
violations of US and European
 
competition laws
 
and unjust enrichment.
In
 
2015, a
 
putative class
 
action was
 
filed in
 
federal court
 
against UBS
 
and numerous
 
other banks
 
on behalf
 
of
persons and
 
businesses in
 
the US
 
who directly purchased
 
foreign currency from
 
the defendants
 
and alleged co-
conspirators for
 
their own
 
end use.
 
In March
 
2017, the
 
court granted
 
UBS’s (and
 
the other
 
banks’) motions
 
to
dismiss the complaint.
 
The plaintiffs
 
filed an amended
 
complaint in August
 
2017. In March
 
2018, the court
 
denied
the defendants’
 
motions to dismiss
 
the amended complaint.
 
In March 2022,
 
the court
 
denied plaintiffs’
 
motion for
class certification.
LIBOR and other benchmark
 
-related regulatory matters:
 
Numerous government
 
agencies conducted investigations
regarding potential improper attempts
 
by UBS, among others, to manipulate
 
LIBOR and other benchmark rates
 
at
certain times. UBS reached settlements
 
or otherwise concluded investigations
 
relating to benchmark interest rates
with the investigating authorities. UBS was granted conditional leniency or conditional immunity from authorities
in certain jurisdictions,
 
including the
 
Antitrust Division
 
of the DOJ
 
and the Swiss
 
Competition Commission
 
(WEKO),
in connection with potential antitrust
 
or competition law violations related to certain
 
rates. However, UBS has not
reached a final settlement with WEKO, as the Secretariat of WEKO has asserted
 
that UBS does not qualify for full
immunity.
LIBOR and
 
other benchm
 
ark
 
-related
 
civil
 
litigation:
 
A number
 
of putative
 
class actions
 
and other
 
actions are
 
pending
in the federal courts
 
in New York against UBS
 
and numerous other banks on behalf of
 
parties who transacted in
certain interest rate benchmark-based derivatives. Also pending in the US and in other jurisdictions are a number
of other
 
actions asserting losses related to
 
various products whose interest rates were
 
linked to
 
LIBOR and other
benchmarks, including
 
adjustable rate
 
mortgages, preferred
 
and debt
 
securities, bonds
 
pledged as
 
collateral, loans,
depository
 
accounts,
 
investments
 
and
 
other
 
interest-bearing
 
instruments.
 
The
 
complaints
 
allege
 
manipulation,
through
 
various
 
means,
 
of
 
certain
 
benchmark interest
 
rates,
 
including
 
USD LIBOR, Euroyen
 
TIBOR, Yen
 
LIBOR,
EURIBOR, CHF LIBOR, GBP LIBOR, SGD SIBOR and SOR and Australian BBSW, and seek unspecified compensatory
and other damages under
 
varying legal theories.
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
75
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
USD LIBOR class and
 
individual actions in the
 
US:
In 2013
 
and 2015, the
 
district court in
 
the USD LIBOR actions
dismissed, in whole or in
 
part, certain plaintiffs’
 
antitrust claims, federal
 
racketeering claims,
 
CEA claims, and
 
state
common law claims,
 
and again dismissed the
 
antitrust claims in
 
2016 following an
 
appeal. In December
 
2021, the
Second Circuit affirmed
 
the district court’s
 
dismissal in part and
 
reversed in
 
part and remanded to
 
the district court
for further
 
proceedings.
 
The Second
 
Circuit, among
 
other things,
 
held that
 
there was
 
personal jurisdiction
 
over UBS
and other foreign defendants
 
based on allegations that
 
at least one alleged co-conspirator
 
undertook an overt
 
act
in
 
the
 
United States.
 
Separately, in
 
2018,
 
the
 
Second Circuit
 
reversed in
 
part
 
the
 
district court’s
 
2015
 
decision
dismissing certain individual
 
plaintiffs’ claims and
 
certain of these
 
actions are now
 
proceeding. In 2018,
 
the district
court denied plaintiffs’ motions
 
for class certification in the USD class
 
actions for claims pending against UBS,
 
and
plaintiffs sought
 
permission to appeal
 
that ruling to the
 
Second Circuit.
 
In July 2018,
 
the Second Circuit
 
denied the
petition to
 
appeal of
 
the
 
class of
 
USD lenders and
 
in November
 
2018 denied
 
the petition
 
of the
 
USD exchange
class. In January 2019, a putative class action was filed in the District Court for the Southern District of New York
against UBS and numerous other banks on behalf
 
of US residents who, since 1 February 2014, directly transacted
with a defendant
 
bank in USD LIBOR
 
instruments. The
 
complaint
 
asserts antitrust
 
claims. The
 
defendants moved
 
to
dismiss
 
the
 
complaint
 
in
 
August
 
2019.
 
In
 
March
 
2020
 
the
 
court
 
granted
 
defendants’
 
motion
 
to
 
dismiss
 
the
complaint in
 
its entirety. Plaintiffs
 
have appealed the
 
dismissal. In
 
March 2022, the
 
Second Circuit dismissed
 
the
appeal because
 
appellants, who
 
had
 
been substituted
 
in
 
to
 
replace the
 
original plaintiffs
 
who
 
had
 
withdrawn,
lacked standing to
 
pursue the
 
appeal. In
 
August 2020, an
 
individual action was
 
filed in
 
the Northern
 
District of
California against UBS
 
and numerous other banks
 
alleging that the
 
defendants conspired to fix
 
the interest
 
rate
used as
 
the basis
 
for loans
 
to consumers by
 
jointly setting
 
the USD LIBOR
 
rate and
 
monopolized the market for
LIBOR-based consumer
 
loans and
 
credit cards. Defendants
 
moved to dismiss
 
the complaint in September
 
2021.
Other benchmark
 
class actions in the US:
 
Yen LIBOR / Euroyen TIBOR –
In 2014, 2015 and
 
2017, the court
 
in one of the
 
Yen LIBOR / Euroyen TIBOR lawsuits
dismissed
 
certain
 
of the
 
plaintiffs’
 
claims,
 
including
 
the
 
plaintiffs’
 
federal antitrust
 
and racketeering
 
claims.
 
In August
2020, the
 
court
 
granted defendants’
 
motion
 
for judgment
 
on the
 
pleadings
 
and dismissed
 
the lone
 
remaining claim
in the action as impermissibly extraterritorial. Plaintiffs have appealed.
 
In 2017, the court dismissed the other Yen
LIBOR /
 
Euroyen TIBOR action
 
in its
 
entirety on
 
standing grounds.
 
In April
 
2020, the
 
appeals court
 
reversed the
dismissal and in
 
August 2020
 
plaintiffs in that
 
action filed
 
an amended
 
complaint
 
focused on Yen LIBOR. The
 
court
granted in part and denied in part
 
defendants’ motion to dismiss
 
the amended complaint in September
 
2021 and
plaintiffs and the remaining defendants
 
have moved for reconsideration.
 
CHF LIBOR
 
– In 2017, the court dismissed the CHF LIBOR action on standing grounds and failure to state a claim.
Plaintiffs filed
 
an amended
 
complaint, and
 
the court
 
granted a
 
renewed motion to
 
dismiss in
 
September 2019.
Plaintiffs appealed.
 
In September 2021,
 
the Second Circuit
 
granted the
 
parties’ joint motion
 
to vacate
 
the dismissal
and remand the case
 
for further proceedings.
 
EURIBOR
 
 
In
 
2017, the
 
court
 
in
 
the
 
EURIBOR lawsuit
 
dismissed
 
the
 
case
 
as
 
to
 
UBS
 
and
 
certain other
 
foreign
defendants for lack
 
of personal jurisdiction.
 
Plaintiffs have appealed.
 
SIBOR / SOR
 
– In
 
October 2018,
 
the court
 
in the SIBOR
 
/ SOR
 
action dismissed
 
all but
 
one of
 
plaintiffs’
 
claims against
UBS.
 
Plaintiffs
 
filed
 
an
 
amended complaint,
 
and
 
the
 
court
 
granted a
 
renewed motion
 
to
 
dismiss in
 
July
 
2019.
Plaintiffs appealed.
 
In March 2021,
 
the Second Circuit
 
reversed the
 
dismissal. Plaintiffs
 
filed an amended
 
complaint
in
 
October 2021,
 
which
 
defendants have
 
moved to
 
dismiss. In
 
March 2022,
 
plaintiffs
 
reached a
 
settlement in
principle with the remaining defendants, including UBS.
 
The court granted preliminary approval of the settlement
in June 2022.
 
BBSW
 
– In November 2018,
 
the court dismissed the BBSW
 
lawsuit as to UBS and
 
certain other foreign defendants
for
 
lack
 
of
 
personal
 
jurisdiction.
 
Plaintiffs
 
filed
 
an
 
amended
 
complaint
 
in
 
April
 
2019,
 
which
 
UBS
 
and
 
other
defendants moved to dismiss.
 
In February 2020, the court
 
granted in part and denied
 
in part defendants’ motions
to dismiss
 
the amended
 
complaint.
 
In August
 
2020, UBS
 
and other
 
BBSW defendants
 
joined a
 
motion for
 
judgment
on the
 
pleadings, which
 
the court
 
denied in
 
May 2021.
 
In February
 
2022, plaintiffs
 
reached a
 
settlement
 
in principle
with the
 
remaining defendants, including UBS. The
 
court granted preliminary approval of
 
the settlement in
 
May
2022.
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
Notes
 
to
 
the
 
UBS
 
Group
 
AG
 
interim
 
consolidated
 
financial
 
statements
 
(unaudited)
 
76
 
 
Note 14
 
Provisions
 
and contingent liabilities
 
(continued)
GBP LIBOR
 
– The court dismissed
 
the GBP LIBOR
 
action in August 2019.
 
Plaintiffs have appealed.
 
Government
 
bonds:
 
Putative
 
class
 
actions
 
have
 
been
 
filed
 
since
 
2015
 
in US
 
federal
 
courts
 
against
 
UBS
 
and
 
other
 
banks
on behalf
 
of persons
 
who
 
participated
 
in markets
 
for
 
US Treasury
 
securities
 
since
 
2007. A
 
consolidated
 
complaint
 
was
filed in 2017
 
in the US
 
District Court for the Southern District of New York alleging that the banks
 
colluded with
respect
 
to, and
 
manipulated
 
prices
 
of, US
 
Treasury
 
securities
 
sold
 
at auction
 
and
 
in the
 
secondary
 
market
 
and asserting
claims
 
under
 
the
 
antitrust
 
laws
 
and for
 
unjust
 
enrichment.
 
Defendants’
 
motions
 
to
 
dismiss
 
the consolidated
 
complaint
were
 
granted
 
in March
 
2021.
 
Plaintiffs
 
filed
 
an amended
 
complaint,
 
which
 
defendants
 
moved
 
to
 
dismiss
 
in June
 
2021.
In March
 
2022,
 
the
 
court
 
granted
 
defendants’
 
motion
 
to
 
dismiss
 
that
 
complaint.
 
Plaintiffs
 
have
 
appealed
 
the
 
dismissal.
Similar class
 
actions
 
have been
 
filed concerning
 
European
 
government
 
bonds and
 
other government
 
bonds.
In May 2021, the European
 
Commission
 
issued a decision
 
finding that
 
UBS and six other
 
banks breached
 
European
Union antitrust rules
 
in 2007–2011 relating
 
to European government
 
bonds. The European Commission
 
fined UBS
EUR
172
m. UBS
 
is appealing
 
the amount
 
of the
 
fine.
With respect
 
to additional
 
matters and
 
jurisdictions not
 
encompassed by
 
the settlements and
 
orders referred
 
to
above, our balance sheet at 30 June 2022 reflected a provision in an amount that UBS believes to be appropriate
under the
 
applicable accounting
 
standard.
 
As in the
 
case of
 
other matters
 
for which
 
we have
 
established
 
provisions,
the future outflow of resources
 
in respect of such
 
matters cannot be determined
 
with certainty based on currently
available information and
 
accordingly may ultimately
 
prove to
 
be substantially greater
 
(or may
 
be less)
 
than the
provision that we have
 
recognized.
6. Swiss retrocessions
The Federal Supreme Court of Switzerland ruled in 2012, in a test case against UBS, that distribution fees paid to
a firm for distributing
 
third-party and
 
intra-group investment
 
funds and structured
 
products must be
 
disclosed and
surrendered to
 
clients who
 
have entered
 
into a
 
discretionary mandate
 
agreement with
 
the firm,
 
absent a
 
valid
waiver. FINMA issued
 
a supervisory
 
note to
 
all Swiss
 
banks in
 
response to
 
the Supreme
 
Court decision.
 
UBS has met
the FINMA requirements and
 
has notified all potentially
 
affected clients.
The Supreme
 
Court decision
 
has resulted,
 
and continues
 
to result,
 
in a number
 
of client
 
requests for
 
UBS to
 
disclose
and potentially surrender
 
retrocessions. Client requests
 
are assessed on a case-by-case
 
basis. Considerations taken
into account
 
when assessing
 
these cases
 
include, among
 
other things,
 
the existence
 
of a discretionary
 
mandate and
whether or not the client
 
documentation contained
 
a valid waiver with
 
respect to distribution
 
fees.
Our
 
balance sheet
 
at 30
 
June 2022
 
reflected a
 
provision with
 
respect to
 
matters described
 
in
 
this item
 
6
 
in an
amount that UBS believes to be appropriate
 
under the applicable accounting
 
standard. The ultimate exposure
 
will
depend on client requests and the
 
resolution thereof, factors that are difficult to predict and
 
assess. Hence, as in
the case of other
 
matters for which we have established provisions, the future outflow
 
of resources in respect of
such matters cannot be
 
determined with certainty based on
 
currently available information and accordingly may
ultimately prove to be substantially
 
greater (or may be less)
 
than the provision
 
that we have recognized.
7. Communications recordkeeping
The SEC and CFTC
 
are conducting investigations
 
of UBS and other
 
financial institutions
 
regarding compliance
 
with
records preservation
 
requirements relating
 
to business
 
communications
 
sent over
 
unapproved electronic
 
messaging
channels. UBS is cooperating
 
with the investigations.
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
AG
 
interim
 
consolidated
 
financial
 
information
 
(unaudited)
 
77
 
UBS AG interim consolidated financial information
(unaudited)
This
 
section
 
contains
 
a
 
comparison
 
of
 
selected
 
financial
 
and
 
capital
 
information
 
between
 
UBS
 
Group
 
AG
consolidated and UBS AG consolidated. Refer to the UBS AG second quarter 2022 report, which will be available
as
 
of
 
29 July
 
2022
 
under
 
“Quarterly
 
reporting”
 
at
ubs.com/investors
,
 
for
 
the
 
interim
 
consolidated
 
financial
statements of UBS AG.
 
Comparison between
 
UBS Group AG consolidated
 
and UBS AG consolidated
The accounting
 
policies applied
 
under International
 
Financial Reporting
 
Standards
 
(IFRS) to both
 
the UBS
 
Group AG
and the UBS AG
 
consolidated financial
 
statements are
 
identical. However,
 
there are
 
certain scope and
 
presentation
differences as noted below.
Assets,
 
liabilities, revenues,
 
operating expenses
 
and
 
tax expenses
 
/
 
(benefits) relating
 
to
 
UBS
 
Group AG
 
and its
directly held
 
subsidiaries,
 
including
 
UBS Business
 
Solutions
 
AG,
 
are reflected
 
in the
 
consolidated
 
financial
 
statements
of
 
UBS Group
 
AG
 
but
 
not of
 
UBS
 
AG. UBS
 
AG’s
 
assets, liabilities,
 
revenues and
 
operating expenses
 
related
 
to
transactions with UBS Group AG and its directly held subsidiaries, including
 
UBS Business Solutions AG and other
shared services
 
subsidiaries, are
 
not subject to elimination
 
in the UBS
 
AG consolidated
 
financial statements,
 
but are
eliminated in the UBS
 
Group AG consolidated
 
financial statements.
Differences
 
in
 
net
 
profit
 
between
 
UBS
 
Group
 
AG
 
consolidated and
 
UBS
 
AG
 
consolidated
 
mainly
 
arise
 
as
 
UBS
Business Solutions AG and
 
other shared services subsidiaries of
 
UBS Group AG charge other
 
legal entities within
the UBS AG consolidation scope for services
 
provided, including a markup
 
on costs incurred. In addition, and to a
lesser extent, differences
 
arise as a result of certain
 
compensation-related matters,
 
including pensions.
The equity of
 
UBS Group AG
 
consolidated was USD 2.1bn higher than
 
the equity of
 
UBS AG
 
consolidated as of
30
 
June 2022. This difference
 
was mainly driven by higher
 
dividends paid by UBS
 
AG to UBS Group AG compared
with
 
the
 
dividend
 
distributions
 
of
 
UBS
 
Group
 
AG,
 
as
 
well
 
as
 
higher
 
retained
 
earnings
 
in
 
the
 
UBS Group
 
AG
consolidated
 
financial
 
statements,
 
largely
 
related
 
to
 
the
 
aforementioned
 
markup
 
charged
 
by
 
shared
 
services
subsidiaries of UBS Group
 
AG to other legal
 
entities in the UBS AG
 
scope of consolidation.
 
In addition, UBS Group
AG is the
 
grantor of
 
the majority
 
of the
 
compensation
 
plans of
 
the
 
Group and
 
recognizes
 
share premium
 
for equity-
settled awards granted.
 
These effects
 
were partly offset
 
by treasury shares
 
acquired as
 
part of our share
 
repurchase
programs and
 
those held
 
to hedge share
 
delivery obligations
 
associated with
 
Group compensation
 
plans, as well
 
as
additional share premium
 
recognized at the UBS AG consolidated
 
level related to the establishment
 
of UBS Group
AG and UBS Business
 
Solutions AG, a wholly
 
owned subsidiary
 
of UBS Group AG.
The going concern
 
capital of
 
UBS Group AG
 
consolidated was
 
USD 3.5bn higher
 
than the going
 
concern capital
 
of
UBS AG consolidated
 
as of 30
 
June 2022, reflecting
 
higher common equity
 
tier 1 (CET1) capital
 
of USD 2.5bn and
going concern loss-absorbing
 
additional tier
 
1 (AT1) capital of USD
 
1.1bn.
 
The CET1
 
capital of UBS Group
 
AG consolidated was USD 2.5bn higher than
 
that of UBS
 
AG consolidated as of
30
 
June 2022. The higher CET1 capital of UBS
 
Group AG consolidated was
 
primarily due to lower UBS Group AG
accruals
 
for
 
dividends to
 
shareholders and
 
higher
 
UBS
 
Group
 
AG
 
consolidated
 
IFRS
 
equity
 
of
 
USD 2.1bn.
 
The
aforementioned factors were partly
 
offset by
 
compensation-related regulatory capital accruals at the
 
UBS Group
AG level.
 
The going concern loss-absorbing AT1 capital of UBS Group AG consolidated was USD 1.1bn higher than that of
UBS AG consolidated
 
as of 30
 
June 2022, mainly
 
reflecting deferred contingent
 
capital plan
 
awards granted
 
at the
Group level to
 
eligible employees
 
for the performance
 
years 2017
 
to 2021, partly
 
offset by four
 
loss-absorbing AT1
capital instruments
 
on-lent by UBS Group AG
 
to UBS AG.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
AG
 
interim
 
consolidated
 
financial
 
information
 
(unaudited)
 
78
 
Comparison between
 
UBS Group AG consolidated
 
and UBS AG consolidated
As of or for the quarter ended
 
30.6.22
USD m, except where indicated
UBS Group AG
consolidated
UBS AG
consolidated
Difference
(absolute)
Income statement
Total revenues
 
8,917
 
9,036
 
(119)
Credit loss expense / (release)
 
7
 
7
 
0
Operating expenses
 
6,295
 
6,577
 
(282)
Operating profit / (loss) before tax
 
 
2,615
 
2,452
 
163
of which: Global Wealth Management
 
1,157
 
1,130
 
27
of which: Personal & Corporate Banking
 
413
 
409
 
4
of which: Asset Management
 
959
 
959
 
0
of which: Investment Bank
 
410
 
388
 
22
of which: Group Functions
 
(324)
 
(433)
 
110
Net profit / (loss)
 
 
2,118
 
1,974
 
144
of which: net profit / (loss) attributable to shareholders
 
2,108
 
1,964
 
144
of which: net profit / (loss) attributable to non
 
-controlling interests
 
10
 
10
 
0
Statement of comprehensive
 
income
Other comprehensive income
(1,039)
(1,009)
(30)
of which: attributable to shareholders
(1,011)
(981)
(30)
of which: attributable to non-controlling
 
interests
(28)
(28)
0
Total comprehensive income
1,079
965
114
of which: attributable to shareholders
1,097
982
114
of which: attributable to non-controlling
 
interests
(17)
(17)
0
Balance sheet
Total assets
1,113,193
1,112,474
719
Total liabilities
1,056,010
1,057,390
(1,380)
Total equity
 
57,184
55,085
2,099
of which: equity attributable to shareholders
56,845
54,746
2,099
of which: equity attributable to non
 
-controlling interests
339
339
0
Capital information
Common equity tier 1 capital
 
44,798
 
42,317
 
2,481
Going concern capital
 
59,907
 
56,359
 
3,548
Risk-weighted assets
 
315,685
 
313,448
 
2,238
Common equity tier 1 capital ratio (%)
 
14.2
 
13.5
 
0.7
Going concern capital ratio (%)
 
19.0
 
18.0
 
1.0
Total loss-absorbing capacity ratio (%)
 
33.7
 
32.8
 
0.9
Leverage ratio denominator
 
1,025,422
 
1,024,811
 
612
Common equity tier 1 leverage ratio
 
(%)
 
4.37
 
4.13
 
0.24
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Consolidated
 
financial
 
statements
 
|
 
UBS
 
AG
 
interim
 
consolidated
 
financial
 
information
 
(unaudited)
 
79
 
As of or for the quarter ended 31.3.22
As of or for the quarter ended 31.12.21
UBS Group AG
consolidated
UBS AG
consolidated
Difference
(absolute)
UBS Group AG
consolidated
UBS AG
consolidated
Difference
(absolute)
 
9,382
 
9,494
 
(112)
 
8,705
 
8,819
 
(114)
 
18
 
18
 
0
 
(27)
 
(27)
 
0
 
6,634
 
6,916
 
(282)
 
7,003
 
7,227
 
(224)
 
2,729
 
2,559
 
170
 
1,729
 
1,619
 
109
 
1,310
 
1,283
 
27
 
563
 
541
 
22
 
428
 
420
 
8
 
365
 
362
 
3
 
174
 
176
 
(2)
 
334
 
328
 
6
 
929
 
908
 
21
 
713
 
710
 
3
 
(112)
 
(227)
 
115
 
(246)
 
(321)
 
75
 
2,144
 
2,012
 
132
 
1,359
 
1,266
 
93
 
2,136
 
2,004
 
132
 
1,348
 
1,255
 
93
 
8
 
8
 
0
 
11
 
11
 
0
(2,216)
(2,134)
(82)
 
(181)
 
(197)
16
(2,234)
(2,152)
 
(82)
 
(177)
 
(194)
 
16
18
18
0
 
(4)
 
(4)
0
(72)
(121)
 
50
 
1,178
 
1,069
109
(98)
(148)
50
 
1,171
 
1,062
109
26
26
0
 
7
 
7
0
1,139,922
1,139,876
46
 
1,117,182
 
1,116,145
 
1,037
1,080,711
1,081,558
(847)
 
1,056,180
 
1,057,702
 
(1,522)
59,212
58,319
893
 
61,002
 
58,442
 
2,559
58,855
57,962
893
 
60,662
 
58,102
 
2,559
356
356
0
 
340
 
340
 
0
 
44,593
 
41,577
 
3,016
 
45,281
 
41,594
 
3,687
 
60,053
 
55,956
 
4,097
 
60,488
 
55,434
 
5,054
 
312,037
 
309,374
 
2,664
 
302,209
 
299,005
 
3,204
 
14.3
 
13.4
 
0.9
 
15.0
 
13.9
 
1.1
 
19.2
 
18.1
 
1.2
 
20.0
 
18.5
 
1.5
 
34.2
 
33.1
 
1.0
 
34.7
 
33.3
 
1.3
 
1,072,953
 
1,072,766
 
186
 
1,068,862
 
1,067,679
 
1,183
 
4.16
 
3.88
 
0.28
 
4.24
 
3.90
 
0.34
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Significant
 
regulated
 
subsidiary
 
and
 
sub
-
group
 
information
 
80
 
Significant regulated
 
subsidiary
and sub-group information
Unaudited
 
 
Financial and regulatory key figures for
 
our significant regulated
subsidiaries and sub-groups
UBS AG
(standalone)
UBS Switzerland AG
(standalone)
UBS Europe SE
(consolidated)
UBS Americas Holding LLC
(consolidated)
All values in million, except where indicated
USD
CHF
EUR
USD
Financial and regulatory requirements
Swiss GAAP
Swiss SRB rules
Swiss GAAP
Swiss SRB rules
IFRS
EU regulatory rules
US GAAP
US Basel III rules
As of or for the quarter ended
30.6.22
31.3.22
30.6.22
31.3.22
30.6.22
31.3.22
1
30.6.22
31.3.22
Financial information
2
Income statement
Total operating income
3
6,056
3,476
2,194
2,209
230
241
3,264
3,632
Total operating expenses
2,608
2,247
1,364
1,447
201
217
3,270
3,199
Operating profit / (loss) before tax
3,448
1,229
831
763
29
24
(6)
433
Net profit / (loss)
3,361
1,182
677
621
28
18
(139)
225
Balance sheet
Total assets
498,351
516,195
323,248
327,902
49,496
52,231
212,582
211,142
Total liabilities
 
443,604
460,608
309,164
312,545
46,045
48,495
186,829
184,712
Total equity
54,747
55,587
14,084
15,357
3,452
3,736
25,753
26,430
Capital
4
Common equity tier 1 capital
 
54,146
 
52,218
 
12,718
 
12,786
2,426
2,766
12,454
12,926
Additional tier 1 capital
 
14,042
 
14,379
 
5,406
 
5,393
600
290
4,055
4,049
Total going concern
 
capital / Tier 1 capital
 
68,188
 
66,597
 
18,124
 
18,178
3,026
3,056
16,509
16,975
Tier 2 capital
 
2,997
 
3,036
152
133
Total capital
3,026
3,056
16,661
17,108
Total gone concern
 
loss-absorbing capacity
 
46,330
 
46,505
 
11,301
 
10,866
 
2,146
5
2,421
5
7,400
6
7,400
6
Total loss-absorbing capacity
 
114,518
 
113,102
 
29,425
 
29,045
5,172
5,477
23,908
24,375
Risk-weighted assets and leverage
 
ratio denominator
4
Risk-weighted assets
 
327,846
 
330,401
 
107,344
 
108,071
11,473
12,276
74,651
72,646
Leverage ratio denominator
 
569,794
 
594,893
 
340,969
 
346,097
47,358
52,250
198,332
197,541
Supplementary leverage ratio denominator
224,259
223,482
Capital and leverage ratios (%)
4
Common equity tier 1 capital ratio
 
16.5
 
15.8
 
11.8
 
11.8
 
21.2
 
22.5
 
16.7
 
17.8
Going concern capital ratio / Tier 1 capital
 
ratio
 
20.8
 
20.2
 
16.9
 
16.8
 
26.4
 
24.9
 
22.1
 
23.4
Total capital ratio
 
26.4
 
24.9
 
22.3
 
23.6
Total loss-absorbing capacity ratio
 
27.4
 
26.9
 
45.1
 
44.6
 
32.0
 
33.6
Tier 1 leverage ratio
 
6.4
 
5.8
 
8.3
 
8.6
Supplementary tier 1 leverage ratio
 
7.4
 
7.6
Going concern leverage ratio
 
12.0
 
11.2
 
5.3
 
5.3
Total loss-absorbing capacity leverage ratio
 
8.6
 
8.4
 
10.9
 
10.5
 
12.1
 
12.3
Gone concern capital coverage ratio
 
115.2
 
112.0
Liquidity coverage ratio
4
High-quality liquid assets (bn)
105
103
94
95
19
18
34
34
Net cash outflows (bn)
55
55
66
67
12
11
24
25
Liquidity coverage ratio (%)
7,8
189.3
188.3
141.4
141.7
165.8
167.9
144.4
138.6
Net stable funding ratio
4,9
Total available stable funding (bn)
245
250
225
229
14
15
Total required stable funding (bn)
266
275
156
160
9
9
Net stable funding ratio (%)
92.2
10
90.7
144.1
10
143.1
148.3
170.4
Other
Joint and several liability between UBS AG
 
and UBS Switzerland AG (bn)
11
4
5
1 Comparative figures
 
have been restated
 
to align
 
with the regulatory
 
reports as
 
submitted to
 
the European
 
Central Bank
 
(the EC
 
B).
 
2 The financial
 
information disclosed
 
does not represent
 
financial statements
under the respective
 
GAAP / IFRS.
 
3 The t
 
otal operating
 
income includes
 
credit loss expense
 
/ release.
 
4 Refer
 
to the 30 June
 
2022 Pillar 3
 
Report, which
 
will be available
 
as of 19
 
August 2022
 
under “Pillar 3
disclosures” at ubs.com/investors,
 
for more information.
 
5 Consists of positions
 
that meet the conditions laid down in Art.
 
72a–b of the Capital Requirements
 
Regulation (CRR) II with regard to contractual,
 
structural
or legal subordination.
 
6 Consists of eligible long
 
-term debt that meets the conditions
 
specified in 12 CFR 252.162
 
of the final TLAC rules. Total
 
loss-absorbing capacity is the
 
sum of tier 1 capital (excluding
 
minority
interest) and eligible long
 
-term debt.
 
7 In the second
 
quarter of 2022, the
 
liquidity coverage ratio
 
(the LCR) of
 
UBS AG was 189.3%,
 
remaining above the
 
prudential requirements
 
communicated
 
by FINMA.
 
8 In
the second quarter
 
of 2022, the LCR
 
of UBS Switzerland AG,
 
which is a Swiss
 
SRB, was 141.4%,
 
remaining above the
 
prudential requirement
 
communicated
 
by FINMA in connection
 
with the Swiss
 
Emergency Plan.
 
9 For UBS Americas
 
Holding LLC consolidated,
 
the NSFR requirement
 
became effective
 
as of 1 July 2021
 
and related disclosures
 
will come into
 
effect in the second
 
quarter of 2023.
 
10 In accordance
 
with Art. 17h
para. 3 and 4 of
 
the Liquidity Ordina
 
nce, UBS AG
 
standalone is required
 
to maintain a
 
minimum NSFR of
 
at least 80% without
 
taking into account
 
excess funding of
 
UBS Switzerland
 
AG and 100% after
 
taking into
account such
 
excess
 
funding.
 
11 Refer
 
to the
 
“Capital, liquidity
 
and
 
funding, and
 
balance
 
sheet”
 
section of
 
our Annual
 
Report 2021
 
for more
 
information
 
about the
 
joint and
 
several liability.
 
Under certain
circumstances, the Swiss Banking
 
Act and FINMA’s
 
Banking Insolvency Ordinance
 
authorize FINMA to modify,
 
extinguish or conver
 
t
 
to common equity liabilities
 
of a bank in connection with
 
a resolution or insolvency
of such bank.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Significant
 
regulated
 
subsidiary
 
and
 
sub
-
group
 
information
 
81
 
UBS
 
Group
 
AG
 
is
 
a
 
holding
 
company
 
and
 
conducts
 
substantially
 
all
 
of
 
its
 
operations
 
through
 
UBS AG
 
and
subsidiaries thereof. UBS Group AG and UBS AG have contributed a significant portion of
 
their respective capital
to,
 
and
 
provide
 
substantial liquidity
 
to,
 
such
 
subsidiaries. Many
 
of
 
these subsidiaries
 
are
 
subject to
 
regulations
requiring compliance
 
with minimum
 
capital, liquidity
 
and similar
 
requirements.
 
The tables
 
in this
 
section summarize
the
 
regulatory
 
capital
 
components
 
and
 
capital
 
ratios
 
of
 
our
 
significant
 
regulated
 
subsidiaries
 
and
 
sub-groups
determined under the
 
regulatory framework
 
of each subsidiary’s
 
or sub-group’s home jurisdiction.
 
Supervisory authorities generally have discretion to impose
 
higher requirements or to otherwise limit the activities
of subsidiaries.
 
Supervisory authorities
 
also may
 
require entities
 
to measure
 
capital and leverage
 
ratios on
 
a stressed
basis and may
 
limit the ability
 
of an entity
 
to engage in
 
new activities
 
or take capital
 
actions based on
 
the results of
those tests.
In
 
June
 
2022, the
 
Federal Reserve
 
Board
 
(the FRB)
 
released the
 
results
 
of
 
its
 
2022
 
Dodd–Frank Act
 
Stress
 
Test
(DFAST).
 
UBS’s
 
US
 
intermediate holding
 
company,
 
UBS
 
Americas
 
Holding
 
LLC, exceeded
 
the
 
minimum
 
capital
requirements under
 
the severely adverse scenario.
Standalone
 
regulatory
 
information
 
for
 
UBS AG
 
and
 
UBS Switzerland
 
AG,
 
as
 
well
 
as
 
consolidated
 
regulatory
information for
 
UBS Europe SE
 
and
 
UBS Americas
 
Holding LLC,
 
is
 
provided in
 
the
 
30
 
June 2022
 
Pillar 3 report,
which will be available
 
as of 19 August 2022
 
under “Pillar 3 disclosures”
 
at
ubs.com/investors
.
Selected financial and regulatory information for UBS AG consolidated is included in
 
the key figures table below.
Refer also to the UBS AG second
 
quarter 2022 report, which
 
will be available as
 
of 29 July 2022 under “Quarterly
reporting” at
ubs.com/investors
.
 
UBS AG consolidated key
 
figures
As of or for the quarter ended
 
As of or year-to-date
USD m, except where indicated
30.6.22
31.3.22
31.12.21
30.6.21
30.6.22
30.6.21
Results
Total revenues
 
9,036
 
9,494
 
8,819
 
8,991
 
18,529
 
17,798
Credit loss expense / (release)
 
7
 
18
 
(27)
 
(80)
 
25
 
(108)
Operating expenses
 
6,577
 
6,916
 
7,227
 
6,589
 
13,492
 
13,274
Operating profit / (loss) before tax
 
2,452
 
2,559
 
1,619
 
2,481
 
5,012
 
4,632
Net profit / (loss) attributable to shareholders
 
1,964
 
2,004
 
1,255
 
1,913
 
3,968
 
3,623
Profitability and growth
Return on equity (%)
 
13.9
 
13.8
 
8.7
 
13.6
 
13.9
 
12.7
Return on tangible equity
 
(%)
 
15.7
 
15.5
 
9.8
 
15.3
 
15.6
 
14.3
Return on common equity tier 1 capital (%)
 
18.7
 
19.3
 
12.1
 
19.4
 
19.0
 
18.6
Return on leverage ratio denominator,
 
gross (%)
 
3.4
 
3.5
 
3.3
 
3.5
 
3.5
 
3.4
Cost / income ratio (%)
 
72.8
 
72.8
 
81.9
 
73.3
 
72.8
 
74.6
Net profit growth (%)
 
2.6
 
17.2
 
(19.7)
 
60.3
 
9.5
 
38.5
Resources
Total assets
 
1,112,474
 
1,139,876
 
1,116,145
 
1,085,861
 
1,112,474
 
1,085,861
Equity attributable to shareholders
 
54,746
 
57,962
 
58,102
 
55,361
 
54,746
 
55,361
Common equity tier 1 capital
1
 
42,317
 
41,577
 
41,594
 
40,190
 
42,317
 
40,190
Risk-weighted assets
1
 
313,448
 
309,374
 
299,005
 
290,470
 
313,448
 
290,470
Common equity tier 1 capital ratio (%)
1
 
13.5
 
13.4
 
13.9
 
13.8
 
13.5
 
13.8
Going concern capital ratio (%)
1
 
18.0
 
18.1
 
18.5
 
19.1
 
18.0
 
19.1
Total loss-absorbing capacity ratio (%)
1
 
32.8
 
33.1
 
33.3
 
34.6
 
32.8
 
34.6
Leverage ratio denominator
1
 
1,024,811
 
1,072,766
 
1,067,679
 
1,039,375
 
1,024,811
 
1,039,375
Common equity tier 1 leverage ratio
 
(%)
1
 
4.13
 
3.88
 
3.90
 
3.87
 
4.13
 
3.87
Other
Invested assets (USD bn)
2
 
3,912
 
4,380
 
4,596
 
4,485
 
3,912
 
4,485
Personnel (full-time equivalents)
 
46,807
 
47,139
 
47,067
 
47,227
 
46,807
 
47,227
1 Based on the
 
Swiss systemically
 
relevant bank
 
framework as
 
of 1 January
 
2020. Refer
 
to the “Capital
 
management” section
 
of this report
 
for more information.
 
2 Consists
 
of invested assets
 
for Global Wealth
Management, Asset Management
 
and Personal & Co
 
rporate Banking. Refer
 
to “Note 32 Invested assets
 
and net new money” in
 
the “Consolidated financial
 
statements” section of our Annual
 
Report 2021 for more
information.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
82
 
Appendix
Alternative performance measures
Alternative performance
 
measures
An alternative performance measure (an APM) is a financial measure
 
of historical or future financial performance,
financial position or
 
cash flows
 
other than
 
a financial measure
 
defined or
 
specified in the
 
applicable recognized
accounting standards
 
or
 
in other
 
applicable regulations.
 
We
 
report a
 
number of
 
APMs in
 
the
 
discussion of
 
the
financial and operating performance
 
of the Group, our business divisions
 
and our Group Functions.
 
We use APMs
to
 
provide
 
a
 
more
 
complete
 
picture
 
of
 
our
 
operating
 
performance
 
and
 
to
 
reflect
 
management’s
 
view
 
of
 
the
fundamental drivers
 
of our
 
business results.
 
A definition of
 
each APM,
 
the method
 
used to
 
calculate it
 
and the
information content are presented in
 
alphabetical order in the table below.
 
Our APMs may
 
qualify as non-GAAP
measures as defined
 
by US Securities
 
and Exchange Commission
 
(SEC) regulations.
 
 
APM label
Calculation
Information content
Active Digital Banking clients
 
in
Corporate & Institutional Clients (%)
– P&C
Calculated as the average number
 
of active clients for
each month in the relevant
 
period divided by the
average number of total clients. “Clients”
 
refers to the
number of unique business relationships
 
or legal
entities operated by Corporate
 
& Institutional Clients,
excluding clients that do not have
 
an account, mono-
product clients and
 
clients that have defaulted on loans
or credit facilities. At the end
 
of each month, any client
that has logged on at least
 
once in that month is
determined to be “active” (a log
 
-in time stamp is
allocated to all business relationship
 
numbers or per
legal entity in a digital banking contract).
This measure provides information
 
about the
proportion of active
 
Digital Banking clients in the total
number of UBS clients (within
 
the aforementioned
meaning) which are
 
serviced by Corporate &
Institutional Clients.
Active Digital Banking clients
 
in
Personal Banking (%)
– P&C
Calculated as the average number
 
of active clients for
each month in the relevant
 
period divided by the
average number of total clients. “Clients”
 
refers to the
number of unique business relationships
 
operated by
Personal Banking, excluding persons under
 
the age of
15, clients who do not have a
 
private account, clients
domiciled outside Switzerland
 
and clients who have
defaulted on loans or credit
 
facilities. At the end of
each month, any client
 
that has logged on at least once
in that month is determined
 
to
 
be “active” (a log-in
time stamp is allocated
 
to all business relationship
numbers in a digital banking contract).
This measure provides information
 
about the
proportion of active
 
Digital Banking clients in the total
number of UBS clients (within
 
the aforementioned
meaning) who are serviced
 
by Personal Banking.
Active Mobile Banking clients in
Personal Banking (%)
– P&C
Calculated as the average number
 
of active clients for
each month in the relevant
 
period divided by the
average number of total clients. “Clients”
 
refers to the
number of unique business relationships
 
operated by
Personal Banking, excluding persons under
 
the age of
15, clients who do not have a
 
private account, clients
domiciled outside Switzerland
 
and clients who have
defaulted on loans or credit
 
facilities. At the end of
each month, any client
 
that has logged on via the
mobile app at least once
 
in that month is determined
to be “active” (a log
 
-in time stamp is allocated to all
business relationship numbers
 
in a digital banking
contract).
This measure provides information
 
about the
proportion of active Mobile Banking
 
clients in the
total number of UBS clients
 
(within the
aforementioned meaning)
 
who are serviced by
Personal Banking.
Cost / income ratio (%)
Calculated as operating expenses divided
 
by total
revenues.
This measure provides information
 
about the
efficiency of the business by comparing
 
operating
expenses with gross income.
Fee and trading income
 
for Corporate
& Institutional Clients (USD and CHF)
– P&C
Calculated as the total of
 
recurring net fee and
transaction-based income for
 
Corporate & Institutional
Clients.
This measure provides information
 
about the amount
of fee and trading income for
 
Corporate &
Institutional Clients.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
83
 
APM label
Calculation
 
Information content
Fee-generating assets (USD)
– GWM
Calculated as the sum of discretionary
 
and
nondiscretionary wealth
 
management portfolios
(mandate volume) and assets
 
where generated
revenues are predominantly
 
of a recurring nature, i.e.,
mainly investment,
 
mutual, hedge and private-market
funds where we have a distribution
 
agreement,
including client commitments into
 
closed-ended
private-market funds from
 
the date that recurring
fees are charged. Assets
 
related to our Global
Financial Intermediaries business
 
are excluded, as are
assets of sanctioned clients.
This measure provides information
 
about the volume
of invested assets that create a
 
revenue stream,
whether as a result of the nature
 
of the contractual
relationship with clients or
 
through the fee structure
of the asset. An increase
 
in the level of fee-generating
assets results in an increase
 
in the associated revenue
stream. Assets of sanctioned
 
clients are excluded from
fee-generating assets.
Fee-generating asset margin
 
(bps)
– GWM
Calculated as revenues from
 
fee-generating assets (a
portion of which is included in
 
recurring fee income
and a portion of which is included
 
in transaction-
based income, annualized as applicable)
 
divided by
average fee-generating assets
 
for the relevant
mandate fee billing period. For the
 
US, fees have
been billed on daily balances since
 
the fourth quarter
of 2020 and average fee-generating
 
assets are
calculated as the average of the monthly
 
average
balances. Prior to the fourth quarter
 
of 2020, billing
was based on prior quarter-end
 
balances, and the
average fee-generating assets
 
were thus the prior
quarter-end balance. For balances
 
outside of the US,
billing is based on prior month
 
-end balances and
average fee-generating assets are
 
thus the average of
the prior month-end balances.
This measure provides information
 
about the revenues
from fee-generating assets
 
in relation to their average
volume during the relevant
 
mandate fee billing
period.
Gross margin on invested assets (bps)
– AM
Calculated as total revenues (annualized
 
as applicable)
divided by average invested assets.
This measure provides information
 
about the total
revenues of the business
 
in relation to invested assets.
Impaired loan portfolio as
 
a percentage
of total loan portfolio, gross (%)
– GWM, P&C
Calculated as impaired loan
 
portfolio divided by total
gross loan portfolio.
This measure provides information
 
about the
proportion of impaired loan
 
portfolio in the total gross
loan portfolio.
Invested assets (USD and CHF)
– GWM, P&C, AM
Calculated as the sum of managed
 
fund assets,
managed institutional assets,
 
discretionary and
advisory wealth management portfolios,
 
fiduciary
deposits, time deposits, savings
 
accounts, and wealth
management securities or brokerage
 
accounts.
This measure provides information
 
about the volume
of client assets managed by or deposited
 
with UBS for
investment purposes.
Investment products for Personal
Banking (USD and CHF)
 
– P&C
Calculated as the sum of investment
 
funds (including
UBS Vitainvest third-pillar
 
pension funds), mandates
and third-party life insurance operated
 
in Personal
Banking.
This measure provides information
 
about the volume
of investment funds (including
 
UBS Vitainvest third-
pillar pension funds), mandates
 
and third-party life
insurance operated in Personal
 
Banking.
Net interest margin (bps)
– P&C
Calculated as net interest
 
income (annualized as
applicable) divided by average loans.
This measure provides information
 
about the
profitability of the business
 
by calculating the
difference between
 
the price charged for lending and
the cost of funding, relative
 
to loan value.
Net new fee-generating assets (USD)
– GWM
Calculated as the sum of the net amount
 
of fee-
generating asset inflows and outflows,
 
including
dividend and interest inflows into mandates
 
and
outflows from mandate
 
fees paid by clients during a
specific period. Excluded
 
from the calculation are the
effects
 
on fee-generating assets of strategic decisions
by UBS to exit markets
 
or services.
This measure provides information
 
about the
development of fee-generating assets
 
during a
specific period as a result of
 
net flows,
 
excluding
movements due to market performance
 
and foreign
exchange translation,
 
as well as the effects on
 
fee-
generating assets of strategic
 
decisions by UBS to exit
markets
 
or services.
Net new fee-generating asset
 
growth rate (%)
– GWM
Calculated as the sum of the net amount
 
of fee-
generating asset inflows and outflows
 
recorded
during a specific period (annualized
 
as applicable)
divided by total fee-generating
 
assets at the
beginning of the period.
This measure provides information
 
about the growth
of fee-generating assets during a
 
specific period as a
result of net new fee-generating
 
asset flows.
Net new investment products for
Personal Banking (USD and CHF)
– P&C
Calculated as the sum of the net amount
 
of inflows
and outflows of investment
 
products during a specific
period.
This measure provides information
 
about the
development of investment products
 
during a specific
period as a result of net
 
new investment product
flows.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
84
 
APM label
Calculation
 
Information content
Net new money (USD)
– GWM, AM
 
Calculated as the sum of the net amount
 
of inflows
and outflows of invested assets
 
(as defined in UBS
policy) recorded during
 
a specific period. Excluded
from the calculation are
 
the effects on invested assets
of strategic decisions by UBS to
 
exit markets
 
or
services. Net new money for
 
Global Wealth
Management is disclosed
 
on an annual basis. Net new
money is not measured for
 
Personal & Corporate
Banking.
This measure provides information
 
about the
development of invested assets
 
during a specific
period as a result of net
 
new money flows and
excludes movements due
 
to market performance,
foreign exchange translation,
 
dividends, interest and
fees, as well as the effects on
 
invested assets of
strategic decisions by UBS
 
to exit markets
 
or services.
Net profit growth (%)
Calculated as the change in net profit
 
attributable to
shareholders from continuing
 
operations between
current and comparison
 
periods divided by net profit
attributable to shareholders
 
from continuing
operations of the comparison period.
This measure provides information
 
about profit
growth since the
 
comparison period.
Pre-tax profit growth
 
(%)
Calculated as the change in net profit
 
before tax
attributable to shareholders
 
from continuing
operations between current
 
and comparison periods
divided by net profit before
 
tax attributable to
shareholders from continuing
 
operations of the
comparison period.
This measure provides information
 
about pre-tax
profit growth since the
 
comparison period.
Recurring net fee income
(USD and CHF)
– GWM, P&C
Calculated as the total of
 
fees for services provided on
an ongoing basis, such as portfolio management
 
fees,
asset-based investment fund fees and
 
custody fees,
which are generated on
 
client assets, and
administrative fees for accounts.
This measure provides information
 
about the amount
of recurring net fee income.
Return on attributed equity (%)
Calculated as annualized business
 
division operating
profit before tax
 
divided by average attributed equity.
This measure provides information
 
about the
profitability of the business
 
divisions in relation to
attributed equity.
Return on common
 
equity tier 1
 
capital (%)
Calculated as annualized net profit
 
attributable to
shareholders divided by average
 
common equity tier 1
capital.
This measure provides information
 
about the
profitability of the business
 
in relation to common
equity tier 1 capital.
Return on equity (%)
Calculated as annualized net profit
 
attributable to
shareholders divided by average equity
 
attributable to
shareholders.
This measure provides information
 
about the
profitability of the business
 
in relation to equity.
Return on leverage ratio denominator,
gross (%)
Calculated as annualized total revenues
 
divided by
average leverage ratio denominator.
This measure provides information
 
about the revenues
of the business in relation to
 
the leverage ratio
denominator.
Return on tangible equity (%)
Calculated as annualized net profit
 
attributable to
shareholders divided by average equity
 
attributable to
shareholders less average
 
goodwill and intangible
assets.
This measure provides information
 
about the
profitability of the business
 
in relation to tangible
equity.
Tangible
 
book value per share
(USD)
Calculated as equity attributable to
 
shareholders less
goodwill and intangible assets divided
 
by the number
of shares outstanding.
This measure provides information
 
about tangible net
assets on a per-share basis.
Total
 
book value per share
 
(USD)
Calculated as equity attributable to
 
shareholders
divided by the number of shares
 
outstanding.
This measure provides information
 
about net assets
on a per-share
 
basis.
Transaction-based
 
income
 
(USD and CHF)
– GWM, P&C
Calculated as the total of
 
the non-recurring portion of
net fee and commission income, mainly
 
composed of
brokerage and
 
transaction-based investment fund
fees, and credit
 
card fees, as well as fees for payment
and foreign exchange transactions,
 
together with
other net income from financial
 
instruments
measured at fair value
 
through profit or loss.
This measure provides information
 
about the amount
of the non-recurring portion
 
of net fee and
commission income, together
 
with other net income
from financial instruments
 
measured at fair value
through profit or loss.
 
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
85
 
 
Abbreviations frequently
 
used in our financial
 
reports
 
A
ABS
 
asset
-
backed securities
 
AGM
 
Annual General
 
Meeting of
shareholders
A
-
IRB
 
advanced internal ratings
-
based
AIV
 
alternative investment
vehicle
ALCO
 
Asset and Liability
Committee
AMA
 
advanced measurement
approach
AML
 
anti
-
money laundering
 
AoA
 
Articles of Association
 
APM
 
alternative performance
measure
ARR
 
alternative reference
 
rate
 
ARS
 
auction rate securities
 
ASF
 
available stable
 
funding
 
AT1
 
additional tier 1
 
AuM
 
assets under manage
ment
 
 
B
BCBS
 
Basel Committee
 
on
Banking Supervision
BIS
 
Bank for International
Settlements
BoD
 
Board of Directors
 
 
C
CAO
 
Capital Adequacy
Ordinance
CCAR
 
Comprehensive
 
Capital
Analysis and
 
Review
CCF
 
credit conversion
 
factor
 
CCP
 
central
counterparty
 
CCR
 
counterparty credit risk
 
CCRC
 
Corporate Culture
 
and
Responsibility
 
Committee
CDS
 
credit default swap
 
CEA
 
Commodity Exchange Act
 
CEO
 
Chief Executive Officer
 
CET1
 
common equity tier 1
 
CFO
 
Chief Financial
 
Officer
 
CFTC
 
US Commodity
Futures
Trading
 
Commission
CGU
 
cash
-
generating unit
 
CHF
 
Swiss franc
 
CIO
 
Chief Investment Office
 
CLS
 
Continuous Linked
Settlement
C&ORC
 
Compliance &
 
Operational
Risk Control
CRD IV
 
EU Capital Requirements
Directive of 2013
CRM
 
credit risk mitigation
 
(credi
t
risk) or comprehensive
 
risk
measure (market
 
risk)
CST
 
combined stress test
 
CUSIP
 
Committee on Uniform
Security Identification
Procedures
CVA
 
credit valuation adjustment
 
 
D
DBO
 
defined benefit obligation
 
DCCP
 
Deferred Contingent
Capital Plan
 
DM
 
discount
margin
 
DOJ
 
US Department of
 
Justice
 
DTA
 
deferred tax asset
 
DVA
 
debit valuation adjustment
 
 
E
EAD
 
exposure at default
 
EB
 
Executive Board
 
EC
 
European Commission
 
ECB
 
European Central
 
Bank
 
ECL
 
expected credit loss
 
EGM
 
Extraordinary General
Meeting of shareholders
EIR
 
effective interest
 
rate
 
EL
 
expected loss
 
EMEA
 
Europe, Middle
 
East and
Africa
EOP
 
Equity Ownership Plan
 
EPS
 
earnings per share
 
ESG
 
environmental, social
 
and
governance
ETD
 
exchange
-
traded derivatives
 
ETF
 
exchange
-
traded fund
 
EU
 
European Union
 
EUR
 
euro
 
EURIBOR
 
Euro Interbank Offered
 
Rate
 
ESR
 
environmental and
 
social
risk
EVE
 
economic value of equity
 
EY
 
Ernst & Young
 
Ltd
 
 
F
FA
 
financial advisor
 
FCA
 
UK Financial Conduct
Authority
FCT
 
foreign currency
 
translation
 
FINMA
 
Swiss Financia
l Market
Supervisory Authority
FMIA
 
Swiss Financial
 
Market
Infrastructure Act
FSB
 
Financial Stability
 
Board
 
FTA
 
Swiss Federal Tax
Administration
FVA
 
funding valuation
adjustment
FVOCI
 
fair value through other
comprehensive income
FVTPL
 
fair value
through profit or
loss
FX
 
foreign exchange
 
 
G
GAAP
 
generally accepted
accounting principles
GBP
 
pound sterling
 
GCRG
 
Group Compliance,
Regulatory & Governance
GDP
 
gross domestic product
 
GEB
 
Group Executive Board
 
GHG
 
greenhouse gas
 
GIA
 
Group Internal Audit
 
G
MD
 
Group Managing
 
Director
 
GRI
 
Global Reporting Initiative
 
G
-
SIB
 
global systemically
important bank
 
H
Hong K
ong
 
Hong Kong Special
 
SAR
 
Administrative Region
 
of
the People’s Republic
 
of
 
China
 
HQLA
 
high-quality liquid
 
assets
 
I
IAS
 
International Accounting
Standards
IASB
 
International Accounting
Standards Board
IBOR
 
interbank offered
 
rate
 
IFRIC
 
International Financial
Reporting Interpretations
Committee
IFRS
 
International Financial
Reporting Standards
IRB
 
internal
ratings
-
based
 
IRRBB
 
interest rate risk in
 
the
banking book
ISDA
 
International Swaps and
Derivatives Association
ISIN
 
International Securities
Identification Number
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
86
 
 
Abbreviations frequently
 
used in our
 
financial reports
 
(continued)
 
K
KRT
 
Key Risk Taker
 
 
L
LAS
 
liquidity
-
adjusted stress
 
LCR
 
liquidity coverage
 
ratio
 
LGD
 
loss given default
 
LIBOR
 
London Interbank Offered
Rate
LLC
 
limited liability company
 
LoD
 
lines of defense
 
LRD
 
leverage ratio denominator
 
LTIP
 
Long
-
Term
 
Incentive Plan
 
LTV
 
loan
-
to
-
value
 
 
M
M&A
 
mergers and acquisitions
 
MiFID II
 
Markets in Financial
Instruments Directive II
MRT
 
Material Risk
 
Taker
 
 
N
NAV
 
net
asset value
 
NII
 
net interest income
 
NSFR
 
net stable funding ratio
 
NYSE
 
New York Stock
 
Exchange
 
 
O
OCA
 
own credit adjustment
 
OCI
 
other comprehensive
income
ORF
 
operational risk
 
framework
 
OTC
 
over
-
the
-
counter
 
 
P
PD
 
probability of default
 
PIT
 
point in time
 
P
&L
 
profit or loss
 
POCI
 
purchased or originated
credit-impaired
PRA
 
UK Prudential Regulation
Authority
 
PRV
 
positive replacement
 
value
 
R
RBA
 
role
-
based allowance
 
RBC
 
risk
-
based capital
 
RbM
 
risk
-
based monitoring
 
REIT
 
real estate investment
 
trust
 
RMBS
 
residential
 
mortgage
-
backed securities
RniV
 
risks not in VaR
 
RoCET1
 
return on CET1 capital
 
RoTE
 
return on tangible equity
 
RoU
 
right
-
of
-
use
 
rTSR
 
relative total shareholder
return
RWA
 
risk
-
weighted assets
 
 
S
SA
 
standardized approach
 
SA
-
CCR
 
standardized approach
 
for
counterparty credit risk
SAR
 
Special Administrative
Region
SBC
 
Swiss Bank Corporation
 
SDG
 
Sustainable
 
Development
Goal
SE
 
structured entity
 
SEC
 
US Securities
 
and Exchange
Commission
SEEOP
 
Senior Executive Equity
Ownership Plan
 
SFT
 
securities financing
transaction
SI
 
sustainable
 
investing or
 
 
sustainable
 
investments
 
SIBOR
 
Singapore Interbank
Offered Rate
SICR
 
significant increase
 
in credit
risk
SIX
 
SIX Swiss Exchange
 
SME
 
small and medium
-
sized
entities
SMF
 
Senior Management
Function
SNB
 
Swiss National
 
Bank
 
SOR
 
Singapore Swap
 
Offer Rate
 
SPPI
 
solely payments
 
of principal
and interest
SRB
 
systemically relevant
 
bank
 
SRM
 
specific risk measure
 
SVaR
 
stressed value
-
at
-
risk
 
T
TBTF
 
too big to fail
 
TCFD
 
Task
 
Force on
Climate
-
related Financial
 
Disclosures
TIBOR
 
Tokyo
 
Interbank Offered
Rate
TLAC
 
total loss
-
absorbing capacity
 
 
U
UoM
 
units of measure
 
USD
 
US dollar
 
 
V
VaR
 
value
-
at
-
risk
 
VAT
 
value added tax
 
 
 
 
 
This is a
 
general list
 
of the
 
abbreviations
 
frequently
 
used in
 
our financial
 
reporting.
 
Not all of
 
the listed
 
abbreviations
may appear in this particular
 
report.
 
 
 
 
 
Second quarter 2022 report
 
|
Appendix
 
87
 
Information sources
 
Reporting publications
Annual publications
Annual Report
 
(SAP No.
 
80531): Published
 
in English,
 
this single-volume
 
report provides
 
descriptions
 
of: our Group
strategy
 
and
 
performance;
 
the
 
strategy
 
and
 
performance of
 
the
 
business
 
divisions
 
and
 
Group
 
Functions; risk,
treasury
 
and
 
capital
 
management;
 
corporate
 
governance,
 
corporate
 
responsibility
 
and
 
our
 
compensation
framework, including information about compensation
 
for the Board of Directors and the Group Executive Board
members; and financial
 
information, including the
 
financial statements.
 
Geschäftsbericht
 
(SAP
 
No. 80531):
 
This publication
 
provides
 
a German
 
translation
 
of selected
 
sections
 
of our
 
Annual
Report.
 
Annual Review (SAP No. 80530):
 
This booklet contains key
 
information about our
 
strategy and performance, with
a focus on corporate responsibility
 
at UBS. It is published
 
in English, German,
 
French and Italian.
 
Compensation
 
Report
 
(SAP
 
No.
 
82307):
 
This
 
report
 
discusses
 
our
 
compensation
 
framework
 
and
 
provides
information about
 
compensation
 
for the Board
 
of Directors
 
and the Group
 
Executive Board members.
 
It is available
in English and German.
Quarterly publications
 
The quarterly financial report provides an update on our strategy and performance
 
for the respective quarter. It is
available in English.
How to order publications
The annual
 
and quarterly publications are
 
available in a
 
fully digital and
 
.pdf format at
ubs.com/investors
, under
“Financial information.”
 
Printed copies of
 
our Annual Report
 
(in English) and our
 
Compensation Report (in
 
English
and German),
 
as well as
 
a German translation of
 
selected sections of our Annual Report,
 
can be requested from
UBS
 
free
 
of
 
charge.
 
For
 
annual
 
publications,
 
refer
 
to
 
the
 
“Investor
 
services”
 
section
 
at
ubs.com/investors.
Alternatively, they
 
can be
 
ordered by
 
quoting the
 
SAP number
 
and the
 
language preference,
 
where applicable,
 
from
UBS AG, F4UK–AUL, P.O.
 
Box, CH-8098 Zurich,
 
Switzerland.
 
Other information
Website
The “Investor
 
Relations”
 
website at
ubs.com/investors
 
provides
 
the following
 
information
 
about
 
UBS: results-related
news
 
releases;
 
financial
 
information,
 
including
 
results-related
 
filings
 
with
 
the
 
US
 
Securities
 
and
 
Exchange
Commission (the SEC);
 
information for
 
shareholders,
 
including UBS
 
share price charts,
 
as well as
 
data and dividend
information,
 
and for
 
bondholders; our
 
corporate calendar; and
 
presentations by management
 
for investors
 
and
financial analysts. Information
 
is available online
 
in English, with some
 
information also available
 
in German.
Results presentations
Our quarterly results
 
presentations are webcast live.
 
Recordings of
 
most presentations can
 
be downloaded from
ubs.com/presentations
.
Messaging service
Email
 
alerts
 
to
 
news
 
about UBS
 
can be
 
subscribed for
 
under “UBS
 
News Alert”
 
at
ubs.com/global/en/investor-
relations/contact/investor-services.html
. Messages are
 
sent in English, German, French
 
or Italian, with an option to
select theme preferences
 
for such alerts.
Form 20-F and other
 
submissions
 
to the US Securities and
 
Exchange Commission
We file periodic
 
reports and submit other information about UBS to
 
the SEC. Principal among these filings
 
is the
annual report on
 
Form 20-F, filed pursuant to
 
the US Securities Exchange Act of 1934.
 
The filing of Form 20
 
-F is
structured as
 
a wraparound document. Most
 
sections of the
 
filing can
 
be satisfied
 
by referring to
 
the combined
UBS Group
 
AG and
 
UBS AG
 
annual
 
report. However,
 
there is
 
a small
 
amount
 
of additional
 
information
 
in Form
 
20-F
that is not presented elsewhere and is particularly targeted at readers in
 
the US. Readers are encouraged to refer
to this
 
additional disclosure. Any document that
 
we file with
 
the SEC is
 
available on the
 
SEC’s website:
sec.gov
.
Refer to
ubs.com/investors
 
for more information.
 
 
 
Second quarter 2022 report
 
|
Appendix
 
88
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cautionary Statement
 
Regarding Forward
 
-Looking Statements |
 
This report
 
contains statements that constitute
 
“forward-looking statements,”
 
including
but not limited
 
to management’s outlook
 
for UBS’s financial
 
performance, statements
 
relating to the
 
anticipated effect
 
of transactions
 
and strategic initiatives
on UBS’s
 
business and
 
future development
 
and goals
 
or intentions
 
to achieve
 
climate, sustainability
 
and other
 
social
 
objectives. Wh
 
ile these
 
forward-looking
statements
 
represent
 
UBS’s judgments,
 
expectations
 
and objectives
 
concerning
 
the matters
 
described,
 
a number
 
of risks,
 
uncertainties
 
and other
 
important
factors could
 
cause actual
 
developments and
 
results to
 
differ materially
 
from UBS’s
 
expectations. Russia’s
 
invasion of
 
Ukraine
 
has led
 
to heightened
 
volatility
across global
 
markets, to the coordinated
 
implementation of sanctions
 
on Russia and Belarus,
 
Russian and Belarusian
 
entities and nationals,
 
and to heightened
political tensions across the
 
globe. In addition, the war
 
has caused significant population
 
displacement, and if the conflict
 
continues, the scale
 
of disruption will
increase
 
and may
 
come to
 
include wide
 
-scale shortages
 
of vital
 
commodities,
 
including causing
 
food insecurity.
 
The speed
 
of implementation
 
and extent
 
of
sanctions, as
 
well as the
 
uncertainty as to
 
how the
 
situation will
 
develop, may
 
have significant
 
adverse effects
 
on the market
 
and macroeconomic
 
conditions,
including in ways that
 
cannot be anticipated.
 
This creates significantly
 
greater uncertainty about
 
forward-looking statements.
 
Other factors that may
 
affect our
performance and
 
ability to achieve
 
our plans, outlook
 
and other objectives
 
also include, but
 
are not limited
 
to: (i) the degree
 
to which
 
UBS is successful
 
in the
ongoing execution of its strategic plans, including its cost reduction and efficiency initiatives and its ability to
 
manage its levels of risk-weighted assets (RWA) and
leverage ratio denominator (LRD), liquidity coverage ratio and other financial resources, including changes in RWA assets and liabilities arising from higher market
volatility;
 
(ii)
 
the
 
degree
 
to
 
which
 
UBS
 
is
 
successful
 
in
 
implementing
 
changes to
 
its
 
businesses
 
to
 
meet
 
changing
 
market,
 
regulatory
 
and
 
other
 
conditions;
(iii) increased interest
 
rate volatility in major markets; (iv) developments in the macroeconomic climate
 
and in the markets in which UBS operates
 
or to which it is
exposed, including
 
movements in
 
securities prices
 
or liquidity,
 
credit spreads,
 
and currency
 
exchange
 
rates, and the
 
effects of
 
economic
 
conditions, including
increasing inflationary
 
pressures, market
 
developments, and increasing
 
geopolitical tensions, and
 
changes to national
 
trade policies on
 
the financial position
 
or
creditworthiness
 
of UBS’s clients
 
and counterparties,
 
as well as
 
on client
 
sentiment and levels
 
of activity,
 
including the
 
COVID-19 pandemic
 
and the measures
taken to manage it, which have had and may also continue to have a significant adverse effect on global and regional economic activity,
 
including disruptions to
global supply
 
chains and
 
labor market
 
displacements; (v) changes
 
in the availability
 
of capital
 
and funding,
 
including any changes
 
in UBS’s credit
 
spreads and
ratings, as
 
well as
 
availability and
 
cost of funding
 
to meet
 
requirements
 
for debt eligible
 
for total
 
loss-absorbing capacity
 
(TLAC); (vi)
 
changes in
 
central bank
policies or
 
the implementation
 
of financial legislation
 
and regulation in
 
Switzerland, the
 
US, the UK,
 
the European Union and
 
other financial centers
 
that have
imposed, or resulted
 
in, or may do so in the
 
future, more stringent or entity
 
-specific capital, TLAC, leverage
 
ratio, net stable funding ratio,
 
liquidity and funding
requirements, heightened
 
operational resilience requirements,
 
incremental tax requirements,
 
additional levies, limitations
 
on permitted
 
activities, constraints on
remuneration, constraints
 
on transfers of capital
 
and liquidity and
 
sharing of operational
 
costs across the Group
 
or other measures,
 
and the effect these
 
will or
would have
 
on UBS’s business activities;
 
(vii) UBS’s ability to
 
successfully implement
 
resolvability and related
 
regulatory requirements
 
and the potential
 
need to
make further changes
 
to the legal structure
 
or booking model of UBS
 
Group in response to
 
legal and regulatory requirements,
 
or other external
 
developments;
(viii)
 
UBS’s ability
 
to maintain
 
and improve
 
its systems
 
and controls
 
for complying
 
with sanctions
 
in a
 
timely manner
 
and for
 
the detection
 
and prevention
 
of
money
 
laundering
 
to meet
 
evolving
 
regulatory
 
requirements
 
and
 
expectations,
 
in
 
particular
 
in
 
current
 
geopolitical
 
turmoil;
 
(ix)
 
the
 
uncertainty
 
arising
 
from
domestic stresses in certain
 
major economies; (x) changes in
 
UBS’s competitive position, including
 
whether differences in regulatory capital
 
and other requirements
among the major financial centers adversely affect UBS’s ability to compete in certain lines of business; (xi) changes in
 
the standards of conduct applicable to our
businesses
 
that may
 
result
 
from new
 
regulations
 
or new
 
enforcement
 
of existing
 
standards,
 
including measures
 
to impose
 
new and
 
enhanced
 
duties when
interacting with customers and in the execution and handling
 
of customer transactions; (xii) the liability to which UBS may be exposed,
 
or possible constraints or
sanctions
 
that
 
regulatory
 
authorities
 
might
 
impose
 
on
 
UBS,
 
due
 
to
 
litigation,
 
contractual
 
claims
 
and
 
regulatory
 
investigations,
 
including
 
the
 
potential
 
for
disqualification
 
from
 
certain
 
businesses,
 
potentially
 
large
 
fines
 
or monetary
 
penalties,
 
or
 
the
 
loss
 
of licenses
 
or privileges
 
as a
 
result
 
of
 
regulatory
 
or other
governmental sanctions, as
 
well as the effect
 
that litigation, regulatory
 
and similar matters
 
have on the
 
operational risk component
 
of our RWA,
 
as well as
 
the
amount of capital available for
 
return to shareholders; (xiii) the effects on
 
UBS’s cross-border banking
 
business of sanctions, tax or regulatory developments
 
and
of possible changes in UBS’s policies and
 
practices relating to this business; (xiv) UBS’s ability to retain and attract the
 
employees necessary to generate revenues
and to manage,
 
support and control
 
its businesses,
 
which may be affected
 
by competitive
 
factors; (xv) changes
 
in accounting
 
or tax standards
 
or policies, and
determinations
 
or interpretations
 
affecting the
 
recognition of gain
 
or loss, the
 
valuation of goodwill,
 
the recognition
 
of deferred
 
tax assets and
 
other matters;
(xvi) UBS’s ability to implement new technologies and business methods, including digital services and technologies,
 
and ability to successfully compete with both
existing and
 
new financial
 
service providers,
 
some of
 
which may
 
not be
 
regulated to
 
the same
 
extent;
 
(xvii) limitations
 
on the
 
effectiveness
 
of UBS’s
 
internal
processes for risk management,
 
risk control, measurement and modeling, and of financial models generally;
 
(xviii) the occurrence of operational
 
failures, such as
fraud, misconduct, unauthorized
 
trading, financial crime, cyberattacks, data
 
leakage and systems failures,
 
the risk of which is increased with
 
cyberattack threats
from nation states and while
 
COVID-19 control measures require large portions of the
 
staff of both UBS
 
and its service providers to
 
work remotely; (xix) restrictions
on the ability
 
of UBS Group
 
AG to make payments
 
or distributions, including
 
due to restrictions
 
on the ability of
 
its subsidiaries
 
to make loans
 
or distributions,
directly or indirectly,
 
or, in
 
the case of financial difficulties,
 
due to the exercise
 
by FINMA or the regulators
 
of UBS’s operations in
 
other countries of their broad
statutory powers
 
in relation
 
to protective
 
measures, restructuring
 
and liquidation
 
proceedings;
 
(xx) the degree
 
to which changes
 
in regulation,
 
capital or legal
structure, financial
 
results or
 
other factors may affect
 
UBS’s ability to maintain
 
its stated capital return
 
objective; (xxi) uncertainty
 
over the scope of
 
actions that
may
 
be
 
required
 
by UBS,
 
governments
 
and others
 
to achieve
 
goals relating
 
to climate,
 
environmental
 
and social
 
matters,
 
as well
 
as the
 
evolving nature
 
of
underlying science and
 
industry and governmental standards
 
and regulations; and
 
(xxii) the effect that these
 
or other factors or unanticipated
 
events may have
on our reputation and the additional consequences that this may have on our business and performance. The sequence in which the factors above are presented
is not indicative of their likelihood of occurrence or the potential magnitude of
 
their consequences. Our business and financial performance could be affected by
other factors identified in our past and future filings and reports, including those filed with
 
the US Securities and Exchange Commission (the SEC). More detailed
information about those
 
factors is set forth in documents furnished by
 
UBS and filings made by UBS
 
with the SEC, including UBS’s Annual Report
 
on Form 20-F
for
 
the
 
year
 
ended
 
31 December
 
2021.
 
UBS
 
is
 
not
 
under
 
any obligation
 
to
 
(and
 
expressly
 
disclaims
 
any obligation
 
to) update
 
or alter
 
its
 
forward-looking
statements, whether as a
 
result of new information, future
 
events, or otherwise.
Rounding |
 
Numbers presented throughout this
 
report may not add up precisely to the
 
totals provided in the tables and text. Percentages
 
and percent changes
disclosed in
 
text and tables
 
are calculated
 
on the basis
 
of unrounded
 
figures. Absolute changes
 
between reporting periods
 
disclosed in the
 
text, which
 
can be
derived from numbers presented
 
in related tables, are calculated on a rounded
 
basis.
Tables
 
|
 
Within tables, blank
 
fields generally indicate non
 
-applicability or that presentation
 
of any content would not
 
be meaningful, or
 
that information is not
available as of the
 
relevant date or for the
 
relevant period. Zero values generally
 
indicate that the respective
 
figure is zero
 
on an actual or rounded
 
basis. Values
that are zero on a
 
rounded basis can be either negative or
 
positive on an actual basis.
 
 
 
This Form 6-K
 
is hereby incorporated by reference into
 
(1) each of the registration statements of UBS AG on
 
Form
F-3
 
(Registration Number
 
333-263376), and
 
of UBS
 
Group AG
 
on Form
 
S-8
 
(Registration Numbers
 
333-200634;
333-200635; 333-200641; 333-200665; 333-215254; 333
 
-215255; 333-228653; 333-230312; and 333-249143), and
into
 
each prospectus
 
outstanding under
 
any of
 
the
 
foregoing registration
 
statements,
 
(2) any
 
outstanding offering
circular or similar document issued or authorized by UBS AG that incorporates by reference any Forms
 
6-K
 
of UBS
AG that are incorporated into its registration statements filed with the
 
SEC, and (3) the base prospectus of
 
Corporate
Asset Backed
 
Corporation (“CABCO”)
 
dated
 
June 23,
 
2004
 
(Registration Number
 
333-111572),
 
the Form
 
8-K of
CABCO filed
 
and dated June
 
23, 2004 (SEC
 
File Number 001-13444),
 
and the Prospectus Supplements
 
relating to
the
 
CABCO Series
 
2004-101 Trust
 
dated May
 
10, 2004
 
and May
 
17, 2004
 
(Registration Number
 
033-91744
 
and
033-91744-05).
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this
report to be signed on their behalf by the undersigned, thereunto duly authorized.
 
 
UBS Group AG
 
 
 
By: _/s/
 
Ralph Hamers _______________
Name:
 
Ralph Hamers
Title:
 
Group Chief Executive Officer
 
 
 
By: _/s/ Sarah Youngwood
 
_____________
Name:
 
Sarah Youngwood
Title:
 
Group Chief Financial Officer
 
 
By: _/s/ Christopher Castello
 
___________
 
Name: Christopher Castello
 
 
Title: Group Controller and
 
 
 
Chief Accounting Officer
 
 
 
 
UBS AG
 
 
 
By:
 
/s/ Ralph Hamers ________________
Name:
 
Ralph Hamers
Title:
 
President of the Executive Board
 
 
By:
 
/s/ Sarah Youngwood
 
_____________
Name:
 
Sarah Youngwood
Title:
 
Chief Financial Officer
 
 
By:
 
/s/ Christopher Castello
 
_____
 
Name:
 
Christopher Castello
 
 
Title:
 
Controller and Chief Accounting Officer
 
 
 
 
 
Date:
 
July 26, 2022
 
 
UBS (NYSE:UBS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more UBS Charts.
UBS (NYSE:UBS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more UBS Charts.